We	O
show	O
here	O
that	O
the	O
HIV-1	O
protease	O
can	O
process	O
p105	O
and	O
increases	O
levels	O
of	O
active	O
nuclear	O
NF-kappa	O
B	O
complex	O
.	O

The	O
proximal	O
sequence	O
element	O
(	O
PSE	O
)	O
-binding	O
transcription	O
factor	O
(	O
PTF	O
)	O
,	O
which	O
binds	O
the	O
PSE	O
of	O
both	O
RNA	O
polymerase	O
II-	O
and	O
RNA	O
polymerase	O
III-transcribed	O
mammalian	O
small	O
nuclear	O
RNA	O
(	O
snRNA	O
)	O
genes	O
,	O
is	O
essential	O
for	O
their	O
transcription	O
.	O

We	O
have	O
tried	O
two	O
different	O
insertions	O
of	O
the	O
Dot-Gal4	O
construct	O
.	O

In	O
addition	O
to	O
these	O
diverse	O
approaches	O
,	O
some	O
groups	O
have	O
combined	O
concepts	O
from	O
several	O
of	O
the	O
above	O
categories	O
in	O
integrative	O
frameworks	O
.	O

Cysteine	O
and	O
NAC	O
also	O
inhibit	O
NF-kappa	O
B	O
activity	O
as	O
determined	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
and	O
chloramphenicol	O
acetyl-transferase	O
(	O
CAT	O
)	O
gene	O
expression	O
under	O
control	O
of	O
NF-kappa	O
B	O
binding	O
sites	O
in	O
uninfected	O
cells	O
.	O

ISG15	O
mRNA	O
accumulation	O
in	O
U937	O
cells	O
is	O
not	O
detectable	O
before	O
6	O
h	O
of	O
IFN-alpha	O
treatment	O
,	O
peaks	O
at	O
24	O
h	O
,	O
and	O
requires	O
protein	O
synthesis	O
.	O

N-Acetylcysteine	O
treatment	O
attenuated	O
neutrophil	O
adhesion	O
in	O
both	O
phases	O
,	O
which	O
indicated	O
a	O
role	O
for	O
GSH	O
in	O
the	O
adhesion	O
responses	O
.	O

DNase	O
footprinting	O
analysis	O
corroborated	O
the	O
functional	O
data	O
showing	O
that	O
a	O
lymphoid-specific	O
protein	O
binds	O
to	O
the	O
microB	O
DNA	O
motif	O
.	O

Formation	O
of	O
complex	O
a	O
was	O
cell-type	O
specific	O
and	O
correlated	O
with	O
a	O
high	O
level	O
of	O
transcription	O
.	O

Thus	O
,	O
the	S
GATA-2	S
transcription	S
factor	S
appears	S
to	S
play	S
a	S
role	S
in	S
regulating	S
the	S
self-renewal	S
capacity	S
of	S
early	S
erythroid	S
progenitor	S
cells	S
.	O

Ser	O
in	O
dorsal	O
cells	O
signals	O
across	O
the	O
D-V	O
boundary	O
to	O
activate	O
N	O
in	O
ventral	O
cells	O
[	O
8,9	O
]	O
.	O

TNF-alpha	O
mRNA	O
and	O
release	O
was	O
inhibited	O
even	O
if	O
IL-10	O
was	O
added	O
up	O
to	O
8	O
h	O
after	O
cryptococcal	O
stimulation	O
.	O

Activity	O
against	O
macrovascular	O
EC	O
(	O
HUVEC	O
)	O
and	O
microvascular	O
EC	O
(	O
human	O
bone	O
marrow	O
EC	O
immortalized	O
by	O
SV40	O
)	O
antigens	O
was	O
detected	O
by	O
enzyme-linked	O
immunosorbent	O
assay	O
.	O

Like	O
Drosophila	O
Toll	O
,	O
human	O
Toll	O
is	O
a	O
type	O
I	O
transmembrane	O
protein	O
with	O
an	O
extracellular	O
domain	O
consisting	O
of	O
a	O
leucine-rich	O
repeat	O
(	O
LRR	O
)	O
domain	O
,	O
and	O
a	O
cytoplasmic	O
domain	O
homologous	O
to	O
the	O
cytoplasmic	O
domain	O
of	O
the	O
human	O
interleukin	O
(	O
IL	O
)	O
-1	O
receptor	O
.	O

The	O
EBV-encoded	O
latent	O
membrane	O
protein	O
1	O
is	O
capable	O
of	O
transactivating	O
the	O
isolated	O
CD48	O
NF-kappa	O
B	O
site	O
but	O
not	O
the	O
intact	O
element	O
,	O
suggesting	S
that	S
the	S
latent	S
membrane	S
protein	S
1-driven	S
activation	S
of	S
NF-kappa	S
B/Rel	S
must	S
interact	S
with	S
other	S
regulatory	S
pathways	S
to	S
control	S
expression	S
of	S
cellular	S
genes	S
as	S
EBV	S
drives	S
resting	S
B	S
cells	S
into	S
the	S
cell	S
cycle	S
.	O

It	O
has	O
been	O
thought	S
that	S
the	S
virally	S
induced	S
inhibition	S
of	S
IFN-MCP	S
is	S
secondary	S
to	S
the	S
shutdown	S
of	S
cellular	S
macromolecular	S
synthesis	S
that	S
accompanies	S
cytopathic	S
virus	S
infections	S
.	O

Stable	O
expression	O
of	O
Tax	O
in	O
CTLL-2	O
transformed	O
cell	O
growth	O
from	O
being	O
IL-2	O
dependent	O
to	O
IL-2	O
independent	O
.	O

Concomitant	O
with	O
receptor	O
oligomerization	O
,	O
the	O
IL-1R-associated	O
kinase	O
(	O
IRAK	O
)	O
is	O
recruited	O
to	O
the	O
TLR2	O
complex	O
.	O

Increased	O
levels	O
of	O
replication	O
of	O
the	O
HIV	O
type	O
1	O
are	O
observed	O
after	O
the	O
activation	O
of	O
infected	O
T	O
cells	O
through	O
the	O
TCR	O
.	O

Deranged	O
cellular	O
cholesterol	O
homeostasis	O
has	O
been	O
widely	O
recognized	O
in	O
the	O
initiation	O
as	O
well	O
as	O
progression	O
of	O
various	O
types	O
of	O
cancers	O
including	O
chronic	O
myeloid	O
leukaemia	O
(	O
CML	O
)	O
.	O

Natori	O
's	O
group	O
showed	O
that	O
proteinase	O
cathepsin	O
B	O
was	O
released	O
from	O
pupal	O
hemocytes	O
when	O
they	O
interacted	O
with	O
the	O
fat	O
body	O
,	O
and	O
that	O
this	O
enzyme	O
digested	O
the	O
basement	O
membrane	O
of	O
the	O
fat	O
body	O
,	O
causing	O
the	O
tissue	O
to	O
dissociate	O
[	O
38,39	O
]	O
.	O

IL-6	O
increases	O
junB	O
mRNA	O
in	O
a	O
biphasic	O
fashion	O
.	O

Electrophoretic	O
mobility	O
shift	O
and	O
methylation	O
interference	O
analyses	O
demonstrated	O
that	O
EBS1	O
and	O
EBS2	O
are	O
essential	O
for	O
the	O
formation	O
of	O
the	O
NFAT-1	O
and	O
NFIL-2B	O
nuclear	O
protein	O
complexes	O
.	O

Importantly	O
,	O
culture	O
of	O
MM	O
cells	O
with	O
RB	O
antisense	O
,	O
but	O
not	O
RB	O
sense	O
,	O
oligonucleotide	O
(	O
ODN	O
)	O
triggered	O
IL-6	O
secretion	O
and	O
proliferation	O
in	O
MM	O
cells	O
;	O

Sensitivity	O
of	O
this	O
test	O
is	O
not	O
high	O
because	O
many	O
organisms	O
that	O
utilize	O
selenocysteine	O
were	O
below	O
the	O
defined	O
threshold	O
.	O

Human	O
cytomegalovirus	O
binding	O
to	O
human	O
monocytes	O
induces	O
immunoregulatory	O
gene	O
expression	O
.	O

All	O
other	O
DNA	O
and	O
protein	O
sequences	O
were	O
accessed	O
from	O
GenBank	O
(	O
NCBI	O
)	O
through	O
the	O
server	O
at	O
http	O
:	O
//www.ncbi.nih.gov/Genbank/	O
and	O
from	O
Ensembl	O
(	O
EMBL-EBI	O
and	O
Sanger	O
Institute	O
)	O
via	O
the	O
server	O
at	O
http	O
:	O
//www.ensembl.org	O
.	O

Although	O
Stat	O
binding	O
to	O
the	O
intracellular	O
domain	O
of	O
the	O
cytokine	O
receptor	O
strongly	O
depends	O
on	O
the	O
phosphotyrosine	O
residue	O
,	O
the	O
recruitment	O
of	O
a	O
specific	O
Stat	O
protein	O
is	O
dictated	O
by	O
amino	O
acid	O
residues	O
C-terminal	O
to	O
the	O
phosphotyrosine	O
.	O

Epitope	O
enhancement	O
was	O
used	O
to	O
confirm	O
the	O
strict	O
lineage-	O
and	O
stage-specific	O
expression	O
of	O
MNDA	O
in	O
bone	O
marrow	O
as	O
well	O
as	O
in	O
other	O
paraffin-embedded	O
fixed	O
tissues	O
.	O

Transcriptional	O
activation	O
by	O
the	O
RFX5	O
fusion	O
protein	O
could	O
be	O
restored	O
in	O
RJ2.2.5	O
by	O
cotransfection	O
with	O
a	O
CIITA	O
expression	O
plasmid	O
.	O

IL-10	O
is	O
a	O
well-known	O
immunosuppressive	O
and/or	O
anti-inflammatory	O
cytokine	O
.	O

Here	O
,	O
using	O
the	O
murine	O
B-cell	O
lymphoma	O
cell	O
line	O
A20	O
,	O
we	O
show	O
that	O
the	O
TNF-alpha	O
gene	O
is	O
regulated	O
in	O
a	O
cell-type-specific	O
manner	O
.	O

The	O
interleukin-1	O
receptor	O
type	O
I	O
(	O
IL-1RI	O
)	O
is	O
associated	O
with	O
other	O
proteins	O
thus	O
forming	O
a	O
complex	O
system	O
by	O
which	O
IL-1	O
exerts	O
its	O
various	O
signals	O
.	O

These	O
data	O
identify	O
LDL	O
as	O
a	O
VCAM-inducer	O
possibly	S
distinct	S
from	S
cytokines	S
and	S
endotoxin	S
.	O

Here	O
,	O
we	O
describe	O
the	O
characterization	O
of	O
an	O
alternatively	O
spliced	O
variant	O
of	O
Spi-B	O
,	O
named	O
deltaSpi-B	O
,	O
which	O
has	O
lost	O
the	O
Ets	O
domain	O
.	O

Motif	O
model	O
abbreviations	O
:	O
cons	O
=	O
consensus	O
;	O
PWM	O
=	O
position	O
weight	O
matrix	O
;	O
mis	O
=	O
consensus	O
with	O
predefined	O
number	O
of	O
allowed	O
non-position-specific	O
mismatches	O
.	O

We	O
demonstrate	O
that	O
,	O
in	O
normal	O
human	O
T	O
cells	O
,	O
an	O
AP-1	O
protein	O
is	O
a	O
component	O
of	O
the	O
NF-AT	O
protein	O
complex	O
.	O

The	O
29-kDa	O
proteins	O
phosphorylated	O
in	O
thrombin-activated	O
human	O
platelets	O
are	O
forms	O
of	O
the	O
estrogen	O
receptor-related	O
27-kDa	O
heat	O
shock	O
protein	O
.	O

In	O
this	O
review	O
,	O
I	O
describe	O
how	O
DNA	O
methylation	O
and	O
specific	O
DNA	O
binding	O
proteins	O
may	S
regulate	S
transcription	S
of	S
the	S
IFN-gamma	S
gene	S
in	S
response	S
to	S
extracellular	S
signals	S
.	O

This	O
indicated	S
that	S
the	S
EKLF-/-	S
erythrocytes	S
in	S
adult	S
animals	S
must	S
be	S
short-lived	S
,	S
apparently	S
due	S
to	S
the	S
imbalance	S
of	S
beta-	S
versus	S
alpha-globin	S
chains	S
,	S
leading	S
to	S
the	S
precipitation	S
of	S
excess	S
alpha-globin	S
chains	S
to	S
form	S
Heinz	S
bodies	S
.	O

Treatment	O
with	O
soluble	O
,	O
bivalent	O
mAb	O
J393	O
killed	O
25-50	O
%	O
of	O
the	O
cell	O
population	O
,	O
while	O
concomitant	O
engagement	O
of	O
either	O
the	O
CD3.TcR	O
complex	O
or	O
the	O
integrins	O
CD18	O
and	O
CD29	O
significantly	O
potentiated	O
this	O
effect	O
.	O

The	O
0.2-kb	O
IRF-CAT	O
construct	O
was	O
induced	O
by	O
PRL	O
stimulation	O
during	O
the	O
G1	O
phase	O
of	O
the	O
cell	O
cycle	O
.	O

Moreover	O
,	O
the	O
DCCs	O
can	O
spread	O
,	O
by	O
several	O
hundred	O
kilobases	O
,	O
into	O
neighboring	O
autosomal	O
DNA	O
.	O

To	O
compare	O
our	O
predictions	O
to	O
these	O
datasets	O
,	O
we	O
consider	S
that	S
two	S
genes	S
interact	S
if	S
at	S
least	S
one	S
of	S
their	S
respective	S
protein	S
products	S
interact	S
.	O

Furthermore	O
,	O
NF-kappaB	O
transcriptional	O
factor	O
of	O
aggregated	O
cells	O
had	O
approximately	O
40-fold	O
higher	O
activity	O
than	O
that	O
of	O
parental	O
cells	O
.	O

Together	O
,	O
these	O
findings	O
suggest	S
that	S
one	S
function	S
of	S
c-Rel	S
is	S
as	S
a	S
physiologic	S
repressor	S
of	S
the	S
HIV-1	S
LTR	S
and	S
IL-2R	S
alpha	S
promoters	S
,	S
serving	S
to	S
efficiently	S
counter	S
the	S
strong	S
transcriptional	S
activating	S
effects	S
of	S
p65	S
.	O

These	O
proteins	O
are	O
differentially	O
expressed	O
in	O
human	O
glioblastoma	O
and	O
neuroblastoma	O
cell	O
lines	O
.	O

OBJECTIVE	O
:	O
To	O
create	O
monoclonal	O
anti-endothelial	O
cell	O
antibodies	O
(	O
mAECA	O
)	O
from	O
a	O
patient	O
with	O
Takayasu	O
arteritis	O
to	O
evaluate	O
their	O
ability	O
to	O
activate	O
human	O
umbilical	O
vein	O
endothelial	O
cells	O
(	O
HUVEC	O
)	O
,	O
and	O
to	O
characterize	O
the	O
mechanism	O
of	O
EC	O
activation	O
.	O

Levels	O
of	O
FOSB	O
mRNA	O
reach	O
a	O
maximum	O
40	O
min	O
after	O
the	O
addition	O
of	O
lectin	O
and	O
decline	O
to	O
control	O
levels	O
over	O
the	O
next	O
6	O
hr	O
.	O

To	O
characterize	O
the	O
human	O
elk-1	O
promoter	O
,	O
we	O
mapped	O
the	O
transcriptional	O
start	O
site	O
and	O
isolated	O
elk-1-specific	O
genomic	O
phage	O
clones	O
that	O
contained	O
extensive	O
upstream	O
and	O
downstream	O
sequences	O
.	O

Stimulation	O
of	O
the	O
latently	O
HIV-infected	O
myelomonocytic	O
cell	O
line	O
OM-10.1	O
with	O
C.	O
neoformans	O
and	O
C.	O
albicans	O
in	O
the	O
presence	O
of	O
pooled	O
human	O
serum	O
caused	O
a	O
ratio-dependent	O
increase	O
in	O
HIV	O
production	O
.	O

Larval	O
hemolymph	O
was	O
collected	O
from	O
several	O
larvae	O
and	O
centrifuged	O
to	O
pellet	O
the	O
hemocytes	O
.	O

Figure	O
7	O
shows	O
the	O
aggregate	O
results	O
of	O
this	O
test	O
,	O
with	O
the	O
SCPD	O
regulons	O
divided	O
into	O
three	O
groups	O
based	O
on	O
SCOPE	O
's	O
accuracy	O
on	O
the	O
true	O
regulon	O
.	O

Heat	O
shock	O
induces	O
HIV-1	O
replication	O
in	O
chronically	O
infected	O
promyelocyte	O
cell	O
line	O
OM10.1	O
.	O

From	O
analyses	O
of	O
mice	O
deficient	O
in	O
transcription	O
factor	O
genes	O
and	O
from	O
the	O
characterizations	O
of	O
chromosome	O
breakpoints	O
in	O
human	O
leukemias	O
,	O
it	O
has	O
become	O
evident	O
that	O
transcription	O
factors	O
are	O
important	O
regulators	O
of	O
hematopoiesis	O
.	O

Our	O
data	O
demonstrate	O
that	O
hydrocortisone	O
induces	O
IkappaB	O
and	O
suppresses	O
NF-kappaB	O
expression	O
in	O
MNC	O
in	O
parallel	O
.	O

The	S
involvement	S
of	S
ion	S
channels	S
in	S
B	S
and	S
T	S
lymphocyte	S
activation	S
is	S
supported	S
by	S
many	S
reports	S
of	S
changes	S
in	S
ion	S
fluxes	S
and	S
membrane	S
potential	S
after	S
mitogen	S
binding	S
.	O

We	O
therefore	O
conclude	O
that	O
D-mib	O
and	O
neur	O
have	O
distinct	O
and	O
complementary	O
functions	O
in	O
Drosophila	O
.	O

This	O
is	O
unavoidable	O
because	O
of	O
the	O
inability	O
of	O
our	O
method	O
to	O
detect	O
species-specific	O
readthrough	O
events	O
.	O

Subsequent	O
cloning	O
of	O
TCF-1	O
identified	O
three	O
splice	O
alternatives	O
.	O

In	O
vivo	O
inhibition	O
of	O
NF-kappa	O
B	O
in	O
T-lineage	O
cells	O
leads	O
to	O
a	O
dramatic	O
decrease	O
in	O
cell	O
proliferation	O
and	O
cytokine	O
production	O
and	O
to	O
increased	O
cell	O
apoptosis	O
in	O
response	O
to	O
mitogenic	O
stimuli	O
,	O
but	O
not	O
to	O
abnormal	O
thymopoiesis	O
.	O

Nuclear	O
factor-kappaB	O
was	O
found	O
to	O
be	O
activated	O
in	O
ventilated	O
macrophages	O
.	O

Although	O
under	O
standard	O
culture	O
conditions	O
,	O
bovine	O
brain	O
gangliosides	O
(	O
100	O
micrograms/ml	O
)	O
suppressed	O
LPS-stimulated	O
TNF	O
production	O
5-fold	O
in	O
PBMC	O
and	O
10-fold	O
in	O
Mono	O
Mac	O
6	O
cells	O
,	O
suppression	O
was	O
more	O
efficient	O
under	O
serum-free	O
conditions	O
.	O

Involvement	O
of	O
the	O
N-terminal	O
region	O
of	O
the	O
human	O
mineralocorticoid	O
receptor	O
hormone-binding	O
domain	O
in	O
agonist	O
and	O
antagonist	O
binding	O
as	O
revealed	O
by	O
a	O
new	O
monoclonal	O
antibody	O
.	O

In	O
conclusion	O
,	O
lysoPC	O
markedly	O
decreases	O
LPS-mediated	O
TF	O
expression	O
of	O
human	O
monocytes	O
,	O
the	O
effect	O
probably	S
being	S
mediated	S
by	S
both	S
transcriptional	S
and	S
posttranscriptional	S
mechanisms	S
.	O

Some	O
subsets	O
of	O
quite	O
high	O
posterior	O
odds	O
have	O
much	O
smaller	O
overlaps	O
with	O
the	O
training	O
set	O
.	O

The	O
complexes	O
detected	O
in	O
electrophoretic	O
mobility	O
shift	O
assays	O
contain	O
p50	O
,	O
p65	O
(	O
RelA	O
)	O
,	O
c-Rel	O
,	O
and	O
most	O
likely	S
other	S
components	S
.	O

D-mib	O
(	O
E	O
)	O
and	O
Ser	O
(	O
F	O
)	O
mutant	O
flies	O
showed	O
similar	O
wing	O
loss	O
phenotypes	O
.	O

Both	O
HIV-2	O
and	O
CMV	O
transactivators	O
enhance	O
HIV-2	O
gene	O
expression	O
by	O
transcriptional	O
activation	O
involving	O
transcript	O
initiation	O
as	O
well	O
as	O
elongation	O
,	O
with	O
CMV	O
transactivator	O
affecting	O
elongation	O
more	O
than	O
the	O
initiation	O
.	O

T3SO4	O
had	O
no	O
thyromimetic	O
effect	O
on	O
the	O
activity	O
of	O
Ca	O
(	O
2+	O
)	O
-ATPase	O
in	O
human	O
erythrocyte	O
membranes	O
at	O
doses	O
up	O
to	O
10,000	O
times	O
the	O
maximally	O
effective	O
dose	O
of	O
T3	O
(	O
10	O
(	O
-10	O
)	O
mol/L	O
)	O
.	O

Multiple	O
Alignment	O
of	O
the	O
RAG1	O
Core	O
and	O
RAG1	O
Core–Like	O
Proteins	O
Encoded	O
by	O
the	O
Sea	O
Urchin	O
and	O
Lancelet	O
Genomes	O

Unexpectedly	O
,	O
stimulation	O
of	O
cloned	O
stably	O
transfected	O
Jurkat	O
T	O
cells	O
leads	O
to	O
a	O
bimodal	O
pattern	O
of	O
beta-gal	O
expression	O
in	O
which	O
some	O
cells	O
express	O
no	O
beta-gal	O
and	O
others	O
express	O
high	O
levels	O
.	O

The	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
)	O
and	O
HTLV-II	O
Tax	O
proteins	O
are	O
potent	O
transactivators	O
of	O
viral	O
and	O
cellular	O
gene	O
expression	O
.	O

Crystal	O
Cells	O
in	O
Late	O
Third	O
Instar	O
Larvae	O

In	O
contrast	O
to	O
IL-2	O
and	O
IFN-alpha	O
,	O
IL-12	O
induced	O
strong	O
tyrosine	O
phosphorylation	O
of	O
STAT4	O
and	O
variable	O
weak	O
phosphorylation	O
of	O
STAT3	O
.	O

To	O
discriminate	O
them	O
from	O
true	O
readthrough	O
genes	O
,	O
evolutionary	O
information	O
was	O
exploited	O
.	O

Bar	O
is	O
50	O
μm	O
in	O
(	O
B–E	O
)	O
and	O
20	O
μm	O
in	O
(	O
F	O
and	O
F	O
'	O
)	O
.	O

Here	O
we	O
summarize	O
the	O
importance	O
of	O
the	O
IgH	O
3'LCR	O
and	O
its	O
putative	S
functional	S
role	S
in	S
IgH	S
gene	S
expression	S
and	O
compare	O
it	O
with	O
the	O
5'LCR	O
regulatory	O
region	O
of	O
the	O
human	O
beta-globin	O
locus	O
.	O

4	O
)	O
Predictors	O
based	O
on	O
functional	O
features	O
exploit	O
non-sequence	O
information	O
to	O
infer	O
interactions	O
.	O

The	O
probability	O
of	O
the	O
observed	O
match	O
between	O
the	O
RSS	O
and	O
Transib	O
termini	O
to	O
occur	O
by	O
chance	O
is	O
less	O
than	O
10-3	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

Binding	O
of	O
superantigens	O
to	O
MHC	O
class	O
II	O
molecules	O
results	O
in	O
transduction	O
of	O
biochemical	O
signals	O
leading	O
to	O
cellular	O
activation	O
and	O
gene	O
expression	O
.	O

For	O
complexes	O
with	O
known	O
structure	O
,	O
it	O
has	O
been	O
shown	O
that	O
domains	O
can	O
mediate	O
interactions	O
1112	O
.	O

Interestingly	O
,	O
all	O
of	O
those	O
events	O
were	O
largely	O
indirect	O
and	O
mediated	O
by	O
endogenously	O
secreted	O
tumor	O
necrosis	O
factor	O
alpha	O
(	O
TNF	O
alpha	O
)	O
,	O
as	O
they	O
were	O
strongly	O
inhibited	O
by	O
a	O
neutralizing	O
anti-TNF	O
alpha	O
monoclonal	O
antibody	O
.	O

It	O
is	O
known	O
that	O
the	O
expression	O
levels	O
of	O
intercellular	O
adhesion	O
molecule-1	O
(	O
ICAM-1	O
)	O
in	O
adult	O
T	O
cell	O
leukemia	O
(	O
ATL	O
)	O
cells	O
are	O
high	O
,	O
whereas	O
those	O
in	O
T-lymphoid	O
cells	O
are	O
not	O
.	O

ROC50	O
and	O
ROC100	O
curves	O
were	O
selected	O
as	O
they	O
consider	O
a	O
large	O
enough	O
number	O
of	O
positives	O
to	O
include	O
all	S
protein	S
pairs	S
predicted	S
to	S
have	S
a	S
posterior	S
odds	S
ratio	S
above	S
1.0	S
by	S
all	S
the	S
predictors	S
investigated	S
.	O

Yet	O
these	O
same	O
cells	O
do	O
initiate	O
early	O
TCR-mediated	O
signaling	O
events	O
,	O
such	O
as	O
generation	O
of	O
inositol	O
phosphates	O
and	O
increased	O
intracellular	O
calcium	O
.	O

RNase	O
treatment	O
prior	O
to	O
hybridization	O
considerably	O
reduces	O
the	O
size	O
of	O
this	O
signals	O
.	O

The	O
results	O
show	O
the	O
presence	O
of	O
several	O
NF-kappaB	O
family	O
members	O
,	O
with	O
the	O
transactivating	O
RelA	O
being	O
engaged	O
in	O
multiple	O
complexes	O
.	O

In	O
contrast	O
,	O
a	O
mutant	O
of	O
Tax	O
that	O
selectively	O
fails	O
to	O
activate	O
nuclear	O
NF-kappa	O
B	O
expression	O
does	O
not	O
associate	O
with	O
p100	O
.	O

Two	O
families	O
of	O
transcription	O
factors	O
that	O
are	O
required	O
for	O
normal	O
hematopoiesis	O
are	O
c-Myb	O
and	O
Ets	O
.	O

Stimulation	O
of	O
the	O
CD28	O
cell	O
surface	O
molecule	O
delivers	O
costimulatory	O
signals	O
essential	O
for	O
lymphokine	O
production	O
in	O
activated	O
T	O
cells	O
via	O
a	O
conserved	O
sequence	O
element	O
found	O
in	O
the	O
promoter	O
of	O
several	O
lymphokine	O
genes	O
.	O

Inducible	O
nitric	O
oxide	O
(	O
iNO	O
)	O
is	O
produced	O
at	O
sites	O
of	O
vascular	O
inflammation	O
by	O
resident	O
and	O
nonresident	O
vascular	O
wall	O
cells	O
,	O
but	O
its	S
role	S
in	S
the	S
inflammatory	S
process	S
is	S
not	S
known	S
.	O

To	O
understand	O
the	O
mechanisms	O
underlined	O
in	O
this	O
regulation	O
in	O
normal	O
human	O
cells	O
,	O
we	O
have	O
analysed	O
in	O
vivo	O
protein-DNA	O
interactions	O
at	O
the	O
Cyclin	O
A	O
locus	O
in	O
primary	O
T	O
lymphocytes	O
.	O

Induction	O
of	O
vascular	O
cell	O
adhesion	O
molecule-1	O
by	O
low-density	O
lipoprotein	O
.	O

NF-kappaB	O
in	O
MNC	O
nuclear	O
extracts	O
decreased	O
at	O
1	O
hr	O
,	O
reached	O
a	O
nadir	O
at	O
4	O
hr	O
,	O
gradually	O
increased	O
at	O
8	O
hr	O
and	O
returned	O
back	O
to	O
baseline	O
levels	O
at	O
24	O
hr	O
.	O

Both	O
these	O
responses	O
are	O
inhibited	O
by	O
CsA	O
.	O

Note	O
that	O
sequence	O
conservation	O
near	O
the	O
selenocysteine	O
is	O
comparable	O
to	O
that	O
of	O
the	O
N-terminal	O
cytochrome	O
domain	O
.	O

Nuclear	O
run-on	O
assays	O
and	O
mRNA	O
stability	O
studies	O
demonstrated	O
that	O
M-CSF	O
regulates	O
c-jun	O
expression	O
by	O
both	O
an	O
increase	O
in	O
transcription	O
rate	O
and	O
a	O
prolongation	O
in	O
the	O
half-life	O
of	O
c-jun	O
transcripts	O
.	O

The	O
highly	O
specific	O
granulomonocyte-associated	O
lysosomal	O
proteins	O
myeloperoxidase	O
(	O
MPO	O
)	O
and	O
lysozyme	O
(	O
LZ	O
)	O
,	O
as	O
well	O
as	O
the	O
transcription	O
factor	O
PU.1	O
,	O
were	O
already	O
detectable	O
in	O
the	O
most	O
immature	O
CD34+Thy-1+	O
subset	O
.	O

Among	O
the	O
necessary	O
RSS	O
nucleotides	O
,	O
only	O
one	O
,	O
marked	O
by	O
a	O
+	O
corresponds	O
to	O
a	O
nucleotide	O
that	O
is	O
100	O
%	O
conserved	O
in	O
hAT	O
transposons	O
.	O

In	O
all	O
rescue	O
experiments	O
,	O
30	O
freshly	O
hatched	O
homozygous	O
first-instar	O
larvae	O
were	O
selected	O
using	O
a	O
GFP	O
dissecting	O
microscope	O
and	O
transferred	O
into	O
fresh	O
vials	O
(	O
at	O
least	O
four	O
vials	O
for	O
each	O
variant	O
)	O
.	O

PGG-Glucan	O
,	O
a	O
soluble	O
beta-	O
(	O
1,6	O
)	O
-branched	O
beta-	O
(	O
1,3	O
)	O
-linked	O
glucose	O
homopolymer	O
derived	O
from	O
the	O
cell	O
wall	O
of	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
,	O
is	O
an	O
immunomodulator	O
which	O
enhances	O
leukocyte	O
anti-infective	O
activity	O
and	O
enhances	O
myeloid	O
and	O
megakaryocyte	O
progenitor	O
proliferation	O
.	O

Co-occurrence	O
of	O
domains	O

Meller	O
et	O
al	O
.	O
[	O
1	O
]	O
have	O
now	O
analyzed	O
and	O
compared	O
roX	O
RNA	O
and	O
MSL	O
protein	O
distribution	O
in	O
females	O
ectopically	O
expressing	O
MSL2	O
but	O
lacking	O
other	O
MSL	O
proteins	O
.	O

Add-back	O
experiments	O
with	O
either	O
cytokines	O
(	O
IL-2	O
or	O
IL-6	O
)	O
,	O
LTB4	O
or	O
conditioned	O
media	O
failed	O
to	O
restore	O
the	O
proliferative	O
response	O
in	O
the	O
presence	O
of	O
tepoxalin	O
.	O

Analysis	O
of	O
the	O
inactive	O
X	O
specific	O
methylation	O
at	O
the	O
androgen	O
receptor	O
gene	O
showed	O
unbalanced	O
inactivation	O
in	O
the	O
twins	O
'	O
fibroblasts	O
and	O
in	O
opposite	O
directions	O
.	O

Our	O
data	O
indicate	S
that	S
decrease	S
of	S
ER	S
level	S
in	S
leukocytes	S
may	S
be	S
related	S
to	S
the	S
pathogenesis	S
of	S
type	S
II	S
diabetes	S
in	S
menopausal	S
period	S
.	O

Deletion	O
or	O
substitution	O
of	O
a	O
putative	S
NF-kappaB	S
binding	S
site	S
identified	S
in	S
the	S
bcl-x	S
promoter	S
significantly	O
decreased	O
Tax-induced	O
transactivation	O
.	O

Interestingly	O
,	O
Nmi	O
lacks	O
an	O
intrinsic	O
transcriptional	O
activation	O
domain	O
;	O
instead	O
,	O
Nmi	O
enhances	O
the	O
association	O
of	O
CBP/p300	O
coactivator	O
proteins	O
with	O
Stat1	O
and	O
Stat5	O
,	O
and	O
together	O
with	O
CBP/p300	O
can	O
augment	O
IL-2-	O
and	O
IFNgamma-dependent	O
transcription	O
.	O

Based	O
on	O
the	O
currently	O
available	O
sequence	O
data	O
,	O
we	O
also	O
reconstructed	O
portions	O
of	O
TPases	O
that	O
were	O
missed	O
in	O
previous	O
studies	O
[	O
17	O
]	O
(	O
Materials	O
and	O
Methods	O
;	O
see	O
Figure	O
S2	O
)	O
.	O

Efficient	O
rescue	O
of	O
the	O
defect	O
requires	O
an	O
intact	O
GATA	O
element	O
in	O
the	O
distal	O
promoter	O
,	O
suggesting	S
autoregulatory	S
control	S
of	S
GATA-1	S
transcription	S
.	O

4	O
.	O

Adenosine	O
deaminase	O
(	O
ADA	O
)	O
is	O
an	O
enzyme	O
present	O
in	O
all	O
organisms	O
that	O
catalyzes	O
the	O
irreversible	O
deamination	O
of	O
adenosine	O
and	O
deoxyadenosine	O
to	O
inosine	O
and	O
deoxyinosine	O
.	O

To	O
differentiate	O
whether	S
the	S
RA	S
effect	S
was	S
mediated	S
by	S
RA	S
receptors	S
alpha	S
,	S
beta	S
,	S
and	S
gamma	S
,	O
the	O
expression	O
of	O
the	O
retinoic	O
acid	O
receptors	O
(	O
RAR	O
)	O
was	O
examined	O
by	O
reverse	O
transcriptase-polymerase	O
chain	O
reaction	O
(	O
RT-PCR	O
)	O
.	O

In	O
conclusion	O
,	O
we	O
demonstrate	O
that	O
the	O
vitamin	O
E	O
derivative	O
TCP	O
succinate	O
prevents	O
monocytic	O
cell	O
adhesion	O
to	O
cytokine-stimulated	O
endothelial	O
cells	O
by	O
inhibiting	O
the	O
activation	O
of	O
NF-kappa	O
B	O
,	O
further	O
emphasizing	O
the	O
antiatherosclerotic	O
potential	O
of	O
lipid	O
soluble	O
antioxidants	O
.	O

Dosage	O
compensation	O
,	O
which	O
ensures	O
that	O
the	O
expression	O
of	O
X-linked	O
genes	O
is	O
equal	O
in	O
males	O
and	O
females	O
,	O
is	O
an	O
essential	O
process	O
in	O
organisms	O
that	O
have	O
sex	O
chromosomes	O
.	O

Given	O
the	O
latter	O
observation	O
,	O
we	O
decided	O
to	O
improve	O
the	O
quality	O
of	O
the	O
PSSM	O
constructed	O
by	O
PSI-BLAST	O
for	O
different	O
Transib	O
TPase	O
sequences	O
.	O

Surfactant	O
protein	O
A	O
activates	O
NF-kappa	O
B	O
in	O
the	O
THP-1	O
monocytic	O
cell	O
line	O
.	O

The	O
V	O
(	O
D	O
)	O
J	O
recombination	O
reaction	O
in	O
jawed	O
vertebrates	O
is	O
catalyzed	O
by	O
the	O
RAG1	O
and	O
RAG2	O
proteins	O
,	O
which	S
are	S
believed	S
to	S
have	S
emerged	S
approximately	S
500	S
million	S
years	S
ago	S
from	S
transposon-encoded	S
proteins	S
.	O

The	O
third	O
site	O
was	O
occupied	O
in	O
quiescent	O
cells	O
or	O
in	O
cells	O
stimulated	O
by	O
anti	O
CD2	O
or	O
anti	O
CD28	O
alone	O
.	O

In	O
mammalian	O
cells	O
,	O
I	O
kappa	O
B	O
alpha	O
and	O
I	O
kappa	O
B	O
beta	O
proteins	O
have	O
been	O
purified	O
and	O
shown	O
to	O
be	O
the	O
inhibitors	O
of	O
NF-kappa	O
B	O
through	O
their	O
association	O
with	O
the	O
p65	O
or	O
c-Rel	O
subunits	O
.	O

Nuclear	O
receptors	O
are	O
important	O
regulators	O
of	O
erythroid	O
cell	O
development	O
.	O

Therefore	O
,	O
the	S
unknown	S
amino	S
acid	S
,	S
if	S
it	S
is	S
encoded	S
by	S
a	S
stop	S
codon	S
,	S
is	S
unlikely	S
to	S
exist	S
in	S
the	S
current	S
databases	S
of	S
microbial	S
genomes	S
.	O

RESULTS	O
:	O
Neutrophil	O
adhesion	O
to	O
cultured	O
corneal	O
endothelial	O
cells	O
increased	O
significantly	O
on	O
exposure	O
to	O
TNFalpha	O
(	O
451.4+/-45.4	O
cells/mm2	O
,	O
n	O
=	O
16	O
)	O
compared	O
to	O
control	O
(	O
156.7+/-27.3	O
cells/mm2	O
,	O
n	O
=	O
16	O
,	O
P	O
<	O
0.01	O
)	O
.	O

When	O
protein	O
pairs	O
contained	O
more	O
than	O
one	O
domain	O
pair	O
,	O
the	O
domain	O
pair	O
assigned	O
to	O
the	O
highest	O
Chi-square	O
score	O
bin	O
was	O
used	O
to	O
assign	O
a	O
likelihood	O
of	O
interaction	O
.	O

Increasing	O
the	O
levels	O
of	O
BCL-2	O
retarded	O
the	O
G0	O
--	O
>	O
S	O
transition	O
,	O
sustained	O
the	O
levels	O
of	O
cyclin-dependent	O
kinase	O
inhibitor	O
p27Kip1	O
,	O
and	O
repressed	O
postactivation	O
death	O
.	O

IL-4	O
,	O
another	O
cytokine	O
that	O
inhibits	O
cytokine	O
mRNA	O
accumulation	O
in	O
monocytes	O
,	O
shows	O
little	O
inhibitory	O
effect	O
on	O
LPS-induced	O
NF	O
kappa	O
B	O
activation	O
.	O

DNA	O
binding	O
by	O
in	O
vitro	O
synthesized	O
GR	O
was	O
blocked	O
by	O
the	O
addition	O
of	O
sodium	O
molybdate	O
to	O
the	O
receptor	O
preparations	O
before	O
steroid	O
addition	O
and	O
thermal	O
activation	O
.	O

The	O
29-kDa	O
proteins	O
were	O
confirmed	O
to	O
be	O
phosphorylated	O
forms	O
of	O
HSP27	O
by	O
immunoprecipitation	O
studies	O
.	O

P	O
values	O

We	O
show	O
that	O
increased	O
transcription	O
of	O
the	O
NF-IL6	O
gene	O
is	O
responsible	O
,	O
at	O
least	O
in	O
part	O
,	O
for	O
induction	O
of	O
NF-IL6	O
mRNA	O
following	O
activation	O
of	O
U937	O
promonocytic	O
cells	O
.	O

Two	O
subclones	O
were	O
found	O
to	O
have	O
an	O
abnormal	O
response	O
to	O
the	O
protein	O
kinase	O
C	O
(	O
PKC	O
)	O
activator	O
PMA	O
.	O

Northern	O
blot	O
analysis	O
showed	O
that	O
the	O
cDNA	O
probe	O
hybridized	O
with	O
a	O
4.5	O
kb	O
transcript	O
which	O
is	O
highly	O
inducible	O
in	O
murine	O
T	O
cells	O
.	O

E3	O
transcripts	O
are	O
present	O
in	O
the	O
myeloid	O
,	O
B-lymphoid	O
,	O
and	O
erythroid	O
lineages	O
,	O
absent	O
in	O
nonhematopoietic	O
cells	O
,	O
and	O
encode	O
a	O
highly	O
hydrophobic	O
,	O
potentially	S
phosphorylated	S
polypeptide	O
of	O
unknown	O
function	O
with	O
significant	O
homology	O
to	O
a	O
putative	S
protein	S
expressed	O
in	O
myeloid	O
cells	O
.	O

Overexpression	O
of	O
NF-IL6	O
enhanced	O
expression	O
of	O
the	O
chloramphenicol	O
acetyl	O
transferase	O
reporter	O
gene	O
linked	O
to	O
the	O
PRE-I-thymidine	O
kinase	O
or	O
the	O
human	O
IL-4	O
promoter	O
more	O
than	O
10-fold	O
in	O
Jurkat	O
cells	O
.	O

Further	O
research	O
into	O
more	O
biologically	O
accurate	O
objective	O
functions	O
may	S
yield	S
better	S
performance	S
for	S
motif	S
discovery	S
algorithms	S
.	O

(	O
A	O
)	O
Expression	O
of	O
D-mib	O
(	O
green	O
)	O
in	O
dorsal	O
cells	O
,	O
using	O
Ser-GAL4	O
,	O
rescued	O
the	O
growth	O
of	O
the	O
wing	O
pouch	O
and	O
margin	O
Cut	O
(	O
red	O
)	O
expression	O
in	O
D-mib2/D-mib3	O
mutant	O
discs	O
.	O

The	O
successful	O
detection	O
of	O
many	O
known	O
proteins	O
is	O
encouraging	O
,	O
because	O
our	O
method	O
relies	O
only	O
on	O
general	O
properties	O
of	O
proteins	O
that	O
contain	O
stop-codon-encoded	O
amino	O
acids	O
,	O
but	O
not	O
on	O
specific	O
features	O
of	O
selenocysteine	O
or	O
pyrrolysine	O
.	O

There	O
was	O
only	O
weak	O
inhibition	O
of	O
the	O
generation	O
of	O
enhancing	O
activity	O
by	O
the	O
corticosteroids	O
in	O
the	O
CR	O
asthmatic	O
individuals	O
.	O

Various	O
stimuli	O
,	O
typically	O
those	O
associated	O
with	O
stress	O
or	O
pathogens	O
,	O
rapidly	O
inactivate	O
I	O
kappa	O
B-alpha	O
.	O

Among	O
these	O
hypersensitive	O
sites	O
,	O
two	O
transcriptional	O
control	O
elements	O
were	O
found	O
,	O
one	O
in	O
the	O
first	O
intron	O
of	O
the	O
GATA-3	O
gene	O
and	O
the	O
other	O
between	O
8.3	O
and	O
5.9	O
kilobases	O
5	O
'	O
from	O
the	O
GATA-3	O
transcriptional	O
initiation	O
site	O
.	O

Comparison	O
of	O
a	O
nearly	O
full-length	O
cDNA	O
sequence	O
with	O
the	O
corresponding	O
genomic	O
sequence	O
reveals	O
one	O
small	O
intron	O
and	O
an	O
open	O
reading	O
frame	O
in	O
the	O
second	O
exon	O
.	O

We	O
have	O
examined	O
the	O
effect	O
of	O
Rb	O
expression	O
on	O
the	O
activation	O
of	O
the	O
promoter	O
for	O
HLA-DRA	O
,	O
the	O
prototype	O
class	O
II	O
gene	O
.	O

Both	O
these	O
signals	O
were	O
necessary	O
for	O
expression	O
of	O
the	O
reporter	O
gene	O
.	O

Initial	O
signaling	O
through	O
the	O
CD4	O
receptor	O
played	O
a	O
major	O
role	O
in	O
the	O
sensitization	O
of	O
HIV-infected	O
T	O
cells	O
to	O
undergo	O
apoptosis	O
.	O

(	O
B	O
)	O
Alignment	O
of	O
the	O
predicted	O
protein	O
and	O
human	O
RAG1	O
(	O
29	O
%	O
identity	O
,	O
E	O
=	O
10-43	O
.	O

Mutagenesis	O
studies	O
,	O
and	O
the	O
use	O
of	O
a	O
reporter	O
construct	O
containing	O
an	O
enhancerless	O
promoter	O
,	O
indicate	S
that	S
these	S
transcriptional	S
effects	S
are	S
due	S
principally	S
to	S
the	S
22-bp	S
sequence	S
duplication	S
and	S
the	S
NF	S
kappa	S
B	S
site	S
contained	S
within	S
it	S
.	O

Deletion	O
mutation	O
analysis	O
of	O
the	O
HIV-2	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
suggests	S
that	S
the	S
element	S
that	S
responds	S
to	S
CMV	S
transactivation	S
in	S
human	S
CD4+	S
lymphocytes	S
is	S
either	S
a	S
diffuse	S
one	S
or	S
located	S
downstream	S
of	S
the	S
HIV-2	S
enhancer	S
element	S
.	O

In	O
contrast	O
,	O
cotransfection	O
with	O
a	O
combination	O
of	O
NF-kappa	O
B	O
and	O
AP-1	O
significantly	O
augmented	O
transcription	O
from	O
the	O
GM-CSF	O
promoter	O
containing	O
the	O
GM-kappa	O
B/GC-box	O
and	O
the	O
CLE0	O
(	O
AP-1/NF-AT	O
)	O
.	O

Results	O
from	O
site-directed	O
mutations	O
and	O
electrophoretic	O
mobility	O
shift	O
assays	O
strongly	O
suggest	S
that	S
this	S
sequence	S
mediates	S
the	S
ionomycin-induced	S
activation	S
of	S
the	S
TCRG	S
enhancer	S
.	O

Our	O
results	O
showed	O
that	O
BSAP	O
plays	O
a	O
role	O
in	O
both	O
IL-4-dependent	O
induction	O
and	O
CD40-mediated	O
upregulation	O
of	O
human	O
epsilon	O
germline	O
transcription	O
.	O

This	O
model	O
is	O
of	O
particular	O
value	O
for	O
exploring	O
physical	O
stress-induced	O
signaling	O
pathways	O
,	O
as	O
well	O
as	O
for	O
testing	O
the	O
effects	O
of	O
novel	O
ventilatory	O
strategies	O
or	O
adjunctive	O
substances	O
aimed	O
at	O
modulating	O
cell	O
activation	O
induced	O
by	O
mechanical	O
ventilation	O
.	O

Activation	O
of	O
NF-kappa	O
B	O
can	O
be	O
inhibited	O
in	O
vivo	O
by	O
treatment	O
with	O
antioxidants	O
,	O
corticosteroids	O
,	O
and	O
the	O
induction	O
of	O
endotoxin	O
tolerance	O
.	O

The	O
cytokines	O
IFN-beta	O
,	O
IFN-gamma	O
,	O
IL-4	O
,	O
and	O
LPS	O
,	O
although	O
unable	O
to	O
induce	O
sialoadhesin	O
expression	O
by	O
themselves	O
,	O
were	O
able	O
to	O
enhance	O
GC-mediated	O
induction	O
of	O
sialoadhesin	O
.	O

This	O
factor	O
is	O
composed	O
of	O
a	O
DNA-binding	O
protein	O
(	O
ISGF3	O
gamma	O
)	O
,	O
which	O
normally	O
is	O
present	O
in	O
the	O
cytoplasm	O
,	O
and	O
other	O
IFN-alpha-activated	O
proteins	O
which	O
preexist	O
as	O
latent	O
cytoplasmic	O
precursors	O
(	O
ISGF3	O
alpha	O
)	O
.	O

The	O
DNA-binding	O
protein	O
GATA-1	O
is	O
required	O
for	O
normal	O
erythroid	O
development	O
and	O
regulates	O
erythroid-expressed	O
genes	O
in	O
maturing	O
erythroblasts	O
.	O

Sequences	O
related	O
to	O
the	O
TCF-1	O
alpha	O
binding	O
motif	O
(	O
5'-GGCACCCTTTGA-3	O
'	O
)	O
are	O
also	O
found	O
in	O
the	O
human	O
TCR	O
delta	O
(	O
and	O
possibly	S
TCR	S
beta	S
)	O
enhancers	O
.	O

CONCLUSIONS	O
:	O
These	O
results	O
provide	O
further	O
evidence	O
for	O
a	O
dysregulation	O
of	O
the	O
HPA	O
axis	O
in	O
PTSD	O
.	O

I	O
kappa	O
B	O
alpha	O
is	O
efficiently	O
resynthesized	O
whereas	O
I	O
kappa	O
B	O
beta	O
levels	O
stay	O
low	O
for	O
a	O
prolonged	O
time	O
.	O

Both	O
signal	O
cascades	O
contribute	O
to	O
the	O
induction	O
of	O
the	O
interleukin	O
2	O
(	O
IL-2	O
)	O
gene	O
during	O
T-cell	O
activation	O
.	O

Furthermore	O
,	O
we	O
show	O
that	O
exogenous	O
PGE2	O
mimics	O
the	O
NF-kappaB	O
inhibitory	O
effect	O
of	O
FCM	O
.	O

There	O
is	O
no	O
significant	O
difference	O
in	O
the	O
turnover	O
of	O
pre-	O
and	O
post-inductive	O
I	O
kappa	O
B	O
alpha	O
.	O

A	O
DNA	O
fragment	O
containing	O
128	O
bp	O
of	O
upstream	O
sequence	O
had	O
strong	O
,	O
monocyte-specific	O
promoter	O
activity	O
in	O
the	O
CD14	O
positive	O
monocytic	O
cell	O
line	O
Mono	O
Mac	O
6	O
as	O
compared	O
to	O
the	O
nonmonocytic	O
cell	O
lines	O
HeLa	O
and	O
REX	O
.	O

Overproduction	O
of	O
NFKB2	O
(	O
lyt-10	O
)	O
and	O
c-Rel	O
:	O
a	O
mechanism	O
for	O
HTLV-I	O
Tax-mediated	O
trans-activation	O
via	O
the	O
NF-kappa	O
B	O
signalling	O
pathway	O
.	O

During	O
studies	O
reported	O
here	O
,	O
we	O
identified	O
11	O
additional	O
new	O
families	O
of	O
Transib	O
transposons	O
and	O
TPases	O
(	O
see	O
Figure	O
S2	O
)	O
that	O
are	O
well	O
preserved	O
in	O
the	O
genomes	O
of	O
fruit	O
flies	O
(	O
Transib5	O
in	O
D.	O
melanogaster	O
;	O
and	O
Transib1_DP	O
,	O
Transib2_DP	O
,	O
Transib3_DP	O
,	O
and	O
Transib4_DP	O
in	O
D.	O
pseudoobscura	O
)	O
,	O
mosquitoes	O
(	O
Transib1_AA	O
,	O
Transib2_AA	O
,	O
Transib3_AA	O
,	O
Transib4_AA	O
,	O
and	O
Transib5_AA	O
from	O
A.	O
aegypti	O
)	O
and	O
sea	O
urchin	O
(	O
Transib1_SP	O
)	O
.	O

Beta-catenin	O
is	O
the	O
vertebrate	O
homolog	O
of	O
the	O
Drosophila	O
segment	O
polarity	O
gene	O
Armadillo	O
and	O
plays	O
roles	O
in	O
both	O
cell-cell	O
adhesion	O
and	O
transduction	O
of	O
the	O
Wnt	O
signaling	O
cascade	O
.	O

The	O
recent	O
definition	O
of	O
a	O
consensus	O
DNA	O
binding	O
sequence	O
for	O
the	O
Ets	O
family	O
of	O
transcription	O
factors	O
has	O
allowed	O
the	O
identification	O
of	O
potential	O
Ets	O
binding	O
sites	O
in	O
the	O
promoters	O
and	O
enhancers	O
of	O
many	O
inducible	O
T-cell	O
genes	O
.	O

However	O
,	O
PHA/PMA	O
but	O
not	O
oxidative	O
signals	O
induced	O
the	O
coordinate	O
activation	O
of	O
reporter	O
constructs	O
containing	O
the	O
AP-1-TRE	O
,	O
NF-AT	O
,	O
and	O
IL-2	O
promoter	O
regions	O
along	O
with	O
IL-2	O
mRNA	O
expression	O
.	O

However	O
,	O
only	O
64.1	O
induced	O
NF-AT	O
in	O
the	O
nucleus	O
,	O
correlating	O
with	O
its	O
ability	O
to	O
activate	O
T	O
cells	O
.	O

The	O
mean	O
concentrations	O
necessary	O
to	O
cause	O
50	O
%	O
inhibition	O
of	O
lymphocyte	O
proliferation	O
(	O
IC50s	O
)	O
for	O
the	O
steroid-sensitive	O
group	O
ranged	O
from	O
2	O
x	O
10	O
(	O
-10	O
)	O
mol/L	O
for	O
budesonide	O
to	O
7	O
x	O
10	O
(	O
-8	O
)	O
mol/L	O
for	O
hydrocortisone	O
,	O
whereas	O
the	O
mean	O
IC50s	O
for	O
the	O
steroid-resistant	O
group	O
ranged	O
from	O
approximately	O
2	O
x	O
10	O
(	O
-8	O
)	O
mol/L	O
for	O
budesonide	O
to	O
greater	O
than	O
10	O
(	O
-6	O
)	O
mol/L	O
for	O
hydrocortisone	O
.	O

The	O
AC	O
unit	O
is	O
demonstrated	O
to	O
enhance	O
basal	O
activity	O
of	O
promoters	O
both	O
in	O
fibroblasts	O
and	O
T	O
cells	O
.	O

One	O
type	O
,	O
EA/S	O
,	O
is	O
located	O
in	O
the	O
upstream	O
promoter	O
region	O
,	O
and	O
the	O
other	O
,	O
E	O
(	O
gre	O
)	O
,	O
is	O
located	O
in	O
a	O
tandem	O
repeat	O
with	O
enhancer	O
properties	O
.	O

Early	O
B-cell	O
factor	O
(	O
EBF	O
)	O
was	O
identified	O
previously	O
as	O
a	O
tissue-specific	O
and	O
differentiation	O
stage-specific	O
DNA-binding	O
protein	O
that	O
participates	O
in	O
the	O
regulation	O
of	O
the	O
pre-B	O
and	O
B	O
lymphocyte-specific	O
mb-1	O
gene	O
.	O

Comparison	O
to	O
other	O
interaction	O
datasets	O

This	O
finding	O
may	S
provide	S
a	S
tool	S
to	S
improve	S
current	S
protocols	S
of	S
immunotherapy	S
and	S
insights	S
to	S
how	S
tumor	S
cells	S
are	S
or	S
are	S
not	S
killed	S
by	S
LAK	S
cells	S
.	O

Nuclear	O
factor	O
of	O
activated	O
T-cells	O
(	O
NFAT-1	O
)	O
is	O
a	O
transcription	O
factor	O
which	S
is	S
considered	S
to	S
be	S
an	S
important	S
regulator	S
in	S
early	S
T-cell	S
activation	S
.	O

This	O
induction	O
was	O
abolished	O
by	O
PD-135,158	O
.	O

Similar	O
effects	O
were	O
obtained	O
for	O
the	O
c-fos	O
gene	O
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
only	O
one	O
study	O
to	O
date	O
has	O
explored	O
ensemble	O
learning	O
in	O
motif	O
finding	O
.	O

An	O
important	O
factor	O
to	O
consider	O
when	O
taking	O
the	O
best	O
of	O
multiple	O
runs	O
is	O
the	O
relative	O
size	O
of	O
the	O
search	O
space	O
.	O

In	O
order	O
to	O
determine	O
the	O
cis-acting	O
elements	O
necessary	O
for	O
both	O
basal	O
and	O
phorbol	O
12-myristate-13	O
acetate	O
(	O
PMA	O
)	O
-enhanced	O
promoter	O
activity	O
,	O
we	O
performed	O
deletion	O
analysis	O
and	O
reporter	O
gene	O
assays	O
.	O

Upon	O
stimulation	O
of	O
the	O
cells	O
,	O
this	O
protein	O
no	O
longer	O
prevents	O
binding	O
of	O
DNA	O
by	O
Band	O
A	O
,	O
and	O
suppression	O
of	O
binding	O
is	O
restored	O
within	O
30	O
min	O
.	O

We	O
demonstrate	O
here	O
,	O
however	O
,	O
that	O
NFAT	O
can	O
be	O
activated	O
,	O
and	O
significant	O
levels	O
of	O
IL-2	O
can	O
be	O
produced	O
by	O
the	O
CsA-resistant	O
CD28-signaling	O
pathway	O
.	O

Genetically	O
,	O
this	S
Drosophila	S
Bcl-2	S
family	S
member	S
appears	S
to	S
function	S
upstream	S
of	S
,	S
or	S
in	S
parallel	S
to	S
,	S
the	S
Drosophila	S
ced-4/apaf-1	S
homolog	S
and	S
downstream	S
of	S
,	S
or	S
in	S
parallel	S
to	S
,	S
the	S
Drosophila	S
regulators	S
of	S
apoptosis	S
,	S
reaper	S
,	S
hid	S
,	S
and	S
grim	S
[	O
22	O
]	O
.	O

Fusion	O
of	O
the	O
upstream	O
portion	O
of	O
the	O
delta	O
promoter	O
to	O
the	O
truncated	O
beta	O
globin	O
promoter	O
yielded	O
a	O
modest	O
increase	O
in	O
promoter	O
strength	O
relative	O
to	O
the	O
truncated	O
beta	O
gene	O
promoter	O
,	O
indicating	O
the	O
presence	O
of	O
a	O
positive	O
transcriptional	O
element	O
(	O
s	O
)	O
in	O
the	O
upstream	O
delta	O
globin	O
regulatory	O
region	O
.	O

NF-kappa	O
B-directed	O
luciferase	O
activity	O
increased	O
approximately	O
3-fold	O
when	O
cells	O
transfected	O
with	O
the	O
plasmid	O
pNF-kappa	O
BLUC	O
containing	O
five	O
copies	O
of	O
consensus	O
NF-kappa	O
B	O
site	O
linked	O
to	O
a	O
minimal	O
adenovirus	O
E1B	O
promoter-luciferase	O
gene	O
were	O
exposed	O
to	O
thrombin	O
,	O
indicating	S
that	S
activation	S
of	S
NF-kappa	S
B	S
was	S
essential	S
for	S
thrombin	S
response	S
.	O

The	O
JAK	O
kinases	O
and	O
the	O
signal	O
transducers	O
and	O
activators	O
of	O
transcription	O
(	O
STAT	O
)	O
factors	O
have	O
been	O
found	O
to	O
be	O
essential	O
components	O
.	O

Administration	O
of	O
dexamethasone	O
to	O
temporal	O
artery-SCID	O
chimeras	O
for	O
1	O
wk	O
induced	O
a	O
partial	O
suppression	O
of	O
T	O
cell	O
and	O
macrophage	O
function	O
as	O
indicated	O
by	O
the	O
reduced	O
tissue	O
concentrations	O
of	O
IL-2	O
,	O
IL-1beta	O
,	O
and	O
IL-6	O
mRNA	O
,	O
and	O
by	O
the	O
diminished	O
expression	O
of	O
inducible	O
NO	O
synthase	O
.	O

This	O
``	O
spontaneous	O
stimulation	O
''	O
is	O
also	O
noted	O
with	O
some	O
other	O
G0S	O
genes	O
and	O
has	O
been	O
attributed	O
to	O
some	O
aspect	O
of	O
the	O
isolation	O
procedure	O
.	O

The	O
PML	O
gene	O
product	O
has	O
been	O
localized	O
to	O
subnuclear	O
dot-like	O
structures	O
variously	O
termed	O
PODs	O
,	O
ND10s	O
,	O
Kr	O
bodies	O
,	O
or	O
PML	O
nuclear	O
bodies	O
(	O
PML	O
NBs	O
)	O
.	O

Interleukin-6	O
protein	O
and	O
IL-6	O
mRNA	O
were	O
measured	O
in	O
control	O
and	O
CMV	O
immediate	O
early	O
transfected	O
cells	O
.	O

Enhanced	O
responsiveness	O
to	O
nuclear	O
factor	O
kappa	O
B	O
contributes	O
to	O
the	O
unique	O
phenotype	O
of	O
simian	O
immunodeficiency	O
virus	O
variant	O
SIVsmmPBj14	O
.	O

Treatment	O
with	O
PMA	O
plus	O
ionomycin	O
(	O
P/I	O
)	O
results	O
in	O
the	O
upregulation	O
of	O
Fas	O
Ligand	O
(	O
FasL	O
)	O
and	O
induction	O
of	O
apoptosis	O
.	O

The	O
final	O
predictions	O
are	O
chosen	O
from	O
the	O
ensemble	O
of	O
methods	O
by	O
a	O
learning	O
rule	O
,	O
which	O
may	S
be	S
as	S
simple	S
as	S
finding	S
the	S
maximum	S
score	S
from	S
all	S
the	S
methods	S
,	S
or	S
as	S
complex	S
as	S
optimizing	S
a	S
weighted	S
scoring	S
scheme	S
from	S
among	S
the	S
methods	S
.	O

4	O
.	O
It	O
is	O
suggested	S
that	S
danazol	S
has	S
an	S
anti-estrogenic	S
action	S
to	S
the	S
monocytes	S
through	S
the	S
competition	S
and	S
suppression	S
of	S
estrogen	S
binding	S
sites	S
as	O
seen	O
in	O
the	O
estrogen	O
target	O
organ	O
.	O

Role	O
of	O
transcriptional	O
regulation	O
by	O
DNA	O
sequence	O
motifs	O
and	O
mRNA	O
stabilization	O
.	O

Activation	O
and	O
regulation	O
of	O
NF-kappa	O
B	O
are	O
tightly	O
controlled	O
by	O
a	O
group	O
of	O
inhibitory	O
proteins	O
(	O
I	O
kappa	O
B	O
)	O
that	O
sequester	O
NF-kappa	O
B	O
in	O
the	O
cytoplasm	O
of	O
immune/inflammatory	O
effector	O
cells	O
.	O

Acute	O
hepatic	O
injury	O
caused	O
by	O
reactive	O
oxygen	O
intermediate	O
production	O
was	O
induced	O
by	O
an	O
intraperitoneal	O
injection	O
of	O
CCl4	O
in	O
mice	O
.	O

Inhibition	O
of	O
the	O
MAP	O
kinase	O
cascade	O
with	O
PD98059	O
,	O
a	O
specific	O
inhibitor	O
of	O
MAPK	O
kinase	O
1	O
,	O
prevented	O
the	O
expression	O
of	O
the	O
alpha2	O
integrin	O
subunit	O
in	O
cells	O
induced	O
to	O
become	O
megakaryocytic	O
.	O

Robustness	O
of	O
SCOPE	O
performance	O
on	O
S.	O
cerevisiae	O
regulons	O
containing	O
extraneous	O
upstream	O
sequences	O
.	O

The	O
Ribophorin	O
I-EVI1	O
fusion	O
in	O
particular	O
may	S
be	S
a	S
common	S
occurrence	S
in	S
t	S
(	S
3	S
;	S
3	S
)	S
.	O

We	O
have	O
examined	O
the	O
DRA	O
promoter	O
for	O
protein-DNA	O
interactions	O
in	O
the	O
intact	O
cell	O
,	O
which	O
may	S
mediate	S
transcriptional	S
activation	S
.	O

The	O
human	O
prointerleukin	O
1	O
beta	O
gene	O
requires	O
DNA	O
sequences	O
both	O
proximal	O
and	O
distal	O
to	O
the	O
transcription	O
start	O
site	O
for	O
tissue-specific	O
induction	O
.	O

Cell-type-specific	O
transactivation	O
of	O
the	O
parathyroid	O
hormone-related	O
protein	O
gene	O
promoter	O
by	O
the	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
)	O
tax	O
and	O
HTLV-II	O
tax	O
proteins	O
.	O

The	O
core-like	O
sequences	O
encoded	O
by	O
the	O
sea	O
urchin	O
WGS	O
sequence	O
contigs	O
29068	O
and	O
12509	O
correspond	O
to	O
either	S
the	S
second	S
or	S
third	S
RAG1	O
exon	O
in	O
teleosts	O
(	O
depending	O
on	O
the	O
number	O
of	O
introns	O
)	O
,	O
which	O
is	O
remarkably	O
consistent	O
with	O
the	O
fusion	O
model	O
.	O

Both	O
nuclear	O
run-on	O
and	O
actinomycin	O
D	O
pulse	O
experiments	O
strongly	O
indicate	S
that	S
HU	S
regulates	S
c-jun	S
mRNA	S
expression	S
by	S
increasing	S
the	S
rate	S
of	S
synthesis	S
as	S
well	S
as	S
stabilizing	S
the	S
c-jun	S
mRNA	S
.	O

Functional	O
DC	O
characteristics	O
include	O
fluid	O
phase	O
macromolecule	O
uptake	O
(	O
FITC-dextran	O
)	O
and	O
activation	O
of	O
resting	O
T	O
cells	O
.	O

3	O
.	O
Danazol	O
bound	O
to	O
these	O
sites	O
in	O
high	O
concentration	O
(	O
10	O
(	O
-6	O
)	O
M	O
,	O
clinical	O
serum	O
concentration	O
during	O
danazol	O
therapy	O
)	O
and	O
decreased	O
the	O
number	O
of	O
both	O
sites	O
.	O

Xenogeneic	O
human	O
serum	O
significantly	O
(	O
P	O
<	O
0.01	O
)	O
increased	O
the	O
number	O
of	O
adherent	O
leukocytes	O
as	O
compared	O
with	O
porcine	O
serum	O
.	O

The	O
monoclonal	O
antibody	O
(	O
mAb	O
)	O
J393	O
induces	O
apoptosis	O
in	O
Jurkat	O
T-cells	O
.	O

The	O
experiments	O
in	O
this	O
report	O
show	O
that	O
cysteine	O
or	O
N-acetylcysteine	O
(	O
NAC	O
)	O
raise	O
the	O
intracellular	O
glutathione	O
(	O
GSH	O
)	O
level	O
and	O
inhibit	O
HIV-1	O
replication	O
in	O
persistently	O
infected	O
Molt-4	O
and	O
U937	O
cells	O
.	O

The	O
15-lipoxygenase	O
(	O
lox	O
)	O
gene	O
is	O
expressed	O
in	O
a	O
tissue-specific	O
manner	O
,	O
predominantly	O
in	O
erythroid	O
cells	O
but	O
also	O
in	O
airway	O
epithelial	O
cells	O
and	O
eosinophils	O
.	O

Human	O
CD36	O
is	O
a	O
scavenger	O
receptor	O
which	O
,	O
in	O
combination	O
with	O
the	O
macrophage	O
vitronectin	O
receptor	O
and	O
thrombospondin	O
,	O
binds	O
apoptotic	O
cells	O
.	O

Chlamydia	O
pneumoniae	O
is	O
an	O
important	O
respiratory	O
pathogen	O
.	O

Sequence	O
analysis	O
of	O
the	O
D-mib3	O
and	O
D-mib4	O
alleles	O
was	O
carried	O
on	O
PCR	O
products	O
prepared	O
from	O
genomic	O
DNA	O
prepared	O
from	O
D-mib3/D-mib2	O
and	O
D-mib4/D-mib2	O
mutant	O
pupae	O
.	O

However	O
,	O
when	O
integrated	O
into	O
the	O
Combined	O
module	O
,	O
domain	O
,	O
PTM	O
and	O
localization	O
information	O
together	O
achieve	O
likelihood	O
ratios	O
that	O
are	O
high	O
enough	O
to	O
predict	O
interaction	O
on	O
their	O
own	O
(	O
i.e	O
.	O
above	O
400	O
)	O
.	O

When	O
the	O
HTLV-1	O
tax	O
gene	O
was	O
expressed	O
or	O
phorbol	O
myristake	O
acetate-A23187	O
stimulation	O
was	O
used	O
,	O
ICSAT	O
expression	O
was	O
induced	O
in	O
Jurkat	O
cells	O
which	O
otherwise	O
do	O
not	O
express	O
ICSAT	O
.	O

In	O
contrast	O
,	O
the	O
affinity	O
of	O
heterodimeric	O
NFKB2	O
(	O
p49	O
)	O
/RelA	O
(	O
p65	O
)	O
for	O
this	O
site	O
is	O
approximately	O
6-fold	O
higher	O
(	O
KD	O
=	O
11.8	O
pM	O
)	O
than	O
that	O
of	O
p49	O
alone	O
.	O

Except	O
for	O
the	O
conserved	O
zinc-finger	O
domains	O
,	O
the	O
amino	O
acid	O
sequences	O
of	O
the	O
three	O
proteins	O
are	O
distinct	O
.	O

We	O
have	O
previously	O
identified	O
a	O
T	O
lymphocyte	O
protein	O
which	O
binds	O
to	O
a	O
site	O
within	O
the	O
LTR	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
and	O
exerts	O
an	O
inhibitory	O
effect	O
on	O
virus	O
gene	O
expression	O
.	O

Conversely	O
,	O
the	O
activity	O
of	O
the	O
neur	O
gene	O
is	O
essential	O
for	O
binary	O
cell-fate	O
decisions	O
in	O
the	O
bristle	O
lineage	O
[	O
22	O
]	O
that	O
do	O
not	O
require	O
the	O
activity	O
of	O
the	O
D-mib	O
gene	O
(	O
no	O
bristle	O
defects	O
were	O
seen	O
in	O
D-mib	O
mutant	O
flies	O
)	O
.	O

Here	O
we	O
show	O
that	O
in	O
a	O
MPC11	O
plasmacytoma	O
x	O
fibroblast	O
environment	O
,	O
the	O
IgH	O
3	O
'	O
enhancer	O
is	O
transcriptionally	O
inactive	O
.	O

There	O
was	O
considerable	O
excitement	O
in	O
the	O
field	O
when	O
potential	O
mammalian	O
and	O
Drosophila	O
homologs	O
for	O
ced-3	O
,	O
ced-4	O
,	O
ced-9	O
,	O
and	O
egl-1	O
were	O
discovered	O
.	O

This	O
indicates	S
an	S
increase	S
in	S
either	S
episomal	S
DNA	S
or	S
concatameric	S
linear	S
DNA	S
.	O

Freshly	O
isolated	O
monocytes	O
treated	O
with	O
the	O
protein	O
phosphatase	O
inhibitor	O
okadaic	O
acid	O
secreted	O
high	O
levels	O
of	O
IL-6	O
protein	O
,	O
which	O
coincided	O
with	O
enhanced	O
binding	O
activity	O
of	O
NF-kappa	O
B	O
as	O
well	O
as	O
with	O
phosphorylation	O
and	O
activation	O
of	O
the	O
ERK1/2	O
and	O
JNK	O
proteins	O
.	O

DNA	O
fragmentation	O
was	O
efficiently	O
blocked	O
by	O
the	O
caspase	O
inhibitor	O
Z-VAD-fmk	O
and	O
partially	O
blocked	O
by	O
Ac-DEVD-fmk	O
,	O
suggesting	S
that	S
SN50-mediated	S
apoptosis	S
is	S
caspase-dependent	S
.	O

To	O
further	O
characterize	O
the	O
protein-DNA	O
interactions	O
mediating	O
IFN-beta	O
induction	O
,	O
positive	O
regulatory	O
domain	O
(	O
PRD	O
)	O
II	O
binding	O
proteins	O
were	O
purified	O
from	O
phorbol	O
ester	O
induced	O
Jurkat	O
T-cells	O
and	O
from	O
IFN	O
primed	O
,	O
cycloheximide/polyinosinic-polycytidylic	O
acid	O
treated	O
HeLa	O
S3	O
cells	O
.	O

The	O
cDNA	O
that	O
we	O
isolated	O
is	O
identical	O
to	O
the	O
cDNA	O
of	O
the	O
recently	O
positionally	O
cloned	O
mouse	O
embryonic	O
ectoderm	O
development	O
gene	O
,	O
eed	O
.	O

The	O
Wilms	O
'	O
tumor	O
gene	O
(	O
WT1	O
)	O
encodes	O
a	O
transcription	O
factor	O
of	O
the	O
zinc	O
finger	O
type	O
.	O

Overexpression	O
of	O
SRF	O
in	O
B	O
cells	O
causes	O
the	O
IL-2R	O
enhancer	O
to	O
function	O
as	O
well	O
as	O
it	O
does	O
in	O
T	O
cells	O
,	O
suggesting	S
that	S
the	S
high	S
level	S
of	S
SRF	S
binding	S
in	S
T	S
cells	S
is	S
functionally	S
important	S
.	O

We	O
have	O
recently	O
cloned	O
the	O
CD14	O
5	O
'	O
upstream	O
sequence	O
and	O
demonstrated	O
its	O
tissue-specific	O
promoter	O
activity	O
.	O

Protein-DNA	O
complexes	O
of	O
constitutive	O
NF-kappa	O
B	O
are	O
similar	O
in	O
mobility	O
to	O
the	O
LPS-induced	O
NF-kappa	O
B	O
and	O
both	O
are	O
recognized	O
by	O
an	O
antibody	O
specific	O
to	O
the	O
p50	O
subunit	O
of	O
NF-kappa	O
B	O
.	O

Because	O
there	O
were	O
no	O
known	O
TPases	O
similar	O
to	O
RAG1	O
,	O
it	O
could	S
be	S
argued	S
that	S
RAG1	S
independently	S
developed	S
some	S
TPase-like	S
properties	S
,	S
rather	S
than	S
deriving	S
them	S
from	S
a	S
TE-encoded	S
TPase	S
[	O
24	O
]	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
constitutive	O
expression	O
of	O
bcl-xl	O
but	O
not	O
bcl-2	O
,	O
bcl-xs	O
,	O
bak	O
,	O
bad	O
,	O
or	O
bax	O
was	O
associated	O
with	O
apoptosis	O
resistance	O
after	O
IL-2	O
deprivation	O
in	O
CTLL-2	O
cells	O
that	O
expressed	O
Tax	O
.	O

T	O
lymphocytes	O
express	O
several	O
low	O
molecular	O
weight	O
transmembrane	O
adaptor	O
proteins	O
that	O
recruit	O
src	O
homology	O
(	O
SH	O
)	O
2	O
domain-containing	O
intracellular	O
molecules	O
to	O
the	O
cell	O
membrane	O
via	O
tyrosine-based	O
signaling	O
motifs	O
.	O

We	O
report	O
on	O
the	O
CTL	O
recognition	O
of	O
a	O
MHC	O
class	O
I-restricted	O
peptide	O
containing	O
a	O
cyclized	O
asparagine	O
(	O
succinimide	O
)	O
residue	O
.	O

Here	O
we	O
identify	O
the	O
cell	O
cycle	O
regulator	O
E2F	O
as	O
an	O
IL-2	O
target	O
in	O
T	O
lymphocytes	O
and	O
PI3K	O
as	O
the	O
critical	O
signaling	O
pathway	O
.	O

All	O
of	O
these	O
phenotypes	O
are	O
strikingly	O
similar	O
to	O
the	O
abnormalities	O
seen	O
in	O
adgf-a	O
mutants	O
,	O
which	O
was	O
our	O
first	O
clue	O
as	O
to	O
a	O
possible	S
interaction	S
of	S
ADGF-A	S
with	S
the	S
Toll	S
signaling	S
pathway	S
.	O

PMA	O
treatment	O
caused	O
a	O
concentration-	O
and	O
time-dependent	O
increase	O
in	O
both	O
c-Fos	O
and	O
Jun	O
immunoreactivity	O
in	O
contrast	O
to	O
cAMP	O
elevation	O
that	O
had	O
only	O
a	O
slight	O
effect	O
.	O

Investigating	O
cytokines	O
known	O
to	O
affect	O
B	O
cell	O
differentiation	O
,	O
we	O
have	O
recently	O
shown	O
that	O
IL-6	O
production	O
is	O
augmented	O
by	O
RA	O
.	O

O-side	O
chain-specific	O
mAb	O
concurrently	O
enhanced	O
complement-dependent	O
LPS	O
uptake	O
by	O
monocytes	O
through	O
complement	O
receptor-1	O
(	O
CR1	O
)	O
and	O
uptake	O
by	O
CHO-CD14	O
cells	O
involving	O
another	O
heat-labile	O
serum	O
factor	O
(	O
s	O
)	O
and	O
cell-associated	O
recognition	O
molecule	O
(	O
s	O
)	O
.	O

Since	O
it	O
is	O
known	O
that	O
PGE2	O
is	O
able	O
to	O
increase	O
cAMP	O
levels	O
,	O
we	O
investigated	O
whether	S
it	S
can	S
affect	S
gene	S
expression	S
through	S
the	S
activation	S
of	S
the	S
transcription	S
factors	S
which	S
bind	S
enhancer	S
elements	S
in	S
the	S
promoter	S
regions	S
of	S
cAMP-regulated	S
genes	S
.	O

1	O
alpha,25-	O
(	O
OH	O
)	O
2D3	O
inhibited	O
CD23	O
expression	O
in	O
U937	O
cells	O
,	O
yet	O
failed	O
to	O
modulate	O
CD23	O
expression	O
in	O
B	O
cells	O
.	O

Notably	O
,	O
two	O
ZFB	O
cysteines	O
are	O
part	O
of	O
the	O
conserved	O
SxxCxxC	O
motif	O
,	O
and	O
mutations	O
of	O
the	O
serine	O
from	O
the	O
same	O
motif	O
cause	O
severe	O
defects	O
in	O
RAG1	O
transpositions	O
in	O
vitro	O
[	O
32	O
]	O
.	O

Constitutive	O
activation	O
of	O
NF-kappaB	O
in	O
primary	O
adult	O
T-cell	O
leukemia	O
cells	O
.	O

Contribution	O
of	O
the	O
modules	O

Prioritising	O
these	O
targets	O
according	O
to	O
the	O
number	O
of	O
covered	O
experimental	O
interactions	O
could	S
increase	S
the	S
coverage	S
of	S
databases	S
like	S
iPfam	S
quickly	S
.	O

This	O
resurgence	O
of	O
I	O
kappa	O
B-alpha	O
protein	O
acts	O
to	O
restore	O
an	O
equilibrium	O
in	O
which	O
NF-kappa	O
B	O
is	O
again	O
inhibited	O
.	O

When	O
the	O
human	O
epsilon-	O
or	O
beta-globin	O
genes	O
driven	O
by	O
the	O
dominant	O
control	O
region	O
(	O
DCR	O
)	O
are	O
introduced	O
into	O
this	O
system	O
,	O
the	O
human	O
epsilon-globin	O
gene	O
,	O
in	O
contrast	O
to	O
the	O
beta-globin	O
gene	O
,	O
is	O
not	O
deregulated	O
by	O
the	O
presence	O
of	O
the	O
DCR	O
and	O
is	O
expressed	O
strictly	O
as	O
an	O
embryonic	O
gene	O
.	O

These	O
changes	O
in	O
the	O
enhancer	O
element	O
were	O
identified	O
in	O
the	O
original	O
AL1	O
virus	O
stock	O
.	O

Deletion	O
of	O
the	O
EBNA2-dependent	O
enhancer	O
located	O
upstream	O
of	O
Cp	O
resulted	O
in	O
a	O
ca	O
.	O
two-	O
to	O
fivefold	O
reduction	O
in	O
Cp	O
activity	O
in	O
the	O
LCLs	O
assayed	O
.	O

Methods	O

An	O
AP-1	O
site	O
at	O
-146	O
to	O
-140	O
was	O
shown	O
to	O
be	O
involved	O
in	O
the	O
expression	O
of	O
the	O
IL-9	O
gene	O
.	O

The	O
final	O
likelihood	O
ratio	O
is	O
then	O
the	O
product	O
of	O
the	O
preliminary	O
score	O
calculated	O
in	O
panel	O
A	O
and	O
the	O
likelihood	O
ratio	O
output	O
by	O
the	O
transitive	O
module	O
in	O
panel	O
B	O
.	O

We	O
translated	O
all	O
three	O
types	O
of	O
nonsense	O
codons	O
into	O
the	O
one-letter	O
code	O
U	O
,	O
so	O
as	O
to	O
simplify	O
visual	O
inspection	O
of	O
sequence	O
alignments	O
.	O

Assays	O
using	O
monocytes	O
or	O
IFN-U937	O
cells	O
were	O
of	O
comparable	O
sensitivity	O
for	O
detection	O
of	O
antibodies	O
against	O
all	O
three	O
types	O
of	O
target	O
cell	O
.	O

Two	O
complementary	O
DNAs	O
were	O
isolated	O
that	O
encode	O
proteins	O
,	O
denoted	O
ITF-1	O
and	O
ITF-2	O
,	O
that	O
are	O
expressed	O
in	O
a	O
variety	O
of	O
cell	O
types	O
and	O
bind	O
the	O
microE5/kappa	O
2	O
motif	O
found	O
in	O
both	O
heavy	O
and	O
kappa	O
light	O
chain	O
enhancers	O
.	O

Inhibition	O
of	O
cytokine	O
production	O
was	O
gene	O
selective	O
and	O
not	O
due	O
to	O
general	O
effects	O
on	O
protein	O
synthesis	O
.	O

Endogenous	O
CED-4	O
is	O
normally	O
localized	O
to	O
the	O
mitochondria	O
by	O
CED-9	O
,	O
unless	O
EGL-1	O
is	O
expressed	O
[	O
12,13	O
]	O
.	O

Binding	O
of	O
erythroid	O
and	O
non-erythroid	O
nuclear	O
proteins	O
to	O
the	O
silencer	O
of	O
the	O
human	O
epsilon-globin-encoding	O
gene	O
.	O

Nearly	O
the	O
entire	O
sequences	O
of	O
several	O
Transib	O
TPases	O
,	O
excluding	O
their	O
100–140-aa	O
N-terminal	O
domains	O
,	O
converged	O
with	O
an	O
approximately	O
600-aa	O
portion	O
of	O
RAG1	O
defined	O
by	O
positions	O
approximately	O
360–1010	O
(	O
Figure	O
S3	O
)	O
.	O

Induction	O
of	O
NF-KB	O
during	O
monocyte	O
differentiation	O
by	O
HIV	O
type	O
1	O
infection	O
.	O

Furthermore	O
,	O
Bcl-2	O
antagonizes	O
drug-induced	O
apoptosis	O
by	O
inhibiting	O
calcineurin	O
activation	O
,	O
blocking	O
NFAT	O
nuclear	O
translocation	O
,	O
and	O
preventing	O
FasL	O
expression	O
.	O

Modulation	O
of	O
the	O
expression	O
of	O
the	O
IFN-gamma	O
receptor	O
beta-chain	O
controls	O
responsiveness	O
to	O
IFN-gamma	O
in	O
human	O
peripheral	O
blood	O
T	O
cells	O
.	O

However	O
,	O
the	O
loss	O
of	O
D-mib	O
activity	O
strongly	O
inhibited	O
the	O
endocytosis	O
of	O
anti-Ser	O
antibodies	O
(	O
Figure	O
5E	O
'	O
)	O
.	O

Using	O
this	O
assay	O
,	O
we	O
found	O
that	O
anti-Ser-and	O
anti-Dl	O
antibodies	O
were	O
internalized	O
in	O
wild-type	O
epithelial	O
cells	O
(	O
Figure	O
5A–5C	O
''	O
)	O
.	O

Members	O
of	O
the	O
cyclic	O
adenosine	O
monophosphate	O
(	O
cAMP	O
)	O
response	O
element	O
binding	O
(	O
CREB	O
)	O
/activating	O
transcription	O
factor	O
1	O
(	O
ATF-1	O
)	O
family	O
of	O
transcription	O
factors	O
bind	O
three	O
21-bp	O
repeats	O
(	O
Tax-responsive	O
element-1	O
,	O
or	O
TRE-1	O
)	O
within	O
the	O
viral	O
promoter	O
and	O
are	O
important	O
for	O
basal	O
and	O
Tax-mediated	O
transcription	O
.	O

However	O
,	O
its	O
activity	O
becomes	O
lower	O
in	O
the	O
double-positive	O
and	O
a	O
fraction	O
of	O
the	O
CD4+	O
CD8int/-	O
cell	O
population	O
,	O
indicating	S
that	S
an	S
additional	S
enhancer	S
,	S
located	S
in	S
either	S
the	S
first	S
or	S
the	S
third	S
intron	S
of	S
the	S
CD4	S
gene	S
,	S
is	S
required	S
for	S
CD4	S
gene	S
expression	S
in	S
this	S
population	S
.	O

Allergen-specific	O
T	O
cells	O
in	O
atopic	O
patients	O
are	O
polarized	O
IL-4-producing	O
Th2	O
cells	O
,	O
promoting	O
IgE	O
synthesis	O
by	O
B	O
cells	O
.	O

Together	O
,	O
these	O
findings	O
suggest	S
that	S
the	S
nuclear	S
localization	S
signal	S
and	S
transactivation	S
domain	S
of	S
NF-kappa	S
B	S
p65	S
constitute	S
a	S
bipartite	S
system	S
that	S
is	S
critically	S
involved	S
in	S
the	S
inhibitory	S
function	S
of	S
I	S
kappa	S
B/MAD-3	S
.	O

We	O
demonstrate	O
that	O
the	O
NF-microB-binding	O
site	O
plays	O
a	O
critical	O
role	O
in	O
the	O
IgH	O
enhancer	O
,	O
because	O
mutation	O
of	O
the	O
microB	O
DNA	O
motif	O
decreased	O
transcriptional	O
activity	O
of	O
the	O
IgH	O
enhancer	O
in	O
cells	O
of	O
the	O
B-cell	O
lineage	O
but	O
not	O
in	O
nonlymphoid	O
cells	O
.	O

Deletion	O
constructs	O
containing	O
as	O
little	O
as	O
72	O
bp	O
of	O
5	O
'	O
-flanking	O
sequence	O
of	O
the	O
collagenase	O
promoter	O
were	O
sufficient	O
for	O
LPS-	O
or	O
zymosan-mediated	O
transcriptional	O
induction	O
,	O
whereas	O
phorbol	O
inducibility	O
exhibited	O
an	O
absolute	O
requirement	O
for	O
upstream	O
elements	O
including	O
the	O
polyoma	O
enhancer	O
A-binding	O
protein-3	O
site	O
(	O
-83	O
to	O
-91	O
)	O
and	O
TTCA	O
sequence	O
(	O
-102	O
to	O
-105	O
)	O
in	O
both	O
monocytic	O
cells	O
and	O
fibroblasts	O
.	O

Furthermore	O
,	O
similar	O
levels	O
of	O
NF	O
kappa	O
B	O
were	O
found	O
in	O
the	O
cytosols	O
of	O
unactivated	O
T	O
cells	O
from	O
both	O
young	O
and	O
elderly	O
donors	O
suggesting	S
that	S
precursor	S
levels	S
of	S
NF	S
kappa	S
B	S
remain	S
unaltered	S
during	S
aging	S
.	O

However	O
,	O
the	S
ES	S
cell	S
system	S
can	S
be	S
used	S
as	S
an	S
alternative	S
until	S
targeted	S
erythroleukemia	S
cells	S
become	S
available	S
.	O

These	O
phosphotyrosines	O
serve	O
as	O
docking	O
sites	O
for	O
latent	O
,	O
cytoplasmic	O
transcription	O
factors	O
known	O
as	O
signal	O
transducers	O
and	O
activators	O
of	O
transcription	O
(	O
Stat	O
)	O
proteins	O
.	O

We	O
have	O
recently	O
identified	O
and	O
cloned	O
a	O
human	O
transcription	O
factor	O
,	O
TCF-1	O
,	O
that	O
binds	O
to	O
a	O
functional	O
element	O
in	O
the	O
T	O
lymphocyte-specific	O
enhancer	O
of	O
CD3-epsilon	O
.	O

Recombinant	O
murine	O
and	O
human	O
TCF-1	O
recognized	O
the	O
same	O
sequence	O
motif	O
in	O
the	O
CD3-epsilon	O
enhancer	O
as	O
judged	O
by	O
gel	O
retardation	O
and	O
methylation	O
interference	O
assays	O
.	O

Since	O
the	O
human	O
genomic	O
sterol	O
regulatory	O
element	O
(	O
SRE	O
)	O
has	O
been	O
shown	O
to	O
regulate	O
various	O
key	O
genes	O
involved	O
in	O
this	O
phenomenon	O
,	O
the	O
present	O
study	O
revealed	O
the	O
existence	O
of	O
a	O
unique	O
47	O
kDa	O
protein	O
factor	O
having	O
affinity	O
for	O
this	O
SRE	O
sequence	O
in	O
lymphocytes	O
from	O
normal	O
subjects	O
,	O
as	O
well	O
as	O
its	O
absence	O
in	O
lymphocytes	O
from	O
untreated	O
CML	O
patients	O
.	O

The	O
hierarchy	O
of	O
transcriptional	O
control	O
in	O
B-cell	O
development	O
has	O
recently	O
been	O
analyzed	O
by	O
targeted	O
gene	O
inactivation	O
in	O
the	O
mouse	O
.	O

The	O
c-Jun	O
delta-domain	O
inhibits	O
neuroendocrine	O
promoter	O
activity	O
in	O
a	O
DNA	O
sequence-	O
and	O
pituitary-specific	O
manner	O
.	O

Our	O
work	O
also	O
shows	O
that	O
forced	O
expression	O
of	O
the	O
ADGF-A	O
gene	O
can	O
rescue	O
the	O
effects	O
of	O
overactive	O
Toll	O
signaling	O
,	O
suggesting	S
that	S
ADGF-A	S
might	S
function	S
downstream	S
of	S
Toll	S
signaling	S
to	S
control	S
its	S
effects	S
.	O

We	O
have	O
developed	O
a	O
system	O
to	O
monitor	O
the	O
transcriptional	O
activity	O
of	O
NFAT-1	O
at	O
the	O
single	O
cell	O
level	O
in	O
whole	O
animals	O
.	O

Furthermore	O
,	O
the	O
ability	O
of	O
these	O
complexes	O
to	O
regulate	O
gene	O
expression	O
is	O
demonstrated	O
by	O
increased	O
transcription	O
from	O
an	O
AP-1	O
driven	O
reporter	O
construct	O
and	O
marked	O
increases	O
in	O
the	O
expression	O
of	O
endogenous	O
AP-1	O
regulated	O
genes	O
.	O

Most	O
erythroleukemic	O
cell	O
lines	O
established	O
in	O
vitro	O
coexpress	O
erythrocytic	O
and	O
megakaryocytic	O
markers	O
that	O
often	O
are	O
associated	O
with	O
expression	O
of	O
Spi-1	O
and/or	O
Fli-1	O
transcription	O
factors	O
known	O
as	O
transactivators	O
of	O
megakaryocyte-specific	O
promoters	O
.	O

We	O
find	O
that	O
HMG-I	O
binds	O
preferentially	O
to	O
the	O
more	O
3	O
'	O
of	O
a	O
pair	O
of	O
GATA	O
motifs	O
in	O
the	O
gamma-globin	O
promoter	O
;	O
this	O
paired	O
motif	O
is	O
bound	O
by	O
the	O
erythroid	O
factor	O
GATA-1	O
.	O

In	O
contrast	O
,	O
AP-1	O
from	O
PHA-activated	O
cells	O
contains	O
c-Jun	O
and	O
low	O
levels	O
of	O
c-Fos	O
.	O

Nonsteroidal	O
anti-inflammatory	O
drugs	O
such	O
as	O
salicylates	O
have	O
been	O
used	O
to	O
treat	O
symptoms	O
of	O
inflammation	O
,	O
and	O
a	O
new	O
mechanism	O
of	O
drug	O
action	O
was	O
suggested	O
recently	O
.	O

Thus	O
,	O
this	O
therapeutic	O
potency	O
may	S
reside	S
in	S
retention	S
of	S
inactive	S
nuclear	S
factor-kappaB	S
in	S
the	S
cytosol	S
thereby	S
abrogating	S
interleukin-1beta	S
gene	S
transcription	S
.	O

The	O
chemiluminescent	O
(	O
CL	O
)	O
response	O
of	O
interferon-gamma-treated	O
U937	O
(	O
IFN-U937	O
)	O
cells	O
to	O
sensitized	O
target	O
cells	O
has	O
been	O
used	O
to	O
detect	O
red	O
cell	O
,	O
platelet	O
and	O
granulocyte	O
antibodies	O
.	O

In	O
addition	O
,	O
we	O
looked	O
at	O
the	O
modulation	O
of	O
nuclear	O
factors	O
binding	O
specifically	O
to	O
the	O
AP-1	O
element	O
after	O
LTB4	O
stimulation	O
.	O

Although	O
the	S
mechanism	S
of	S
HIV-1	S
activation	S
with	S
heat	S
shock	S
has	S
not	S
been	S
fully	S
elucidated	S
yet	S
,	O
it	O
is	O
presumed	O
PKC	O
plays	O
an	O
important	O
role	O
in	O
HIV-1	O
activation	O
.	O

NF-kappa	O
B	O
activation	O
was	O
independent	O
of	O
the	O
transmembrane	O
domain	O
of	O
CD40	O
,	O
suggesting	S
that	S
it	S
is	S
independent	S
of	S
p23	S
,	S
a	S
molecule	S
that	S
associates	S
with	S
CD40	S
in	S
a	S
region	S
other	S
than	S
the	S
cytoplasmic	S
domain	S
.	O

The	O
cDNA	O
encoding	O
hTAFII105	O
reveals	O
a	O
highly	O
conserved	O
C-terminal	O
domain	O
shared	O
by	O
hTAFII130	O
and	O
oTAFII110	O
,	O
while	O
the	O
N-terminal	O
coactivator	O
domain	O
has	O
diverged	O
significantly	O
.	O

However	O
,	O
examination	O
of	O
proteasome	O
activity	O
in	O
these	O
T	O
cells	O
using	O
fluorogenic	O
peptide	O
assays	O
revealed	O
a	O
significant	O
age-related	O
decline	O
in	O
chymotryptic	O
activity	O
.	O

Group	O
C	O
,	O
adenovirus	O
serotype	O
5	O
(	O
Ad5	O
)	O
infection	O
inhibits	O
both	O
IFN-MCP	O
and	O
cellular	O
protein	O
synthesis	O
.	O

In	O
summary	O
,	O
we	O
have	O
discovered	O
that	O
expression	O
of	O
C/EBP	O
epsilon	O
mRNA	O
is	O
markedly	O
enhanced	O
as	O
the	O
NB4	O
promyelocytes	O
are	O
induced	O
by	O
retinoids	O
to	O
differentiate	O
towards	O
granulocytes	O
.	O

Analyses	O
with	O
cultured	O
cells	O
and	O
cell-free	O
systems	O
have	O
provided	O
strong	O
evidence	O
that	O
GATA-1	O
is	O
involved	O
in	O
control	O
of	O
globin	O
gene	O
expression	O
during	O
erythroid	O
differentiation	O
.	O

Pretreatment	O
of	O
ACH-2	O
T	O
cells	O
by	O
NAC	O
followed	O
by	O
stimulation	O
with	O
PMA	O
,	O
TNF-alpha	O
,	O
or	O
hydrogen	O
peroxide	O
(	O
H2O2	O
)	O
resulted	O
in	O
strong	O
suppression	O
of	O
NF-kappa	O
B	O
activation	O
.	O

These	O
results	O
indicate	S
that	S
DCoH	S
regulates	S
formation	S
of	S
transcriptionally	S
active	S
tetrameric	S
complexes	S
and	S
may	S
contribute	S
to	S
the	S
developmental	S
specificity	S
of	S
the	S
complex	S
.	O

This	O
was	O
in	O
sharp	O
contrast	O
to	O
endometrial	O
cells	O
where	O
3	O
kb	O
5'-flanking	O
DNA	O
conferred	O
strong	O
transcriptional	O
activation	O
on	O
the	O
dPRL	O
promoter	O
in	O
decidualized	O
endometrial	O
stromal	O
cells	O
actively	O
secreting	O
PRL	O
,	O
but	O
did	O
not	O
allow	O
transcription	O
in	O
undifferentiated	O
non-PRL-secreting	O
endometrial	O
stromal	O
cells	O
.	O

These	S
effects	S
of	S
D-ribose	S
seemed	S
almost	S
irreversible	S
but	O
could	O
be	O
prevented	O
by	O
addition	O
of	O
1	O
mM	O
aminoguanidine	O
or	O
10	O
mM	O
N-acetylcysteine	O
,	O
thus	O
suggesting	S
that	S
glycation	S
and	S
reactive	S
oxygen	S
species	S
,	S
generated	S
through	S
the	S
glycation	S
reaction	S
,	S
serve	S
as	S
mediators	S
of	S
the	S
phenomena	S
.	O

Furthermore	O
,	O
the	O
results	O
obtained	O
with	O
TNF	O
alpha	O
proved	O
that	O
NF-kappa	O
B	O
activation	O
was	O
not	O
sufficient	O
for	O
induction	O
of	O
neuroblastoma	O
differentiation	O
.	O

This	O
study	O
examined	O
the	O
role	O
of	O
various	O
cis-acting	O
regulatory	O
elements	O
in	O
the	O
lipopolysaccharide	O
(	O
LPS	O
)	O
induction	O
of	O
the	O
human	O
TNF-alpha	O
promoter	O
in	O
cells	O
of	O
monocytic	O
lineage	O
.	O

Analysis	O
of	O
the	O
nuclear	O
extracts	O
with	O
antibodies	O
directed	O
against	O
the	O
major	O
components	O
of	O
NF-kappa	O
B	O
the	O
p50	O
and	O
RelA	O
(	O
p65	O
)	O
proteins	O
,	O
indicated	O
that	O
the	O
composition	O
of	O
NF-kappa	O
B	O
was	O
similar	O
in	O
neonatal	O
and	O
adult	O
cells	O
.	O

Nuclear	O
factor	O
of	O
activated	O
T	O
cell	O
(	O
NFAT	O
)	O
family	O
members	O
play	O
a	O
critical	O
role	O
in	O
regulating	O
IL-4	O
transcription	O
and	O
interact	O
with	O
up	O
to	O
five	O
sequences	O
(	O
termed	O
P0	O
through	O
P4	O
)	O
in	O
the	O
IL-4	O
promoter	O
.	O

The	O
suppression	O
of	O
productive	O
LAI	O
replication	O
in	O
naive	O
T	O
cells	O
is	O
not	O
due	O
to	O
differential	O
expression	O
of	O
viral	O
coreceptors	O
,	O
nor	O
is	O
it	O
due	O
to	O
inhibition	O
of	O
activation	O
of	O
the	O
important	O
HIV	O
transcription	O
factors	O
,	O
nuclear	O
factor-kappaB	O
and	O
activator	O
protein-1	O
.	O

Nuclear	O
extracts	O
of	O
anti-CD15	O
cross-linked	O
cells	O
demonstrated	O
enhanced	O
levels	O
of	O
the	O
transcriptional	O
factor	O
activator	O
protein-1	O
,	O
minimally	O
changed	O
nuclear	O
factor-kappa	O
B	O
,	O
and	O
did	O
not	O
affect	O
SV40	O
promoter	O
specific	O
protein-1	O
.	O

Here	O
we	O
show	O
that	O
blockade	O
of	O
NF-kappaB	O
activity	O
,	O
using	O
a	O
dominant	O
negative	O
IkappaBalpha	O
,	O
has	O
opposite	O
effects	O
on	O
these	O
two	O
apoptotic	O
signals	O
.	O

The	O
-326	O
to	O
-615	O
region	O
contained	O
positive	O
regulatory	O
elements	O
.	O

There	O
is	O
no	S
clear	S
evidence	S
for	S
cytochrome	S
c	S
release	S
during	S
apoptosis	S
in	S
C.	S
elegans	S
or	S
Drosophila	S
,	S
however	S
.	O

Remarkably	O
,	O
we	O
observed	O
that	O
these	O
samples	O
displayed	O
a	O
persistent	O
expression	O
of	O
the	O
c-fos	O
protooncogene	O
,	O
associated	O
to	O
an	O
increased	O
AP-1	O
DNA-binding	O
activity	O
,	O
whereas	O
no	O
variations	O
of	O
CREB	O
or	O
NF-kB	O
were	O
detected	O
.	O

Implications	O
for	O
replication	O
of	O
HIV-1	O
.	O

Evaluation	O
of	O
the	O
role	O
of	O
ligand	O
and	O
thermal	O
activation	O
of	O
specific	O
DNA	O
binding	O
by	O
in	O
vitro	O
synthesized	O
human	O
glucocorticoid	O
receptor	O
.	O

The	O
link	O
between	O
cellular	O
production	O
of	O
such	O
important	O
mediators	O
of	O
inflammation	O
and	O
the	O
antioxidant	O
(	O
AO	O
)	O
thiols	O
,	O
cysteine	O
and	O
reduced	O
glutathione	O
(	O
GSH	O
)	O
,	O
is	O
discussed	O
and	O
it	O
is	O
hypothesised	S
that	S
NF-kappa	S
B	S
antagonists	S
may	S
offer	S
important	S
therapeutic	S
benefits	S
.	O

These	O
results	O
show	O
that	O
IL-2	O
is	O
capable	O
of	O
inducing	O
the	O
nuclear	O
expression	O
of	O
NF-kappaB	O
in	O
primary	O
CD8+	O
T-PLL	O
cells	O
,	O
and	O
that	O
this	O
effect	O
is	O
mediated	O
,	O
at	O
least	O
in	O
part	O
,	O
at	O
a	O
pretranslational	O
level	O
.	O

To	O
examine	O
the	O
behavior	O
of	O
Bcl-2	O
in	O
normal	O
cells	O
,	O
T	O
cell	O
blasts	O
were	O
transiently	O
transfected	O
with	O
Bcl-2	O
and	O
related	O
gene	O
products	O
to	O
determine	O
the	O
effect	O
on	O
apoptotic	O
signaling	O
.	O

A	O
4-bp	O
mutation	O
of	O
the	O
core	O
Sp1	O
consensus	O
element	O
(	O
GC	O
box	O
)	O
(	O
-20	O
)	O
reduced	O
overall	O
promoter	O
activity	O
of	O
the	O
1-kb	O
fragment	O
.	O

These	O
results	O
indicate	S
that	S
the	S
BCL-6	S
protein	S
can	S
function	S
as	S
a	S
sequence-specific	S
transcriptional	S
repressor	S
and	O
have	O
implications	O
for	O
the	O
role	O
of	O
BCL6	O
in	O
normal	O
lymphoid	O
development	O
and	O
lymphomagenesis	O
.	O

IL-10	O
profoundly	O
inhibited	O
release	O
of	O
IL-1beta	O
from	O
PBMC	O
stimulated	O
by	O
all	O
three	O
stimuli	O
.	O

LPS	O
is	O
not	O
able	O
to	O
induce	O
HIV-1	O
production	O
in	O
a	O
cloned	O
T	O
cell	O
line	O
.	O

In	O
contrast	O
,	O
inhibition	O
of	O
IL-1	O
beta	O
mRNA	O
was	O
of	O
lesser	O
magnitude	O
and	O
occurred	O
only	O
when	O
IL-10	O
was	O
added	O
within	O
2	O
h	O
of	O
cryptococcal	O
stimulation	O
.	O

These	O
results	O
imply	S
that	S
Myc	S
promotes	S
activation-induced	S
apoptosis	S
by	S
obligatory	S
heterodimerization	S
with	S
Max	S
,	S
and	S
therefore	S
,	S
by	S
regulating	S
gene	S
transcription	S
.	O

Finally	O
,	O
a	O
110-kDa	O
protein	O
has	O
been	O
identified	O
in	O
the	O
nuclei	O
of	O
all	O
the	O
B	O
,	O
but	O
not	O
T	O
,	O
cell	O
lines	O
that	O
specifically	O
binds	O
to	O
this	O
A-MYB	O
N-terminal	O
domain	O
.	O

Defining	O
therapeutic	O
targets	O
by	O
using	O
adenovirus	O
:	O
blocking	O
NF-kappaB	O
inhibits	O
both	O
inflammatory	O
and	O
destructive	O
mechanisms	O
in	O
rheumatoid	O
synovium	O
but	O
spares	O
anti-inflammatory	O
mediators	O
.	O

In	O
this	O
study	O
,	O
the	O
effect	O
of	O
anti-E.	O
chaffeensis	O
antibody	O
complexed	O
with	O
E.	O
chaffeensis	O
on	O
the	O
expression	O
of	O
major	O
proinflammatory	O
cytokines	O
in	O
human	O
monocytes	O
was	O
examined	O
.	O

To	O
investigate	O
the	O
activity	O
of	O
a	O
single	O
transcription	O
factor	O
in	O
individual	O
viable	O
cells	O
,	O
we	O
have	O
applied	O
an	O
assay	O
that	O
uses	O
the	O
fluorescence-activated	O
cell	O
sorter	O
to	O
quantitate	O
beta-galactosidase	O
(	O
beta-gal	O
)	O
.	O

Inverted	O
complement	O
contigs	O
are	O
marked	O
by	O
“c”	O
followed	O
by	O
the	O
contig	O
number	O
.	O

The	O
dissociation	O
constant	O
(	O
Kd	O
)	O
and	O
maximum	O
binding	O
capacity	O
(	O
MBC	O
)	O
of	O
the	O
NT3R	O
values	O
were	O
log	O
transformed	O
to	O
minimize	O
between-subject	O
variability	O
.	O

Remixing	O
of	O
purified	O
T	O
cells	O
showed	O
that	O
naive	O
T	O
cells	O
do	O
not	O
suppress	O
LAI	O
replication	O
in	O
memory	O
T	O
cells	O
and	O
that	O
memory	O
T	O
cells	O
do	O
not	O
restore	O
LAI	O
expression	O
in	O
naive	O
T	O
cells	O
.	O

Instead	O
of	O
the	O
whole	O
length	O
of	O
the	O
amino	O
acid	O
sequence	O
,	O
a	O
window	O
of	O
101	O
residues	O
centered	O
at	O
the	O
inframe	O
stop	O
codon	O
was	O
used	O
as	O
a	O
BLAST	O
query	O
.	O

We	O
find	O
that	O
OCA-B	O
binds	O
DNA	O
directly	O
in	O
the	O
major	O
groove	O
between	O
the	O
two	O
subdomains	O
of	O
the	O
POU	O
domain	O
,	O
requiring	O
both	O
an	O
A	O
at	O
the	O
fifth	O
position	O
of	O
the	O
octamer	O
element	O
and	O
contact	O
with	O
the	O
POU	O
domain	O
.	O

One	O
of	O
the	O
isolated	O
genes	O
,	O
that	O
for	O
retinaldehyde	O
dehydrogenase	O
2	O
(	O
RALDH2	O
)	O
,	O
was	O
regularly	O
expressed	O
in	O
most	O
of	O
the	O
T-ALL	O
cell	O
lines	O
that	O
coexpressed	O
TAL1	O
and	O
LMO	O
.	O

Tissue	O
and	O
cell-type	O
specific	O
expression	O
of	O
the	O
tuberous	O
sclerosis	O
gene	O
,	O
TSC2	O
,	O
in	O
human	O
tissues	O
.	O

The	O
p-value	O
reported	O
for	O
the	O
paired	O
t-test	O
was	O
Bonferroni-corrected	O
to	O
account	O
for	O
multiple	O
(	O
three	O
)	O
comparisons	O
.	O

This	O
may	S
be	S
an	S
important	S
molecular	S
site	S
of	S
steroid	S
action	S
.	O

The	O
large	O
number	O
of	O
individual	O
genes	O
represented	O
among	O
the	O
63	O
clones	O
and	O
their	O
apparent	O
non-cell-type-specific	O
expression	O
suggest	S
that	S
the	S
majority	S
of	S
the	S
Kruppel-related	S
zinc	S
finger	S
genes	S
are	S
likely	S
to	S
be	S
expressed	S
in	S
most	S
human	S
tissues	S
.	O

IL-2R	O
alpha	O
is	O
rapidly	O
and	O
potently	O
induced	O
in	O
T	O
cells	O
in	O
response	O
to	O
mitogenic	O
stimuli	O
.	O

CD15	O
engagement	O
by	O
monoclonal	O
antibody	O
also	O
attenuated	O
IL-1	O
beta	O
transcript	O
degradation	O
,	O
demonstrating	O
that	O
signaling	O
via	O
CD15	O
also	O
had	O
posttranscriptional	O
effects	O
.	O

All	S
sequence	S
motifs	S
within	S
the	S
functional	S
core	S
of	S
HS-40	S
,	S
as	S
mapped	S
by	S
transient	S
expression	S
analysis	S
,	S
appeared	S
to	S
bind	S
a	S
nuclear	S
factor	S
(	S
s	S
)	S
in	S
living	S
K562	S
cells	S
but	S
not	S
in	S
nonerythroid	S
cells	S
.	O

Overall	O
taxonomy	O
,	O
including	O
common	O
and	O
Latin	O
names	O
,	O
is	O
reported	O
on	O
the	O
right	O
side	O
of	O
the	O
figure	O
.	O

This	O
indication	O
of	O
precocious	O
metamorphic	O
changes	O
[	O
36	O
]	O
in	O
the	O
mutant	O
is	O
further	O
supported	O
by	O
the	O
finding	O
that	O
hemocytes	O
aggregate	O
in	O
a	O
segmental	O
pattern	O
in	O
early	O
rather	O
than	O
late	O
third	O
instar	O
(	O
see	O
Figure	O
4H–4J	O
)	O
,	O
and	O
that	O
the	O
hemocytes	O
lose	O
expression	O
of	O
Hemolectin	O
in	O
late	O
third-instar	O
larvae	O
rather	O
than	O
at	O
the	O
onset	O
of	O
metamorphosis	O
(	O
see	O
Figure	O
4G	O
)	O
[	O
21	O
]	O
.	O

Type	O
II	O
major	O
histocompatibility	O
complex	O
combined	O
immune	O
deficiency	O
(	O
type	O
II	O
MHC	O
CID	O
or	O
bare	O
lymphocyte	O
syndrome	O
)	O
is	O
a	O
congenital	O
immunodeficiency	O
disease	O
characterized	O
by	O
absent	O
MHC	O
class	O
II	O
expression	O
.	O

In	O
this	O
section	O
,	O
we	O
detail	O
the	O
objective	O
functions	O
we	O
used	O
and	O
their	O
effect	O
on	O
SCOPE	O
's	O
performance	O
.	O

Subsequently	O
,	O
conservation	O
of	O
the	O
inframe	O
stop	O
codons	O
in	O
each	O
cluster	O
was	O
examined	O
.	O

We	O
have	O
hypothesized	S
that	S
such	S
defects	S
in	S
fetal/neonatal	S
T-cell	S
activation	S
may	S
be	S
due	S
to	S
lack	S
of	S
expression	S
of	S
the	S
transcriptional	S
regulatory	S
elements	S
required	S
for	S
T-cell	S
activation	S
.	O

Adherence	O
is	O
an	O
important	O
initial	O
step	O
in	O
the	O
transition	O
of	O
a	O
circulating	O
monocyte	O
to	O
a	O
tissue	O
macrophage	O
.	O

Minimizing	O
energy	O
studies	O
of	O
BMT	O
structure	O
reveal	O
that	O
a	O
trans-disulfide	O
of	O
thiamine	O
(	O
holo	O
drug	O
)	O
disulfide	O
(	O
TDS	O
,	O
protodrug	O
)	O
is	O
allosterically	O
transited	O
to	O
the	O
reactive	O
twisted	O
disulfide	O
of	O
BMT	O
(	O
allo	O
drug	O
)	O
by	O
o	O
,	O
o'-bismyristoyl	O
esterification	O
of	O
TDS	O
.	O

Coordinate	O
inhibition	O
of	O
the	O
transcription	O
of	O
genes	O
for	O
inflammatory	O
cytokines	O
could	O
provide	O
a	O
strategy	O
for	O
therapy	O
of	O
diseases	O
with	O
inflammatory	O
pathogenesis	O
and	O
for	O
septic	O
shock	O
.	O

Finally	O
,	O
by	O
co-transfection	O
experiments	O
,	O
we	O
study	O
the	O
elements	O
involved	O
in	O
the	O
hGATA-1	O
transactivation	O
of	O
the	O
R-PK	O
promoter	O
in	O
HeLa	O
cells	O
.	O

Posterior	O
part	O
of	O
late	O
third-instar	O
wild-type	O
larva	O
(	O
H	O
)	O
.	O

Analysis	O
of	O
CAT	O
activity	O
revealed	O
that	O
cipro	O
enhanced	O
IL-2	O
gene	O
induction	O
.	O

However	O
,	O
reintroduction	O
of	O
a	O
functional	O
5-LOX	O
system	O
in	O
these	O
cells	O
allowed	O
ROI	O
production	O
and	O
5-LOX-dependent	O
NF-kappaB	O
activation	O
.	O

The	O
binding	O
of	O
oxidized	O
low-density	O
lipoprotein	O
(	O
Ox	O
LDL	O
)	O
by	O
monocyte-macrophages	O
causes	O
pleiotropic	O
effects	O
,	O
including	O
changes	O
in	O
gene	O
expression	O
,	O
and	O
is	S
thought	S
to	S
represent	S
an	S
early	S
event	S
in	S
atherogenesis	S
.	O

Apoptosis	O
mediated	O
by	O
HIV	O
protease	O
is	O
preceded	O
by	O
cleavage	O
of	O
Bcl-2	O
.	O

From	O
each	O
regulon	O
from	O
the	O
SCPD	O
database	O
15	O
we	O
selected	O
ten	O
six-mers	O
at	O
random	O
from	O
the	O
upstream	O
sequences	O
and	O
ten	O
six-mers	O
at	O
random	O
from	O
the	O
collection	O
of	O
known	O
binding	O
sites	O
for	O
that	O
regulon	O
.	O

To	O
isolate	O
cDNA	O
clones	O
that	O
dominantly	O
inhibit	O
the	O
DNA-binding	O
activity	O
of	O
Oct-2	O
,	O
chosen	O
as	O
a	O
representative	O
factor	O
,	O
we	O
have	O
developed	O
a	O
novel	O
screening	O
system	O
.	O

A	O
protein	O
Dpro_2	O
contains	O
yet	O
another	O
inframe	O
stop	O
codon	O
(	O
TAG	O
)	O
at	O
the	O
column	O
189	O
.	O

Normal	O
RBC	O
show	O
none	O
of	O
these	O
phenomena	O
.	O

In	O
T	O
lymphocytes	O
these	O
drugs	O
disrupt	O
an	O
unknown	O
step	O
in	O
the	O
transmission	O
of	O
signals	O
from	O
the	O
T-cell	O
antigen	O
receptor	O
to	O
cytokine	O
genes	O
that	O
coordinate	O
the	O
immune	O
response	O
.	O

Both	O
compounds	O
inhibited	O
the	O
mixed	O
lymphocyte	O
reaction	O
,	O
and	O
this	O
inhibition	O
was	O
reversed	O
by	O
exogenous	O
IL-2	O
.	O

Analogously	O
to	O
V	O
(	O
D	O
)	O
J	O
recombination	O
,	O
transposition	O
of	O
the	O
fly	O
Hermes	O
transposon	O
,	O
which	O
belongs	O
to	O
the	O
hAT	O
superfamily	O
,	O
is	O
also	O
characterized	O
by	O
a	O
double-strand	O
break	O
via	O
hairpin	O
formation	O
on	O
flanking	O
DNA	O
and	O
3	O
'	O
OH	O
joining	O
to	O
the	O
target	O
DNA	O
[	O
25	O
]	O
.	O

Antisense	O
cDNA	O
to	O
clone	O
18	O
inhibited	O
the	O
expression	O
of	O
a	O
reporter	O
construct	O
containing	O
the	O
DPA	O
promoter	O
,	O
indicating	O
its	O
functional	O
importance	O
in	O
the	O
expression	O
of	O
this	O
class	O
II	O
gene	O
.	O

Association	O
between	O
expression	O
of	O
intercellular	O
adhesion	O
molecule-1	O
and	O
integration	O
of	O
human	O
T-cell-leukemia	O
virus	O
type	O
1	O
in	O
adult	O
T-cell	O
leukemia	O
cells	O
.	O

However	O
,	O
mutation	O
of	O
the	O
AP-1	O
site	O
markedly	O
diminished	O
both	O
the	O
basal	O
and	O
PMA-activated	O
promoter	O
activity	O
.	O

Thus	O
,	O
the	O
data	O
by	O
Akthar	O
et	O
al	O
.	O
[	O
2	O
]	O
suggests	S
a	S
new	S
and	S
rather	S
unexpected	S
role	S
for	S
these	S
modules	S
in	S
RNA	S
binding	S
.	O

In	O
fact	O
,	O
we	O
find	O
a	O
two-fold	O
enrichment	O
for	O
iPfam	O
domain	O
pairs	O
in	O
the	O
complexes	O
described	O
by	O
Gavin	O
et	O
al	O
.	O
29	O
.	O

It	O
is	O
very	O
likely	S
that	S
these	S
domains	S
bind	S
megakaryocyte-specific	S
nuclear	S
proteins	S
acting	S
as	S
positive	S
transcription	S
factors	S
.	O

Anti-TNF-alpha	O
antibody	O
but	O
not	O
anti-IL-1	O
beta	O
antibody	O
strongly	O
inhibited	O
both	O
the	O
induction	O
of	O
HIV-1-LTR-driven	O
transcription	O
and	O
the	O
induction	O
of	O
NF-kappa	O
B	O
by	O
Fc	O
gamma	O
R	O
cross-linking	O
.	O

HIV-1	O
infection	O
of	O
myeloid	O
cells	O
can	S
lead	S
to	S
the	S
expression	S
of	S
surface	S
receptors	S
associated	S
with	S
cellular	S
activation	S
and/or	S
differentiation	S
that	S
increase	S
the	S
responsiveness	S
of	S
these	S
cells	S
to	S
cytokines	S
secreted	S
by	S
neighboring	S
cells	S
as	S
well	S
as	S
to	S
bacteria	S
or	S
other	S
pathogens	S
.	O

If	O
an	O
iORF	O
matched	O
any	O
protein-coding	O
genes	O
(	O
E-value	O
<	O
10-3	O
)	O
and	O
their	O
reading	O
frames	O
did	O
not	O
coincide	O
,	O
the	O
iORF	O
was	O
discarded	O
.	O

We	O
have	O
examined	O
the	O
effects	O
of	O
N-acetyl-L-cysteine	O
(	O
NAC	O
)	O
,	O
a	O
well-characterized	O
,	O
thiol-containing	O
antioxidant	O
,	O
on	O
agonist-induced	O
monocytic	O
cell	O
adhesion	O
to	O
endothelial	O
cells	O
(	O
EC	O
)	O
.	O

Human	O
monocytes	O
isolated	O
from	O
peripheral	O
blood	O
of	O
healthy	O
donors	O
show	O
a	O
time-dependent	O
differentiation	O
into	O
macrophages	O
upon	O
in	O
vitro	O
cultivation	O
,	O
closely	O
mimicking	O
their	O
in	O
vivo	O
migration	O
and	O
maturation	O
into	O
extravascular	O
tissues	O
.	O

We	O
have	O
previously	O
reported	O
that	O
infection	O
with	O
herpes	O
simplex	O
virus	O
type	O
1	O
(	O
HSV-1	O
)	O
activates	O
expression	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
provirus	O
in	O
T	O
cells	O
.	O

To	O
further	O
explore	O
the	O
ramifications	O
of	O
CD19	O
signaling	O
,	O
the	O
current	O
study	O
examined	O
whether	S
phosphorylation	S
of	S
Elk-1	S
,	S
activation	S
of	S
activator	S
protein-1	S
(	S
AP-1	S
)	S
,	S
or	S
activation	S
of	S
nuclear	S
factor-kappaB	S
(	S
NF-kappaB	S
)	S
transcription	S
factors	S
occurred	S
following	S
CD19	S
cross-linking	S
.	O

Finally	O
,	O
GM3	O
greatly	O
reduced	O
the	O
concentration	O
of	O
endogenous	O
GM-CSF	O
mRNA	O
induced	O
by	O
different	O
stimuli	O
in	O
Jurkat	O
T	O
cells	O
but	O
did	O
not	O
affect	O
interleukin	O
3	O
mRNA	O
levels	O
in	O
the	O
same	O
cells	O
.	O

Expression	O
of	O
IL-1alpha	O
by	O
HTLV-I	O
productively	O
infected	O
cells	O
may	S
be	S
important	S
in	S
the	S
hypercalcemia	S
,	S
osteolytic	S
bone	S
lesions	S
,	S
neutrophilia	S
,	S
elevation	S
of	S
C-reactive	S
protein	S
,	S
and	S
fever	S
frequently	S
seen	S
in	S
patients	S
with	S
HTLV-I-induced	S
adult	S
T-cell	S
leukemia/lymphoma	S
.	O

NK	O
cells	O
do	O
not	O
express	O
NFATc	O
constitutively	O
,	O
but	O
NFATc	O
mRNA	O
accumulation	O
is	O
induced	O
in	O
these	O
cells	O
within	O
2	O
h	O
of	O
stimulation	O
with	O
CD16	O
ligands	O
.	O

This	O
enhanced	O
DNA	O
binding	O
activity	O
was	O
inhibited	O
by	O
coincubation	O
of	O
CD36	O
transfected	O
cells	O
with	O
the	O
human	O
CD36-specific	O
antibody	O
OKM5	O
.	O

We	O
show	O
that	O
at	O
least	O
one	O
inducible	O
,	O
C1	O
,	O
and	O
one	O
constitutive	O
,	O
C2	O
,	O
protein	O
can	O
bind	O
to	O
the	O
HIV	O
enhancer	O
in	O
Jurkat	O
cells	O
.	O

Further	O
dissection	O
of	O
the	O
317	O
base	O
pair	O
region	O
demonstrates	O
that	O
,	O
whereas	O
all	O
317	O
base	O
pairs	O
are	O
required	O
for	O
expression	O
in	O
megakaryocytes	O
,	O
only	O
the	O
5	O
'	O
62	O
base	O
pairs	O
are	O
needed	O
for	O
erythroid-specific	O
reporter	O
expression	O
.	O

Although	O
the	O
average	O
performance	O
of	O
the	O
programs	O
did	O
not	O
differ	O
significantly	O
,	O
the	O
authors	O
found	O
that	O
,	O
for	O
each	O
pair	O
of	O
programs	O
,	O
each	O
program	O
performed	O
better	O
than	O
the	O
other	O
on	O
some	O
subset	O
of	O
the	O
data	O
5	O
.	O

CONCLUSION	O
:	O
We	O
suggest	S
that	S
Oct1	S
,	S
YY1	S
,	S
and	S
octamer-like	S
factors	S
binding	S
to	S
the	S
-90/-79	S
sequence	S
within	S
the	S
proximal	S
IL-5	S
promoter	S
are	S
involved	S
in	S
suppression	S
of	S
IL-5	S
transcription	S
in	S
T	S
cells	S
.	O

Lipopolysaccharide-induced	O
E-selectin	O
expression	O
requires	O
continuous	O
presence	O
of	O
LPS	O
and	O
is	O
inhibited	O
by	O
bactericidal/permeability-increasing	O
protein	O
.	O

Both	O
IL-2	O
and	O
IL-7	O
induced	O
substantial	O
amounts	O
of	O
STAT5A/STAT5B	O
heterodimerization	O
.	O

Thus	O
,	O
while	O
IL-10	O
has	O
deactivating	O
effects	O
on	O
PBMC	O
responses	O
to	O
all	O
three	O
stimuli	O
,	O
disparate	O
stimulus-	O
and	O
response-specific	O
patterns	O
of	O
deactivation	O
are	O
seen	O
.	O

Furthermore	O
there	O
was	O
a	O
clear-cut	O
synergy	O
between	O
the	O
PKC	O
stimulator	O
and	O
the	O
cAMP	O
elevating	O
agents	O
.	O

However	O
,	O
almost	O
no	O
novel	O
candidates	O
for	O
readthrough	O
genes	O
were	O
predicted	O
.	O

LPS	O
signaling	O
was	O
found	O
to	O
involve	O
NF	O
kappa	O
B	O
activation	O
by	O
the	O
p50/p65	O
heterodimers	O
.	O

Indeed	O
,	O
we	O
detected	O
gangliosides	O
in	O
supernatants	O
from	O
RCC	O
explants	O
and	O
not	O
from	O
adjacent	O
normal	O
kidney	O
tissue	O
.	O

However	O
,	O
continuous	O
treatments	O
with	O
subcytotoxic	O
concentrations	O
of	O
etoposide	O
(	O
0.15	O
microM	O
)	O
and	O
ICRF-193	O
(	O
0.3	O
microM	O
)	O
produced	O
several	O
similar	O
effects	O
,	O
namely	O
decreased	O
cell	O
proliferation	O
,	O
accumulation	O
of	O
cells	O
at	O
G2	O
,	O
increase	O
in	O
cell	O
mass	O
,	O
and	O
induction	O
of	O
differentiation	O
.	O

To	O
test	O
whether	S
the	S
reported	S
sea	S
urchin	S
sequences	S
represent	S
a	S
true	S
RAG1-like	S
match	S
,	O
we	O
cut	O
off	O
the	O
ring	O
finger	O
motif	O
and	O
repeated	O
the	O
BLASTP	O
search	O
against	O
all	O
GenBank	O
proteins	O
.	O

The	O
expression	O
of	O
the	O
TINUR	O
gene	O
is	O
induced	O
within	O
1	O
h	O
after	O
the	O
cross-linking	O
of	O
the	O
T	O
cell	O
Ag	O
receptor	O
complex	O
.	O

Rheumatoid	O
arthritis	O
is	O
a	O
multistep	O
disorder	O
associated	O
with	O
autoimmune	O
features	O
of	O
yet	O
unknown	O
etiology	O
.	O

On	O
the	O
basis	O
of	O
binding	O
,	O
reconstitution	O
and	O
cotransfection	O
experiments	O
,	O
we	O
propose	S
that	S
activation	S
of	S
NF-AT	S
occurs	S
in	S
at	S
least	S
two	S
stages	S
:	S
a	S
CsA-sensitive	S
stage	S
involving	S
modification	S
and/or	S
translocation	S
of	S
the	S
pre-existing	S
NF-AT	S
complex	S
,	S
and	S
a	S
CsA-insensitive	S
stage	S
involving	S
the	S
addition	S
of	S
newly	S
synthesized	S
Fos	S
or	S
Fos/Jun	S
proteins	S
to	S
the	S
pre-existing	S
complex	S
.	O

This	O
synergistic	O
suppression	O
could	O
not	O
be	O
explained	O
by	O
an	O
increase	O
in	O
cAMP	O
accumulation	O
in	O
T	O
cells	O
stimulated	O
with	O
DEX	O
and	O
PGE2	O
.	O

The	O
cyclosporin	O
A	O
(	O
CsA	O
)	O
/FK506-sensitive	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NFAT	O
)	O
plays	O
a	O
key	O
role	O
in	O
the	O
inducible	O
expression	O
of	O
cytokine	O
genes	O
in	O
T	O
cells	O
.	O

To	O
determine	O
the	O
role	O
of	O
AP-2	O
in	O
the	O
regulation	O
of	O
the	O
HTLV-I	O
LTR	O
gene	O
expression	O
,	O
we	O
used	O
an	O
AP-2	O
cDNA	O
in	O
DNA	O
binding	O
and	O
transient	O
expression	O
assays	O
.	O

The	S
current	S
human	S
protein	S
interaction	S
map	S
is	S
estimated	S
to	S
be	S
only	S
10	S
%	S
complete	S
18	O
.	O

However	O
,	O
activation	S
of	S
the	S
T	S
cell	S
lines	S
leading	S
to	S
enhanced	S
HIV-1	S
replication	S
can	S
be	S
induced	S
by	S
antigens	S
,	S
mitogens	S
,	S
and	S
cytokines	S
(	S
tumor	S
necrosis	S
factor	S
alpha	S
[	S
TNF-alpha	S
]	S
,	S
interleukin	S
1	S
,	S
and	S
interleukin-2	S
)	S
.	O

Eosinophil	O
granule	O
major	O
basic	O
protein	O
(	O
MBP	O
)	O
is	O
expressed	O
exclusively	O
in	O
eosinophils	O
and	O
basophils	O
in	O
hematopoietic	O
cells	O
.	O

The	O
appearance	O
of	O
a	O
novel	O
fusion	O
transcript	O
(	O
RAZ	O
)	O
,	O
which	O
comprised	O
regions	O
of	O
the	O
BZLF-1	O
locus	O
and	O
the	O
adjacent	O
BRLF-1	O
locus	O
,	O
was	O
detected	O
by	O
RT-PCR	O
.	O

Pb-induced	O
activation	O
of	O
NF-kappa	O
B	O
is	O
blocked	O
by	O
antibodies	O
for	O
p65	O
and	O
p50	O
subunits	O
but	O
not	O
cRel	O
,	O
indicating	S
that	S
the	S
p65	S
:	S
p50	S
heterodimer	S
(	S
NF-kappa	S
B	S
)	S
is	S
involved	S
.	O

This	O
allows	O
us	O
to	O
address	S
a	S
number	S
of	S
questions	S
:	S
what	S
proportion	S
of	S
each	S
organism	S
's	S
protein	S
interaction	S
network	S
,	S
its	S
interactome	S
,	S
can	S
be	S
attributed	S
to	S
a	S
known	S
domain–domain	S
interaction	S
?	O

The	O
P	O
sequence	O
was	O
located	O
between	O
positions	O
-79	O
and	O
-69	O
relative	O
to	O
the	O
transcription	O
start	O
site	O
of	O
the	O
human	O
IL-4	O
gene	O
,	O
and	O
this	O
location	O
was	O
confirmed	O
by	O
base-substitution	O
mutations	O
.	O

These	O
data	O
demonstrate	O
that	O
VitD3	O
induces	O
CD14	O
indirectly	O
through	O
some	O
intermediary	O
factor	O
,	O
and	O
suggest	S
a	S
critical	S
role	S
for	S
Sp1	S
in	S
this	S
process	S
.	O

Activation	O
of	O
the	O
transcription	O
factor	O
NF-kappaB	O
in	O
lipopolysaccharide-stimulated	O
U937	O
cells	O
.	O

Thus	O
the	O
suppression	O
of	O
CD11b/CD18	O
expression	O
by	O
tepoxalin	O
may	S
involve	S
IL-8	S
.	O

Pyrrolysine	O
,	O
the	O
22nd	O
amino	O
acid	O
encoded	O
by	O
stop	O
codon	O
UAG	O
,	O
was	O
recently	O
discovered	O
from	O
a	O
methanogenic	O
archaea	O
56	O
.	O

After	O
cellular	O
activation	O
,	O
I	O
kappa	O
B	O
alpha	O
is	O
rapidly	O
degraded	O
in	O
concert	O
with	O
the	O
induced	O
nuclear	O
translocation	O
of	O
NF-kappa	O
B	O
.	O

In	O
a	O
T-cell	O
clone	O
specific	O
for	O
pigeon	O
cytochrome	O
c	O
in	O
the	O
context	O
of	O
I-Ek	O
,	O
Oct-2	O
was	O
induced	O
by	O
antigen	O
stimulation	O
,	O
with	O
the	O
increase	O
in	O
Oct-2	O
protein	O
seen	O
first	O
at	O
3	O
h	O
after	O
activation	O
and	O
continuing	O
for	O
at	O
least	O
24	O
h	O
.	O

In	O
contrast	O
,	O
neither	O
ascorbate	O
nor	O
AZT	O
affected	O
NF-kappa	O
B	O
activity	O
under	O
all	O
three	O
induction	O
conditions	O
in	O
the	O
ACH-2	O
cell	O
line	O
.	O

Nuclear	O
extracts	O
assayed	O
for	O
the	O
presence	O
of	O
ISRE	O
binding	O
factors	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
show	O
that	O
ISGF3	O
is	O
induced	O
by	O
IFN-alpha	O
within	O
6	O
h	O
from	O
undetectable	O
basal	O
levels	O
in	O
untreated	O
U937	O
cells	O
.	O

In	O
a	O
recent	O
study	O
31	O
,	O
Gandhi	O
et	O
al	O
.	O
have	O
assessed	O
the	O
conservation	O
of	O
protein	O
interactions	O
as	O
the	O
co-occurrence	O
of	O
orthologous	O
interacting	O
proteins	O
.	O

These	O
results	O
lead	O
to	O
a	O
general	O
model	O
for	O
the	O
synergistic	O
function	O
of	O
activation	O
domains	O
in	O
Oct-1	O
and	O
OCA-B	O
(	O
mediated	O
by	O
the	O
combined	O
action	O
of	O
the	O
multiple	O
USA	O
components	O
)	O
and	O
,	O
further	O
,	O
suggest	S
a	S
functional	S
redundancy	S
in	S
general	S
coactivators	S
.	O

We	O
conclude	O
that	O
the	O
MAP	O
kinase	O
signal	O
transduction	O
pathway	O
consisting	O
of	O
Raf-1	O
,	O
MEK1	O
,	O
and	O
ERK1	O
and	O
ERK2	O
functions	O
in	O
the	O
stimulation	O
IL-2	O
gene	O
transcription	O
in	O
activated	O
T	O
lymphocytes	O
.	O

Purified	O
bcl-2	O
is	O
cleaved	O
by	O
HIV	O
protease	O
between	O
phenylalanine	O
112	O
and	O
alanine	O
113	O
.	O

The	O
data	O
suggest	S
that	S
differences	S
in	S
functional	S
responses	S
elicited	S
in	S
monocytes	S
by	S
all	S
three	S
factors	S
may	S
be	S
dependent	S
on	S
different	S
routes	S
on	S
nuclear	S
signalling	S
employed	S
by	S
the	S
factors	S
.	O

To	O
examine	O
intrafamily	O
conservation	O
of	O
the	O
inframe	O
stop	O
codons	O
,	O
these	O
iORFs	O
were	O
clustered	O
into	O
protein	O
families	O
based	O
on	O
sequence	O
similarity	O
.	O

Interleukin-2	O
(	O
IL-2	O
)	O
gene	O
expression	O
is	O
controlled	O
transcriptionally	O
by	O
the	O
cooperative	O
activity	O
of	O
specific	O
trans-activating	O
factors	O
that	O
bind	O
to	O
the	O
IL-2	O
enhancer	O
.	O

For	O
example	O
,	O
Zinc	O
finger	O
transcription	O
factors	O
have	O
been	O
demonstrated	O
to	O
bind	O
three	O
triplets	O
of	O
nucleotides	O
which	O
overlap	O
at	O
their	O
third	O
base	O
positions	O
21	O
.	O

These	O
data	O
suggest	S
that	S
CD19-mediated	S
signal	S
transduction	S
activates	S
different	S
transcription	S
factors	S
at	S
juxtaposed	S
stages	S
of	S
B	S
cell	S
development	S
that	S
may	S
culminate	S
in	S
the	S
activation	S
or	S
suppression	S
of	S
distinct	S
sets	S
of	S
genes	S
.	O

Nevertheless	O
,	O
dibutyryl	O
cAMP	O
induced	O
a	O
down-regulation	O
of	O
the	O
levels	O
of	O
this	O
proto-oncogene	O
.	O

Here	O
we	O
describe	O
the	O
functional	O
characterization	O
of	O
this	O
promoter	O
and	O
identification	O
of	O
the	O
factors	O
in	O
B	O
and	O
T	O
cells	O
that	O
regulate	O
its	O
activity	O
.	O

In	O
addition	O
,	O
proteins	O
specific	O
to	O
a	O
cellular	O
compartment	O
may	S
have	S
different	S
characteristics	S
to	S
proteins	S
in	S
other	S
compartments	S
.	O

A	O
phosphoform	O
of	O
newly	O
synthesized	O
I	O
kappa	O
B	O
alpha	O
is	O
visible	O
when	O
degradation	O
by	O
the	O
proteasome	O
is	O
inhibited	O
and	O
new	O
I	O
kappa	O
B	O
alpha	O
displays	O
the	O
same	O
properties	O
regarding	O
phosphorylation	O
and	O
degradation	O
in	O
response	O
to	O
a	O
second	O
inducer	O
.	O

Deletion	O
of	O
the	O
NF-kappa	O
B	O
elements	O
of	O
the	O
HIV-1	O
LTR	O
significantly	O
inhibited	O
Tat-mediated	O
transactivation	O
in	O
T-cell	O
lines	O
,	O
as	O
well	O
as	O
in	O
a	O
monocyte	O
line	O
,	O
U937	O
.	O

Furthermore	O
,	O
our	O
results	O
indicated	S
that	S
thymocytes	S
have	S
a	S
constitutively	S
active	S
form	S
of	S
NF-kB	S
,	O
suggesting	S
that	S
they	S
are	S
activated	S
in	S
vivo	S
.	O

Transient	O
transfection	O
studies	O
demonstrate	O
further	O
that	O
TCR-stimulated	O
activation	O
of	O
the	O
Ras	O
signaling	O
pathway	O
is	O
required	O
for	O
optimal	O
activation	O
of	O
CD95	O
ligand	O
.	O

We	O
report	O
the	O
characterization	O
of	O
the	O
cis-	O
and	O
trans-acting	O
elements	O
involved	O
in	O
the	O
tissue-specific	O
activity	O
of	O
the	O
L	O
gene	O
erythroid	O
promoter	O
.	O

Human	O
T	O
cell	O
transcription	O
factor	O
GATA-3	O
stimulates	O
HIV-1	O
expression	O
.	O

Transgenic	O
mice	O
with	O
a	O
lymphocyte-specific	O
defect	O
in	O
NF-kappaB	O
activation	O
were	O
produced	O
by	O
targeted	O
expression	O
of	O
human	O
IkappaB	O
alpha	O
.	O

We	O
identified	O
a	O
protein	O
,	O
p37	O
,	O
which	O
specifically	O
bound	O
to	O
DRE	O
1	O
.	O

It	O
is	O
well	O
known	O
that	O
the	O
genetic	O
code	O
varies	O
in	O
several	O
organisms	O
22	O
.	O

Proliferation	O
and	O
immunologic	O
function	O
of	O
T	O
lymphocytes	O
are	O
initiated	O
by	O
signals	O
from	O
the	O
antigen	O
receptor	O
that	O
are	O
inhibited	O
by	O
the	O
immunosuppressant	O
FK506	O
but	O
not	O
by	O
its	O
structural	O
analog	O
,	O
rapamycin	O
.	O

CsA	O
similarly	O
mediated	O
a	O
reduction	O
of	O
up	O
to	O
65	O
%	O
in	O
GM-CSF	O
mRNA	O
and	O
protein	O
expression	O
in	O
activated	O
endothelial	O
cells	O
.	O

Present	O
evidence	O
indicates	O
a	O
pathway	O
of	O
signal	O
transmission	O
in	O
T	O
cells	O
that	O
is	O
outlined	O
in	O
figure	O
1	O
.	O

Species	O
abbreviations	O
are	O
as	O
follows	O
:	O
AA	O
,	O
yellow	O
fever	O
mosquito	O
;	O
AG	O
,	O
African	O
malaria	O
mosquito	O
;	O
BF	O
,	O
lancelet	O
;	O
CL	O
,	O
bull	O
shark	O
;	O
DP	O
,	O
D.	O
pseudoobscura	O
fruit	O
fly	O
;	O
FR	O
,	O
fugu	O
fish	O
;	O
HM	O
,	O
hydra	O
;	O
HS	O
,	O
human	O
;	O
NV	O
,	O
starlet	O
sea	O
anemone	O
;	O
SP	O
,	O
sea	O
urchin	O
;	O
XL	O
,	O
frog	O
.	O

IL-2	O
induced	O
less	O
STAT1	O
alpha	O
activation	O
and	O
IFN-alpha	O
induced	O
greater	O
STAT5	O
activation	O
in	O
NK3.3	O
cells	O
compared	O
with	O
preactivated	O
primary	O
NK	O
cells	O
.	O

Taken	O
together	O
,	O
our	O
results	O
suggest	S
that	S
the	S
age-related	S
hyporesponsiveness	S
can	S
not	S
be	S
attributed	S
to	S
a	S
skewing	S
of	S
the	S
T	S
cell	S
population	S
towards	S
a	S
memory	S
phenotype	S
in	S
the	S
elderly	S
.	O

Addition	O
of	O
KCl	O
resulted	O
in	O
less	O
DNA	O
binding	O
either	S
due	S
to	S
blockage	S
of	S
DNA-receptor	S
complex	S
formation	S
or	S
disruption	S
of	S
the	S
complexes	S
.	O

Regulation	O
of	O
programmed	O
cell	O
death	O

Treatment	O
of	O
chronically	O
HIV-infected	O
PBMC	O
with	O
anti-CD2	O
mAb	O
has	O
been	O
shown	O
to	O
induce	O
the	O
expression	O
of	O
infectious	O
virus	O
from	O
these	O
cultures	O
.	O

CsA	O
also	O
suppressed	O
E-selectin	O
,	O
but	O
not	O
vascular	O
cell	O
adhesion	O
molecule-1	O
(	O
VCAM-1	O
)	O
expression	O
in	O
endothelial	O
cells	O
,	O
even	O
though	O
the	O
E-selectin	O
promoter	O
is	O
activated	O
by	O
NF-kappa	O
B	O
rather	O
than	O
NFAT	O
.	O

From	O
nuclear	O
runoff	O
experiments	O
,	O
we	O
found	O
that	O
one	O
subunit	O
in	O
particular	O
,	O
the	O
B2	O
isoform	O
(	O
Mr	O
=	O
56,000	O
)	O
,	O
was	O
amplified	O
primarily	O
by	O
transcriptional	O
means	O
.	O

This	O
protein	O
is	O
most	O
similar	O
to	O
the	O
105-kDa	O
precursor	O
polypeptide	O
of	O
p50-NF-kappa	O
B	O
.	O

There	O
was	O
a	O
more	O
marked	O
rise	O
of	O
the	O
number	O
of	O
receptors	O
in	O
middle-aged	O
(	O
44-55	O
years	O
)	O
hypertensives	O
vs	O
elderly	O
(	O
61-80	O
years	O
)	O
subjects	O
after	O
captopril	O
treatment	O
.	O

Eicosanoids	O
were	O
measured	O
in	O
peripheral	O
blood	O
monocytes	O
and	O
mammary	O
tissue	O
by	O
means	O
of	O
HPLC	O
;	O

These	O
data	O
demonstrate	O
that	O
PBMC	O
differentially	O
regulate	O
basal	O
HTLV-I	O
transcription	O
compared	O
with	O
Jurkat	O
T	O
cells	O
,	O
and	O
this	O
differential	O
regulation	O
is	O
due	O
,	O
in	O
part	O
to	O
differential	O
phosphorylation	O
and	O
binding	O
of	O
CREB/ATF-1	O
to	O
TRE-1	O
in	O
the	O
HTLV-I	O
promoter	O
.	O

AP-1	O
but	O
not	O
NF-IL-6	O
DNA	O
binding	O
activity	O
was	O
also	O
detected	O
in	O
C5a-stimulated	O
PBMC	O
;	O
however	O
,	O
its	O
delayed	O
expression	O
(	O
maximal	O
at	O
4	O
hours	O
)	O
suggested	S
a	S
less	S
important	S
role	S
in	S
the	S
rapid	S
production	S
of	S
IL-8	S
.	O

Taken	O
together	O
,	O
our	O
data	O
indicate	S
that	S
MS-2	S
mediates	S
induction	S
of	S
the	S
CD11b	S
gene	S
as	S
cells	S
of	S
the	S
monocytic	S
lineage	S
mature	S
.	O

Co-infection	O
of	O
T	O
cells	O
by	O
HIV-1	O
and	O
HHV-6	O
can	S
lead	S
to	S
both	S
activation	S
of	S
the	S
HIV-1	S
promoter	S
and	S
acceleration	S
of	S
the	S
cytopathic	S
effects	S
.	O

It	O
is	O
a	O
critically	O
important	O
enzyme	O
for	O
human	O
survival	O
because	O
its	O
congenital	O
absence	O
causes	O
severe	O
combined	O
immunodeficiency	O
disease	O
(	O
SCID	O
)	O
.	O

Because	O
the	O
vast	O
repertoire	O
of	O
BCRs	O
and	O
TCRs	O
can	O
not	O
be	O
encoded	O
genetically	O
,	O
ancestors	O
of	O
jawed	O
vertebrates	O
adopted	O
an	O
elegant	O
combinatorial	O
solution	O
[	O
1	O
]	O
.	O

These	O
22889	O
human	O
proteins	O
are	O
encoded	O
by	O
16904	O
distinct	O
genes	O
and	O
are	O
referred	O
to	O
as	O
the	O
Informative	O
Protein	O
Set	O
.	O

We	O
thus	O
chose	O
to	O
attach	O
a	O
flag	O
to	O
each	O
motif	O
,	O
indicating	O
whether	S
or	S
not	S
the	S
motif	S
should	S
be	S
orientation-neutral	S
.	O

It	O
is	O
known	O
that	O
expression	O
of	O
a	O
single	O
viral	O
immediate-early	O
protein	O
,	O
BZLF1	O
,	O
is	O
sufficient	O
to	O
initiate	O
the	O
switch	O
from	O
latent	O
to	O
lytic	O
infection	O
in	O
B	O
cells	O
.	O

Transcription	O
factor	O
NF-kappaB	O
is	O
crucial	O
in	O
activating	O
the	O
transcription	O
of	O
genes	O
encoding	O
proinflammatory	O
cytokines	O
.	O

We	O
have	O
investigated	O
the	O
constitutive	O
and	O
inducible	O
transcriptional	O
activity	O
mediated	O
by	O
five	O
kappa	O
B-related	O
sequence	O
elements	O
in	O
two	O
different	O
cell	O
types	O
.	O

To	O
address	O
the	O
role	O
of	O
Oct-2	O
in	O
the	O
T-cell	O
lineage	O
,	O
we	O
studied	O
the	O
expression	O
of	O
Oct-2	O
mRNA	O
and	O
protein	O
in	O
nontransformed	O
human	O
and	O
mouse	O
T	O
cells	O
.	O

A	O
new	O
gene	O
,	O
TINUR	O
,	O
was	O
cloned	O
from	O
apoptotic	O
PEER	O
cells	O
.	O

In	O
the	O
first	O
male	O
patient	O
,	O
the	O
number	O
of	O
receptors	O
was	O
very	O
low	O
,	O
while	O
the	O
affinity	O
was	O
lower	O
than	O
that	O
in	O
controls	O
.	O

We	O
note	O
that	O
all	O
the	O
motif	O
finders	O
tested	O
,	O
including	O
SCOPE	O
,	O
performed	O
poorly	O
on	O
the	O
Drosophila	O
dataset	O
.	O

Analogous	O
to	O
costimulation	O
via	O
CD28	O
,	O
this	O
activity	O
is	O
mediated	O
through	O
activation	O
of	O
Rel/kappaB	O
,	O
a	O
family	O
of	O
transcription	O
factors	O
known	O
to	O
regulate	O
IL-2	O
and	O
other	O
activation-inducible	O
proteins	O
.	O

Gel	O
shift	O
analysis	O
revealed	O
that	O
oxidative	O
suppression	O
of	O
NF-AT	O
represented	O
inhibition	O
in	O
the	O
early	O
generation	O
of	O
NFAT	O
complexes	O
rather	O
than	O
the	O
binding	O
of	O
preformed	O
NF-AT	O
complexes	O
.	O

Costimulatory	O
signals	O
,	O
such	O
as	O
activation	O
of	O
the	O
CD28	O
cell	O
surface	O
molecule	O
on	O
T	O
cells	O
,	O
lead	O
to	O
activation	O
through	O
a	O
distinct	O
region	O
of	O
the	O
granulocyte-macrophage	O
colony-stimulating	O
factor	O
(	O
GM-CSF	O
)	O
promoter	O
.	O

Congruous	O
with	O
the	O
involvement	O
of	O
a	O
Stat	O
protein	O
,	O
IL-4	O
induced	O
robust	O
Janus	O
kinase	O
3	O
(	O
JAK3	O
)	O
activity	O
in	O
BL-2	O
cells	O
.	O

Mice	O
treated	O
with	O
antisense	O
to	O
NF-kappa	O
B	O
ODNs	O
showed	O
rapid	O
regression	O
of	O
transplanted	O
fibrosarcomas	O
.	O

Binding	O
experiments	O
,	O
using	O
COS-7	O
cells	O
transiently	O
transfected	O
with	O
PML-RAR	O
and	O
the	O
normal	O
RAR	O
alpha	O
,	O
show	O
that	O
AM580	O
has	O
a	O
lower	O
affinity	O
than	O
ATRA	O
for	O
both	O
receptors	O
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

In	O
addition	O
to	O
activating	O
transcription	O
from	O
the	O
viral	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
through	O
the	O
cyclic	O
AMP	O
response	O
element	O
binding	O
protein/activating	O
transcription	O
factor	O
(	O
CREB/ATF	O
)	O
family	O
of	O
transcription	O
factors	O
,	O
Tax	O
activates	O
the	O
expression	O
of	O
multiple	O
cellular	O
promoters	O
through	O
the	O
NF-kappaB	O
pathway	O
of	O
transcriptional	O
activation	O
.	O

Conclusion	O

In	O
transient	O
transfectin	O
experiments	O
,	O
BCL6	O
can	O
repress	O
transcription	O
from	O
promoters	O
linked	O
to	O
its	O
DNA	O
target	O
sequence	O
and	O
this	O
activity	O
is	O
dependent	O
upon	O
specific	O
DNA-binding	O
and	O
the	O
presence	O
of	O
an	O
intact	O
N-terminal	O
half	O
of	O
the	O
protein	O
.	O

When	O
responses	O
to	O
G	O
(	O
Anh	O
)	O
MTetra	O
were	O
compared	O
with	O
those	O
to	O
LPS	O
and	O
muramyldipeptide	O
(	O
MDP	O
)	O
,	O
it	O
was	O
found	O
that	O
the	O
optimal	O
response	O
to	O
G	O
(	O
Anh	O
)	O
MTetra	O
induction	O
was	O
similar	O
to	O
that	O
of	O
LPS	O
but	O
significantly	O
higher	O
than	O
the	O
response	O
to	O
MDP	O
.	O

By	O
contrast	O
,	O
treatment	O
of	O
cells	O
with	O
pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
)	O
will	O
only	O
block	O
LPS-induced	O
NF-kappa	O
B	O
,	O
but	O
not	O
the	O
constitutive	O
binding	O
protein	O
.	O

Thus	O
,	O
NF-kappa	O
B	O
,	O
a	O
potent	O
transcriptional	O
activator	O
of	O
HIV	O
expression	O
,	O
is	O
also	O
involved	O
in	O
the	O
expression	O
of	O
RANTES	O
,	O
a	O
chemokine	O
that	O
blocks	O
infection	O
by	O
macrophage-tropic	O
strains	O
of	O
HIV	O
.	O

The	O
effect	O
of	O
NAC	O
was	O
also	O
examined	O
on	O
deletional	O
switch	O
recombination	O
underlying	O
the	O
isotype	O
switch	O
to	O
IgE	O
.	O

[	O
Regulation	O
of	O
transcription	O
of	O
the	O
interleukin-2	O
gene	O
in	O
B-lymphocytes	O
]	O

The	S
importance	S
of	S
resolution	S
of	S
this	S
controversy	S
is	S
that	S
future	S
research	S
in	S
this	S
area	S
should	S
be	S
directed	S
toward	S
the	S
understanding	S
of	S
alternative	S
mechanisms	S
that	S
can	S
result	S
in	S
the	S
successful	S
production	S
of	S
NO	S
.	O

This	O
result	O
was	O
not	O
attributable	O
to	O
lack	O
of	O
HLA-DQ	O
alpha	O
or	O
-DQ	O
beta	O
transcription	O
,	O
because	O
both	O
transcripts	O
were	O
present	O
in	O
the	O
CIITA-transfected	O
hybrids	O
,	O
although	O
at	O
reduced	O
levels	O
.	O

A	O
similar	O
localization	O
at	O
the	O
apical	O
cortex	O
and	O
in	O
the	O
cytoplasm	O
was	O
seen	O
for	O
a	O
functional	O
yellow	O
fluorescent	O
protein	O
(	O
YFP	O
)	O
:	O
:D-mib	O
fusion	O
protein	O
(	O
see	O
Figure	O
6	O
below	O
)	O
.	O

Northern	O
blot	O
analysis	O
failed	O
to	O
detect	O
IL-2	O
mRNA	O
,	O
suggesting	S
that	S
IL-2	S
may	S
act	S
in	S
a	S
paracrine	S
manner	S
in	S
vivo	S
.	O

Tissue	O
factor	O
(	O
TF	O
)	O
is	O
expressed	O
rapidly	O
by	O
human	O
monocytes	O
exposed	O
to	O
bacterial	O
endotoxin	O
(	O
lipopolysaccharide	O
,	O
or	O
LPS	O
)	O
.	O

Ligand	O
activation	O
of	O
c-ErbB	O
induced	O
the	O
tyrosine	O
phosphorylation	O
,	O
DNA-binding	O
,	O
and	O
reporter	O
gene	O
transcription	O
of	O
Stat	O
5b	O
in	O
erythroblasts	O
.	O

CD40/CD40	O
ligand	O
interactions	O
play	O
a	O
key	O
role	O
in	O
the	O
immune	O
responses	O
of	O
B	O
lymphocytes	O
,	O
monocytes	O
,	O
and	O
dendritic	O
cells	O
.	O

Our	O
results	O
suggest	S
that	S
AhR	S
may	S
play	S
an	S
important	S
role	S
in	S
the	S
function	S
of	S
monocytes	S
and	S
also	S
in	S
the	S
eventual	S
activation	S
of	S
environmental	S
carcinogens	S
.	O

Taken	O
together	O
,	O
our	O
data	O
demonstrate	O
that	O
TNF	O
gene	O
expression	O
in	O
monocytes	O
induced	O
by	O
different	O
types	O
of	O
stimuli	O
can	O
be	O
blocked	O
by	O
gangliosides	O
at	O
an	O
early	O
step	O
of	O
signal	O
transduction	O
.	O

The	O
ability	O
of	O
both	O
mitogens	O
and	O
cytokines	O
to	O
activate	O
NF-kappa	O
B	O
was	O
also	O
blocked	O
in	O
Jurkat	O
cells	O
constitutively	O
expressing	O
Tax	O
.	O

Functional	O
studies	O
indicated	S
that	S
the	S
TF	S
site	S
conferred	S
LPS	S
inducibility	S
on	S
a	S
heterologous	S
promoter	S
and	S
was	S
transactivated	S
by	S
c-Rel	S
or	S
p65	S
.	O

METHODS	O
:	O
Allergen-specific	O
T	O
cell	O
clones	O
and	O
T	O
cell	O
hybridomas	O
were	O
established	O
from	O
the	O
peripheral	O
blood	O
lymphocytes	O
of	O
patients	O
with	O
asthma	O
,	O
and	O
the	O
responses	O
to	O
various	O
stimuli	O
were	O
determined	O
.	O

The	S
primDCC	S
might	S
then	S
be	S
reinforced	S
by	S
the	S
addition	S
of	S
the	S
remaining	S
two	S
proteins	S
,	S
MSL3	S
and	S
MOF	S
,	O
one	S
or	S
both	S
of	O
which	O
might	S
recognize	S
other	S
motifs	S
within	S
the	S
roX2	S
RNA	S
,	S
to	S
form	S
the	S
mature	S
complex	S
(	S
matDCC	S
)	S
.	O

We	O
therefore	O
propose	S
that	S
such	S
cross-talking	S
among	S
distinct	S
adhesion	S
molecules	S
may	S
be	S
involved	S
in	S
the	S
pathogenesis	S
of	S
inflammation	S
,	S
including	S
RA	S
synovitis	S
.	O

To	O
study	O
this	O
element	O
and	O
its	O
role	O
in	O
class	O
II	O
gene	O
regulation	O
further	O
,	O
a	O
cDNA	O
library	O
was	O
screened	O
with	O
oligonucleotide	O
probes	O
containing	O
both	O
the	O
S	O
element	O
and	O
the	O
nearby	O
J	O
element	O
of	O
the	O
human	O
DPA	O
gene	O
.	O

The	O
activation	O
of	O
calcineurin	O
and	O
the	O
nuclear	O
import	O
of	O
NF-ATc	O
can	O
both	O
be	O
blocked	O
by	O
cyclosporin	O
A	O
or	O
FK506	O
in	O
complex	O
with	O
their	O
respective	O
immunophilins	O
.	O

NF-IL6	O
mRNA	O
was	O
found	O
in	O
human	O
Jurkat	O
T	O
cells	O
and	O
in	O
the	O
mouse	O
Th2	O
clone	O
D10	O
,	O
but	O
not	O
in	O
Th1	O
clone	O
29	O
.	O

Unfortunately	O
,	O
no	O
roX2	O
mutations	O
have	O
been	O
recovered	O
yet	O
;	O
they	O
would	S
be	S
important	S
tools	S
for	S
validating	S
the	S
significance	S
of	S
the	S
roX	S
RNAs	S
in	S
vivo	S
.	O

Our	O
results	O
lend	O
further	O
support	O
to	O
the	O
hypothesis	S
that	S
inflammatory	S
and	S
immune	S
responses	S
of	S
monocytes/macrophages	S
may	S
be	S
modulated	S
at	S
the	S
molecular	S
level	S
by	S
signals	S
originating	S
from	S
tissue	S
structural	S
cells	S
such	S
as	S
fibroblasts	S
.	O

IL-2R	O
alpha	O
transcription	O
is	O
at	O
least	O
in	O
part	O
controlled	O
by	O
two	O
positive	O
regulatory	O
regions	O
,	O
PRRI	O
and	O
PRRII	O
.	O

Addition	O
of	O
rIL-2	O
fully	O
restored	O
the	O
proliferative	O
response	O
and	O
partially	O
restored	O
the	O
production	O
of	O
IL-4	O
and	O
IL-5	O
,	O
but	O
not	O
that	O
of	O
other	O
cytokines	O
.	O

A	O
concatenated	O
form	O
of	O
Epstein-Barr	O
viral	O
DNA	O
in	O
lymphoblastoid	O
cell	O
lines	O
induced	O
by	O
transfection	O
with	O
BZLF1	O
.	O

The	O
involvement	O
of	O
the	O
CCK	O
(	O
B	O
)	O
receptor	O
in	O
such	O
a	O
stimulation	O
was	O
demonstrated	O
by	O
the	O
inhibiting	O
effect	O
of	O
the	O
selective	O
CCK	O
(	O
B	O
)	O
receptor	O
antagonist	O
PD-135,158	O
.	O

Our	O
results	O
demonstrate	O
that	O
IL-10	O
can	O
inhibit	O
the	O
induction	O
of	O
NF-kappa	O
B/Rel	O
nuclear	O
activity	O
in	O
CD3-stimulated	O
T	O
lymphocytes	O
.	O

these	O
cells	O
can	O
respond	O
to	O
IFN-gamma	O
and	O
express	O
beta-chain	O
.	O

A	O
well-preserved	O
4132-bp	O
Transib1_SP	O
element	O
(	O
contig	O
7839	O
,	O
positions	O
376–4506	O
)	O
is	O
flanked	O
by	O
a	O
5-bp	O
CGGCG	O
TSD	O
,	O
and	O
it	O
encodes	O
a	O
676-aa	O
TPase	O
(	O
two	O
exons	O
)	O
that	O
is	O
most	O
similar	O
to	O
the	O
Transib2	O
TPase	O
(	O
34	O
%	O
identity	O
)	O
.	O

Finally	O
,	O
ectopic	O
expression	O
of	O
neur	O
in	O
D-mib	O
mutant	O
larvae	O
rescues	O
the	O
wing	O
D-mib	O
phenotype	O
,	O
indicating	S
that	S
Neur	S
can	S
compensate	S
for	S
the	S
lack	S
of	S
D-mib	S
activity	S
.	O

These	O
data	O
may	S
expand	S
the	S
understanding	S
of	S
the	S
anti-thrombotic	S
and	S
anti-inflammatory	S
effects	S
of	S
these	S
drugs	S
when	S
activation	S
of	S
monocytes	S
occurs	S
.	O

Inhibition	O
of	O
protein	O
phosphatases	O
by	O
okadaic	O
acid	O
induces	O
AP1	O
in	O
human	O
T	O
cells	O
.	O

T	O
cell	O
receptor	O
(	O
TCR	O
)	O
cross-linking	O
is	O
in	O
part	O
required	O
for	O
activation	O
of	O
NF-kappaB	O
,	O
which	O
is	O
dependent	O
on	O
the	O
phosphorylation	O
and	O
degradation	O
of	O
IkappaBalpha	O
.	O

Whereas	O
anti-CD28	O
together	O
with	O
PMA	O
increased	O
the	O
DNA	O
binding	O
and	O
trans-activation	O
activity	O
of	O
NF-kappa	O
B	O
,	O
PMA-induced	O
activation	O
of	O
AP-1	O
was	O
significantly	O
suppressed	O
.	O

The	O
system	O
described	O
here	O
may	S
serve	S
as	S
a	S
model	S
for	S
studying	S
the	S
the	S
essential	S
genes	S
for	S
differentiation	S
of	S
normal	S
bone	S
marrow	S
cells	S
.	O

Oxidoreductive	O
regulation	O
of	O
nuclear	O
factor	O
kappa	O
B	O
.	O

In	O
5	O
cases	O
there	O
was	O
a	O
divergent	O
reaction	O
with	O
ER	O
and	O
PR	O
antibody	O
.	O

However	O
,	O
longer	O
periods	O
of	O
incubation	O
were	O
associated	O
with	O
a	O
return	O
to	O
the	O
distribution	O
of	O
PKC	O
in	O
control	O
cells	O
.	O

These	O
results	O
indicate	S
that	S
the	S
IL-5	S
gene	S
is	S
positively	S
regulated	S
by	S
cAMP	S
in	S
a	S
manner	S
opposite	S
to	S
that	S
for	S
the	S
IL-2	S
gene	S
.	O

Induction	O
of	O
endothelial	O
adhesion	O
molecules	O
by	O
the	O
cytokine	O
tumor	O
necrosis	O
factor-alpha	O
(	O
TNF	O
)	O
can	O
occur	O
independently	O
of	O
protein	O
kinase	O
C	O
and	O
activation	O
of	O
a	O
protein	O
tyrosine	O
kinase	O
(	O
PTK	O
)	O
has	O
recently	O
been	O
implicated	O
in	O
the	O
upregulation	O
of	O
vascular	O
cell	O
adhesion	O
molecule	O
1	O
(	O
VCAM-1	O
)	O
by	O
interleukin-4	O
(	O
IL-4	O
)	O
on	O
endothelial	O
cells	O
.	O

However	O
,	O
in	O
contrast	O
to	O
human	O
lymphocytes	O
,	O
IFN-gamma	O
production	O
was	O
inhibited	O
and	O
IFN-gamma	O
mRNA	O
levels	O
were	O
unaffected	O
at	O
24	O
h	O
and	O
only	O
slightly	O
upregulated	O
at	O
48	O
and	O
72	O
h	O
of	O
culture	O
in	O
murine	O
splenocytes	O
incubated	O
with	O
cipro	O
(	O
20	O
micrograms/ml	O
)	O
.	O

13,800	O
+/-	O
300	O
)	O
.	O

These	O
findings	O
suggest	S
that	S
bHLH	S
factors	S
are	S
required	S
to	S
control	S
T	S
cell	S
development	S
after	S
the	S
T/NK	S
developmental	S
checkpoint	S
.	O

When	O
the	O
MLE	O
protein	O
,	O
which	O
encodes	O
an	O
RNA	O
helicase	O
,	O
was	O
absent	O
,	O
both	O
roX	O
RNAs	O
were	O
found	O
only	O
at	O
their	O
site	O
of	O
transcription	O
but	O
not	O
in	O
any	O
other	O
of	O
the	O
35	O
entry	O
sites	O
where	O
MSL1	O
and	O
MSL2	O
were	O
present	O
,	O
suggesting	S
that	S
neither	S
of	S
the	S
roX	S
RNAs	S
can	S
be	S
integrated	S
in	S
a	S
minimal	S
MSL1-MSL2	S
complex	S
.	O

Different	O
types	O
of	O
acute	O
myeloid	O
leukemia	O
blast	O
cells	O
were	O
induced	O
to	O
differentiate	O
in	O
vitro	O
with	O
all-trans-retinoic	O
acid	O
(	O
ATRA	O
)	O
and	O
vitamin	O
D3	O
(	O
VD	O
)	O
.	O

IL-4	O
enhanced	O
CD11b	O
,	O
but	O
inhibited	O
CD26	O
expression	O
and	O
delayed	O
CD13	O
loss	O
.	O

By	O
multimerizing	O
the	O
regulatory	O
elements	O
of	O
the	O
GM-CSF	O
promoter	O
,	O
we	O
found	O
that	O
one	O
of	O
the	O
target	O
sites	O
for	O
the	O
CN	O
action	O
is	O
the	O
conserved	O
lymphokine	O
element	O
0	O
(	O
CLE0	O
)	O
,	O
located	O
at	O
positions	O
between	O
-54	O
and	O
-40	O
.	O

Cg-Gal4	O
is	O
expressed	O
only	O
in	O
certain	O
compartments	O
of	O
lymph	O
gland	O
lobes	O
containing	O
relatively	O
mature	O
hemocytes	O
,	O
and	O
strongly	O
in	O
most	O
circulating	O
hemocytes	O
[	O
22	O
,	O
23	O
]	O
.	O

NF-kappa	O
B-dependent	O
induction	O
of	O
the	O
NF-kappa	O
B	O
p50	O
subunit	O
gene	O
promoter	O
underlies	O
self-perpetuation	O
of	O
human	O
immunodeficiency	O
virus	O
transcription	O
in	O
monocytic	O
cells	O
.	O

Both	O
adenosine	O
and	O
deoxyadenosine	O
are	O
biologically	O
active	O
purines	O
that	O
can	O
have	O
a	O
deep	O
impact	O
on	O
cellular	O
physiology	O
;	O
notably	O
,	O
ADA	O
deficiency	O
in	O
humans	O
causes	O
severe	O
combined	O
immunodeficiency	O
.	O

To	O
identify	O
an	O
EBNA2	O
dependent	O
cis-acting	O
element	O
,	O
various	O
TP1	O
promoter-reporter	O
gene	O
constructs	O
were	O
transfected	O
in	O
the	O
absence	O
and	O
presence	O
of	O
an	O
EBNA2	O
expression	O
vector	O
into	O
the	O
established	O
B-cell	O
line	O
BL41-P3HR1	O
.	O

These	O
redox	O
changes	O
are	O
similar	O
to	O
those	O
observed	O
with	O
anoxia/reoxygenation	O
.	O

Thus	O
,	O
our	O
data	O
suggest	S
that	S
TPO	S
has	S
a	S
distinct	S
action	S
on	S
erythropoiesis	S
.	O

Coincident	O
with	O
many	O
inflammatory	O
diseases	O
is	O
tissue	O
hypoxia	O
.	O

Differentiation	O
assays	O
using	O
water	O
soluble	O
phorbol	O
esters	O
reveal	O
that	O
differentiation	O
becomes	O
irreversible	O
soon	O
after	O
AP-1	O
appears	O
.	O

We	O
therefore	O
tested	O
the	O
possibility	S
that	S
the	S
GM-CSF	S
gene	S
is	S
also	S
regulated	S
by	S
a	S
cognate	S
motif	S
for	S
the	S
NF-kappa	S
B	S
transcription	S
factor	S
.	O

In	O
parallel	O
with	O
such	O
differentiation	O
,	O
HIV	O
transcription	O
,	O
monitored	O
using	O
an	O
HIV	O
long	O
terminal	O
repeat	O
reporter	O
gene	O
construct	O
,	O
is	O
activated	O
in	O
such	O
cells	O
under	O
the	O
influence	O
of	O
enhanced	O
NF-kappa	O
B	O
expression	O
.	O

However	O
,	O
MAPK	O
activation	O
was	O
easily	O
detected	O
by	O
in	O
vitro	O
kinase	O
assays	O
,	O
after	O
FcR	O
cross-linking	O
with	O
immune	O
complexes	O
.	O

Furthermore	O
,	O
CD40	O
ligation	O
of	O
a	O
HLA-A2+	O
,	O
MelanA/MART1+	O
MM	O
cell	O
line	O
enhanced	O
its	O
susceptibility	O
to	O
specific	O
lysis	O
by	O
a	O
HLA-A2-restricted	O
,	O
MelanA/MART-1-specific	O
CTL	O
clone	O
.	O

With	O
respect	O
to	O
arginine	O
residues	O
,	O
only	O
the	O
two	O
single	O
mutations	O
of	O
R-276	O
and	O
R-394	O
to	O
alanine	O
showed	O
a	O
dramatic	O
decrease	O
of	O
agonist	O
and	O
antagonist	O
binding	O
whereas	O
the	O
R272A	O
mutation	O
showed	O
only	O
a	O
slight	O
effect	O
.	O

Prx	O
;	O
Peroxiredoxin	O
,	O
TPO	O
;	O
thiol	O
:	O
protein	O
disulphide	O
oxidereductase	O
,	O
Adeh	O
;	O
Anaeromyxobacter	O
dehalogenans	O
,	O
Gmet	O
;	O
Geobacter	O
metallireducens	O
,	O
Gsul	O
;	O
G.	O
sulfurreducens	O
,	O
Dpsy	O
;	O
Desulfotalea	O
psychrophila	O
.	O

We	O
have	O
constructed	O
an	O
HIV-1	O
genome	O
carrying	O
the	O
cDNA	O
of	O
a	O
proteolysis-resistant	O
nuclear	O
factor-kappaB	O
inhibitor	O
(	O
IkappaB-alphaS32/36A	O
)	O
in	O
the	O
nef	O
region	O
.	O

Expression	O
of	O
the	O
human	O
RAR-alpha	O
in	O
receptor-negative	O
erythroblasts	O
conferred	O
RA-induced	O
regulation	O
of	O
differentiation	O
to	O
the	O
otherwise	O
unresponsive	O
cells	O
,	O
thus	O
showing	O
that	O
the	O
RAR-alpha	O
is	O
essential	O
for	O
the	O
RA	O
effect	O
.	O

We	O
have	O
shown	O
elsewhere	O
that	O
both	O
the	O
major	O
immediate-early	O
gene	O
(	O
MIE	O
)	O
and	O
lytic	O
cycle	O
infectious	O
progeny	O
virus	O
expression	O
can	O
be	O
induced	O
in	O
otherwise	O
nonpermissive	O
monocyte-like	O
U-937	O
cell	O
cultures	O
infected	O
with	O
either	O
human	O
CMV	O
(	O
HCMV	O
)	O
or	O
simian	O
CMV	O
(	O
SCMV	O
)	O
by	O
treatment	O
with	O
the	O
phorbol	O
ester	O
12-O-tetradecanoylphorbol-13-acetate	O
(	O
TPA	O
)	O
.	O

Activated	O
NF-kappa	O
B	O
in	O
nuclear	O
extracts	O
was	O
measured	O
by	O
an	O
electrophoretic	O
mobility	O
shift	O
assay	O
using	O
32P-labeled	O
probe	O
.	O

Multiple	O
Oct2	O
isoforms	O
are	O
generated	O
by	O
alternative	O
splicing	O
.	O

In	O
this	O
study	O
,	O
therefore	O
,	O
TNF-alpha	O
bioavailability	O
from	O
mononuclear	O
cells	O
isolated	O
from	O
10	O
patients	O
with	O
thalassaemia	O
or	O
sickle	O
cell	O
anaemia	O
given	O
DFX	O
as	O
compared	O
to	O
10	O
untreated	O
subjects	O
has	O
been	O
evaluated	O
.	O

The	O
in	O
vitro	O
transendothelial	O
migration	O
of	O
circulating	O
filarial	O
antigen-specific	O
T-cells	O
was	O
examined	O
in	O
Wuchereria	O
banerofti	O
infection	O
.	O

A	O
protein	O
footprint	O
was	O
visible	O
over	O
this	O
region	O
of	O
the	O
c-myb	O
5	O
'	O
flanking	O
sequence	O
in	O
activated	O
T	O
cells	O
but	O
not	O
in	O
unactivated	O
T	O
cells	O
.	O

Nuclear	O
factor-kappa	O
B	O
(	O
NF-kappa	O
B	O
)	O
plays	O
a	O
broad	O
role	O
in	O
gene	O
regulation	O
,	O
but	O
it	O
is	O
not	S
evident	S
whether	S
NF-kappa	S
B	S
acts	S
as	S
a	S
messenger	S
system	S
for	S
germline	S
C	S
epsilon	S
transcription	S
.	O

The	O
total	O
number	O
of	O
missing	O
proteins	O
will	O
be	O
lower	O
,	O
as	O
several	O
entries	O
from	O
different	O
databases	O
refer	O
to	O
the	O
same	O
sequence	O
.	O

Neutrophil	O
maturation	O
and	O
the	O
role	O
of	O
retinoic	O
acid	O
.	O

E-selectin	O
is	O
induced	O
within	O
1-2	O
h	O
,	O
peaks	O
at	O
4-6	O
h	O
,	O
and	O
gradually	O
returns	O
to	O
basal	O
level	O
by	O
24	O
h	O
.	O

Activation	O
of	O
PPARgamma	O
may	S
play	S
a	S
role	S
in	S
the	S
induction	S
of	S
differentiation	S
of	S
macrophages	S
to	S
foam	S
cells	S
that	S
are	S
associated	S
with	S
atherosclerotic	S
lesions	S
.	O

The	O
most	O
severe	O
cact	O
null	O
mutation	O
(	O
cactE8/cactD13	O
)	O
,	O
leading	O
to	O
developmental	O
arrest	O
in	O
larvae	O
(	O
less	O
than	O
8	O
%	O
pupate	O
)	O
,	O
is	O
partially	O
rescued	O
in	O
animals	O
with	O
overexpression	O
of	O
ADGF-A	O
when	O
the	O
pupariation	O
rate	O
is	O
increased	O
3-fold	O
(	O
Figure	O
8A	O
)	O
.	O

We	O
previously	O
characterized	O
Drosophila	O
and	O
human	O
TAF	O
subunits	O
that	O
make	O
up	O
the	O
core	O
TFIID	O
complex	O
found	O
in	O
all	O
cells	O
.	O

Nuclear	O
translocation	O
of	O
NF-kappaB	O
subunits	O
may	S
ultimately	S
increase	S
the	S
intracellular	S
pool	S
of	S
NF-kappaB/IkappaBalpha	S
by	S
an	S
autoregulatory	S
mechanism	S
.	O

Primary	O
(	O
partial	O
)	O
cortisol	O
receptor	O
resistance	O
was	O
previously	O
reported	O
in	O
a	O
total	O
of	O
7	O
patients	O
and	O
14	O
asymptomatic	O
family	O
members	O
.	O

The	O
transcription	O
factor	O
GATA-1	O
is	O
essential	O
for	O
normal	O
erythropoiesis	O
.	O

In	O
particular	O
,	O
our	O
findings	O
suggest	S
that	S
local	S
metabolism	S
of	S
steroids	S
by	S
normal	S
as	S
well	S
as	S
leukemic	S
myeloid	S
cells	S
influences	S
their	S
responsiveness	S
to	S
D3	S
and	S
retinoids	S
.	O

This	O
revealed	O
that	O
NF-kappaB	O
generation	O
was	O
sensitive	O
to	O
chloroquine	O
,	O
an	O
inhibitor	O
of	O
acidic	O
sphingomyelinase	O
,	O
but	O
not	O
to	O
the	O
phosphatidylinositol	O
3-kinase	O
inhibitor	O
,	O
wortmannin	O
.	O

LPS-specific	O
Abs	O
thus	O
mediate	O
anti-inflammatory	O
and	O
proinflammatory	O
functions	O
,	O
respectively	O
,	O
by	O
preventing	O
target	O
cell	O
uptake	O
of	O
LPS	O
through	O
mCD14	O
and	O
augmenting	O
uptake	O
through	O
CR1	O
or	O
other	O
cell	O
receptors	O
.	O

The	S
difference	S
in	S
effectiveness	S
may	S
be	S
explained	S
by	S
the	S
different	S
expression	S
patterns	S
of	S
the	S
drivers	S
.	O

The	O
transcription	O
factor	O
GATA-1	O
is	O
expressed	O
in	O
a	O
subset	O
of	O
hemopoietic	O
cells	O
,	O
where	O
it	O
mediates	O
the	O
cell-type	O
specific	O
expression	O
of	O
several	O
genes	O
.	O

There	O
is	O
another	O
approach	O
to	O
searching	O
for	O
the	O
23rd	O
amino	O
acid	O
.	O

These	O
findings	O
suggest	S
that	S
PRE-I	S
may	S
play	S
a	S
role	S
in	S
the	S
differential	S
regulation	S
of	S
IL-4	S
gene	S
expression	S
levels	S
.	O

Our	O
results	O
define	O
the	O
NF-kappa	O
B	O
system	O
as	O
an	O
intermediate	O
event	O
in	O
CD40	O
signaling	O
and	O
suggest	S
that	S
the	S
CD40	S
pathway	S
can	S
influence	S
the	S
expression	S
of	S
B	S
cell-associated	S
genes	S
with	S
NF-kappa	S
B	S
consensus	S
sites	S
.	O

Furthermore	O
,	O
CD28-dependent	S
elevation	S
of	S
c-jun	S
mRNA	S
does	S
not	S
appear	S
to	S
be	S
mediated	S
at	S
the	S
level	S
of	S
mRNA	S
stability	S
.	O

Similarly	O
,	O
the	O
p105	O
precursor	O
of	O
the	O
NF-kappa	O
B	O
p50	O
subunit	O
is	O
also	O
post-translationally	O
processed	O
in	O
the	O
proteasome	O
.	O

This	O
difference	O
in	O
gene	O
regulation	O
suggests	S
distinct	S
biological	S
roles	S
in	S
the	S
control	S
of	S
cell	S
proliferation	S
for	S
the	S
respective	S
proteins	S
.	O

Specifically	O
,	O
removal	O
of	O
the	O
N-terminal	O
36	O
amino	O
acids	O
of	O
I	O
kappa	O
B	O
alpha	O
failed	O
to	O
disrupt	O
its	O
ability	O
to	O
form	O
latent	O
complexes	O
with	O
NF-kappa	O
B	O
in	O
the	O
cytoplasm	O
.	O

The	O
number	O
and	O
overlap	O
of	O
distinct	O
proteins	O
(	O
shown	O
in	O
B	O
)	O
and	O
distinct	O
interactions	O
(	O
shown	O
in	O
C	O
)	O
are	O
shown	O
for	O
the	O
LR400	O
dataset	O
,	O
the	O
Rhodes	O
prediction	O
dataset	O
and	O
the	O
June	O
2006	O
version	O
of	O
the	O
HPRD	O
.	O

Contig	O
accession	O
numbers	O
are	O
shown	O
in	O
the	O
left	O
column	O
.	O

Unlike	O
other	O
class	O
II	O
promoters	O
,	O
the	O
HLA-DR	O
alpha	O
(	O
DRA	O
)	O
promoter	O
also	O
contains	O
one	O
element	O
identical	O
to	O
the	O
``	O
octamer	O
''	O
motif	O
of	O
immunoglobulin	O
variable	O
region	O
promoters	O
that	O
is	O
responsible	O
for	O
B	O
cell-specific	O
transcription	O
.	O

Increasing	O
quantities	O
of	O
randomly	O
selected	O
upstream	O
regions	O
were	O
added	O
to	O
each	O
regulon	O
.	O

Both	S
these	S
proteins	S
are	S
believed	S
to	S
be	S
part	S
of	S
the	S
SNARE	S
(	S
soluble	S
N-ethylmaleimide-sensitive	S
factor	S
attachment	S
protein	S
receptor	S
)	S
family	S
of	S
proteins	S
which	S
are	S
involved	S
in	S
membrane	S
fusion	S
events	S
.	O

Instead	O
of	O
NF	O
kappa	O
B	O
,	O
the	O
activator	O
protein	O
3	O
binds	O
to	O
the	O
divergent	O
site	O
in	O
HIV-2	O
.	O

The	O
oxLDL-induced	O
NF-kappa	O
B	O
activation	O
was	O
accompanied	O
by	O
an	O
initial	O
depletion	O
of	O
I	O
kappa	O
B-alpha	O
followed	O
by	O
a	O
slight	O
transient	O
increase	O
in	O
the	O
level	O
of	O
this	O
inhibitor	O
protein	O
.	O

Inducible	O
expression	O
and	O
phosphorylation	O
of	O
coactivator	O
BOB.1/OBF.1	O
in	O
T	O
cells	O
[	O
see	O
comments	O
]	O

Taken	O
together	O
,	O
these	O
results	O
suggest	S
that	S
inhibition	S
of	S
NF	S
kappa	S
B	S
activation	S
may	S
be	S
an	S
important	S
mechanism	S
for	S
IL-10	S
suppression	S
of	S
cytokine	S
gene	S
transcription	S
in	S
human	S
monocytes	S
.	O

Superantigens	O
activate	O
HIV-1	O
gene	O
expression	O
in	O
monocytic	O
cells	O
.	O

We	O
have	O
therefore	O
investigated	O
the	O
changes	O
in	O
protein	O
kinase	O
C	O
(	O
PKC	O
)	O
activity	O
upon	O
exposure	O
of	O
monocytes	O
to	O
M-CSF	O
.	O

The	O
levels	O
of	O
secreted	O
IL-1beta	O
,	O
TNF-alpha	O
,	O
and	O
IL-6	O
during	O
24	O
h	O
of	O
stimulation	O
were	O
comparable	O
to	O
those	O
induced	O
by	O
Escherichia	O
coli	O
lipopolysaccharide	O
at	O
1	O
microg/ml	O
.	O

Alternatively	O
,	O
the	O
IL-4Ralpha	O
chain	O
may	S
transduce	S
intracellular	S
signals	S
that	S
lead	S
to	S
Cepsilon	S
gene	S
transcription	S
independently	S
of	S
its	S
association	S
with	S
other	S
chains	S
.	O

Evidence	O
for	O
a	O
role	O
for	O
PKCalpha	O
as	O
an	O
effector	O
of	O
Rho	O
was	O
obtained	O
by	O
the	O
observation	O
that	O
coexpression	O
of	O
the	O
N-terminal	O
domain	O
of	O
PKCalpha	O
blocked	O
the	O
effects	O
of	O
activated	O
Rho	O
plus	O
PMA	O
on	O
AP-1	O
transcriptional	O
activity	O
.	O

The	O
activity	O
of	O
the	O
enhancer	O
is	O
almost	O
completely	O
dependent	O
on	O
the	O
integrity	O
of	O
a	O
dimeric	O
GATA-1	O
binding	O
site	O
.	O

The	O
critical	O
third	O
nucleotide	O
of	O
the	O
hAT	O
5	O
'	O
termini	O
is	O
always	O
G	O
,	O
as	O
opposed	O
to	O
C	O
in	O
the	O
RSS	O
heptamer	O
.	O

To	O
test	O
whether	S
this	S
specific	S
increase	S
in	S
the	S
level	S
of	S
Ser	S
at	S
the	S
apical	S
cortex	S
resulted	S
from	S
reduced	S
Ser	S
endocytosis	S
in	S
D-mib	S
mutant	S
cells	S
,	O
we	O
followed	O
the	O
endocytosis	O
of	O
Ser	O
in	O
living	O
imaginal	O
discs	O
using	O
an	O
antibody	O
uptake	O
assay	O
.	O

Remarkably	O
,	O
the	O
hydra	O
RAG1L_NM	O
protein	O
turned	O
out	O
to	O
be	O
significantly	O
similar	O
to	O
the	O
Transib	O
TPase	O
(	O
26	O
%	O
identity	O
;	O
E-value	O
is	O
approximately	O
equal	O
to	O
10-14	O
in	O
a	O
BLASTX	O
search	O
against	O
GenBank	O
proteins	O
combined	O
with	O
the	O
Transib	O
TPase	O
sequences	O
)	O
.	O

Nucleotide	O
positions	O
of	O
the	O
RAG1-like	O
sequences	O
are	O
shown	O
beneath	O
the	O
white	O
rectangles	O
.	O

Although	O
the	O
-20	O
GATA	O
binding	O
site	O
(	O
AGATAA	O
)	O
is	O
also	O
a	O
potential	O
TFIID	O
binding	O
site	O
,	O
it	O
does	O
not	O
bind	O
TFIID	O
.	O

Chloramphenicol	O
acetyltransferase	O
(	O
CAT	O
)	O
activities	O
directed	O
by	O
5	O
'	O
upstream	O
promoter	O
were	O
detected	O
preferentially	O
in	O
perforin-expressing	O
cell	O
lines	O
.	O

Stimulation	O
of	O
the	O
cAMP	O
signal	O
transduction	O
pathway	O
,	O
which	O
skews	O
cytokine	O
production	O
toward	O
a	O
Th2	O
pattern	O
,	O
resulted	O
in	O
the	O
preferential	O
suppression	O
of	O
Stat1	O
activity	O
.	O

7	O
.	O
Our	O
results	O
suggest	S
that	S
the	S
balance	S
between	S
oxidation	S
of	S
SMX	S
to	S
its	S
toxic	S
metabolites	S
and	S
their	S
reduction	S
is	S
an	S
important	S
protective	S
cellular	S
mechanism	S
.	O

Expression	O
of	O
all	O
mammalian	O
genes	O
of	O
the	O
MCM	O
family	O
is	O
induced	O
by	O
growth	O
stimulation	O
,	O
unlike	O
yeast	O
,	O
and	O
the	O
mRNA	O
levels	O
peak	O
at	O
G1/S	O
boundary	O
.	O

NGFI-B/nur77	O
binds	O
to	O
the	O
response	O
element	O
by	O
monomer	O
or	O
heterodimer	O
with	O
retinoid	O
X	O
receptor	O
(	O
RXR	O
)	O
.	O

In	O
order	O
to	O
confirm	O
the	O
significance	O
of	O
this	O
region	O
in	O
the	O
context	O
of	O
viral	O
replication	O
,	O
we	O
constructed	O
several	O
of	O
these	O
LS	O
mutations	O
(	O
-201	O
to	O
-	O
184	O
,	O
-183	O
to	O
-166	O
,	O
-165	O
to	O
-148	O
,	O
and	O
-148	O
to	O
-130	O
)	O
in	O
proviruses	O
and	O
prepared	O
viral	O
stocks	O
by	O
cocultivation	O
of	O
transfected	O
RD	O
cells	O
with	O
CEMx174	O
cells	O
.	O

The	O
translocation	O
found	O
in	O
acute	O
promyelocytic	O
leukemia	O
rearranges	O
the	O
promyelocytic	O
leukemia	O
gene	O
(	O
PML	O
)	O
on	O
chromosome	O
15	O
with	O
the	O
retinoic	O
acid	O
receptor	O
alpha	O
(	O
RARalpha	O
)	O
on	O
chromosome	O
17	O
.	O

B-cell-specific	O
transcription	O
of	O
this	O
gene	O
was	O
dependent	O
on	O
the	O
octamer	O
element	O
5'-ATGCAAAG-3	O
'	O
,	O
located	O
in	O
the	O
upstream	O
region	O
of	O
this	O
promoter	O
and	O
in	O
the	O
promoters	O
of	O
all	O
other	O
immunoglobulin	O
heavy-	O
and	O
light-chain	O
genes	O
.	O

The	O
greater	O
selectivity	O
of	O
PF	O
,	O
compared	O
with	O
FK506	O
,	O
at	O
both	O
the	O
molecular	O
and	O
cellular	O
levels	O
may	S
prove	S
advantageous	S
in	S
manipulating	S
T	S
cell	S
responses	S
in	S
vivo	S
.	O

Retinoid-like	O
receptors	O
play	O
a	O
central	O
role	O
in	O
hormonal	O
responses	O
by	O
forming	O
heterodimers	O
with	O
other	O
nuclear	O
hormone	O
receptors	O
.	O

However	O
,	O
PDTC	O
failed	O
to	O
inhibit	O
the	O
endonuclease	O
activity	O
contained	O
in	O
the	O
whole	O
cell	O
lysates	O
.	O

Further	O
,	O
like	O
PMA	O
,	O
TG	O
markedly	O
induced	O
NF	O
kappa	O
B	O
in	O
Jurkat	O
T	O
cells	O
.	O

Dissected	O
imaginal	O
discs	O
were	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
(	O
15	O
min	O
)	O
and	O
incubated	O
with	O
antibodies	O
at	O
room	O
temperature	O
in	O
PBS	O
1X	O
with	O
0.1	O
%	O
TritonX-100	O
.	O

The	O
NFAT-controlled	O
luciferase	O
gene	O
system	O
distinguishes	O
CIF	O
from	O
other	O
T	O
cell	O
inhibitory	O
activities	O
present	O
in	O
colostrum	O
,	O
in	O
particular	O
,	O
TGF	O
beta	O
1	O
and	O
TGF	O
beta	O
2	O
and	O
the	O
glucocorticoids	O
.	O

Viral	S
reactivation	S
from	S
latency	S
and	S
spread	S
from	S
this	S
lymphoid	S
reservoir	S
is	S
presumably	S
required	S
for	S
development	S
of	S
nonlymphoid	S
tumors	S
like	S
KS	S
.	O

Note	O
that	O
mutant	O
ventral	O
cells	O
abutting	O
wild-type	O
dorsal	O
cells	O
expressed	O
Cut	O
(	O
arrow	O
in	O
[	O
D	O
]	O
)	O
,	O
indicating	S
that	S
D-mib	S
is	S
not	S
required	S
for	S
N	S
signal	S
transduction	S
.	O

The	O
cell	O
lines	O
exhibit	O
a	O
low	O
level	O
of	O
constitutive	O
TNF	O
mRNA	O
expression	O
.	O

Here	O
,	O
we	O
present	O
the	O
isolation	O
and	O
characterization	O
of	O
the	O
full-length	O
cDNA	O
clone	O
encoding	O
NF-X2	O
.	O

Interestingly	O
,	O
it	O
has	O
been	O
shown	O
that	O
M-CSF	O
can	O
induce	O
the	O
expression	O
of	O
its	O
own	O
gene	O
.	O

No	O
effect	O
was	O
seen	O
with	O
non	O
transfected	O
cells	O
or	O
with	O
cells	O
transfected	O
with	O
a	O
control	O
plasmid	O
.	O

Histological	O
diagnosis	O
was	O
``	O
malignant	O
lymphoma	O
,	O
diffuse	O
,	O
large	O
cell	O
''	O
type	O
according	O
to	O
an	O
International	O
Working	O
Formulation	O
.	O

The	O
absence	O
of	O
slow	O
migrating	O
forms	O
of	O
I	O
kappa	O
B	O
beta	O
following	O
stimulation	O
suggests	S
that	S
the	S
phosphorylation	S
does	S
not	S
necessarily	S
constitute	S
the	S
signal-induced	S
event	S
which	S
targets	S
the	S
molecule	S
for	S
proteolysis	S
.	O

In	O
conclusion	O
,	O
the	O
presence	O
of	O
myeloid-associated	O
growth	O
factor	O
receptor	O
transcripts	O
in	O
CD34+	O
CB	O
subsets	O
does	O
not	O
discriminate	O
the	O
various	O
stages	O
of	O
differentiation	O
,	O
with	O
the	O
exception	O
of	O
the	O
M-CSF	O
receptor	O
.	O

Thus	O
,	O
such	O
unique	O
activation	O
of	O
the	O
inhibitory	O
p50/p50	O
homodimer	O
by	O
acute	O
ethanol	O
treatment	O
may	S
result	S
in	S
inhibition	S
rather	S
than	S
activation	S
of	S
NF-kappa	S
B-regulated	S
inflammatory	S
cytokine	S
genes	S
.	O

The	O
induced	O
differentiation	O
occurs	O
with	O
down-regulation	O
of	O
c-fos	O
protein	O
and	O
an	O
accompanying	O
up-regulation	O
of	O
RB	O
protein	O
expression	O
,	O
consistent	S
with	S
a	S
possible	S
need	S
for	S
up-regulated	S
RB	S
expression	S
to	S
maintain	S
a	S
given	S
differentiated	S
phenotype	S
and	S
suppress	S
transcriptional	S
activators	S
that	S
might	S
typically	S
be	S
associated	S
with	S
proliferation	S
.	O

Each	O
of	O
the	O
35-bp	O
insertion	O
sites	O
corresponds	O
to	O
two	O
20-bp	O
DNA	O
fragments	O
flanking	O
a	O
genomic	O
Transib	O
element	O
at	O
its	O
5	O
'	O
and	O
3	O
'	O
termini	O
.	O

Reporter	O
luciferase	O
gene	O
vectors	O
containing	O
the	O
human	O
gamma	O
3	O
ECS	O
were	O
used	O
to	O
transfect	O
CL-01	O
cells	O
,	O
which	O
have	O
been	O
shown	O
to	O
undergo	O
Smu	O
--	O
>	O
S	O
gamma	O
3	O
DNA	O
recombination	O
,	O
upon	O
engagement	O
of	O
CD40	O
by	O
CD40	O
ligand	O
(	O
CD40L	O
)	O
and	O
exposure	O
to	O
IL-4	O
.	O

Importantly	O
,	O
nucleoprotein	O
extracts	O
showing	O
decreased	O
DNA-binding	O
activity	O
had	O
normal	O
amounts	O
of	O
Oct-1	O
proteins	O
as	O
determined	O
by	O
immunoprecipitation	O
,	O
implying	S
a	S
functional	S
defect	S
in	S
the	S
Oct-1	S
protein	S
.	O

beta-Catenin	O
and	O
LEF-1	O
complexes	O
can	O
activate	O
reporter	O
gene	O
expression	O
in	O
a	O
transformed	O
T-lymphocyte	O
cell	O
line	O
(	O
Jurkat	O
)	O
but	O
not	O
in	O
normal	O
T	O
lymphocytes	O
,	O
even	O
though	O
both	O
factors	O
are	O
nuclear	O
.	O

However	O
,	O
this	S
appears	S
to	S
add	S
more	S
noise	S
to	S
the	S
prediction	S
without	S
increasing	S
the	S
accuracy	S
.	O

Infection	O
with	O
the	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
has	O
been	O
shown	O
to	O
induce	O
production	O
of	O
several	O
cytokines	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

This	O
antibody	O
also	O
recognizes	O
in	O
human	O
T	O
lymphocytes	O
a	O
70-kDa	O
protein	O
corresponding	O
in	O
size	O
to	O
that	O
predicted	O
for	O
the	O
fkhrl1	O
gene	O
product	O
.	O

The	S
molecular	S
mechanisms	S
regulating	S
human	S
immunodeficiency	S
virus	S
(	S
HIV	S
)	S
persistence	S
in	S
a	S
major	S
cell	S
reservoir	S
such	S
as	S
the	S
macrophage	S
remain	S
unknown	S
.	O

These	O
results	O
indicate	S
that	S
activation	S
of	S
the	S
CREB/ATF	S
pathway	S
by	S
Tax	S
is	S
dispensable	S
for	S
the	S
immortalization	S
of	S
T	S
cells	S
by	S
HTLV-1	S
,	S
whereas	S
activation	S
of	S
the	S
NF-kappaB	S
pathway	S
may	S
be	S
critical	S
.	O

These	O
protein	O
pairs	O
represent	O
the	O
most	O
probable	S
interactors	S
with	O
respect	O
to	O
the	O
features	O
considered	O
,	O
among	O
all	O
protein	O
pairs	O
examined	O
by	O
the	O
predictor	O
.	O

Taken	O
together	O
,	O
our	O
findings	O
suggest	S
that	S
tumor-derived	S
gangliosides	S
may	S
blunt	S
antitumor	S
immune	S
responses	S
in	S
patients	S
with	S
RCCs	S
.	O

One	O
p21ras	O
effector	O
pathway	O
involves	O
the	O
MAP	O
kinase	O
ERK-2	O
,	O
and	O
we	O
have	O
examined	O
its	O
role	O
in	O
NFAT	O
regulation	O
.	O

When	O
cells	O
were	O
preincubated	O
with	O
dihydrolipoic	O
acid	O
(	O
0.2	O
mM	O
)	O
the	O
expression	O
of	O
c-fos	O
mRNA	O
was	O
suppressed	O
at	O
30	O
min	O
after	O
stimulation	O
of	O
TPA	O
(	O
0.5	O
microM	O
)	O
whereas	O
in	O
the	O
case	O
of	O
preincubation	O
of	O
alpha-lipoic	O
acid	O
(	O
0.2	O
microM	O
)	O
,	O
the	O
expression	O
was	O
enhanced	O
at	O
30	O
min	O
.	O

A	O
rule	O
requiring	O
that	O
efficient	O
V	O
(	O
D	O
)	O
J	O
recombination	O
occur	O
between	O
RSS12	O
and	O
RSS23	O
is	O
known	O
as	O
the	O
“12/23”	O
rule	O
[	O
1	O
]	O
.	O

The	O
IC50	O
of	O
alpha-tcp	O
on	O
an	O
IL-1-induced	O
response	O
was	O
45	O
microM	O
.	O

Human	O
RAR	O
alpha	O
was	O
expressed	O
in	O
H9	O
,	O
U937	O
and	O
THP-1	O
cells	O
,	O
but	O
almost	O
undetectable	O
in	O
CEM	O
cells	O
.	O

Regulation	O
of	O
replicative	O
functions	O
in	O
the	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
genome	O
is	O
mediated	O
through	O
activation	O
of	O
a	O
virally	O
encoded	O
transcription	O
factor	O
,	O
Z	O
(	O
BZLF1	O
)	O
.	O

The	O
adoR	O
mutation	O
also	O
significantly	O
reduced	O
melanotic	O
tumor	O
formation	O
in	O
the	O
adgf-a	O
mutant	O
(	O
see	O
Figure	O
6A	O
)	O
,	O
but	O
disintegration	O
of	O
the	O
fat	O
body	O
appeared	O
at	O
the	O
same	O
rate	O
as	O
in	O
the	O
single	O
mutant	O
(	O
see	O
Figure	O
6A	O
)	O
.	O

A	O
substantial	O
proportion	O
of	O
domain	O
interactions	O
are	O
conserved	O
between	O
E.	O
coli	O
,	O
S.	O
cerevisiae	O
and	O
H.	O
sapiens	O
.	O

VitD3	O
induction	O
resulted	O
in	O
the	O
formation	O
of	O
VDR/RXR	O
DNA-binding	O
complexes	O
on	O
both	O
VitD3	O
response	O
elements	O
and	O
RA	O
response	O
elements	O
(	O
RAREs	O
)	O
.	O

However	O
,	O
CTLA-4	S
ligation	S
did	S
not	S
appear	S
to	S
affect	S
the	S
CD28-mediated	S
stabilization	S
of	S
IL-2	S
mRNA	S
.	O

Physical	O
interaction	O
of	O
AML1	O
with	O
BSAP	O
correlates	O
with	O
functional	O
cooperativity	O
in	O
transfection	O
studies	O
where	O
AML1	O
and	O
BSAP	O
synergistically	O
activate	O
blk	O
promoter	O
transcription	O
by	O
more	O
than	O
50-fold	O
.	O

Most	O
recent	O
programs	O
represent	O
motifs	O
as	O
position	O
weight	O
matrices	O
(	O
PWMs	O
)	O
,	O
which	O
record	O
the	O
frequency	O
of	O
each	O
base	O
at	O
every	O
position	O
in	O
the	O
motif	O
.	O

In	O
the	O
first	O
approach	O
,	O
stable	O
clones	O
of	O
two	O
B-cell	O
lines	O
carrying	O
an	O
LMP1	O
gene	O
under	O
the	O
control	O
of	O
an	O
inducible	O
metallothionein	O
promoter	O
were	O
induced	O
to	O
express	O
LMP1	O
in	O
all	O
cells	O
.	O

Furthermore	O
,	O
roX1	O
and	O
roX2	O
are	O
only	O
the	O
first	O
two	O
of	O
about	O
35	O
chromatin	O
entry	O
sites	O
,	O
although	O
perhaps	S
they	S
are	S
the	S
most	S
important	S
ones	S
.	O

Each	O
bar	O
shows	O
the	O
number	O
of	O
all	O
circulating	O
hemocytes	O
,	O
and	O
the	O
gray	O
part	O
of	O
the	O
bars	O
represent	O
the	O
lamellocyte	O
population	O
.	O

Secretion	O
of	O
myeloid	O
cell-derived	O
cytokines	O
may	S
both	S
increase	S
virus	S
production	S
and	S
contribute	S
to	S
AIDS-associated	S
disorders	S
.	O

Using	O
antibodies	O
in	O
an	O
electrophoretic	O
mobility	O
supershift	O
assay	O
,	O
one	O
of	O
these	O
complexes	O
was	O
shown	O
to	O
contain	O
NF-kappa	O
B1	O
and	O
RelA	O
,	O
and	O
to	O
bind	O
with	O
higher	O
affinity	O
to	O
the	O
consensus	O
kappa	O
B	O
site	O
in	O
the	O
HIV	O
long	O
terminal	O
repeat	O
.	O

We	O
report	O
a	O
65-year-old	O
woman	O
with	O
non-Hodgkin	O
's	O
lymphoma	O
(	O
NHL	O
)	O
carrying	O
a	O
t	O
(	O
3	O
;	O
14	O
)	O
(	O
q27	O
;	O
q11	O
)	O
and	O
BCL6	O
rearrangement	O
in	O
the	O
affected	O
cells	O
.	O

In	O
many	O
other	O
cells	O
their	O
expression	O
can	O
be	O
induced	O
by	O
IFN-gamma	O
.	O

To	O
overcome	O
this	O
problem	O
,	O
we	O
have	O
exploited	O
the	O
observation	O
that	O
activated	O
human	O
T	O
cell	O
blasts	O
can	O
be	O
stimulated	O
via	O
the	O
CD28	O
surface	O
molecule	O
in	O
the	O
absence	O
of	O
antigenic	O
challenge	O
;	O
thus	O
,	O
we	O
have	O
been	O
able	O
to	O
observe	O
the	O
response	O
of	O
normal	O
T	O
cells	O
to	O
CD28	O
activation	O
in	O
isolation	O
.	O

Activation	O
of	O
Stat	O
5b	O
in	O
erythroid	O
progenitors	O
correlates	O
with	O
the	O
ability	O
of	O
ErbB	O
to	O
induce	O
sustained	O
cell	O
proliferation	O
.	O

TNF-alpha	O
was	O
able	O
to	O
increase	O
expression	O
of	O
the	O
HIV	O
LTR	O
in	O
T	O
cells	O
,	O
but	O
in	O
monocytic	O
cells	O
,	O
TNF-alpha	O
did	O
not	O
induce	O
the	O
HIV	O
LTR	O
above	O
a	O
constitutive	O
level	O
of	O
activity	O
.	O

Immune	O
hyperactivation	O
of	O
HIV-1-infected	O
T	O
cells	O
mediated	O
by	O
Tat	O
and	O
the	O
CD28	O
pathway	O
.	O

In	O
addition	O
,	O
V3-BH10	O
generated	O
the	O
arrest	O
of	O
Kit225	O
cells	O
and	O
also	O
purified	O
CD8-positive	O
lymphocytes	O
in	O
G1	O
phase	O
in	O
the	O
presence	O
of	O
IL-2	O
.	O

Activation	O
of	O
distinct	O
transcription	O
factors	O
in	O
neutrophils	O
by	O
bacterial	O
LPS	O
,	O
interferon-gamma	O
,	O
and	O
GM-CSF	O
and	O
the	O
necessity	O
to	O
overcome	O
the	O
action	O
of	O
endogenous	O
proteases	O
.	O

While	O
the	O
sera	O
of	O
EBV-negative	O
individuals	O
(	O
0/3	O
)	O
or	O
healthy	O
carriers	O
(	O
0/33	O
)	O
did	O
not	O
contain	O
detectable	O
levels	O
of	O
antibodies	O
,	O
patients	O
with	O
mononucleosis	O
(	O
5/18	O
)	O
,	O
chronic	O
EBV	O
infection	O
(	O
2/7	O
)	O
,	O
EBV	O
reactivation	O
(	O
7/20	O
)	O
and	O
human	O
immunodeficiency	O
virus	O
infection	O
(	O
5/24	O
)	O
showed	O
elevated	O
antibody	O
titres	O
against	O
the	O
enzyme	O
.	O

In	O
prokaryotes	O
,	O
most	O
stop-codon-encoded	O
amino	O
acids	O
are	O
located	O
inside	O
a	O
domain	O
,	O
the	O
unit	O
of	O
evolutionary	O
sequence	O
conservation	O
.	O

The	O
role	O
of	O
nuclear	O
factor-kappa	O
B	O
in	O
cytokine	O
gene	O
regulation	O
.	O

ADT	O
,	O
a	O
pro-glutathione	O
antioxidant	O
,	O
was	O
observed	O
to	O
be	O
capable	O
of	O
modulating	O
NF-kappa	O
B	O
activation	O
.	O

Therefore	O
,	O
initiation	O
of	O
the	O
EBV	O
lytic	O
cycle	O
by	O
the	O
ZEBRA	O
protein	O
requires	O
a	O
function	O
in	O
addition	O
to	O
transcriptional	O
activation	O
;	O
a	O
change	O
of	O
serine	O
186	O
to	O
alanine	O
in	O
the	O
DNA-binding	O
domain	O
of	O
ZEBRA	O
abolished	O
this	O
additional	O
function	O
and	O
uncovered	O
a	O
new	O
role	O
for	O
the	O
ZEBRA	O
protein	O
in	O
disruption	O
of	O
EBV	O
latency	O
.	O

These	O
results	O
imply	S
that	S
TK	S
activity	S
is	S
not	S
obligatory	S
for	S
CD14-mediated	S
signal	S
transduction	S
to	S
occur	S
in	S
response	S
to	S
LPS	S
.	O

Structure	O
of	O
hAT	O
5	O
'	O
Termini	O

METHODS	O
AND	O
RESULTS	O
:	O
Gel-shift	O
analyses	O
demonstrated	O
dose-dependent	O
inhibition	O
of	O
TNF-induced	O
NF-kappa	O
B	O
mobilization	O
by	O
aspirin	O
at	O
concentrations	O
ranging	O
from	O
1	O
to	O
10	O
mmol/L	O
.	O

In	O
addition	O
,	O
EL-4	O
cells	O
incubated	O
with	O
ciprofloxacin	O
showed	O
an	O
early	O
peak	O
and	O
more	O
activated	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NFAT-1	O
)	O
as	O
compared	O
to	O
control	O
cells	O
without	O
antibiotics	O
.	O

We	O
here	O
report	O
that	O
(	O
i	O
)	O
like	O
PML-RAR	O
alpha	O
expression	O
,	O
PLZF-RAR	O
alpha	O
expression	O
blocks	O
terminal	O
differentiation	O
of	O
hematopoietic	O
precursor	O
cell	O
lines	O
(	O
U937	O
and	O
HL-60	O
)	O
in	O
response	O
to	O
different	O
stimuli	O
(	O
vitamin	O
D3	O
,	O
transforming	O
growth	O
factor	O
beta1	O
,	O
and	O
dimethyl	O
sulfoxide	O
)	O
;	O
(	O
ii	O
)	O
PML-RAR	O
alpha	O
,	O
but	O
not	O
PLZF-RAR	O
alpha	O
,	O
increases	O
RA	O
sensitivity	O
of	O
hematopoietic	O
precursor	O
cells	O
and	O
restores	O
RA	O
sensitivity	O
of	O
RA-resistant	O
hematopoietic	O
cells	O
;	O
(	O
iii	O
)	O
PML-RAR	O
alpha	O
and	O
PLZF-RAR	O
alpha	O
have	O
similar	O
RA	O
binding	O
affinities	O
;	O
and	O
(	O
iv	O
)	O
PML-RAR	O
alpha	O
enhances	O
the	O
RA	O
response	O
of	O
RA	O
target	O
genes	O
(	O
those	O
for	O
RAR	O
beta	O
,	O
RAR	O
gamma	O
,	O
and	O
transglutaminase	O
type	O
II	O
[	O
TGase	O
]	O
)	O
in	O
vivo	O
,	O
while	O
PLZF-RAR	O
alpha	O
expression	O
has	O
either	O
no	O
effect	O
(	O
RAR	O
beta	O
)	O
or	O
an	O
inhibitory	O
activity	O
(	O
RAR	O
gamma	O
and	O
type	O
II	O
TGase	O
)	O
.	O

These	O
agents	O
also	O
significantly	O
decreased	O
TNF-	O
and	O
LPS-stimulated	O
increases	O
in	O
HUVEC	O
surface	O
VCAM-1	O
.	O

The	O
human	O
C/EBP-epsilon	O
protein	O
exhibited	O
strong	O
and	O
specific	O
binding	O
to	O
double-stranded	O
DNA	O
containing	O
consensus	O
C/EBP	O
sites	O
.	O

Nuclear	O
run-on	O
transcription	O
assays	O
showed	O
that	O
IL-10	O
inhibited	O
the	O
rate	O
of	O
IFN-gamma-induced	O
transcription	O
of	O
the	O
ICAM-1	O
gene	O
,	O
and	O
mRNA	O
stability	O
studies	O
showed	O
that	O
IL-10	O
did	O
not	O
alter	O
the	O
half-life	O
of	O
IFN-gamma-induced	O
ICAM-1	O
message	O
.	O

Additional	O
upstream	O
gene	O
segments	O
dramatically	O
affected	O
B29	O
minimal	O
promoter	O
activity	O
.	O

This	O
region	O
contains	O
binding	O
sites	O
for	O
the	O
cAMP	O
response	O
element-binding	O
protein/activation	O
transcription	O
factor	O
(	O
CREB/ATF	O
)	O
and	O
Sp1	O
families	O
of	O
transcription	O
factors	O
.	O

This	O
lack	O
of	O
sensitivity	O
is	O
unexplained	O
but	O
is	O
not	O
attributable	O
to	O
abnormalities	O
of	O
cellular	O
glucocorticoid	O
receptors	O
.	O

In	O
cases	O
where	O
the	O
program	O
failed	O
to	O
return	O
a	O
result	O
,	O
the	O
sensitivity	O
is	O
0	O
and	O
the	O
PPV	O
is	O
undefined	O
.	O

A	O
mammalian	O
histone	O
deacetylase	O
related	O
to	O
the	O
yeast	O
transcriptional	O
regulator	O
Rpd3p	O
[	O
see	O
comments	O
]	O

The	O
microA	O
motif	O
was	O
required	O
for	O
microB-dependent	O
enhancer	O
activity	O
,	O
which	O
suggests	S
that	S
a	S
minimal	S
B	S
cell-specific	S
enhancer	S
is	S
composed	S
of	S
both	S
the	S
PU.1	S
and	S
Ets-1	S
binding	S
sites	S
.	O

Although	O
much	O
is	O
understood	O
about	O
the	O
induction	O
of	O
genes	O
expressed	O
early	O
(	O
within	O
24	O
h	O
)	O
after	O
T-cell	O
activation	O
,	O
little	O
is	O
known	O
about	O
the	O
regulation	O
of	O
expression	O
of	O
genes	O
expressed	O
'late	O
'	O
(	O
three	O
or	O
more	O
days	O
)	O
post-stimulation	O
.	O

The	O
kappa	O
B-binding	O
activity	O
with	O
the	O
HIV	O
enhancer	O
is	O
inhibited	O
only	O
if	O
it	O
is	O
activated	O
via	O
the	O
mitogen	O
phytohemagglutinin	O
whereas	O
phorbol	O
myristate	O
acetate-mediated	O
activation	O
is	O
completely	O
insensitive	O
to	O
the	O
drug	O
.	O

Histamine	O
modulates	O
the	O
expression	O
of	O
c-fos	O
through	O
cyclic	O
AMP	O
production	O
via	O
the	O
H2	O
receptor	O
in	O
the	O
human	O
promonocytic	O
cell	O
line	O
U937	O
.	O

All	O
agents	O
tested	O
induced	O
expression	O
of	O
Hsp60	O
6	O
hr	O
after	O
application	O
.	O

Among	O
the	O
20	O
selected	O
oligonucleotides	O
,	O
two	O
potent	O
15-mer	O
AS	O
oligonucleotides	O
(	O
C-JUN	O
AS	O
oligonucleotides	O
)	O
exhibited	O
significant	O
inhibition	O
of	O
cell	O
growth	O
in	O
a	O
dose-dependent	O
manner	O
between	O
2	O
and	O
10	O
microM	O
.	O

A	O
less	O
pronounced	O
reduction	O
in	O
lambda	O
L	O
chain	O
and	O
microH	O
chain	O
was	O
also	O
noted	O
.	O

To	O
analyze	O
the	O
mechanisms	O
that	O
lead	O
to	O
the	O
expression	O
of	O
IL-1alpha	O
in	O
HTLV-I-infected	O
cell	O
lines	O
,	O
we	O
studied	O
regulatory	O
regions	O
of	O
the	O
human	O
IL-1alpha	O
promoter	O
involved	O
in	O
activation	O
of	O
the	O
IL-1alpha	O
gene	O
.	O

Overall	O
therefore	O
,	O
exposure	O
to	O
NSAIDs	O
leads	O
to	O
a	O
profound	O
switch	O
in	O
gene	O
expression	O
in	O
monocytic	O
cells	O
,	O
with	O
suppression	O
of	O
genes	O
involved	O
in	O
macrophage	O
activation	O
and	O
induction	O
of	O
stress	O
genes	O
and	O
HSF1	S
appears	S
to	S
play	S
a	S
regulatory	S
role	S
in	S
these	S
effects	S
.	O

Molecular	O
analysis	O
of	O
the	O
cDNA	O
and	O
genomic	O
clones	O
indicated	O
the	O
presence	O
of	O
two	O
exons	O
encoding	O
a	O
protein	O
with	O
an	O
apparent	S
molecular	S
mass	S
of	S
32	S
kDa	S
and	O
a	O
pI	O
of	O
9.5	O
.	O

The	O
signaling	O
capabilities	O
of	O
the	O
IL-10R	O
for	O
activating	O
specific	O
STAT	O
proteins	O
and	O
inducing	O
gene	O
transcription	O
were	O
defined	O
by	O
reconstitution	O
of	O
receptor	O
functions	O
in	O
transfected	O
tissue	O
culture	O
cells	O
.	O

Similarly	O
,	O
none	O
of	O
SCOPE	O
's	O
component	O
algorithms	O
outperformed	O
the	O
other	O
ten	O
programs	O
on	O
this	O
dataset	O
by	O
a	O
statistically	O
significant	O
margin	O
.	O

Evidence	O
for	O
a	O
trans-acting	O
activator	O
function	O
regulating	O
the	O
expression	O
of	O
the	O
human	O
CD5	O
antigen	O
.	O

Fos	O
expression	O
may	S
be	S
a	S
pivotal	S
event	S
in	S
converting	S
ligand-receptor	S
interactions	S
at	S
the	S
membrane	S
into	S
functional	S
modulation	S
of	S
cell	S
phenotype	S
.	O

MLE	S
might	S
be	S
removed	S
in	S
vitro	S
(	S
for	S
example	S
,	S
by	S
elevated	S
ionic	S
strength	S
)	S
without	S
destroying	S
the	S
entire	S
complex	S
,	S
because	S
of	S
the	S
stabilizing	S
presence	S
of	S
MOF-MSL3	S
.	O

The	O
CRE	O
and	O
kappaB3	O
sites	O
in	O
region	O
II	O
together	O
conferred	O
strong	O
LPS	O
responsiveness	O
to	O
a	O
heterologous	O
promoter	O
,	O
whereas	O
individually	O
they	O
failed	O
to	O
provide	O
transcriptional	O
activation	O
.	O

Tobacco	O
smoke	O
induces	O
coordinate	O
activation	O
of	O
HSF	O
and	O
inhibition	O
of	O
NFkappaB	O
in	O
human	O
monocytes	O
:	O
effects	O
on	O
TNFalpha	O
release	O
.	O

Whereas	O
the	O
CRE	O
site	O
was	O
essential	O
in	O
mediating	O
the	O
negative	O
activity	O
of	O
the	O
upstream	O
regulatory	O
region	O
in	O
Jurkat	O
but	O
not	O
in	O
HeLa	O
cells	O
,	O
mutation	O
of	O
the	O
Sp1/AP-2	O
site	O
decreased	O
promoter	O
activity	O
in	O
both	O
cell	O
lines	O
.	O

A	O
small	O
population	O
of	O
UT-7/GM	O
cells	O
positively	O
stained	O
for	O
hemoglobin	O
(	O
Hb	O
)	O
after	O
a	O
7-day	O
exposure	O
to	O
TPO	O
.	O

Induction	O
of	O
transcription	O
factors	O
in	O
human	O
T	O
lymphocytes	O
by	O
aspirin-like	O
drugs	O
.	O

In	O
contrast	O
,	O
the	O
expression	O
of	O
actin	O
and	O
fibronectin	O
receptor	O
mRNA	O
was	O
more	O
sustained	O
,	O
and	O
the	O
expression	O
of	O
these	O
genes	O
remained	O
elevated	O
at	O
24	O
to	O
48	O
h	O
after	O
M-CSF	O
addition	O
.	O

The	O
evolutionarily	O
conserved	O
sequence	O
upstream	O
of	O
the	O
human	O
Ig	O
heavy	O
chain	O
S	O
gamma	O
3	O
region	O
is	O
an	O
inducible	O
promoter	O
:	O
synergistic	O
activation	O
by	O
CD40	O
ligand	O
and	O
IL-4	O
via	O
cooperative	O
NF-kappa	O
B	O
and	O
STAT-6	O
binding	O
sites	O
.	O

Peptide	O
vaccination	O
can	S
lead	S
to	S
enhanced	S
tumor	S
growth	S
through	S
specific	S
T-cell	S
tolerance	S
induction	S
.	O

We	O
examined	O
signaling	O
molecules	O
of	O
peripheral	O
blood	O
T	O
lymphocytes	O
obtained	O
from	O
women	O
with	O
breast	O
cancer	O
.	O

Consistent	O
with	O
these	O
observations	O
,	O
coexpression	O
of	O
constitutively	O
active	O
forms	O
of	O
Raf-1	O
and	O
calcineurin	O
synergistically	O
induced	O
kappaB-dependent	O
reporter	O
activity	O
,	O
suggesting	S
a	S
physiologically	S
relevant	S
functional	S
interaction	S
between	S
the	S
kinase	S
and	S
the	S
phosphatase	S
.	O

In	O
vitro	O
studies	O
on	O
hematopoietic	O
control	O
mechanisms	O
have	O
been	O
hampered	O
by	O
the	O
heterogeneity	O
of	O
the	O
analyzed	O
cell	O
populations	O
,	O
ie	O
,	O
lack	O
of	O
lineage	O
specificity	O
and	O
developmental	O
stage	O
homogeneity	O
of	O
progenitor/precursor	O
cells	O
growing	O
in	O
culture	O
.	O

Defective	O
transcription	O
of	O
the	O
IL-2	O
gene	O
is	O
associated	O
with	O
impaired	O
expression	O
of	O
c-Fos	O
,	O
FosB	O
,	O
and	O
JunB	O
in	O
anergic	O
T	O
helper	O
1	O
cells	O
.	O

The	O
inability	O
to	O
detect	O
EBV	O
in	O
the	O
lower	O
epithelial	O
layers	O
of	O
oral	O
hairy	O
leukoplakia	O
raises	S
questions	S
concerning	S
the	S
nature	S
of	S
EBV	S
latency	S
and	S
persistence	S
in	S
stratified	S
squamous	S
epithelium	S
.	O

Considering	O
that	O
nuclear	O
regulatory	O
factor-kappa	O
beta	O
(	O
NF-kappa	O
B	O
)	O
/Rel	O
is	O
a	O
common	O
regulatory	O
element	O
of	O
the	O
promoter	O
region	O
of	O
the	O
inflammatory	O
cytokine	O
genes	O
,	O
herein	O
,	O
we	O
tested	O
the	O
hypothesis	S
that	S
acute	S
ethanol	S
affects	S
NF-kappa	S
B	S
activation	S
in	S
human	S
monocytes	S
.	O

Restoration	O
of	O
terminal	O
differentiation	O
in	O
the	O
mouse	O
erythroleukemia	O
(	O
MEL	O
)	O
cells	O
requires	O
a	O
decline	O
in	O
the	O
level	O
of	O
PU.1	O
,	O
indicating	S
that	S
PU.1	S
can	S
block	S
erythroid	S
differentiation	S
.	O

Here	O
we	O
show	O
that	O
,	O
unexpectedly	O
,	O
expression	O
of	O
another	O
viral	O
immediate-early	O
protein	O
,	O
BRLF1	O
,	O
can	O
disrupt	O
viral	O
latency	O
in	O
an	O
epithelial	O
cell-specific	O
fashion	O
.	O

Invariably	O
,	O
the	O
BCL-6	O
coding	O
region	O
is	O
intact	O
,	O
but	O
its	O
5	O
'	O
untranslated	O
region	O
is	O
replaced	O
with	O
sequences	O
from	O
the	O
translocation	O
partner	O
.	O

Nitric	O
oxide	O
decreases	O
cytokine-induced	O
endothelial	O
activation	O
.	O

Flow	O
diagram	O
for	O
SCOPE	O
.	O

Here	O
we	O
describe	O
cloning	O
and	O
characterization	O
of	O
full-length	O
cDNA	O
encoding	O
murine	O
(	O
m	O
)	O
NFATc	O
which	O
predicts	O
that	O
the	O
protein	O
has	O
all	O
the	O
conserved	O
structural	O
motifs	O
of	O
NFAT	O
family	O
members	O
,	O
including	O
the	O
rel	O
homology	O
domain	O
,	O
the	O
NFAT	O
homology	O
domain	O
and	O
the	O
nuclear	O
translocation	O
signals	O
.	O

Control	O
of	O
cell	O
cycle	O
entry	O
and	O
apoptosis	O
in	O
B	O
lymphocytes	O
infected	O
by	O
Epstein-Barr	O
virus	O
.	O

These	O
results	O
establish	O
a	O
crucial	O
PI3K/PKB-mediated	O
link	O
between	O
the	O
IL-2	O
teceptor	O
and	O
the	O
cell	O
cycle	O
machinery	O
.	O

both	O
catecholamines	O
,	O
however	O
,	O
dose-dependently	O
increased	O
the	O
production	O
of	O
IL-10	O
.	O

Glucocorticoids	O
and	O
interferon-alpha	O
in	O
the	O
acquired	O
immunodeficiency	O
syndrome	O
.	O

Transcriptional	O
regulation	O
of	O
the	O
ferritin	O
heavy-chain	O
gene	O
:	O
the	O
activity	O
of	O
the	O
CCAAT	O
binding	O
factor	O
NF-Y	O
is	O
modulated	O
in	O
heme-treated	O
Friend	O
leukemia	O
cells	O
and	O
during	O
monocyte-to-macrophage	O
differentiation	O
.	O

Cyclosporin	O
A	O
(	O
CsA	O
)	O
and	O
FK506	O
inhibit	O
the	O
production	O
of	O
IL-2	O
in	O
T	O
lymphocytes	O
at	O
the	O
level	O
of	O
gene	O
transcription	O
.	O

Using	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
we	O
found	O
that	O
in	O
the	O
presence	O
of	O
rabbit	O
reticulocyte	O
lysate	O
,	O
human	O
ER	O
reduced	O
the	O
binding	O
activities	O
of	O
chicken	O
immature	O
erythrocyte	O
nuclear	O
extracted	O
proteins	O
to	O
GATA	O
and	O
CACCC	O
sites	O
in	O
the	O
H5	O
promoter	O
and	O
enhancer	O
.	O

Taken	O
together	O
,	O
our	O
data	O
suggest	S
that	S
two	S
interactive	S
mechanisms	S
regulate	S
monocytic	S
I	S
kappa	S
B	S
alpha/MAD-3	S
mRNA	S
levels	S
.	O

In	O
vitro	O
mutagenesis	O
experiments	O
demonstrated	O
that	O
both	O
the	O
Ets	O
and	O
AP-1	O
sites	O
are	O
required	O
for	O
binding	O
of	O
the	O
inducible	O
PB1	O
nuclear	O
protein	O
complex	O
and	O
for	O
the	O
transcriptional	O
activity	O
of	O
this	O
element	O
and	O
the	O
GM-CSF	O
promoter	O
in	O
activated	O
T	O
cells	O
.	O

The	O
ADGF-A	O
promoter	O
contains	O
consensus	O
binding	O
sites	O
for	O
effectors	O
of	O
both	O
Toll	O
and	O
ecdysone	O
signaling	O
.	O

The	O
capacity	O
of	O
GH	O
to	O
inhibit	O
LPS-induced	O
TNF-alpha	O
production	O
by	O
monocytes	O
without	O
altering	O
other	O
pathways	O
leading	O
to	O
TNF-alpha	O
production	O
may	S
be	S
of	S
potential	S
relevance	S
in	S
septic	S
shock	S
,	O
since	O
GH	O
is	O
available	O
for	O
clinical	O
use	O
.	O

The	O
glucocorticoid	O
receptor	O
was	O
shown	O
to	O
repress	O
activity	O
of	O
both	O
the	O
RelA	O
homodimer	O
and	O
the	O
NF-kappa	O
B1/RelA	O
heterodimer	O
.	O

This	O
protein	O
reduces	O
or	O
abolishes	O
in	O
vitro	O
the	O
DNA	O
binding	O
activity	O
of	O
wild-type	O
proteins	O
of	O
the	O
same	O
family	O
(	O
KBF1/p50	O
,	O
c-	O
and	O
v-rel	O
)	O
.	O

This	O
study	O
describes	O
the	O
inheritance	O
of	O
a	O
defect	O
in	O
pyrimidine	O
catabolism	O
and	O
its	O
association	O
with	O
drug-induced	O
toxicity	O
in	O
a	O
patient	O
receiving	O
5-fluorouracil	O
(	O
FUra	O
)	O
as	O
adjuvant	O
chemotherapy	O
for	O
breast	O
carcinoma	O
.	O

By	O
primer	O
extension	O
analysis	O
to	O
discriminate	O
two	O
transcripts	O
,	O
we	O
found	O
that	O
the	O
levels	O
of	O
PAFR	O
transcript	O
1	O
(	O
leukocyte-type	O
)	O
,	O
but	O
not	O
PAFR	O
transcript	O
2	O
(	O
tissue-type	O
)	O
,	O
are	O
upregulated	O
by	O
PAF	O
as	O
well	O
as	O
by	O
12-O-tetradecanoylphorbol-13-acetate	O
(	O
TPA	O
)	O
in	O
the	O
human	O
stomach	O
cancer	O
cell	O
line	O
(	O
JR-St	O
cells	O
)	O
which	O
expresses	O
both	O
functional	O
PAFR	O
transcript	O
1	O
and	O
PAFR	O
transcript	O
2	O
endogenously	O
.	O

In	O
immature	O
hematopoietic	O
cells	O
,	O
tal-1	O
and	O
GATA-1	O
genes	O
are	O
coexpressed	O
in	O
committed	O
progenitors	O
cells	O
(	O
CD34+/CD38	O
(	O
2+	O
)	O
)	O
,	O
whereas	O
they	O
are	O
not	O
detectable	O
in	O
the	O
most	O
primitive	O
cells	O
(	O
CD34	O
(	O
2+	O
)	O
/CD38-	O
)	O
.	O

That	O
PKC-zeta	O
is	O
specific	O
in	O
regulating	O
NF-kappa	O
B	O
is	O
concluded	O
from	O
the	O
inability	O
of	O
PKC-zeta	O
(	O
mut	O
)	O
to	O
interfere	O
with	O
the	O
basal	O
or	O
phorbol	O
myristate	O
acetate-inducible	O
CREB-	O
or	O
AP1-dependent	O
transcriptional	O
activity	O
.	O

These	O
factors	O
are	O
detected	O
at	O
the	O
time	O
the	O
CD11b	O
promoter	O
is	O
activated	O
.	O

This	O
means	O
that	O
for	O
more	O
than	O
32	O
%	O
of	O
the	O
protein	O
interactions	O
in	O
the	O
PDB	O
,	O
the	O
iPfam	O
domain	O
pair	O
assignment	O
is	O
correct	O
.	O

Lymphocyte	O
glucocorticoid	O
receptor	O
binding	O
during	O
depression	O
and	O
after	O
clinical	O
recovery	O
.	O

The	O
Transitive	O
module	O
investigates	O
whether	S
two	S
proteins	S
(	S
such	S
as	S
i	S
and	S
j	S
)	S
that	S
share	S
many	S
common	S
interactors	S
and	S
have	S
few	S
additional	S
interactors	S
that	S
are	S
not	S
common	S
to	S
both	S
proteins	S
are	S
more	S
likely	S
to	S
interact	S
than	S
two	S
proteins	S
(	S
such	S
as	S
i	S
'	S
and	S
j	S
'	S
)	S
that	S
share	S
few	S
common	S
interactors	S
.	O

Thus	O
,	O
Sp1	O
and	O
Egr-1	O
physically	O
and	O
functionally	O
cooperate	O
to	O
mediate	O
maximal	O
IL-2Rbeta	O
promoter	O
activity	O
.	O

These	O
results	O
demonstrate	O
that	O
P-selectin	O
,	O
through	O
its	O
ligands	O
on	O
monocytes	O
,	O
may	S
locally	S
regulate	S
cytokine	S
secretion	S
in	S
inflamed	S
tissues	S
.	O

The	O
stop-codon-encoded	O
amino	O
acids	O
of	O
prokaryotes	O
are	O
usually	O
located	O
inside	O
domains	O
,	O
the	O
units	O
of	O
evolutionary	O
sequence	O
conservation	O
.	O

They	O
inhibit	O
synthesis	O
of	O
almost	O
all	O
known	O
cytokines	O
and	O
of	O
several	O
cell	O
surface	O
molecules	O
required	O
for	O
immune	O
function	O
,	O
but	O
the	S
mechanism	S
underlying	S
this	S
activity	S
has	S
been	S
unclear	S
.	O

At	O
this	O
stage	O
,	O
the	O
Hml	O
marker	O
disappeared	O
from	O
the	O
most	O
of	O
the	O
hemocytes	O
in	O
mutants	O
(	O
see	O
Figure	O
4F	O
and	O
4G	O
)	O
.	O

These	O
studies	O
provide	O
a	O
potential	S
mechanism	S
through	S
which	S
CD30	S
,	S
as	S
well	S
as	S
other	S
TRAF-binding	S
members	S
of	S
the	S
TNFR	S
superfamily	S
,	S
can	S
negatively	S
regulate	S
cell	S
survival	S
.	O

The	O
ability	O
of	O
ascorbate	O
to	O
enhance	O
cytoplasmic	O
inhibitory	O
IkBalpha	O
protein	O
degradation	O
correlates	O
completely	O
with	O
its	O
capacity	O
to	O
induce	O
NF-kappaB	O
binding	O
to	O
DNA	O
and	O
to	O
potentiate	O
NF-kappaB-mediated	O
transactivation	O
of	O
the	O
HIV-1	O
long	O
terminal	O
repeat	O
promoter	O
in	O
TNF-alpha-stimulated	O
Jurkat	O
cells	O
but	O
not	O
in	O
cells	O
stimulated	O
with	O
PMA	O
plus	O
ionomycin	O
.	O

The	O
present	O
study	O
was	O
based	O
on	O
reports	O
that	O
antioxidants	O
which	O
eliminate	O
ROS	O
should	S
block	S
the	S
activation	S
of	S
NF-kappa	S
B	S
and	S
subsequently	S
HIV	S
transcription	S
,	O
and	O
thus	O
antioxidants	S
can	S
be	S
used	S
as	S
therapeutic	S
agents	S
for	S
AIDS	S
.	O

Tax	O
expression	O
promotes	O
N-terminal	O
phosphorylation	O
and	O
degradation	O
of	O
IkappaB	O
alpha	O
,	O
a	O
principal	O
cytoplasmic	O
inhibitor	O
of	O
NF-kappaB	O
.	O

One	O
of	O
the	O
latter	O
elements	O
,	O
the	O
IgH	O
3	O
'	O
enhancer	O
,	O
is	O
of	O
particular	O
interest	O
:	O
(	O
1	O
)	O
it	O
is	O
B	O
cell-specific	O
and	O
active	O
only	O
in	O
late	O
B	O
cell	O
development	O
;	O
(	O
2	O
)	O
in	O
rodent	O
plasmacytomas	O
and	O
in	O
some	O
human	O
Burkitt	O
's	O
lymphomas	O
it	O
is	O
part	O
of	O
a	O
locus	O
control	O
region	O
(	O
LCR	O
)	O
that	O
is	O
involved	O
in	O
deregulation	O
of	O
the	O
c-myc	O
oncogene	O
as	O
a	O
result	O
of	O
translocation	O
into	O
the	O
IgH	O
locus	O
;	O
and	O
(	O
3	O
)	O
it	O
has	O
been	O
implicated	O
in	O
the	O
mechanisms	O
that	O
control	O
Ig	O
gene	O
class	O
switch	O
recombination	O
.	O

Interleukin-3	O
(	O
IL-3	O
)	O
is	O
exclusively	O
expressed	O
by	O
activated	O
T	O
and	O
natural	O
killer	O
cells	O
,	O
a	O
function	O
that	O
is	O
tightly	O
controlled	O
both	O
in	O
a	O
lineage-specific	O
and	O
in	O
a	O
stimulation-dependent	O
manner	O
.	O

Comparison	O
to	O
predictions	O
generated	O
using	O
alternative	O
training	O
sets	O

As	O
a	O
result	O
,	O
Ei-values	O
for	O
matches	O
of	O
RAG1s	O
to	O
a	O
new	O
PSSM	O
based	O
on	O
alignment	O
of	O
nine	O
Transib	O
TPases	O
(	O
the	O
two	O
GenBank	O
TPase-like	O
proteins	O
plus	O
seven	O
added	O
TPases	O
)	O
noticeably	O
dropped	O
in	O
comparison	O
with	O
the	O
Ei-values	O
obtained	O
for	O
the	O
PSSM	O
constructed	O
in	O
the	O
previous	O
step	O
based	O
on	O
alignment	O
of	O
the	O
three	O
TPases	O
(	O
Table	O
1	O
)	O
.	O

Peripheral	O
blood	O
mononuclear	O
cell	O
GCR	O
binding	O
affinities	O
for	O
dexamethasone	O
and	O
budesonide	O
were	O
also	O
determined	O
for	O
both	O
patient	O
groups	O
by	O
using	O
a	O
radioligand	O
binding	O
assay	O
and	O
Scatchard	O
analysis	O
.	O

BSAP	O
has	O
been	O
identified	O
previously	O
as	O
a	O
transcription	O
factor	O
that	O
is	O
expressed	O
at	O
early	O
,	O
but	O
not	O
late	O
,	O
stages	O
of	O
B-cell	O
differentiation	O
.	O

HIV	O
does	O
not	O
replicate	O
in	O
naive	O
CD4	O
T	O
cells	O
stimulated	O
with	O
CD3/CD28	O
.	O

We	O
conclude	O
that	O
ectopic	O
expression	O
of	O
Neur	O
compensates	O
for	O
the	O
loss	O
of	O
D-mib	O
activity	O
.	O

Multiple	O
sequence	O
alignments	O
of	O
novel	O
candidate	O
proteins	O

Enumeration	O
of	O
iORFs	O
from	O
prokaryotic	O
genomes	O

Not	O
only	O
was	O
this	O
effect	O
observed	O
at	O
the	O
mRNA	O
level	O
,	O
but	O
activator	O
protein-1	O
(	O
AP-1	O
)	O
DNA	O
binding	O
capacity	O
was	O
affected	O
as	O
well	O
,	O
A	O
strong	O
reduction	O
was	O
observed	O
in	O
the	O
LPS-induced	O
DNA-binding	O
activity	O
of	O
AP-1	O
in	O
the	O
presence	O
of	O
IFN-gamma	O
.	O

Furthermore	O
,	O
as	O
compared	O
to	O
regulation	O
by	O
phorbol	O
ester	O
,	O
collagenase	O
induction	O
in	O
monocytic	O
cells	O
by	O
cell	O
wall	O
derivatives	O
of	O
bacteria	O
or	O
yeast	O
is	O
largely	O
independent	O
of	O
upstream	O
promoter	O
sequences	O
.	O

Finally	O
,	O
RNA	O
from	O
activated	O
lymphocytes	O
was	O
amplified	O
by	O
polymerase	O
chain	O
reaction	O
using	O
oligonucleotide	O
primers	O
flanking	O
the	O
196	O
base	O
pair	O
long	O
region	O
encoding	O
the	O
DNA-binding	O
domain	O
of	O
the	O
human	O
intestinal	O
receptor	O
.	O

The	O
binding	O
activity	O
of	O
transcription	O
factor	O
AP-1	O
,	O
which	O
consists	O
of	O
dimers	O
of	O
Fos	O
and	O
Jun	O
family	O
proteins	O
,	O
was	O
also	O
studied	O
using	O
a	O
gel	O
shift	O
assay	O
.	O

Tax	O
activates	O
the	O
GM-CSF	O
promoter	O
through	O
the	O
CK-1/CD28RE	O
region	O
and	O
also	O
activates	O
nuclear	O
factor-kappa	O
B	O
binding	O
to	O
this	O
region	O
.	O

The	O
expression	O
of	O
hGATA-3	O
,	O
a	O
T	O
cell-specific	O
factor	O
known	O
to	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
the	O
transcription	O
of	O
TcR	O
delta	O
locus	O
,	O
was	O
analyzed	O
by	O
Northern	O
blot	O
,	O
in	O
cultured	O
NK	O
cell	O
population	O
and	O
clones	O
(	O
but	O
not	O
in	O
freshly	O
derived	O
cell	O
populations	O
)	O
.	O

In	O
contrast	O
to	O
MEL	O
cells	O
,	O
however	O
,	O
K562	O
cells	O
acquired	O
a	O
macrophage-like	O
morphology	O
and	O
exhibited	O
a	O
complete	O
failure	O
to	O
generate	O
benzidine-positive	O
cells	O
.	O

Collectively	O
this	O
study	O
shows	O
that	O
expression	O
of	O
the	O
Btk	O
gene	O
is	O
regulated	O
by	O
the	O
combined	O
action	O
of	O
Sp1-	O
and	O
PU.1-family	O
members	O
.	O

Using	O
a	O
cell	O
line	O
that	O
is	O
stably	O
transfected	O
with	O
a	O
trimer	O
of	O
the	O
NFAT-1	O
regulatory	O
element	O
linked	O
to	O
a	O
lac-Z	O
reporter	O
gene	O
,	O
we	O
screened	O
for	O
inhibitors	O
of	O
NFAT-1-mediated	O
beta-galactosidase	O
activity	O
.	O

A	O
putative	S
function	S
of	S
BHRF1	S
in	S
EBV-infected	S
epithelial	S
cells	S
may	S
be	S
to	S
protect	S
virus-infected	S
cells	S
from	S
TNF-	S
and/or	S
anti-Fas-	S
induced	S
cell	S
death	S
in	S
order	S
to	S
maximize	S
virus	S
production	S
.	O

The	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
Rev	O
protein	O
is	O
essential	O
for	O
viral	O
structural	O
protein	O
expression	O
(	O
Gag	O
,	O
Pol	O
,	O
and	O
Env	O
)	O
and	O
,	O
hence	O
,	O
for	O
viral	O
replication	O
.	O

J	O
delta	O
K	O
cells	O
may	S
provide	S
a	S
useful	S
model	S
for	S
characterizing	S
NF-kappa	S
B-independent	S
transcriptional	S
activation	S
of	S
the	S
HIV	S
LTR	S
.	O

In	O
Jurkat	O
T	O
cells	O
,	O
induction	O
of	O
PIF	O
DNA	O
binding	O
activity	O
was	O
rapidly	O
induced	O
,	O
required	O
de	O
novo	O
protein	O
synthesis	O
,	O
and	O
was	O
sustained	O
at	O
a	O
high	O
level	O
for	O
at	O
least	O
23	O
h	O
.	O

The	O
resultant	O
primer	O
products	O
are	O
analysed	O
by	O
denaturing	O
polyacrylamide	O
gel	O
electrophoresis	O
and	O
autoradiography	O
.	O

Unexpectedly	O
,	O
the	O
CD8+	O
T-cell	O
subpopulation	O
failed	O
to	O
respond	O
.	O

Since	O
1988	O
,	O
several	O
families	O
of	O
functionally	O
important	O
T	O
cell	O
transcription	O
factors	O
have	O
been	O
identified	O
.	O

The	O
presence	O
of	O
an	O
AP-1	O
protein	O
in	O
the	O
NF-AT	O
protein	O
complex	O
may	S
regulate	S
NF-AT-binding	S
activity	S
through	S
protein-protein	S
interaction	S
.	O

Rapid	O
shuttling	O
of	O
NF-AT	O
in	O
discrimination	O
of	O
Ca2+	O
signals	O
and	O
immunosuppression	O
.	O

Blocking	O
mAbs	O
against	O
CD18	O
and	O
CD11b	O
abrogated	O
fibrinogen-induced	O
NF-kappa	O
B	O
activation	O
.	O

Furthermore	O
,	O
it	O
has	O
recently	O
been	O
estimated	S
that	S
the	S
overall	S
average	S
false	S
positive	S
rate	S
of	S
available	S
computational	S
and	S
high-throughput	S
experimental	S
interaction	S
datasets	S
is	S
as	S
high	S
as	S
90	S
%	S
.	O

The	O
NF-kappaB	O
family	O
of	O
transcription	O
factors	O
regulates	O
the	O
inducible	O
expression	O
of	O
a	O
variety	O
of	O
genes	O
.	O

They	O
analyzed	O
146	O
prokaryotic	O
genomes	O
,	O
but	O
no	O
likely	O
tRNA	O
of	O
the	O
novel	O
amino	O
acid	O
was	O
detected	O
.	O

It	O
should	O
be	O
noted	O
that	O
predictors	O
tested	O
on	O
datasets	O
consisting	O
of	O
equal	O
numbers	O
of	O
positives	O
and	O
negatives	O
achieve	O
much	O
higher	O
accuracy	O
measures	O
than	O
those	O
tested	O
on	O
datasets	O
containing	O
100	O
times	O
more	O
negatives	O
than	O
positives	O
.	O

Since	O
induction	O
of	O
the	O
IL-2	O
receptor	O
alpha	O
subunit	O
is	O
a	O
hallmark	O
of	O
lymphocyte	O
activation	O
,	O
we	O
suggest	S
that	S
p21ras	S
naturally	S
triggers	S
B	S
cell	S
activation	S
.	O

The	O
functional	O
analysis	O
of	O
the	O
IL-8	O
gene	O
revealed	O
that	O
both	O
AP-1-	O
and	O
NF-kappaB	O
factor-binding	O
elements	O
were	O
involved	O
in	O
conferring	O
the	O
responsiveness	O
to	O
CMV	O
.	O

Thus	O
,	O
EBV	O
binding	O
to	O
its	O
cellular	O
receptor	O
on	O
resting	O
B	O
cells	O
triggers	O
an	O
NF-kappaB-dependent	O
intracellular	O
signaling	O
pathway	O
which	O
is	O
required	O
for	O
infection	O
.	O

These	O
results	O
can	O
not	O
be	O
explained	O
by	O
receptor	O
down-regulation	O
due	O
to	O
higher	O
level	O
of	O
mineralocorticoids	O
of	O
the	O
zona	O
glomerulosa	O
.	O

Role	O
of	O
cellular	O
tumor	O
necrosis	O
factor	O
receptor-associated	O
factors	O
in	O
NF-kappaB	O
activation	O
and	O
lymphocyte	O
transformation	O
by	O
herpesvirus	O
Saimiri	O
STP	O
.	O

Protein	O
kinase	O
C	O
(	O
PKC	O
)	O
depletion	O
generated	O
by	O
a	O
long-term	O
phorbol	O
12	O
myristate	O
13-acetate	O
treatment	O
had	O
weak	O
effects	O
on	O
proliferation	O
.	O

Because	O
interferon	O
(	O
IFN	O
)	O
regulatory	O
factors	O
(	O
IRF-1	O
and	O
IRF-2	O
)	O
and	O
other	O
IFN-inducible	O
gene	O
products	O
regulate	O
cell	O
growth	O
,	O
we	O
analyzed	O
the	O
effects	O
of	O
ATRA	O
on	O
the	O
expression	O
of	O
these	O
genes	O
.	O

Human	O
monocytic	O
cell	O
line	O
THP-1	O
was	O
treated	O
with	O
E.	O
chaffeensis	O
which	O
had	O
been	O
preincubated	O
with	O
human	O
anti-E.	O
chaffeensis	O
serum	O
for	O
2	O
h	O
,	O
and	O
the	O
levels	O
of	O
cytokine	O
mRNAs	O
were	O
evaluated	O
by	O
competitive	O
reverse	O
transcription-PCR	O
.	O

We	O
propose	S
that	S
the	S
inducible	S
transcription	S
factor	S
binding	S
sites	S
in	S
the	S
5'-UTR	S
comprise	S
a	S
downstream	S
enhancer	S
domain	S
that	S
can	S
function	S
independent	S
of	S
,	S
or	S
in	S
concert	S
with	S
,	S
the	S
LTR	S
promoter	S
to	S
rapidly	S
increase	S
latent	S
proviral	S
transcription	S
in	S
response	S
to	S
cell	S
activation	S
signals	S
.	O

Human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
(	O
HTLV-1	O
)	O
is	O
the	O
etiologic	O
agent	O
of	O
adult	O
T-cell	O
leukemia	O
.	O

The	O
low	O
copy	O
repeat	O
detected	O
by	O
the	O
probe	O
Fr35-II	O
is	O
obviously	O
included	O
in	O
Y	O
chromosomal	O
rearrangements	O
during	O
hominid	O
evolution	O
.	O

Recently	O
,	O
the	O
cat	O
eye	O
syndrome	O
critical	O
region	O
protein	O
1	O
(	O
CECR1	O
)	O
gene	O
was	O
identified	O
and	O
shown	O
to	O
encode	O
a	O
protein	O
representing	O
a	O
subfamily	O
of	O
proteins	O
related	O
to	O
but	O
distinct	O
from	O
classical	O
ADAs	O
[	O
9	O
]	O
.	O

These	O
are	O
:	O
helper-inducer	O
(	O
memory	O
)	O
T	O
cells	O
(	O
CD4+CD45R0+CD45RA-CD29highCD11a+	O
)	O
,	O
CD20+	O
B	O
cells	O
,	O
and	O
cytotoxic	O
T	O
cells	O
(	O
CD8+CD56+/CD57+	O
)	O
.	O

Cytoplasmic	O
domain	O
heterogeneity	O
and	O
functions	O
of	O
IgG	O
Fc	O
receptors	O
in	O
B	O
lymphocytes	O
.	O

To	O
test	O
this	O
possibility	O
,	O
we	O
tried	O
to	O
rescue	O
the	O
phenotype	O
by	O
feeding	O
mutant	O
larvae	O
20E	O
,	O
which	O
can	O
initiate	O
pupariation	O
in	O
the	O
ecd1	O
mutant	O
,	O
which	O
has	O
an	O
extremely	O
low	O
level	O
of	O
ecdysone	O
[	O
30,31	O
]	O
.	O

Indeed	O
,	O
the	O
availability	O
of	O
selective	O
and	O
orally	O
active	O
proteasome	O
inhibitors	O
should	S
prove	S
useful	S
in	S
delineating	S
the	S
roles	S
of	S
the	S
proteasome	S
and	S
NF-kappa	S
B	S
in	S
other	S
pathophysiological	S
conditions	S
such	S
as	S
cancer	S
and	S
heart	S
disease	S
.	O

Therefore	O
,	O
the	S
presence	S
of	S
serine	S
in	S
this	S
motif	S
is	S
expected	S
to	S
be	S
crucial	S
to	S
Transib	S
transpositions	S
.	O

NF-kappa	O
B/Rel	O
proteins	O
have	O
been	O
shown	O
to	O
physically	O
interact	O
with	O
both	O
AP-1	O
and	O
Sp1	O
proteins	O
.	O

The	O
effect	O
of	O
the	O
Tat	O
protein	O
constitutively	O
expressed	O
by	O
these	O
cells	O
upon	O
their	O
differentiation	O
was	O
then	O
evaluated	O
by	O
looking	O
for	O
the	O
expression	O
of	O
the	O
c-fos	O
and	O
of	O
the	O
c-fms	O
proto-oncogenes	O
which	O
are	O
linked	O
to	O
the	O
differentiation	O
of	O
myelomonoblastic	O
cells	O
.	O

Transcriptional	O
regulation	O
of	O
the	O
pyruvate	O
kinase	O
erythroid-specific	O
promoter	O
.	O

As	O
a	O
result	O
,	O
Ca2+	O
signaling	O
and	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NF-AT	O
)	O
-driven	O
gene	O
expression	O
are	O
inhibited	O
.	O

However	O
,	O
taking	O
the	O
subset	O
of	O
5164	O
proteins	O
from	O
the	O
September	O
2005	O
version	O
that	O
are	O
seen	O
in	O
the	O
June	O
2006	O
version	O
(	O
20842	O
distinct	O
interactions	O
)	O
,	O
gave	O
a	O
prior	O
odds	O
of	O
interaction	O
estimate	O
of	O
1/639	O
.	O

In	O
addition	O
,	O
extracellular	O
factor	O
(	O
s	O
)	O
released	O
by	O
X-ray-treated	O
human	O
colonic	O
carcinoma	O
cell	O
line	O
(	O
HT29	O
)	O
might	S
activate	S
the	S
long	S
terminal	S
repeat	S
(	S
LTR	S
)	S
of	S
HIV-1	S
in	S
non-irradiated	S
HT29	S
cells	S
.	O

No	O
correlation	O
between	O
chromosome	O
1	O
alterations	O
and	O
nuclear	O
grade	O
,	O
age	O
,	O
size	O
,	O
lymph-node	O
involvement	O
,	O
hormonal	O
receptor	O
presence	O
,	O
proliferation	O
activity	O
or	O
p53	O
protein	O
expression	O
was	O
detected	O
.	O

The	O
limited	O
phylogenetic	O
distribution	O
of	O
pyrrolysine	O
suggests	S
that	S
its	S
incorporation	S
into	S
the	S
genetic	S
code	S
of	S
methanogen	S
is	S
relatively	S
recent	S
,	S
and	S
the	S
insertion	S
mechanism	S
of	S
a	S
novel	S
amino	S
acid	S
can	S
evolve	S
in	S
a	S
shorter	S
period	S
of	S
time	S
than	S
anticipated	S
.	O

Both	O
ATF/CRE	O
motifs	O
overlap	O
binding	O
sequences	O
for	O
the	O
multifunctional	O
YY1	O
transcription	O
factor	O
,	O
which	O
has	O
previously	O
been	O
shown	O
to	O
be	O
nuclear	O
matrix	O
associated	O
.	O

Although	O
the	O
two	O
proteins	O
are	O
only	O
38	O
%	O
identical	O
to	O
each	O
other	O
,	O
they	O
share	O
common	O
features	O
:	O
(	O
1	O
)	O
their	O
N-terminal	O
portions	O
are	O
missing	O
and	O
the	O
RAG1-like	O
sequences	O
start	O
at	O
positions	O
17	O
or	O
18	O
;	O
(	O
2	O
)	O
in	O
both	O
proteins	O
the	O
first	O
aa	O
residue	O
overlaps	O
with	O
the	O
acceptor	O
splice	O
site	O
;	O
and	O
(	O
3	O
)	O
their	O
similarity	O
to	O
RAG1	O
starts	O
at	O
positions	O
corresponding	O
to	O
position	O
470	O
of	O
the	O
human	O
RAG1	O
.	O

We	O
undertook	O
a	O
detailed	O
analysis	O
of	O
E2F	O
DNA-binding	O
activities	O
and	O
their	O
cell	O
cycle	O
behavior	O
in	O
primary	O
human	O
T	O
cells	O
.	O

Human	O
T	O
cell	O
activation	O
through	O
the	O
activation-inducer	O
molecule/CD69	O
enhances	O
the	O
activity	O
of	O
transcription	O
factor	O
AP-1	O
.	O

The	O
inhibitory	O
effect	O
of	O
PDTC	O
was	O
also	O
observed	O
in	O
etoposide-	O
and	O
dexamethasone-induced	O
apoptosis	O
in	O
human	O
thymocytes	O
at	O
a	O
concentration	O
of	O
1-10	O
microM	O
.	O

However	O
,	O
under	O
some	O
conditions	O
,	O
engagement	O
of	O
the	O
TCR	O
leads	O
instead	O
to	O
apoptosis	O
.	O

The	O
activation	O
of	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
(	O
STAT	O
)	O
proteins	O
in	O
a	O
primary	O
TCR-mediated	O
activation	O
of	O
T	O
cells	O
have	O
been	O
explored	O
.	O

We	O
hypothesize	S
that	S
interference	S
in	S
DNA-binding	S
activities	S
of	S
GATA-1	S
and	S
CACCC-binding	S
proteins	S
is	S
the	S
mechanism	S
by	S
which	S
the	S
ER	S
inhibits	S
regulation	S
of	S
these	S
genes	S
.	O

To	O
identify	O
ets-related	O
transcriptional	O
regulators	O
expressed	O
in	O
pre-B	O
lymphocytes	O
that	O
may	S
interact	S
with	S
either	S
the	S
pi	S
or	S
the	S
microB	S
site	S
,	O
we	O
have	O
used	O
a	O
PCR	O
approach	O
with	O
degenerate	O
oligonucleotides	O
encoding	O
conserved	O
sequences	O
in	O
all	O
members	O
of	O
the	O
ets	O
family	O
.	O

Here	O
,	O
we	O
demonstrate	O
a	O
novel	O
role	O
for	O
IK	O
in	O
MHC	O
class	O
II	O
expression	O
since	O
over-expression	O
of	O
this	O
protein	O
by	O
stable	O
transfection	O
into	O
human	O
B	O
cells	O
led	O
to	O
a	O
total	O
disappearance	O
of	O
constitutive	O
MHC	O
class	O
II	O
mRNA	O
expression	O
.	O

The	O
results	O
were	O
compared	O
with	O
those	O
of	O
12	O
menopausal	O
women	O
without	O
diabetes	O
and	O
12	O
normal	O
women	O
of	O
childbearing	O
age	O
.	O

Further	O
evidence	O
suggests	S
that	S
Nef	S
inhibits	S
NF-kappa	S
B	S
induction	S
by	S
interfering	S
with	S
a	S
signal	S
derived	S
from	S
the	S
T-cell	S
receptor	S
complex	S
.	O

the	O
Kd	O
was	O
unchanged	O
(	O
9.3	O
+/-	O
2.6	O
vs	O
9.2	O
+/-	O
2.4	O
nM	O
)	O
.	O

The	O
GATA-3	O
transcription	O
factor	O
is	O
required	O
for	O
development	O
of	O
the	O
T-cell	O
lineage	O
and	O
Th2	O
cytokine	O
gene	O
expression	O
in	O
CD4	O
T-cells	O
.	O

The	O
regulatory	O
mechanisms	O
of	O
the	O
human	O
and	O
murine	O
TNF	O
genes	O
are	O
discussed	O
.	O

[	O
Regulatory	O
effect	O
of	O
insulin	O
on	O
glucocorticoid	O
receptor	O
in	O
human	O
peripheral	O
leukocytes	O
]	O

Materials	O
and	O
Methods	O

Activation	O
of	O
T	O
lymphocytes	O
to	O
produce	O
cytokines	O
is	O
regulated	O
by	O
the	O
counterbalance	O
of	O
protein-tyrosine	O
kinases	O
and	O
protein-tyrosine	O
phosphatases	O
,	O
many	O
of	O
which	O
have	O
a	O
high	O
degree	O
of	O
substrate	O
specificity	O
because	O
of	O
physical	O
association	O
with	O
their	O
targets	O
.	O

A	O
microtitre	O
assay	O
system	O
for	O
glucocorticoid	O
receptors	O
:	O
decreased	O
receptor	O
concentration	O
in	O
myocardial	O
infarction	O
.	O

Electrophoretic	O
mobility	O
shift	O
assay	O
(	O
EMSA	O
)	O
and	O
supershift	O
assay	O
using	O
an	O
NF-kappa	O
B	O
binding	O
sequence	O
from	O
the	O
kappa	O
light	O
chain	O
as	O
a	O
probe	O
,	O
revealed	O
that	O
both	O
p65	O
(	O
RelA	O
)	O
and	O
c-Rel	O
were	O
present	O
in	O
CD40-stimulated	O
B	O
cells	O
.	O

A	O
regulatory	O
element	O
in	O
the	O
human	O
interleukin	O
2	O
gene	O
promoter	O
is	O
a	O
binding	O
site	O
for	O
the	O
zinc	O
finger	O
proteins	O
Sp1	O
and	O
EGR-1	O
.	O

This	S
implicates	S
E2F	S
as	S
a	S
multifunctional	S
target	S
for	S
proteins	S
and	S
enzymes	S
,	S
possibly	S
,	S
responsive	S
to	S
DNA	S
damage	S
through	S
the	S
negative	S
effect	S
of	S
UDG	S
on	S
E2F-mediated	S
transcriptional	S
activity	S
.	O

Within	O
the	O
human	O
enhancer	O
,	O
these	O
two	O
sites	O
are	O
located	O
within	O
the	O
previously	O
defined	O
DNase	O
I	O
footprints	O
,	O
NFAT-1	O
and	O
NFIL-2B	O
,	O
respectively	O
.	O

It	O
was	O
generated	O
by	O
integrating	O
seven	O
different	O
features	O
(	O
four	O
of	O
which	O
involve	O
transferring	O
interactions	O
or	O
characteristics	O
of	O
protein	O
pairs	O
from	O
model	O
organisms	O
to	O
human	O
)	O
in	O
a	O
probabilistic	O
framework	O
.	O

Given	O
that	O
this	O
network	O
already	O
comprises	O
around	O
60000	O
interactions	O
,	O
questions	O
arise	O
as	O
to	O
how	O
such	O
networks	O
have	O
evolved	O
and	O
how	O
they	O
are	O
organised	O
.	O

Cytomegalovirus	O
(	O
CMV	O
)	O
infection	O
is	O
nonpermissive	O
or	O
persistent	O
in	O
many	O
lymphoid	O
and	O
myeloid	O
cell	O
types	O
but	O
can	O
be	O
activated	O
in	O
differentiated	O
macrophages	O
.	O

In	O
contrast	O
,	O
the	O
half-life	O
of	O
c-jun	O
RNA	O
in	O
TPA-treated	O
HL-60	O
cells	O
exposed	O
to	O
cycloheximide	O
and	O
actinomycin	O
D	O
was	O
greater	O
than	O
2	O
h	O
.	O

Because	O
the	O
elevated	O
Myb	O
:	O
Maf	O
status	O
seen	O
in	O
differentiating	O
cells	O
can	O
be	O
recapitulated	O
by	O
overexpression	O
of	O
c-Maf	O
in	O
myeloid	O
cell	O
lines	O
,	O
we	O
inducibly	O
expressed	O
the	O
c-Maf	O
cDNA	O
in	O
2	O
bipotent	O
human	O
myeloid	O
progenitor	O
cells	O
.	O

We	O
found	O
that	O
two	O
IL-1alpha	O
kappaB-like	O
sites	O
(	O
positions	O
-1,065	O
to	O
-1,056	O
and	O
+646	O
to	O
+655	O
)	O
specifically	O
formed	O
a	O
complex	O
with	O
NF-kappaB-containing	O
nuclear	O
extract	O
from	O
MT-2	O
cells	O
and	O
that	O
NF-kappaB	O
bound	O
with	O
higher	O
affinity	O
to	O
the	O
3	O
'	O
NF-kappaB	O
binding	O
site	O
than	O
to	O
the	O
5	O
'	O
NF-kappaB	O
site	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrate	O
that	O
tolerance	O
to	O
LPS	O
is	O
determined	O
by	O
post-receptor	O
mechanisms	O
that	O
involve	O
an	O
altered	O
composition	O
of	O
the	O
NF-kappa	O
B	O
complex	O
.	O

T	O
cell-specific	O
negative	O
regulation	O
of	O
transcription	O
of	O
the	O
human	O
cytokine	O
IL-4	O
.	O

Five	O
such	O
validated	O
predictions	O
are	O
reported	O
here	O
:	O

Despite	O
the	O
low	O
overall	O
coverage	O
,	O
iPfam	O
domain	O
pairs	O
are	O
found	O
in	O
more	O
protein	O
interactions	O
than	O
would	S
be	S
expected	S
by	S
chance	S
(	O
see	O
Table	O
1	O
)	O
.	O

As	O
a	O
functional	O
consequence	O
,	O
adhesion	O
of	O
U937	O
monocytes	O
to	O
TNF-stimulated	O
HUVECs	O
was	O
markedly	O
reduced	O
by	O
aspirin	O
due	O
to	O
suppression	O
of	O
VCAM-1	O
and	O
E-selectin	O
upregulation	O
.	O

In	O
adhering	O
cells	O
,	O
pre-treatment	O
with	O
cytochalasin	O
D	O
suppresses	O
tyrosine	O
phosphorylation	O
of	O
FAK	O
and	O
paxillin	O
but	O
not	O
of	O
Syk	O
,	O
while	O
IL-1	O
beta	O
message	O
induction	O
is	O
unaffected	O
.	O

Three-step	O
filtering	O
of	O
the	O
candidate	O
clusters	O

Here	O
we	O
show	O
that	O
the	O
I	O
alpha1	O
promoter	O
contains	O
several	O
binding	O
sites	O
for	O
the	O
AML/PEBP2/CBF	O
family	O
of	O
transcription	O
factors	O
and	O
that	O
AML	O
and	O
Ets	O
proteins	O
are	O
major	O
regulators	O
of	O
the	O
basal	O
and	O
TGF-beta-inducible	O
promoter	O
activity	O
.	O

Nuclear	O
levels	O
of	O
NF-kappaB	O
correlate	O
with	O
syncytium-forming	O
capacity	O
of	O
8e51	O
cells	O
,	O
expressing	O
a	O
defective	O
HIV	O
virus	O
.	O

Gel	O
retardation	O
assays	O
,	O
using	O
a	O
32P-probe	O
containing	O
the	O
HIV-1	O
NF-kB	O
probe	O
and	O
nuclear	O
extracts	O
from	O
PMA-treated	O
cells	O
,	O
showed	O
significantly	O
reduced	O
induction	O
of	O
nuclear	O
NF-kB	O
binding	O
proteins	O
in	O
these	O
two	O
subclones	O
compared	O
with	O
wild	O
type	O
CEM	O
and	O
a	O
control	O
subclone	O
.	O

In	O
addition	O
,	O
treatment	O
of	O
these	O
nuclear	O
extracts	O
with	O
sodium	O
deoxycholate	O
restored	O
their	O
ability	O
to	O
form	O
the	O
heterodimer	O
,	O
suggesting	S
the	S
presence	S
of	S
an	S
inhibitor	S
of	S
NF-kappa	S
B	S
activity	S
.	O

The	O
in	O
vitro	O
immunization	O
of	O
peripheral	O
blood	O
lymphocytes	O
from	O
four	O
patients	O
in	O
remission	O
(	O
S.	O
R.	O
,	O
F.	O
R.	O
,	O
M.	O
M.	O
,	O
P.	O
G.	O
)	O
with	O
BCR1/25	O
,	O
a	O
25-mer	O
pml/RAR-alpha	O
,	O
did	O
not	O
elicit	O
either	O
a	O
polyclonal	O
or	O
a	O
clonal	O
immune	O
response	O
specific	O
to	O
the	O
peptide	O
.	O

We	O
show	O
here	O
that	O
c-Rel	O
binds	O
to	O
kappa	O
B	O
sites	O
as	O
homodimers	O
as	O
well	O
as	O
heterodimers	O
with	O
p50	O
.	O

Programmed	O
cell	O
death	O
is	O
a	O
conserved	O
,	O
gene-directed	O
mechanism	O
for	O
the	O
elimination	O
of	O
unnecessary	O
or	O
dangerous	O
cells	O
from	O
an	O
organism	O
.	O

The	O
current	O
study	O
investigates	O
the	O
hypothesis	S
that	S
CD40	S
expressed	S
on	S
lung	S
fibroblasts	S
is	S
an	S
activation	S
structure	S
and	S
mechanism	S
for	S
interaction	S
with	S
hemopoietic	S
cells	S
.	O

Surprisingly	O
,	O
multimers	O
of	O
kappa	O
1-kappa	O
3	O
can	O
confer	O
PMA	O
inducibility	O
on	O
a	O
heterologous	O
promoter	O
in	O
a	O
B	O
(	O
Raji	O
)	O
,	O
but	O
not	O
a	O
T	O
(	O
HUT78	O
)	O
cell	O
line	O
.	O

However	O
,	O
the	O
overall	O
structure	O
of	O
the	O
ring	O
gland	O
is	O
not	O
visibly	O
affected	O
even	O
in	O
the	O
oldest	O
larvae	O
(	O
10	O
d	O
,	O
i.e.	O
,	O
5	O
d	O
after	O
the	O
heterozygous	O
siblings	O
pupariated	O
)	O
with	O
a	O
fully	O
disintegrated	O
fat	O
body	O
(	O
Figure	O
7B	O
and	O
7C	O
)	O
.	O

Immunoelectron	O
microscopy	O
demonstrated	O
the	O
presence	O
of	O
intensely	O
labelled	O
structures	O
likely	S
to	S
represent	S
the	S
GATA-1	S
foci	S
seen	S
by	S
immunofluorescence	S
.	O

Because	O
these	O
induced	O
gene	O
products	O
have	O
NF-kappaB	O
sites	O
in	O
their	O
promoter	O
regions	O
,	O
we	O
next	O
examined	O
whether	S
there	S
was	S
an	S
up-regulation	S
of	S
nuclear	S
NF-kappaB	S
levels	S
.	O

Tumors	O
with	O
high	O
Ki-67	O
proliferation	O
indices	O
(	O
>	O
20	O
%	O
)	O
were	O
associated	O
with	O
a	O
higher	O
4-year	O
probability	O
of	O
relapse	O
of	O
disease	O
(	O
55.3	O
%	O
versus	O
79.1	O
%	O
;	O
P	O
=	O
0.003	O
)	O
and	O
death	O
(	O
71	O
%	O
versus	O
95.6	O
%	O
;	O
P	O
=	O
0.00005	O
)	O
when	O
compared	O
with	O
tumors	O
with	O
low	O
Ki-67	O
values	O
.	O

In	O
Drosophila	O
,	O
dosage	O
compensation	O
is	O
achieved	O
in	O
the	O
heterogametic	O
male	O
by	O
a	O
twofold	O
chromosome-wide	O
up-regulation	O
(	O
hypertranscription	O
)	O
of	O
essentially	O
all	O
genes	O
on	O
the	O
single	O
X	O
chromosome	O
.	O

The	O
Bcl-2	S
family	S
appears	S
to	S
function	S
in	S
regulating	S
the	S
release	S
of	S
pro-apoptotic	S
components	S
from	S
mitochondria	S
as	S
well	S
as	S
by	S
possibly	S
inhibiting	S
Apaf-1	S
directly	S
.	O

Two	O
distinct	O
elements	O
have	O
been	O
implicated	O
in	O
function	O
of	O
the	O
HTLV-I	O
enhancer	O
.	O

Mineralocorticoid	O
effector	O
mechanism	O
in	O
preeclampsia	O
.	O

Using	O
deletion	O
mutants	O
,	O
the	O
downstream	O
parathyroid	O
hormone-related	O
protein	O
(	O
PTHrP	O
)	O
promoter	O
is	O
shown	O
to	O
be	O
responsive	O
to	O
both	O
HTLV-I	O
and	O
HTLV-II	O
Tax	O
as	O
well	O
as	O
the	O
AP1/c-jun	O
proto-oncogene	O
.	O

The	O
six	O
5	O
'	O
upstream	O
and	O
one	O
intronic	O
DHS	O
were	O
detected	O
in	O
only	O
perforin-expressing	O
lymphocytes	O
.	O

In	O
addition	O
,	O
aberrancies	O
in	O
NF-kappaB	O
activity	O
have	O
been	O
implicated	O
in	O
the	O
immunopathogenesis	O
of	O
diseases	O
involving	O
immune	O
or	O
inflammatory	O
processes	O
such	O
as	O
atherosclerosis	O
and	O
HIV-1	O
infection	O
.	O

When	O
the	O
supplemented	O
cytokine	O
was	O
switched	O
from	O
GM-CSF	O
to	O
EPO	O
,	O
hemoglobin	O
synthesis	O
in	O
M-TAT/GM-CSF	O
cells	O
increased	O
rapidly	O
(	O
within	O
5	O
h	O
)	O
,	O
and	O
the	O
level	O
of	O
GATA-1	O
mRNA	O
increased	O
.	O

These	O
findings	O
suggest	S
that	S
LTR	S
sequence	S
changes	S
can	S
significantly	S
affect	S
basal	S
LTR	S
function	S
and	S
transcription	S
factor	S
recruitment	S
,	S
which	S
may	S
,	S
in	S
turn	S
,	S
alter	S
the	S
course	S
of	S
viral	S
replication	S
in	S
cells	S
of	S
CNS	S
and	S
immune	S
system	S
origin	S
.	O

Positive-pressure	O
mechanical	O
ventilation	O
supports	O
gas	O
exchange	O
in	O
patients	O
with	O
respiratory	O
failure	O
but	O
is	O
also	O
responsible	O
for	O
significant	O
lung	O
injury	O
.	O

One	O
63-kDa	O
isoform	O
,	O
termed	O
I	O
kappa	O
B	O
gamma-1	O
,	O
which	O
lacks	O
59	O
amino	O
acids	O
C-terminal	O
to	O
ankyrin	O
repeat	O
7	O
,	O
has	O
a	O
novel	O
35-amino	O
acid	O
C	O
terminus	O
encoded	O
by	O
an	O
alternative	O
reading	O
frame	O
of	O
the	O
p105	O
gene	O
.	O

The	O
rest	O
of	O
the	O
Y	O
chromosome	O
has	O
undergone	O
several	O
rearrangements	O
in	O
the	O
different	O
great	O
apes	O
.	O

Hydrogen	O
peroxide	O
and	O
oxygen	O
radicals	O
are	O
agents	O
commonly	O
produced	O
during	O
inflammatory	O
processes	O
.	O

In	O
particular	O
,	O
Tax	O
is	O
capable	O
of	O
modulating	O
the	O
expression	O
or	O
activity	O
of	O
various	O
host	O
transcription	O
factors	O
,	O
including	O
members	O
of	O
the	O
NF-kappa	O
B/Rel	O
and	O
CREB/ATF	O
families	O
,	O
as	O
well	O
as	O
the	O
cellular	O
factors	O
HEB-1	O
and	O
p67SRF	O
.	O

In	O
addition	O
to	O
the	O
assembled	O
contigs	O
,	O
Baylor	O
College	O
of	O
Medicine	O
,	O
Human	O
Genome	O
Sequencing	O
Center	O
(	O
http	O
:	O
//www.hgsc.bcm.tmc.edu	O
)	O
produced	O
an	O
approximately	O
8-Gb	O
set	O
of	O
short	O
unassembled	O
WGS	O
sequences	O
,	O
called	O
“traces”	O
,	O
which	O
cover	O
nearly	O
the	O
entire	O
sea	O
urchin	O
genome	O
.	O

Freshly	O
isolated	O
monocytes	O
constitutively	O
expressed	O
high	O
levels	O
of	O
transcriptionally	O
inactive	O
p50	O
homodimer	O
which	O
decreased	O
with	O
time	O
in	O
culture	O
in	O
favor	O
of	O
the	O
transcriptionally	O
active	O
p50/p65	O
and	O
p50/RelB	O
heterodimers	O
.	O

Glucocorticoid-induced	O
apoptosis	O
and	O
regulation	O
of	O
NF-kappaB	O
activity	O
in	O
human	O
leukemic	O
T	O
cells	O
.	O

We	O
have	O
analyzed	O
the	O
expression	O
of	O
TCL1	O
mRNA	O
and	O
protein	O
in	O
peripheral	O
blood	O
lymphocytes	O
(	O
PBLs	O
)	O
from	O
four	O
AT	O
cases	O
and	O
from	O
healthy	O
controls	O
.	O

Nuclear	O
factor-kappa	O
B	O
activity	O
in	O
T	O
cells	O
from	O
patients	O
with	O
rheumatic	O
diseases	O
:	O
a	O
preliminary	O
report	O
.	O

These	O
data	O
are	O
in	O
agreement	O
with	O
the	O
concept	O
that	O
different	O
GCH	O
compounds	O
might	S
differ	S
in	S
their	S
binding	S
and	S
affinity	S
properties	S
,	S
tissue-specific	S
metabolism	S
,	S
and	S
interaction	S
with	S
transcription	S
factor	S
.	O

The	O
involvement	O
of	O
members	O
of	O
the	O
PEBP2/CBF	O
family	O
in	O
chromosome	O
translocations	O
associated	O
with	O
acute	O
myeloid	O
leukemia	O
,	O
and	O
in	O
the	O
transcriptional	O
regulation	O
of	O
the	O
myeloid-specific	O
genes	O
encoding	O
for	O
myeloperoxidase	O
,	O
elastase	O
,	O
and	O
the	O
colony-stimulating	O
factor	O
receptor	O
,	O
highlights	O
the	O
relevance	O
of	O
the	O
regulation	O
of	O
the	O
CD36	O
gene	O
promoter	O
in	O
monocytic	O
cells	O
by	O
members	O
of	O
the	O
PEBP2/CBF	O
family	O
.	O

Glutathione-S-transferase	O
(	O
GST	O
)	O
-Grb2	O
fusion	O
proteins	O
have	O
been	O
used	O
to	O
identify	O
the	O
potential	O
role	O
of	O
Grb2-binding	O
proteins	O
in	O
platelet	O
activation	O
by	O
the	O
platelet	O
low-affinity	O
IgG	O
receptor	O
,	O
Fc	O
gamma	O
RIIA	O
.	O

The	O
latter	O
``	O
nuclear	O
factor	O
for	O
activated	O
T	O
cells	O
''	O
likely	S
contributes	S
to	S
the	S
tissue	S
specificity	S
of	S
IL-2	S
gene	S
expression	S
.	O

Other	O
I	O
kappa	O
B	O
proteins	O
are	O
rather	O
involved	O
in	O
terminating	O
NF-kappa	O
B	O
's	O
activity	O
in	O
the	O
nucleus	O
.	O

NF-kappaB-mediated	O
up-regulation	O
of	O
Bcl-x	O
and	O
Bfl-1/A1	O
is	O
required	O
for	O
CD40	O
survival	O
signaling	O
in	O
B	O
lymphocytes	O
.	O

Here	O
we	O
report	O
the	O
expression	O
of	O
a	O
fork	O
head	O
domain	O
protein	O
in	O
human	O
T	O
helper	O
cells	O
.	O

Transient	O
expression	O
analyses	O
in	O
cells	O
of	O
neuroglial	O
and	O
lymphocytic	O
origin	O
demonstrated	O
that	O
some	O
of	O
these	O
LTRs	O
had	O
activities	O
which	O
varied	O
significantly	O
from	O
the	O
LAI	O
LTR	O
in	O
U-373	O
MG	O
cells	O
(	O
an	O
astrocytoma	O
cell	O
line	O
)	O
as	O
well	O
as	O
in	O
Jurkat	O
cells	O
(	O
a	O
CD4-positive	O
lymphocyte	O
cell	O
line	O
)	O
.	O

This	O
proves	O
that	O
the	O
observed	O
iPfam	O
coverage	O
is	O
significantly	O
higher	O
than	O
expected	O
and	O
iPfam	O
domain	O
pairs	O
are	O
enriched	O
in	O
real	O
experimental	O
protein	O
interactions	O
.	O

TNF	O
is	O
one	O
of	O
the	O
cytokines	O
secreted	O
by	O
the	O
cells	O
of	O
the	O
immune	O
system	O
.	O

Statistical	O
significance	O
was	O
estimated	O
by	O
likelihood	O
ratio	O
test	O
29	O
.	O

When	O
three-dimensional	O
structures	O
are	O
available	O
for	O
both	S
proteins	S
thought	S
to	S
interact	S
,	O
high	S
quality	S
predictions	S
and	S
additional	S
information	S
such	S
as	S
the	S
residues	S
involved	S
in	S
the	S
interaction	S
and	S
their	S
binding	S
affinity	S
may	S
be	S
estimated	S
(	O
reviewed	O
in	O
24	O
)	O
.	O

An	O
NFAT	O
oligonucleotide	O
carrying	O
mutations	O
in	O
the	O
5	O
'	O
purine-rich	O
part	O
of	O
the	O
NFAT	O
sequence	O
failed	O
to	O
form	O
a	O
complex	O
and	O
to	O
compete	O
with	O
the	O
wild	O
type	O
motif	O
for	O
NFAT	O
complex	O
formation	O
in	O
both	O
T	O
and	O
B	O
cells	O
.	O

A	S
nucleotide	S
substitution	S
within	S
a	S
recently	S
described	S
OAP40	S
element	S
located	S
just	S
upstream	S
of	S
an	S
NF-AT	S
site	S
(	S
P	S
sequence	S
)	S
appears	S
to	S
be	S
largely	S
responsible	S
for	S
the	S
increased	S
promotor	S
strength	S
of	S
this	S
particular	S
allelic	S
form	S
of	S
the	S
IL-4	S
promoter	S
.	O

(	O
A	O
)	O
TransibN1_AG	O
family	O
from	O
mosquito	O
.	O

This	O
paper	O
aims	O
to	O
review	O
the	O
role	O
of	O
free	O
radical-induced	O
tissue	O
damage	O
and	O
antioxidant	O
defence	O
mechanisms	O
in	O
inflammatory	O
diseases	O
that	O
involve	O
pathogenic	O
processes	O
similar	O
to	O
the	O
periodontal	O
diseases	O
.	O

Furthermore	O
,	O
given	O
that	O
the	O
sea	O
urchin	O
,	O
lancelet	O
,	O
hydra	O
,	O
and	O
starlet	O
sea	O
anemone	O
genomes	O
harbor	O
several	O
highly	O
divergent	O
N-terminal–like	O
domains	O
,	O
separate	O
from	O
the	O
RAG1	O
core–like	O
sequences	O
and	O
known	O
transposable	O
elements	O
,	O
it	O
is	O
very	O
likely	S
that	S
the	S
N-terminal–like	S
domains	S
of	S
RAG1	S
also	S
form	S
a	S
multigene	S
family	S
that	S
can	S
be	S
traced	S
back	S
to	S
a	S
common	S
ancestor	S
of	S
Deuterostomes	S
(	O
see	O
Figure	O
1	O
)	O
.	O

Furthermore	O
,	O
our	O
study	O
of	O
this	O
mutant	O
provides	O
strong	O
evidence	O
that	O
the	O
fat	O
body	O
disintegration	O
is	O
promoted	O
by	O
the	O
action	O
of	O
hemocytes	O
.	O

This	O
portion	O
of	O
RAG1	O
corresponds	O
to	O
the	O
“RAG1	O
core	O
,	O
”	O
hereafter	O
numbered	O
relative	O
to	O
human	O
RAG1	O
(	O
residues	O
387–1011	O
)	O
,	O
which	O
along	O
with	O
RAG2	O
is	O
known	O
to	O
be	O
sufficient	O
to	O
perform	O
V	O
(	O
D	O
)	O
J	O
cleavage	O
even	O
after	O
deletions	O
of	O
the	O
383-aa	O
N-terminal	O
and	O
32-aa	O
C-terminal	O
portions	O
of	O
RAG1	O
[	O
19,20	O
]	O
.	O

One	O
region	O
,	O
centered	O
at	O
-54	O
,	O
is	O
similar	O
to	O
a	O
nuclear	O
factor	O
E1-binding	O
site	O
,	O
and	O
a	O
region	O
located	O
at	O
position	O
-233	O
contains	O
a	O
CCAAT	O
motif	O
.	O

These	O
results	O
reveal	O
a	O
new	O
link	O
between	O
the	O
dopamine	O
system	O
,	O
cytokine	O
signaling	O
pathway	O
and	O
regulation	O
of	O
gene	O
expression	O
via	O
the	O
involvement	O
of	O
NF-kappaB	O
in	O
T	O
cells	O
and	O
PBMC	O
.	O

In	O
addition	O
,	O
domains	O
that	O
exist	O
as	O
separate	O
proteins	O
in	O
some	O
genomes	O
but	O
are	O
also	O
seen	O
fused	O
in	O
a	O
single	O
protein	O
in	O
other	O
genomes	O
have	O
been	O
used	O
to	O
suggest	S
the	S
isolated	S
domains	S
may	S
interact	S
3132	O
.	O

To	O
identify	O
mechanisms	O
responsible	O
for	O
this	O
lineage-specific	O
and	O
interferon-regulated	O
expression	O
,	O
the	O
5	O
'	O
flanking	O
sequence	O
of	O
the	O
gene	O
has	O
been	O
characterized	O
.	O

The	O
mechanism	O
of	O
action	O
of	O
the	O
immunosuppressive	O
drug	O
cyclosporin	O
A	O
(	O
CsA	O
)	O
is	O
the	O
inactivation	O
of	O
the	O
Ca2+/calmodulin-dependent	O
serine-threonine	O
phosphatase	O
calcineurin	O
by	O
the	O
drug-immunophilin	O
complex	O
.	O

This	O
inhibition	O
prevented	O
the	O
degradation	O
of	O
the	O
NF-kappa	O
B	O
inhibitor	O
,	O
I	O
kappa	O
B	O
,	O
and	O
therefore	O
NF-kappa	O
B	O
was	O
retained	O
in	O
the	O
cytosol	O
.	O

A	O
comparison	O
of	O
in	O
situ	O
hybridization	O
to	O
EBV	O
DNA	O
and	O
viral	O
capsid	O
antigen	O
staining	O
with	O
BZ1	O
reactivity	O
suggested	S
that	S
BZLF1	S
expression	S
precedes	S
rampant	S
virus	S
replication	S
.	O

Even	O
if	O
both	O
the	O
upstream	O
and	O
downstream	O
regions	O
of	O
the	O
inframe	O
stop	O
codon	O
code	O
proteins	O
,	O
they	O
may	S
be	S
two	S
adjacent	S
genes	S
instead	S
of	S
a	S
readthrough	S
protein	S
.	O

The	O
IFN-dependent	O
increase	O
in	O
RAR	O
(	O
alpha	O
)	O
levels	O
and	O
the	O
enhancing	O
effect	O
of	O
the	O
cytokine	O
on	O
retinoid-dependent	O
granulocytic	O
markers	O
expression	O
may	S
be	S
a	S
characteristic	S
of	S
PML-RAR	S
positive	S
cells	S
,	O
since	O
the	O
phenomena	O
are	O
not	O
observed	O
in	O
HL-60	O
promyelocytes	O
.	O

Cloning	O
of	O
the	O
novel	O
human	O
myeloid-cell-specific	O
C/EBP-epsilon	O
transcription	O
factor	O
.	O

Gel	O
retardation	O
and	O
methylation	O
interference	O
studies	O
revealed	O
that	O
bacterially	O
produced	O
AP-2	O
bound	O
specifically	O
and	O
with	O
high	O
affinity	O
to	O
all	O
three	O
21	O
bp	O
repeats	O
,	O
and	O
that	O
it	O
required	O
the	O
core	O
sequence	O
AGGC	O
for	O
specific	O
binding	O
.	O

We	O
tested	O
the	O
necessity	O
for	O
appropriate	O
spatial	O
alignment	O
of	O
these	O
elements	O
by	O
using	O
mutated	O
enhancers	O
with	O
altered	O
spacings	O
.	O

(	O
A	O
)	O
Molecular	O
map	O
of	O
the	O
D-mib	O
locus	O
showing	O
the	O
position	O
of	O
the	O
P-element	O
inserted	O
into	O
the	O
5	O
'	O
untranslated	O
region	O
(	O
allele	O
D-mib1	O
)	O
and	O
the	O
13.6	O
kb	O
deletion	O
that	O
removes	O
the	O
D-mib	O
and	O
the	O
RpS31	O
genes	O
(	O
allele	O
D-mib2	O
)	O
.	O

However	O
,	O
stimulation	O
of	O
B-cells	O
from	O
B-CLL	O
patients	O
under	O
conditions	O
which	O
induced	O
differentiation	O
into	O
plasma	O
cells	O
was	O
associated	O
with	O
induction	O
of	O
Bcd	O
gene	O
expression	O
.	O

We	O
demonstrated	O
that	O
IL-9	O
gene	O
expression	O
is	O
controlled	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
transcriptional	O
activation	O
.	O

The	O
beta-casein	O
promoter	O
has	O
been	O
widely	O
used	O
to	O
monitor	O
the	O
activation	O
of	O
STAT	O
(	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
)	O
5	O
since	O
STAT5	O
was	O
originally	O
found	O
as	O
a	O
mediator	O
of	O
PRL-inducible	O
beta-casein	O
expression	O
.	O

We	O
demonstrate	O
that	O
recombination	O
signal	O
sequences	O
(	O
RSSs	O
)	O
were	O
derived	O
from	O
terminal	O
inverted	O
repeats	O
of	O
an	O
ancient	O
Transib	O
transposon	O
.	O

Transfection	O
studies	O
of	O
LTR	O
reporter	O
constructs	O
indicated	O
that	O
mutation	O
of	O
the	O
DSE	O
sites	O
abrogated	O
the	O
LTR-mediated	O
synergy	O
induced	O
by	O
Ctx	O
and	O
TNFalpha	O
,	O
whereas	O
the	O
synergy	O
induced	O
by	O
Ctx	O
and	O
IL-1beta	O
was	O
unaffected	O
,	O
suggesting	S
TNFalpha	S
and	S
IL-1beta	S
cooperate	S
differently	S
with	S
the	S
cAMP/PKA	S
activation	S
pathway	S
to	S
induce	S
HIV-1	S
expression	S
in	S
U1	S
cells	S
.	O

These	O
experiments	O
showed	O
that	O
,	O
in	O
fact	O
,	O
NF-kappaB	O
was	O
translocated	O
to	O
the	O
nucleus	O
following	O
viral	O
binding	O
or	O
purified	O
viral	O
ligand	O
binding	O
.	O

CONCLUSIONS	O
:	O
Leukocyte	O
adhesion	O
to	O
the	O
corneal	O
endothelium	O
was	O
shown	O
to	O
be	O
mediated	O
by	O
CD18	O
expressed	O
on	O
activated	O
leukocytes	O
.	O

This	O
removal	O
occurred	O
by	O
activation	O
of	O
the	O
constitutive	O
Sp1	O
factor	O
,	O
whose	O
increased	O
binding	O
activity	O
and	O
phosphorylation	O
were	O
mediated	O
by	O
IFN-gamma	O
.	O

To	O
determine	O
whether	S
it	S
is	S
possible	S
to	S
artificially	S
enhance	S
the	S
opening	S
of	S
the	S
chromatin	S
structure	S
of	S
a	S
minimal	S
beta-globin	S
promoter	S
,	O
we	O
placed	O
a	O
101bp	O
,	O
erythroid-specific	O
DNase	O
1	O
hypersensitive	O
site-forming	O
element	O
(	O
HSFE	O
)	O
immediately	O
upstream	O
of	O
the	O
beta-globin	O
promoter	O
and	O
gene	O
.	O

We	O
conclude	O
that	O
interactions	O
between	O
TAFII32	O
and	O
CIITA	O
are	O
responsible	O
for	O
activation	O
of	O
class	O
II	O
genes	O
.	O

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
the	O
AP-1	O
site	O
and	O
a	O
distal	O
promoter	O
element	O
regulate	O
transcriptional	O
induction	O
of	O
collagenase-1	O
during	O
monocytic	O
differentiation	O
.	O

Circular	O
dichroism	O
analysis	O
reveals	O
that	O
NO	O
induces	O
a	O
profound	O
conformational	O
change	O
in	O
p21ras	O
in	O
association	O
with	O
GDP/GTP	O
exchange	O
.	O

This	O
ANG	O
II	O
effect	O
was	O
blocked	O
by	O
the	O
angiotensin	O
AT1	O
receptor	O
antagonist	O
losartan	O
.	O

In	O
addition	O
,	O
two	O
out	O
of	O
three	O
M10-expressing	O
CEM	O
clones	O
were	O
also	O
resistant	O
to	O
highly	O
productive	O
infection	O
by	O
a	O
heterogeneous	O
HIV-1	O
pool	O
.	O

IL-2	O
and	O
IL-7	O
induce	O
heterodimerization	O
of	O
STAT5	O
isoforms	O
in	O
human	O
peripheral	O
blood	O
T	O
lymphoblasts	O
.	O

Ratios	O
greater	O
than	O
100	O
were	O
not	O
considered	O
because	O
they	O
are	O
computationally	O
infeasible	O
given	O
the	O
size	O
of	O
our	O
datasets	O
and	O
the	O
architecture	O
of	O
the	O
predictor	O
.	O

Clone	O
C3/5	O
showed	O
specific	O
proliferation	O
,	O
cytotoxicity	O
,	O
and	O
cytokine	O
(	O
tumor	O
necrosis	O
factor	O
alpha	O
,	O
granulocyte-macrophage	O
colony-stimulating	O
factor	O
)	O
production	O
when	O
challenged	O
with	O
autologous	O
lymphoblastic	O
cell	O
lines	O
pulsed	O
with	O
peptide	O
BCR1/25	O
.	O

We	O
have	O
established	O
the	O
essential	O
nature	O
of	O
GATA-1	O
during	O
both	O
primitive	O
and	O
definitive	O
erythropoiesis	O
.	O

Ubiquitin	O
is	O
a	O
76-amino-acid	O
polypeptide	O
that	O
is	O
covalently	O
linked	O
to	O
substrates	O
in	O
a	O
multi-step	O
process	O
that	O
involves	O
a	O
ubiquitin-activating	O
enzyme	O
(	O
E1	O
)	O
,	O
a	O
ubiquitin-conjugating	O
enzyme	O
(	O
E2	O
)	O
,	O
and	O
a	O
ubiquitin–protein	O
ligase	O
(	O
E3	O
)	O
.	O

We	O
demonstrated	O
that	O
AP-2	O
mRNA	O
was	O
present	O
in	O
T-lymphocytes	O
and	O
that	O
cellular	O
factors	O
from	O
both	O
non-transformed	O
and	O
transformed	O
T-lymphocytes	O
specifically	O
bound	O
to	O
the	O
consensus	O
motif	O
for	O
AP-2	O
in	O
each	O
21	O
bp	O
.	O

A	O
decrease	O
in	O
the	O
translation	O
rate	O
is	O
observed	O
when	O
the	O
cells	O
are	O
induced	O
to	O
differentiate	O
along	O
the	O
monocytic/macrophage	O
pathway	O
or	O
along	O
the	O
granulocytic	O
pathway	O
.	O

Various	O
cellular	O
stress	O
agents	O
like	O
ionizing	O
radiation	O
exposure	O
could	O
activate	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-	O
1	O
)	O
replication	O
or	O
reporter	O
gene	O
expression	O
.	O

In	O
addition	O
,	O
over-expression	O
of	O
STAT2	O
by	O
transfection	O
of	O
the	O
cDNA	O
prevented	O
apoptosis	O
of	O
the	O
T	O
cell	O
clones	O
.	O

It	O
is	O
intriguing	O
to	O
speculate	S
that	S
the	S
chromodomain	S
of	S
other	S
remodeling	S
proteins	S
also	S
exert	S
their	S
activity	S
through	S
RNA	S
interactions	S
and	S
that	S
RNAs	S
might	S
be	S
more	S
common	S
than	S
generally	S
appreciated	S
in	S
transcriptional	S
regulation	S
.	O

Furthermore	O
,	O
after	O
its	O
recruitment	O
,	O
the	O
RAG1	O
core	O
most	O
likely	S
went	S
through	S
a	S
period	S
of	S
intensive	S
transformations	S
due	S
to	S
diversifying/positive	S
selection	S
,	S
which	S
further	S
decreased	S
its	S
similarity	S
to	S
Transib	S
TPase	S
.	O

Many	O
recent	O
studies	O
have	O
revealed	O
that	O
endocytosis	O
plays	O
multiple	O
roles	O
in	O
the	O
regulation	O
of	O
N	O
signaling	O
(	O
reviewed	O
in	O
[	O
2	O
]	O
;	O
see	O
also	O
[	O
53,54	O
]	O
)	O
.	O

Glucocorticoid	O
receptors	O
in	O
lymphocytes	O
in	O
anorexia	O
nervosa	O
.	O

These	O
findings	O
show	O
that	O
the	O
nuclear	O
accumulation	O
of	O
NFAT4	O
promoted	O
by	O
calcineurin	O
is	O
opposed	O
by	O
the	O
JNK	O
signal	O
transduction	O
pathway	O
.	O

In	O
contrast	O
,	O
expression	O
of	O
IL-4	O
,	O
IL-10	O
,	O
and	O
IFN-gamma	O
was	O
strongly	O
inhibited	O
in	O
the	O
transgenic	O
T	O
cells	O
.	O

We	O
demonstrate	O
that	O
although	O
the	O
individual	O
components	O
of	O
this	O
element	O
do	O
not	O
respond	O
to	O
IL-2	O
,	O
together	O
they	O
form	O
a	O
composite	O
element	O
capable	O
of	O
conferring	O
IL-2	O
responsiveness	O
to	O
a	O
heterologous	O
promoter	O
.	O

We	O
measured	O
effects	O
on	O
the	O
HIV-1	O
LTR	O
in	O
T	O
cell	O
lines	O
that	O
were	O
stimulated	O
with	O
antibodies	O
against	O
CD45	O
and	O
in	O
those	O
that	O
lacked	O
the	O
expression	O
of	O
CD45	O
on	O
their	O
surfaces	O
.	O

Our	O
studies	O
reported	O
here	O
demonstrate	O
that	O
GATA-3	O
is	O
critical	O
for	O
expression	O
of	O
the	O
IL-5	O
gene	O
in	O
bona	O
fide	O
Th2	O
cells	O
.	O

Within	O
5	O
min	O
of	O
monocyte	O
adhesion	O
,	O
the	O
level	O
of	O
the	O
I	O
kappa	O
B	O
alpha	O
protein	O
is	O
markedly	O
diminished	O
but	O
is	O
rapidly	O
replaced	O
in	O
a	O
cycloheximide-sensitive	O
manner	O
within	O
20	O
min	O
.	O

In	O
contrast	O
,	O
CREB	S
appears	S
to	S
dampen	S
transcription	S
from	S
this	S
element	S
.	O

GrpL	O
,	O
a	O
Grb2-related	O
adaptor	O
protein	O
,	O
interacts	O
with	O
SLP-76	O
to	O
regulate	O
nuclear	O
factor	O
of	O
activated	O
T	O
cell	O
activation	O
.	O

The	O
expression	O
of	O
c-fos	O
,	O
c-jun	O
,	O
and	O
c-myc	O
genes	O
is	O
regulated	O
by	O
heat	O
shock	O
in	O
human	O
lymphoid	O
cells	O
.	O

These	O
data	O
suggest	S
that	S
E2	S
is	S
one	S
of	S
the	S
activating	S
factors	S
for	S
NK/LGL	S
cells	S
.	O

The	O
viral	O
transcriptional	O
pattern	O
similar	O
to	O
that	O
of	O
nasopharyngeal	O
carcinoma	O
and	O
Hodgkin	O
's	O
disease	O
suggests	S
that	S
EBV	S
can	S
exploit	S
common	S
regulatory	S
mechanisms	S
for	S
gene	S
transcription	S
in	S
diverse	S
host	S
cell	S
types	S
.	O

Altogether	O
these	O
data	O
indicate	S
that	S
,	S
in	S
7TD1	S
cells	S
,	S
IL-6	S
controls	S
junB	S
transcription	S
in	S
a	S
biphasic	S
fashion	S
by	S
means	S
of	S
two	S
separate	S
transduction	S
pathways	S
.	O

HL60	O
cells	O
,	O
expressing	O
some	O
characteristics	O
of	O
promyelocytes	O
,	O
can	O
be	O
induced	O
to	O
monocytoid	O
differentiation	O
by	O
calcitriol	O
.	O

These	O
domains	O
are	O
related	O
to	O
essential	O
cellular	O
functions	O
,	O
suggesting	S
that	S
many	S
domain	S
interactions	S
were	S
already	S
present	S
in	S
the	S
last	S
universal	S
common	S
ancestor	S
.	O

MR	O
count	O
was	O
significantly	O
(	O
P	O
less	O
than	O
0.0005	O
)	O
decreased	O
in	O
the	O
PIH	O
group	O
(	O
148	O
+/-	O
9	O
binding	O
sites/cell	O
)	O
compared	O
with	O
the	O
control	O
group	O
(	O
300	O
+/-	O
17	O
binding	O
sites/cell	O
;	O
mean	O
+/-	O
SEM	O
)	O
.	O

The	O
5	O
'	O
flanking	O
DNA	O
also	O
contains	O
a	O
cluster	O
of	O
three	O
binding	O
sites	O
for	O
the	O
GATA	O
family	O
of	O
transcription	O
factors	O
.	O

We	O
conclude	O
that	O
CD28	O
costimulation	O
can	O
cause	O
substantial	O
T	O
cell	O
proliferation	O
in	O
the	O
absence	O
of	O
IL-2	O
,	O
which	O
is	O
driven	O
by	O
a	O
soluble	O
factor	O
independent	O
of	O
NF-AT	O
transactivation	O
.	O

We	O
show	O
that	O
the	O
expression	O
of	O
four	O
cell	O
genes	O
,	O
cdc-2	O
,	O
cyclin	O
E	O
,	O
CD23	O
,	O
and	O
cyclin	O
D2	O
,	O
are	O
up-regulated	O
approximately	O
100-fold	O
as	O
a	O
result	O
of	O
EBV-mediated	O
immortalization	O
.	O

Together	O
,	O
these	O
results	O
show	O
that	O
NF-kappa	O
B	O
controls	O
the	O
expression	O
of	O
I	O
kappa	O
B	O
alpha	O
by	O
means	O
of	O
an	O
inducible	O
autoregulatory	O
pathway	O
.	O

We	O
compared	O
the	O
motif	O
finding	O
programs	O
using	O
the	O
criteria	O
set	O
forth	O
in	O
Sinha	O
and	O
Tompa	O
,	O
including	O
average	O
accuracy	O
and	O
the	O
number	O
of	O
total	O
wins	O
(	O
highest	O
accuracy	O
on	O
a	O
regulon	O
,	O
where	O
that	O
accuracy	O
is	O
at	O
least	O
0.1	O
)	O
6	O
.	O

Furthermore	O
overexpression	O
of	O
exogenous	O
c-fos	O
has	O
an	O
inhibitory	O
effect	O
on	O
GR-dependent	O
transcription	O
from	O
GRE	O
in	O
T	O
cells	O
.	O

The	O
combination	O
of	O
dopamine	O
and	O
TNF-alpha	O
led	O
to	O
a	O
stimulation	O
of	O
HIV-1	O
transcription	O
and	O
replication	O
.	O

Thus	O
,	O
PML	O
is	O
localized	O
to	O
a	O
second	O
subnuclear	O
domain	O
that	O
is	O
morphologically	O
and	O
biochemically	O
distinct	O
from	O
PML	O
NBs	O
.	O

The	O
immediate-early	O
gene	O
egr-1	O
encodes	O
a	O
transcription	O
factor	O
(	O
EGR1	O
)	O
that	O
links	O
B-cell	O
antigen	O
receptor	O
(	O
BCR	O
)	O
signals	O
to	O
downstream	O
activation	O
events	O
through	O
the	O
regulation	O
of	O
previously	O
unidentified	O
target	O
genes	O
.	O

These	O
observations	O
demonstrate	O
that	O
CD4	O
signaling	O
mediates	O
HIV-induced	O
apoptosis	O
by	O
a	O
mechanism	O
independent	O
of	O
Fas-Fas	O
ligand	O
interaction	O
,	O
does	O
not	O
require	O
p56	O
(	O
lck	O
)	O
signaling	O
,	O
and	O
may	S
involve	S
a	S
critical	S
region	S
for	S
CD4	S
dimerization	S
.	O

Taken	O
together	O
,	O
the	O
findings	O
of	O
the	O
present	O
study	O
are	O
consistent	O
with	O
a	O
role	O
for	O
NF-kappaB	O
in	O
the	O
development	O
of	O
A/R	O
tolerance	O
(	O
with	O
respect	O
to	O
PMN	O
adhesion	O
)	O
,	O
perhaps	O
by	O
transcriptional	O
regulation	O
of	O
GTP-cyclohydrolase	O
.	O

In	O
the	O
DRA	O
promoter	O
,	O
one	O
of	O
these	O
cis-acting	O
regulatory	O
motifs	O
is	O
the	O
X2-box	O
to	O
which	O
nuclear	O
factor	O
X2	O
(	O
NF-X2	O
)	O
binds	O
.	O

We	O
have	O
observed	O
that	O
the	O
R24	O
mAb	O
stimulates	O
GD3+	O
T	O
cell	O
proliferation	O
,	O
cytotoxicity	O
,	O
and	O
surface	O
marker	O
expression	O
of	O
IL-2R	O
alpha-chain	O
,	O
IL-2R	O
beta-chain	O
,	O
HLA-DR	O
,	O
CD11a	O
,	O
and	O
CD11c	O
.	O

The	O
derived	O
103-amino-acid	O
basic	O
protein	O
has	O
two	O
potential	O
alpha-helical	O
domains	O
separated	O
by	O
a	O
hydrophobic	O
region	O
with	O
the	O
potential	O
to	O
generate	O
turns	O
and	O
assume	O
a	O
beta-sheet	O
conformation	O
.	O

Human	O
herpesvirus	O
6	O
(	O
HHV-6	O
)	O
is	O
a	O
lymphotropic	O
herpesvirus	O
,	O
and	O
in	O
vitro	O
,	O
it	O
can	O
productively	O
infect	O
human	O
CD4+	O
T	O
cells	O
as	O
HIV-1	O
.	O

The	O
SCL	O
protein	O
displays	O
cell-specific	O
heterogeneity	O
in	O
size	O
.	O

From	O
these	O
observations	O
we	O
conclude	O
that	O
free	O
thiols	O
in	O
the	O
IL-1RI	O
complex	O
are	O
essential	O
for	O
the	O
activation	O
of	O
the	O
IL-1RI-associated	O
protein	O
kinase	O
and	O
that	O
this	O
process	O
is	O
mandatory	O
for	O
IL-1	O
signaling	O
leading	O
to	O
NF-kappa	O
B	O
activation	O
.	O

Number	O
of	O
Circulating	O
Hemocytes	O
in	O
Late	O
Third-Instar	O
Larvae	O

For	O
each	O
of	O
the	O
above	O
clusters	O
,	O
an	O
all-against-all	O
comparison	O
of	O
cluster	O
members	O
was	O
performed	O
.	O

alpha	O
B	O
is	O
the	O
mouse	O
homologue	O
of	O
human	O
AML1	O
gene	O
detected	O
at	O
the	O
breakpoints	O
of	O
t	O
(	O
8	O
;	O
21	O
)	O
and	O
t	O
(	O
3	O
;	O
21	O
)	O
myeloid	O
leukemias	O
.	O

After	O
two	O
days	O
of	O
treatment	O
with	O
5	O
x	O
10	O
(	O
-8	O
)	O
M	O
dexamethasone	O
,	O
CEM	O
C7	O
cells	O
showed	O
a	O
two-fold	O
increase	O
in	O
suppressor	O
activity	O
compared	O
to	O
untreated	O
cells	O
.	O

In	O
all	O
cells	O
tested	O
,	O
IL-10	O
activated	O
Stat1	O
and	O
Stat3	O
and	O
induced	O
the	O
formation	O
of	O
three	O
distinct	O
DNA	O
binding	O
complexes	O
that	O
contained	O
different	O
combinations	O
of	O
these	O
two	O
transcription	O
factors	O
.	O

In	O
the	O
present	O
study	O
we	O
focused	O
on	O
the	O
pathophysiology	O
of	O
PIH	O
,	O
mainly	O
on	O
the	O
role	O
of	O
mineralocorticoids	O
,	O
reversed	O
blood	O
pressure	O
patterns	O
,	O
and	O
the	O
resulting	O
necessity	O
of	O
continuous	O
monitoring	O
of	O
the	O
preeclamptic	O
mother	O
.	O

The	O
IL-2R	O
alpha	O
enhancer	O
binds	O
NF-kappa	O
B	O
poorly	O
and	O
is	O
only	O
weakly	O
activated	O
by	O
the	O
NF-kappa	O
B	O
site	O
alone	O
.	O

Bioinformatics	O
analysis	O
of	O
unusual	O
tRNA	O
genes	O
and	O
codon	O
usage	O
may	S
provide	S
insights	S
into	S
this	S
problem	S
.	O

After	O
weight	O
gain	O
(	O
14	O
+/-	O
2	O
to	O
16	O
+/-	O
2	O
kg/m2	O
)	O
,	O
receptor	O
numbers	O
were	O
8421	O
+/-	O
2126	O
(	O
pre	O
)	O
and	O
9011	O
+/-	O
500	O
(	O
post	O
)	O
sites/cell	O
,	O
which	O
are	O
not	O
significantly	O
different	O
(	O
P	O
greater	O
than	O
0.2	O
)	O
;	O

One	O
of	O
the	O
proteins	O
that	O
binds	O
to	O
these	O
sites	O
is	O
TRAF2	O
,	O
a	O
signal	O
transduction	O
molecule	O
that	O
is	O
also	O
utilized	O
by	O
TNFR1	O
to	O
mediate	O
the	O
activation	O
of	O
several	O
downstream	O
kinases	O
and	O
transcription	O
factors	O
.	O

At	O
10	O
to	O
100	O
micromol/L	O
for	O
>	O
24	O
hours	O
,	O
oleate	O
inhibited	O
the	O
expression	O
of	O
all	O
adhesion	O
molecules	O
tested	O
.	O

USF-related	O
transcription	O
factor	O
,	O
HIV-TF1	O
,	O
stimulates	O
transcription	O
of	O
human	O
immunodeficiency	O
virus-1	O
.	O

In	O
promoter	O
regions	O
,	O
the	O
actively	O
transcribed	O
genes	O
demonstrated	O
extensive	O
and	O
consistent	O
footprints	O
over	O
the	O
canonical	O
elements	O
,	O
such	O
as	O
CACCC	O
and	O
CCAAT	O
motifs	O
.	O

IL-13	O
induces	O
phosphorylation	O
and	O
activation	O
of	O
JAK2	O
Janus	O
kinase	O
in	O
human	O
colon	O
carcinoma	O
cell	O
lines	O
:	O

The	O
v-erbA	O
oncoprotein	O
represents	O
a	O
retrovirus-transduced	O
oncogenic	O
version	O
of	O
the	O
thyroid	O
hormone	O
(	O
T3/T4	O
)	O
receptor	O
c-erbA	O
(	O
type	O
alpha	O
)	O
.	O

Defective	O
translocation	O
of	O
protein	O
kinase	O
C	O
in	O
multidrug-resistant	O
HL-60	O
cells	O
confers	O
a	O
reversible	O
loss	O
of	O
phorbol	O
ester-induced	O
monocytic	O
differentiation	O
.	O

The	O
first	O
such	O
predictor	O
integrated	O
co-expression	O
data	O
,	O
co-essentiality	O
as	O
well	O
as	O
biological	O
function	O
in	O
a	O
naive	O
Bayes	O
network	O
to	O
provide	O
proteome-wide	O
de	O
novo	O
prediction	O
of	O
yeast	O
protein	O
interactions	O
37	O
.	O

Hemocytes	O
from	O
the	O
adgf-a	O
mutant	O
developing	O
filamentous	O
extensions	O
(	O
B	O
and	O
C	O
)	O
or	O
membranous	O
extension	O
surrounding	O
the	O
cell	O
(	O
D	O
)	O
.	O

These	O
results	O
demonstrate	O
that	O
CD40	O
,	O
like	O
sIg	O
,	O
may	S
employ	S
PKC	S
in	S
producing	S
select	S
outcomes	S
,	O
that	O
individual	O
B	O
cell	O
receptors	O
may	S
signal	S
downstream	S
events	S
via	S
both	S
PKC-dependent	S
and	S
PKC-independent	S
pathways	S
,	O
and	O
that	O
multiple	S
signal	S
transduction	S
pathways	S
may	S
be	S
used	S
to	S
activate	S
the	S
expression	S
of	S
closely	S
related	S
genes	S
.	O

All	O
combinations	O
of	O
modules	O
were	O
examined	O
to	O
determine	O
which	O
of	O
the	O
resulting	O
predictors	O
achieved	O
the	O
highest	O
prediction	O
accuracy	O
.	O

When	O
investigated	O
as	O
a	O
separate	O
feature	O
,	O
the	O
chi-square	O
score	O
of	O
co-occurrence	O
of	O
domain	O
pairs	O
correlates	O
well	O
with	O
the	O
likelihood	O
of	O
interaction	O
of	O
protein	O
pairs	O
that	O
contain	O
these	O
domains	O
,	O
with	O
the	O
highest	O
chi-square	O
score	O
bin	O
obtaining	O
a	O
likelihood	O
ratio	O
of	O
14	O
,	O
as	O
shown	O
in	O
Figure	O
3A	O
.	O

Tyloxapol	O
also	O
reduces	O
the	O
viscosity	O
of	O
CF	O
sputum	O
(	O
from	O
463	O
+/-	O
133	O
to	O
128	O
+/-	O
52	O
centipoise	O
)	O
.	O

The	O
region	O
of	O
A-MYB	O
responsible	O
for	O
the	O
B	O
cell	O
specific	O
activity	O
was	O
defined	O
to	O
be	O
the	O
N-terminal	O
218	O
amino	O
acids	O
containing	O
the	O
DNA	O
binding	O
domain	O
.	O

These	O
findings	O
thus	O
emphasize	O
the	O
importance	O
of	O
IFN-alpha	O
as	O
a	O
T-cell	O
regulatory	O
cytokine	O
.	O

These	O
binding	O
activities	O
are	O
expressed	O
only	O
in	O
activated	O
T	O
cells	O
.	O

Within	O
this	O
region	O
,	O
we	O
have	O
identified	O
several	O
sequences	O
that	O
are	O
implicated	O
in	O
DNA	O
protein	O
interactions	O
as	O
shown	O
in	O
DNAse	O
I	O
footprints	O
and	O
gel	O
mobility	O
shift	O
assays	O
.	O

In	O
this	O
study	O
we	O
demonstrated	O
that	O
a	O
mutant	O
Escherichia	O
coli	O
endotoxin	O
lacking	O
myristoyl	O
fatty	O
acid	O
at	O
the	O
3	O
'	O
R-3-hydroxymyristate	O
position	O
of	O
the	O
lipid	O
A	O
moiety	O
retained	O
its	O
full	O
capacity	O
to	O
coagulate	O
Limulus	O
amoebocyte	O
lysate	O
compared	O
with	O
the	O
wild-type	O
E.	O
coli	O
endotoxin	O
and	O
markedly	O
stimulated	O
the	O
activation	O
of	O
human	O
monocyte	O
nuclear	O
factor-kappaB	O
and	O
the	O
induction	O
of	O
Mn	O
SOD	O
mRNA	O
and	O
enzyme	O
activity	O
.	O

they	O
bind	O
endogenous	O
intracellular	O
receptors	O
,	O
the	O
immunophilins	O
,	O
and	O
the	O
resulting	O
complex	O
targets	O
the	O
protein	O
phosphatase	O
,	O
calcineurin	O
,	O
to	O
exert	O
the	O
immunosuppressive	O
effect	O
.	O

Irrespective	O
of	O
the	O
human	O
cell	O
partner	O
used	O
for	O
fusion	O
,	O
a	O
certain	O
number	O
of	O
hybrids	O
lost	O
CD5	O
surface	O
expression	O
over	O
a	O
period	O
of	O
time	O
in	O
culture	O
.	O

STAT5A-STAT5A	O
homodimers	O
and	O
STAT5A-STAT5B	O
heterodimers	O
formed	O
in	O
response	O
to	O
GM-CSF	O
.	O

cAMP	O
inhibited	O
the	O
induction	O
of	O
expression	O
of	O
IL-2	O
receptor	O
components	O
,	O
but	O
did	O
not	O
inhibit	O
IL-4	O
receptor	O
alpha-chain	O
and	O
CD69	O
expression	O
or	O
the	O
induction	O
of	O
activator	O
protein	O
1	O
transcription	O
factors	O
.	O

At	O
present	O
,	O
the	O
role	O
of	O
the	O
IKKs	O
in	O
LPS	O
signaling	O
has	O
not	O
been	O
investigated	O
.	O

GrpL	O
can	O
be	O
coimmunoprecipitated	O
with	O
SLP-76	O
but	O
not	O
with	O
Sos1	O
or	O
Sos2	O
from	O
Jurkat	O
cell	O
lysates	O
.	O

Datasets	O

To	O
further	O
understand	O
its	O
mechanism	O
of	O
action	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
HU	O
on	O
regulation	O
of	O
c-jun	O
expression	O
prior	O
to	O
the	O
onset	O
of	O
erythroid	O
differentiation	O
of	O
K562	O
cells	O
.	O

This	O
factor	O
has	O
a	O
DNA-binding	O
specificity	O
similar	O
to	O
that	O
of	O
NF-kappa	O
B	O
but	O
is	O
unrelated	O
to	O
this	O
or	O
other	O
Rel	O
proteins	O
by	O
functional	O
and	O
biochemical	O
criteria	O
.	O

Surface	O
marker	O
analysis	O
showed	O
that	O
HMBA-induced	O
cells	O
expressed	O
reduced	O
levels	O
of	O
glycophorin	O
A	O
,	O
CD5	O
,	O
CD7	O
and	O
CD11b	O
.	O

The	O
cell	O
system	O
described	O
in	O
these	O
experiments	O
provides	O
a	O
tool	O
for	O
the	O
detection	O
of	O
EBV	O
reactivation	O
and	O
demonstrates	O
the	O
potential	O
of	O
the	O
lytic	O
regulatory	O
gene	O
BZLF	O
1	O
.	O

However	O
,	O
the	S
NF-kappaB	S
activation	S
pathway	S
involving	S
the	S
acidic	S
sphingomyelinase	S
of	S
the	S
endolysosomial	S
membrane	S
did	S
not	S
seem	S
to	S
participate	S
in	S
the	S
LPS-induced	S
NF-kappaB	S
activation	S
in	S
U937	S
cells	S
.	O

(	O
C–D	O
''	O
'	O
)	O
are	O
high-magnification	O
views	O
(	O
apical	O
[	O
C–C	O
''	O
'	O
]	O
and	O
basal	O
[	O
D–D	O
''	O
'	O
]	O
)	O
of	O
the	O
disc	O
shown	O
in	O
(	O
B–B	O
''	O
)	O
.	O

This	O
suggests	S
that	S
in	S
these	S
cells	S
GR	S
within	S
the	S
nucleus	S
interacts	S
with	S
cytokine-stimulated	S
transcription	S
factors	S
by	S
the	S
process	S
of	S
cross	S
coupling	S
.	O

Finally	O
,	O
co-immunoprecipitation	O
analysis	O
revealed	O
that	O
Tax	O
is	O
able	O
to	O
stably	O
bind	O
to	O
both	O
Sp1	O
and	O
NGFI-A/Egr-1	O
.	O

Further	O
,	O
the	O
level	O
of	O
nuclear	O
proteins	O
capable	O
of	O
binding	O
to	O
the	O
NF-kappa	O
B	O
sites	O
in	O
activated	O
T	O
cells	O
increased	O
in	O
response	O
to	O
DM	O
.	O

The	O
third	O
approach	O
was	O
to	O
monitor	O
the	O
replication	O
competence	O
in	O
U937	O
cells	O
of	O
an	O
infectious	O
HIV-1	O
provirus	O
carrying	O
point	O
mutations	O
in	O
the	O
kappaB-responsive	O
elements	O
of	O
both	O
long	O
terminal	O
repeats	O
.	O

The	O
matrix	O
in	O
Table	O
2	O
shows	O
the	O
pair-wise	O
conservation	O
of	O
iPfam	O
domain	O
pairs	O
.	O

Stable	O
expression	O
of	O
HB24	O
,	O
a	O
diverged	O
human	O
homeobox	O
gene	O
,	O
in	O
T	O
lymphocytes	O
induces	O
genes	O
involved	O
in	O
T	O
cell	O
activation	O
and	O
growth	O
.	O

Analysis	O
of	O
the	O
major	O
histocompatibility	O
complex	O
class	O
II	O
gene	O
promoter	O
DRA	O
has	O
previously	O
identified	O
at	O
least	O
five	O
cis-acting	O
regions	O
required	O
for	O
maximal	O
expression	O
.	O

In	O
this	O
report	O
,	O
we	O
present	O
data	O
demonstrating	O
that	O
HIV	O
LTR	O
activation	O
is	O
not	O
a	O
general	O
consequence	O
of	O
cellular	O
DNA	O
damage	O
,	O
but	O
rather	O
a	O
process	O
unique	O
to	O
specific	O
genotoxic	O
stimuli	O
,	O
and	O
that	O
it	O
does	O
not	O
necessarily	O
depend	O
on	O
activation	O
of	O
NF-kappa	O
B	O
.	O

Induction	O
of	O
tyrosine	O
phosphorylation	O
and	O
T-cell	O
activation	O
by	O
vanadate	O
peroxide	O
,	O
an	O
inhibitor	O
of	O
protein	O
tyrosine	O
phosphatases	O
.	O

Priming	O
with	O
IFN-gamma	O
followed	O
by	O
LPS	O
stimulation	O
resulted	O
in	O
a	O
further	O
increase	O
in	O
the	O
expression	O
of	O
p65	O
mRNA	O
.	O

Cross-linking	O
CD19	O
on	O
early	O
human	O
B	O
lineage	O
cells	O
induces	O
the	O
formation	O
of	O
a	O
CD19/Vav/phosphatidylinositol-3	O
kinase	O
complex	O
,	O
tyrosine	O
phosphorylation	O
of	O
CD19	O
and	O
Vav	O
,	O
and	O
activation	O
of	O
the	O
Ras	O
pathway	O
.	O

Alternative	O
splicing	O
of	O
RNA	O
transcripts	O
encoded	O
by	O
the	O
murine	O
p105	O
NF-kappa	O
B	O
gene	O
generates	O
I	O
kappa	O
B	O
gamma	O
isoforms	O
with	O
different	O
inhibitory	O
activities	O
.	O

The	O
human	O
monocytic	O
leukemia	O
cell	O
line	O
THP-1	O
differentiates	O
into	O
macrophage-like	O
cells	O
when	O
treated	O
with	O
phorbol	O
esters	O
.	O

Inhibition	O
of	O
p105	O
processing	O
by	O
NF-kappaB	O
proteins	O
in	O
transiently	O
transfected	O
cells	O
.	O

Northern	O
blot	O
analysis	O
indicated	O
the	O
expression	O
of	O
human	O
PEBP2	O
alpha	O
A	O
,	O
alpha	O
B	O
(	O
AML1	O
)	O
,	O
and	O
beta	O
genes	O
in	O
Jurkat	O
cells	O
.	O

Addition	O
of	O
phosphorothioate	O
oligonucleotides	O
that	O
contained	O
the	O
octamer	O
consensus	O
to	O
Jurkat	O
T	O
leukemia	O
cells	O
inhibited	O
interleukin-2	O
(	O
IL-2	O
)	O
secretion	O
to	O
a	O
degree	O
similar	O
to	O
that	O
observed	O
with	O
a	O
mutated	O
octamer	O
site	O
in	O
the	O
IL-2	O
enhancer	O
.	O

Ligand-induced	O
tyrosine	O
phosphorylation	O
of	O
the	O
STATs	O
promotes	O
their	O
homodimer	O
and	O
heterodimer	O
formation	O
and	O
subsequent	O
nuclear	O
translocation	O
.	O

We	O
have	O
previously	O
shown	O
that	O
after	O
a	O
mutation	O
of	O
Leu122	O
to	O
Arg	O
the	O
DNA	O
binding	O
basic	O
domain	O
of	O
MyoD	O
confers	O
c-myc-like	O
functional	O
characteristics	O
to	O
the	O
protein	O
.	O

Although	O
GM-CSF	S
does	S
not	S
appear	S
to	S
be	S
essential	S
for	S
normal	S
hemopoiesis	S
,	O
overexpression	O
of	O
GM-CSF	O
has	O
been	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
some	O
diseases	O
such	O
as	O
myeloid	O
leukemia	O
and	O
chronic	O
inflammation	O
.	O

The	O
Tax1-inducible	O
transcription	O
factors	O
identified	O
here	O
are	O
encoded	O
by	O
the	O
members	O
of	O
immediate	O
early	O
genes	O
under	O
the	O
control	O
of	O
growth	O
signals	O
.	O

We	O
show	O
that	O
PNU156804	O
does	O
not	O
inhibit	O
c-myc	O
and	O
bcl-2	O
mRNA	O
induction	O
.	O

Elf-1	O
contains	O
a	O
DNA	O
binding	O
domain	O
that	O
is	O
nearly	O
identical	O
to	O
that	O
of	O
E74	O
,	O
the	O
ecdysone-inducible	O
Drosophila	O
transcription	O
factor	O
required	O
for	O
metamorphosis	O
(	O
hence	O
the	O
name	O
Elf-1	O
,	O
for	O
E74-like	O
factor	O
1	O
)	O
.	O

The	O
generation	O
of	O
genomic	O
diversity	O
during	O
the	O
course	O
of	O
infection	O
has	O
the	O
potential	O
to	O
affect	O
all	O
aspects	O
of	O
HIV-1	O
replication	O
,	O
including	O
expression	O
of	O
the	O
proviral	O
genome	O
.	O

The	O
activated	O
form	O
of	O
NF-kappa	O
B	O
,	O
which	O
is	O
rapidly	O
taken	O
up	O
into	O
nuclei	O
,	O
initiates	O
transcription	O
from	O
immediate	O
early	O
genes	O
in	O
a	O
wide	O
variety	O
of	O
cell	O
types	O
.	O

To	O
identify	O
genes	O
that	O
are	O
expressed	O
in	O
T	O
cells	O
after	O
stimulation	O
,	O
mRNA	O
from	O
T	O
lymphocytes	O
that	O
had	O
been	O
activated	O
by	O
the	O
simultaneous	O
stimulation	O
of	O
the	O
CD3	O
and	O
CD28	O
trigger	O
molecules	O
was	O
transcribed	O
for	O
a	O
differential	O
mRNA	O
display	O
analysis	O
into	O
cDNA	O
and	O
was	O
compared	O
with	O
cDNA	O
from	O
CD28-	O
or	O
CD3-activated	O
or	O
resting	O
lymphocytes	O
.	O

SCOPE	O
demonstrates	O
that	O
combining	O
multiple	O
,	O
focused	O
motif	O
discovery	O
algorithms	O
can	O
provide	O
a	O
significant	O
gain	O
in	O
performance	O
.	O

The	O
functional	O
domains	O
of	O
HS-40	O
were	O
also	O
mapped	O
.	O

Furthermore	O
,	O
p95vav	O
synergizes	O
with	O
TCR	O
stimulation	O
in	O
inducing	O
NFAT-	O
and	O
interleukin-2-dependent	O
transcription	O
.	O

Both	O
constitutively	O
active	O
forms	O
of	O
CN	O
and	O
protein	O
kinase	O
C	O
(	O
PKC	O
)	O
synergistically	O
activated	O
transcription	O
from	O
the	O
GM-CSF	O
promoter	O
.	O

These	O
data	O
suggest	S
that	S
different	S
members	S
or	S
isoforms	S
of	S
NFAT	S
gene	S
family	S
may	S
regulate	S
inducible	S
expression	S
of	S
different	S
cytokine	S
genes	S
.	O

The	O
son	O
of	O
the	O
unaffected	O
twin	O
sister	O
was	O
shown	O
to	O
be	O
hemizygous	O
.	O

Promoter	O
deletion	O
constructs	O
demonstrated	O
the	O
potential	S
role	S
of	S
distal	S
promoter	S
sequences	S
in	S
regulating	S
collagenase-1	S
transcription	S
.	O

Drosophila	O
also	O
contains	O
a	O
gene	O
,	O
termed	O
Ada	O
,	O
with	O
sequence	O
similarity	O
to	O
human	O
ADA	O
,	O
but	O
as	O
we	O
have	O
previously	O
shown	O
the	O
product	O
of	O
this	O
gene	O
is	O
most	O
likely	S
not	S
an	S
active	S
ADA	S
[	O
16	O
]	O
.	O

Interleukin-6	O
(	O
IL-6	O
)	O
mediates	O
autocrine	O
and	O
paracrine	O
growth	O
of	O
multiple	O
myeloma	O
(	O
MM	O
)	O
cells	O
and	O
inhibits	O
tumor	O
cell	O
apoptosis	O
.	O

By	O
contrast	O
,	O
the	O
expression	O
of	O
other	O
adherence-associated	O
early	O
genes	O
,	O
such	O
as	O
IL-8	O
and	O
IL-1	O
beta	O
,	O
was	O
not	O
up-regulated	O
in	O
PBMC	O
of	O
tuberculous	O
patients	O
.	O

Fat	O
body	O
observation	O

Constitutive	O
activation	O
of	O
different	O
Jak	O
tyrosine	O
kinases	O
in	O
human	O
T	O
cell	O
leukemia	O
virus	O
type	O
1	O
(	O
HTLV-1	O
)	O
tax	O
protein	O
or	O
virus-transformed	O
cells	O
.	O

Sequences	O
of	O
the	O
Transib1	O
through	O
Transib4	O
and	O
Transib1_AG	O
through	O
Transib3_AG	O
transposons	O
[	O
17	O
]	O
were	O
obtained	O
from	O
the	O
D.	O
melanogaster	O
(	O
drorep.ref	O
)	O
and	O
A.	O
gambiae	O
(	O
angrep.ref	O
)	O
sections	O
of	O
Repbase	O
Update	O
[	O
39	O
]	O
at	O
Genetic	O
Information	O
Research	O
Institute	O
(	O
http	O
:	O
//www.girinst.org	O
)	O
.	O

Mutational	O
analyses	O
indicate	S
that	S
the	S
carboxy-terminal	S
domain	S
of	S
Oct2	S
is	S
critical	S
for	S
enhancer	S
activation	S
.	O

Bar	O
is	O
50	O
μm	O
for	O
(	O
A	O
and	O
A	O
'	O
)	O
and	O
10	O
μm	O
for	O
(	O
B–F	O
''	O
)	O
.	O

Indeed	O
,	O
it	O
has	O
been	O
estimated	S
recently	S
that	S
the	S
current	S
yeast	S
and	S
human	S
protein	S
interaction	S
maps	S
are	S
only	S
50	S
%	S
and	S
10	S
%	S
complete	S
,	S
respectively	S
18	O
.	O

Moreover	O
,	O
platelet-activating	O
factor	O
was	O
capable	O
of	O
inducing	O
transcription	O
of	O
the	O
nuclear	O
proto-oncogenes	O
c-fos	O
and	O
c-jun	O
.	O

TCF-1	O
alpha	O
is	O
currently	O
unique	O
among	O
the	O
newly	O
emerging	O
family	O
of	O
DNA-binding	O
regulatory	O
proteins	O
that	O
share	O
the	O
HMG	O
motif	O
in	O
that	O
it	O
is	O
a	O
highly	O
tissue-specific	O
RNA	O
polymerase	O
II	O
transcription	O
factor	O
.	O

Regulation	O
of	O
the	O
Ets-related	O
transcription	O
factor	O
Elf-1	O
by	O
binding	O
to	O
the	O
retinoblastoma	O
protein	O
.	O

Thus	O
,	O
constitutive	O
activation	O
of	O
Egr-1	O
gene	O
is	O
invariably	O
associated	O
with	O
unrestricted	O
expression	O
of	O
viral	O
latent	O
genes	O
in	O
all	O
group	O
III	O
EBV	O
genome	O
carrying	O
cell	O
lines	O
.	O

This	O
boundary	O
is	O
established	O
in	O
first	O
instar	O
larvae	O
and	O
is	O
defined	O
by	O
the	O
apterous	O
expression	O
boundary	O
.	O

The	O
NFATd	O
element	O
,	O
which	O
binds	O
the	O
transcription	O
factor	O
NFAT-1	O
and	O
is	O
very	O
active	O
in	O
T	O
cells	O
,	O
is	O
only	O
weakly	O
active	O
in	O
one	O
B	O
clone	O
and	O
not	O
at	O
all	O
in	O
another	O
.	O

The	O
regulatory	O
effect	O
of	O
insulin	O
on	O
the	O
specific	O
binding	O
power	O
of	O
glucocorticoid	O
receptor	O
(	O
GR	O
)	O
of	O
human	O
leukocytes	O
was	O
assessed	O
by	O
the	O
unoccupied	O
receptor	O
sites	O
capable	O
of	O
combining	O
with	O
[	O
3H	O
]	O
labelled	O
dexamethasone	O
measured	O
at	O
3	O
and	O
24	O
h	O
after	O
incubation	O
with	O
various	O
concentrations	O
of	O
insulin	O
added	O
to	O
the	O
medium	O
.	O

In	O
day	O
7	O
and	O
day	O
10	O
erythroid	O
precursors	O
cultured	O
with	O
Steel	O
factor	O
,	O
SCL	O
protein	O
was	O
increased	O
significantly	O
compared	O
to	O
control	O
.	O

Since	O
the	O
induction	O
of	O
NF-AT	O
and	O
AP-1	O
is	O
induced	O
by	O
the	O
same	O
stimuli	O
that	O
stimulate	O
IL-2	O
production	O
,	O
these	O
results	O
indicate	S
that	S
the	S
immunosuppressant	S
action	S
of	S
CsA	S
and	S
FK506	S
is	S
exerted	S
at	S
the	S
level	S
of	S
these	S
trans-activating	S
factors	S
.	O

Binding	O
of	O
plasma	O
Factor	O
VII/VIIa	O
to	O
the	O
tissue	O
factor	O
(	O
TF	O
)	O
receptor	O
initiates	O
the	O
coagulation	O
protease	O
cascades	O
.	O

Signaling	O
by	O
IL-2	O
and	O
related	O
cytokines	O
:	O
JAKs	O
,	O
STATs	O
,	O
and	O
relationship	O
to	O
immunodeficiency	O
.	O

Domain	O
pairs	O
that	O
cluster	O
to	O
the	O
left	O
of	O
the	O
plot	O
can	O
be	O
called	O
specific	O
domain	O
pairs	O
,	O
as	O
they	O
only	O
occur	O
in	O
very	O
few	O
covered	O
experimental	O
interactions	O
.	O

Expression	O
of	O
Neur	O
,	O
using	O
actin-GAL4	O
,	O
restored	O
growth	O
of	O
the	O
wing	O
pouch	O
and	O
formation	O
of	O
the	O
wing	O
margin	O
(	O
data	O
not	O
shown	O
)	O
.	O

Not	O
only	O
functional	O
but	O
also	O
specific	O
binding	O
interactions	O
between	O
CIITA	O
and	O
CBP	O
were	O
demonstrated	O
.	O

Although	O
the	O
CRE	O
site	O
is	O
necessary	O
,	O
optimal	O
induction	O
of	O
bcl-2	O
expression	O
requires	O
participation	O
of	O
the	O
upstream	O
regulatory	O
element	O
,	O
suggesting	S
that	S
phosphorylation	S
of	S
CREB	S
alters	S
its	S
interaction	S
with	S
the	S
upstream	S
regulatory	S
element	S
.	O

Furthermore	O
,	O
Diablo/Smac	O
interacts	O
through	O
its	O
amino	O
terminus	O
with	O
the	O
BIR	O
(	O
baculovirus	O
IAP	O
repeat	O
)	O
domains	O
of	O
IAPs	O
,	O
similar	O
to	O
Reaper	O
,	O
Hid	O
,	O
and	O
Grim	O
[	O
32,33	O
]	O
.	O

The	O
detection	O
of	O
both	O
M-CSF	O
and	O
c-fms	O
expression	O
by	O
cells	O
of	O
the	O
monocyte	O
lineage	O
has	O
suggested	S
that	S
M-CSF	S
may	S
act	S
by	S
an	S
autocrine	S
mechanism	S
.	O

implications	O
for	O
viral	O
latency	O
.	O

The	O
three	O
circles	O
represent	O
the	O
iPfam	O
domain	O
pairs	O
observed	O
in	O
the	O
respective	O
species	O
.	O

Our	O
results	O
suggest	S
that	S
superantigens	S
and	S
other	S
MHC	S
class	S
II	S
ligands	S
may	S
activate	S
HIV-1	S
gene	S
expression	S
in	S
monocytes/macrophages	S
.	O

The	O
localization-derived	O
negative	O
trained	O
predictor	O
tested	O
on	O
sets	O
containing	O
localization-derived	O
negatives	O
achieves	O
a	O
lower	O
accuracy	O
than	O
that	O
of	O
the	O
random	O
negative	O
trained	O
predictor	O
tested	O
on	O
a	O
test	O
set	O
containing	O
randomly-generated	O
negatives	O
(	O
0.0686	O
+/-	O
0.0010	O
vs	O
0.0747	O
+/-	O
0.0022	O
)	O
.	O

Promoter	O
function	O
of	O
the	O
5	O
'	O
flanking	O
region	O
of	O
the	O
thromboxane	O
receptor	O
gene	O
was	O
evaluated	O
by	O
transfection	O
of	O
thromboxane	O
receptor	O
gene	O
promoter/chloramphenicol	O
acetyltransferase	O
(	O
CAT	O
)	O
chimera	O
plasmids	O
into	O
platelet-like	O
K562	O
cells	O
.	O

This	O
is	O
practically	O
indispensable	O
for	O
objective	O
classification	O
of	O
candidates	O
,	O
but	O
there	O
is	O
no	S
guarantee	S
that	S
unknown	S
proteins	S
with	S
the	S
23rd	S
amino	S
acid	S
will	S
score	S
higher	S
than	S
the	S
thresholds	S
.	O

Ad2	O
infection	O
induced	O
transient	O
increase	O
in	O
the	O
mRNA	O
levels	O
for	O
TNF-alpha	O
and	O
IL-1	O
beta	O
in	O
both	O
monocytes	O
and	O
in	O
macrophages	O
,	O
although	O
the	O
kinetics	O
of	O
the	O
transcription	O
was	O
slightly	O
different	O
.	O

Furthermore	O
,	O
the	O
degree	O
of	O
CN	O
inhibition	O
was	O
reflected	O
by	O
a	O
similar	O
degree	O
of	O
reduction	O
in	O
lymphocyte	O
proliferation	O
and	O
IFN-gamma	O
production	O
in	O
the	O
allogeneic	O
mixed	O
lymphocyte	O
cultures	O
.	O

Clonal	O
assay	O
showed	O
that	O
the	O
suppression	O
was	O
irreversible	O
and	O
appeared	S
analogous	S
to	S
the	S
commitment	S
of	S
murine	S
erythroleukemia	S
(	S
MEL	S
)	S
cells	S
to	S
terminal	S
differentiation	S
.	O

Electron	O
microscopy	O
revealed	O
a	O
marked	O
increase	O
in	O
granules	O
resembling	O
those	O
specific	O
for	O
eosinophils	O
.	O

Transient	O
short-term	O
expression	O
of	O
the	O
Tax	O
protein	O
of	O
human	O
T-cell	O
leukemia	O
virus	O
type-I	O
(	O
HTLV-I	O
)	O
leads	O
to	O
activation	O
of	O
the	O
pleiotropic	O
transcription	O
factor	O
NF-kappa	O
B	O
.	O

This	O
includes	O
the	O
distances	O
between	O
the	O
second	O
D	O
and	O
E	O
residues	O
,	O
which	O
are	O
much	O
longer	O
in	O
Transib	O
transposons	O
(	O
206–214	O
aa	O
)	O
and	O
RAG1	O
(	O
253	O
aa	O
)	O
than	O
in	O
DDE	O
TPases	O
from	O
other	O
studied	O
superfamilies	O
(	O
e.g.	O
,	O
approximately	O
35-aa	O
in	O
Mariner/Tc1	O
[	O
23	O
]	O
,	O
2-aa	O
in	O
P	O
[	O
23	O
]	O
,	O
approximately	O
35-aa	O
in	O
Harbinger	O
[	O
24	O
]	O
,	O
with	O
hAT	O
as	O
an	O
exception	O
(	O
325-aa	O
,	O
[	O
25	O
]	O
)	O
.	O

We	O
investigated	O
the	O
function	O
of	O
the	O
evolutionary	O
conserved	O
X2	O
box	O
in	O
the	O
promoter	O
of	O
the	O
HLA-DRA	O
gene	O
from	O
the	O
human	O
major	O
histocompatibility	O
complex	O
(	O
MHC	O
)	O
in	O
resting	O
and	O
activated	O
B	O
cells	O
.	O

To	O
produce	O
a	O
UAS-ADGF-Amyc	O
construct	O
,	O
the	O
ADGF-A	O
fragment	O
was	O
amplified	O
(	O
by	O
ProofStart	O
from	O
pOT2	O
vector	O
)	O
using	O
the	O
following	O
primers	O
:	O
5'-	O
AATCTCGAGCTCATCATGTCGCCAGTCATC-3	O
'	O
(	O
5	O
'	O
end	O
with	O
XhoI	O
tail	O
)	O
and	O
5'-	O
TATCTAGATCGATCCGTTGACTGGGGG-3	O
'	O
(	O
3	O
'	O
end	O
with	O
XbaI	O
tail	O
)	O
.	O

We	O
have	O
analyzed	O
several	O
molecular	O
aspects	O
of	O
IBR/F	O
and	O
shown	O
that	O
the	O
factor	O
associates	O
as	O
stable	O
homodimers	O
and	O
that	O
the	O
dimer	O
is	O
the	O
relevant	O
DNA-binding	O
species	O
.	O

µ	O
and	O
σ	O
are	O
estimated	O
through	O
the	O
randomisation	O
experiments	O
.	O

Tandem	O
copies	O
of	O
this	O
67-bp	O
MnlI-AluI	O
fragment	O
,	O
when	O
fused	O
to	O
the	O
chloramphenicol	O
acetyltransferase	O
gene	O
driven	O
by	O
the	O
conalbumin	O
promoter	O
,	O
stimulated	O
transcription	O
in	O
B	O
cells	O
but	O
not	O
in	O
Jurkat	S
T	S
cells	S
or	S
HeLa	S
cells	S
.	O

In	O
contrast	O
,	O
the	O
accumulation	O
of	O
Ser	O
at	O
the	O
apical	O
cortex	O
was	O
strongly	O
increased	O
(	O
Figure	O
4E	O
)	O
and	O
Ser	O
accumulation	O
in	O
Dl-positive	O
vesicles	O
was	O
dramatically	O
reduced	O
(	O
Figure	O
4E	O
'	O
)	O
in	O
D-mib1	O
mutant	O
discs	O
.	O

An	O
iron-responsive	O
element	O
(	O
IRE	O
)	O
motif	O
has	O
been	O
identified	O
in	O
the	O
5'-untranslated	O
region	O
of	O
the	O
human	O
erythroid	O
ALAS	O
mRNA	O
,	O
but	O
is	O
not	O
present	O
in	O
the	O
housekeeping	O
ALAS	O
mRNA	O
.	O

METHODS	O
:	O
Cultured	O
bovine	O
corneal	O
endothelium	O
was	O
stimulated	O
for	O
6	O
hours	O
by	O
40	O
micron/ml	O
tumor	O
necrosis	O
factor	O
alpha	O
(	O
TNFalpha	O
)	O
.	O

A	O
common	O
feature	O
of	O
all	O
stages	O
of	O
atherosclerosis	O
is	O
inflammation	O
of	O
the	O
vessel	O
wall	O
.	O

Normal	O
human	O
monocytes	O
were	O
isolated	O
,	O
carefully	O
washed	O
,	O
and	O
incubated	O
for	O
36	O
to	O
48	O
h	O
in	O
fetal	O
bovine	O
serum-containing	O
medium	O
.	O

The	O
disappearance	O
of	O
NF	O
kappa	O
B	O
from	O
the	O
nucleus	O
was	O
concentration	O
dependent	O
between	O
10	O
and	O
50	O
ng/ml	O
of	O
phorbol	O
ester	O
.	O

The	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
I	O
(	O
HTLV-I	O
)	O
is	O
a	O
causative	O
agent	O
of	O
adult	O
T-cell	O
leukemia	O
.	O

Structure	O
function	O
analysis	O
of	O
vitamin	O
D	O
analogs	O
with	O
C-ring	O
modifications	O
.	O

For	O
each	O
pair	O
of	O
proteins	O
in	O
the	O
training	O
set	O
,	O
the	O
product	O
of	O
the	O
likelihood	O
ratios	O
from	O
all	O
other	O
modules	O
(	O
referred	O
to	O
as	O
the	O
preliminary	O
score	O
(	O
PS	O
)	O
in	O
Figure	O
1	O
)	O
was	O
calculated	O
for	O
all	O
protein	O
pairs	O
neighboring	O
the	O
pair	O
(	O
i.e	O
.	O
all	O
protein	O
pairs	O
which	O
involve	O
one	O
protein	O
from	O
the	O
initial	O
protein	O
pair	O
under	O
study	O
and	O
for	O
which	O
it	O
is	O
possible	S
to	S
calculate	S
such	S
a	S
score	S
)	O
.	O

We	O
previously	O
showed	O
that	O
repression	S
of	S
the	S
beta-globin	S
gene	S
appears	S
to	S
be	S
mediated	S
through	S
two	S
DNA	S
sequences	S
,	S
silencers	S
I	S
and	S
II	S
,	O
and	O
identified	O
a	O
protein	O
termed	O
BP1	O
which	O
binds	O
to	O
both	O
silencer	O
sequences	O
.	O

Multiple	O
factors	O
including	O
Stat5	O
,	O
Elf-1	O
,	O
HMG-I	O
(	O
Y	O
)	O
and	O
GATA	O
family	O
proteins	O
bind	O
to	O
the	O
IL-2	O
response	O
element	O
and	O
mutation	O
of	O
any	O
one	O
of	O
these	O
binding	O
sites	O
diminishes	O
the	O
activity	O
of	O
this	O
element	O
.	O

Similar	O
to	O
its	O
effect	O
on	O
the	O
induction	O
of	O
AP1	O
by	O
okadaic	O
acid	O
,	O
PMA	O
inhibits	O
the	O
induction	O
of	O
c-jun	O
mRNA	O
by	O
okadaic	O
acid	O
.	O

This	O
abnormality	O
was	O
not	O
seen	O
in	O
resting	O
T	O
cells	O
nor	O
T	O
cells	O
from	O
patients	O
with	O
systemic	O
lupus	O
erythematosus	O
,	O
rheumatoid	O
arthritis	O
(	O
RA	O
)	O
,	O
or	O
SS	O
accompanied	O
by	O
RA	O
.	O

Biochemical	O
analysis	O
by	O
Western	O
blotting	O
of	O
fetal	O
and	O
adult	O
hematopoietic	O
populations	O
shows	O
several	O
runt	O
isoforms	O
.	O

In	O
contrast	O
,	O
overexpression	O
of	O
Vav	O
leads	O
to	O
enhanced	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
activity	O
without	O
affecting	O
AP-1	O
.	O

They	O
have	O
also	O
shown	O
that	O
proteasome	O
inhibitors	O
block	O
the	O
processing	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Whereas	O
a	O
background	O
set	O
of	O
promoter	O
regions	O
is	O
easy	O
to	O
identify	O
,	O
it	O
is	O
not	S
clear	S
how	S
to	S
define	S
a	S
reasonable	S
genomic	S
sample	S
of	S
enhancers	S
.	O

The	O
cell	O
type-specific	O
regulation	O
of	O
the	O
CD34	O
promoter	O
by	O
MZF-1	O
suggests	S
the	S
presence	S
of	S
tissue-specific	S
regulators/adapters	S
or	S
differential	S
MZF-1	S
modifications	S
that	S
determine	S
MZF-1	S
transcriptional	S
regulatory	S
function	S
.	O

To	O
approach	O
this	O
,	O
we	O
generated	O
a	O
luciferase	O
reporter	O
construct	O
containing	O
elements	O
of	O
the	O
CD95	O
ligand	O
promoter	O
.	O

This	O
shows	O
that	O
the	O
effect	O
on	O
hemocyte	O
development	O
is	O
related	O
to	O
only	O
one	O
other	O
aspect	O
of	O
the	O
adgf-a	O
phenotype—namely	O
,	O
fat	O
body	O
disintegration—and	O
the	O
developmental	O
arrest	O
of	O
adgf-a	O
mutants	O
is	O
probably	O
independent	O
of	O
this	O
process	O
.	O

The	O
lancelet	O
RAG1L_BF	O
protein	O
is	O
encoded	O
by	O
several	O
overlapping	O
WGS	O
trace	O
sequences	O
(	O
for	O
example	O
,	O
GenBank	O
Trace	O
Archive	O
identification	O
numbers	O
543943730	O
,	O
538583629	O
)	O
.	O

A	O
comparison	O
to	O
other	O
large	O
human	O
interaction	O
datasets	O
revealed	O
the	O
average	O
false	O
positive	O
rate	O
of	O
our	O
dataset	O
to	O
be	O
76	O
%	O
,	O
which	O
is	O
much	O
lower	O
than	O
the	O
overall	O
average	O
for	O
most	O
large	O
scale	O
,	O
currently	O
available	O
,	O
human	O
interaction	O
datasets	O
(	O
experimental	O
and	O
computational	O
)	O
estimated	S
to	S
be	S
90	S
%	S
18	O
.	O

From	O
the	O
genome	O
sequences	O
of	O
the	O
191	O
organisms	O
,	O
all	O
possible	O
iORFs	O
were	O
enumerated	O
.	O

The	O
regulation	O
of	O
nuclear	O
factor	O
(	O
NF	O
)	O
-kappa	O
B	O
activation	O
by	O
the	O
T	O
cell	O
receptor	O
(	O
TcR	O
)	O
/CD3	O
complex	O
in	O
primary	O
human	O
T	O
cells	O
has	O
been	O
studied	O
at	O
various	O
times	O
after	O
activation	O
.	O

In	O
the	O
transgenic	O
mice	O
,	O
all	O
the	O
lymphoid	O
tissues	O
examined	O
showed	O
a	O
dramatic	O
reduction	O
in	O
the	O
number	O
of	O
B	O
lymphocytes	O
(	O
B	O
cells	O
)	O
.	O

In	O
contrast	O
,	O
JNK	O
activation	O
in	O
calcineurin-stimulated	O
cells	O
caused	O
nuclear	O
exclusion	O
of	O
NFAT4	O
.	O

Oxidant-regulation	O
of	O
gene	O
expression	O
in	O
the	O
chronically	O
inflamed	O
intestine	O
.	O

Adhesion	O
to	O
extracellular	O
matrices	O
is	O
known	O
to	O
modulate	O
leukocyte	O
activation	O
,	O
although	O
the	S
mechanisms	S
are	S
not	S
fully	S
understood	S
.	O

Thus	O
these	O
data	O
suggest	S
that	S
the	S
phorbol	S
myristate-induced	S
signal	S
(	S
prolonged	S
protein	S
kinase	S
C	S
activation	S
?	S
)	S
can	S
not	S
be	S
inhibited	S
by	S
prior	S
incubation	S
with	S
dexamethasone	S
and	S
it	S
also	S
protects	S
the	S
induced	S
mRNA	S
for	S
the	S
degradative	S
action	S
of	S
dexamethasone	S
.	O

Second	O
,	O
genomic	O
sequencing	O
of	O
the	O
D-mib3	O
allele	O
revealed	O
the	O
presence	O
of	O
a	O
stop	O
codon	O
at	O
position	O
258	O
(	O
Figure	O
1B	O
)	O
.	O

Both	O
mobility	O
shift	O
and	O
sequence	O
specificity	O
of	O
NF-AT	O
were	O
similar	O
to	O
those	O
of	O
NF	O
(	O
P	O
)	O
and	O
only	O
a	O
small	O
amount	O
of	O
P65	O
was	O
detected	O
in	O
NF	O
(	O
P	O
)	O
in	O
crude	O
nuclear	O
extracts	O
.	O

The	O
rules	O
of	O
assembly	O
of	O
the	O
cognate	O
ligands	O
of	O
TF	O
,	O
namely	O
the	O
zymogen	O
plasma	O
factors	O
VII	O
and	O
the	O
serine	O
protease	O
factor	O
VIIa	O
,	O
with	O
the	O
soluble	O
surface	O
domain	O
of	O
TF	O
in	O
free	O
solution	O
,	O
in	O
the	O
presence	O
of	O
phospholipid	O
surfaces	O
and	O
cell	O
surface	O
and	O
of	O
the	O
anchored	O
TF	O
molecule	O
have	O
been	O
described	O
.	O

Monocytes	O
were	O
isolated	O
from	O
human	O
donors	O
.	O

While	O
LTRs	O
which	O
demonstrated	O
the	O
highest	O
activities	O
in	O
U-373	O
MG	O
cells	O
also	O
yielded	O
high	O
activities	O
in	O
Jurkat	O
cells	O
,	O
the	O
LTRs	O
were	O
generally	O
more	O
active	O
in	O
Jurkat	O
cells	O
when	O
compared	O
to	O
the	O
LAI	O
LTR	O
.	O

In	O
addition	O
,	O
these	O
proteases	O
were	O
detected	O
in	O
certain	O
subclones	O
of	O
THP-1	O
and	O
HL-60	O
cells	O
and	O
in	O
primary	O
monocytes	O
,	O
in	O
each	O
case	O
correlating	O
with	O
the	O
truncated	O
from	O
of	O
p65	O
.	O

By	O
contrast	O
,	O
T	O
cells	O
from	O
elderly	O
subjects	O
with	O
normal	O
levels	O
of	O
IL-2	O
production	O
exhibited	O
normal	O
activation	O
of	O
AP-1	O
and	O
NF-AT	O
.	O

The	O
effect	O
of	O
18C7	O
on	O
the	O
binding	O
was	O
similar	O
with	O
both	O
hormones	O
.	O

BOB.1/OBF.1	O
can	O
efficiently	O
activate	O
octamer-dependent	O
promoters	O
in	O
fibroblasts	O
;	O
however	O
,	O
it	O
fails	O
to	O
stimulate	O
octamer-dependent	O
enhancer	O
activity	O
.	O

One	O
of	O
these	O
subregions	O
,	O
NRE	O
gamma	O
,	O
is	O
active	O
in	O
both	O
HeLa	O
cervical	O
carcinoma	O
cells	O
and	O
Huh7	O
hepatoma	O
cells	O
and	O
was	O
found	O
to	O
be	O
bound	O
by	O
a	O
protein	O
factor	O
present	O
in	O
both	O
cell	O
types	O
.	O

An	O
erythroid	O
specific	O
enhancer	O
upstream	O
to	O
the	O
gene	O
encoding	O
the	O
cell-type	O
specific	O
transcription	O
factor	O
GATA-1	O
.	O

Putative	O
cis-acting	O
control	O
elements	O
present	O
within	O
a	O
300-bp	O
core	O
promoter	O
included	O
two	O
ets	O
sites	O
,	O
an	O
Sp1	O
site	O
,	O
tandem	O
E-box	O
domains	O
,	O
two	O
GATA-associated	O
sites	O
(	O
CACCC	O
)	O
,	O
an	O
AP-2	O
binding	O
site	O
,	O
and	O
a	O
GATA	O
element	O
at	O
-24	O
.	O

The	O
adenosine	O
concentration	O
in	O
the	O
adgf-a	O
mutant	O
was	O
1.14	O
±	O
0.26	O
μM	O
compared	O
to	O
less	O
than	O
0.08	O
μM	O
in	O
the	O
wild	O
type	O
,	O
and	O
the	O
deoxyadenosine	O
concentration	O
in	O
mutants	O
was	O
1.66	O
±	O
0.99	O
μM	O
compared	O
to	O
an	O
undetectable	O
level	O
in	O
the	O
wild	O
type	O
.	O

The	O
glucocorticoid	O
receptor	O
levels	O
in	O
mononuclear	O
leukocytes	O
correlated	O
with	O
those	O
in	O
polymorphonuclear	O
leukocytes	O
,	O
and	O
there	O
was	O
a	O
linear	O
relationship	O
between	O
the	O
cellular	O
glucocorticoid	O
receptor	O
levels	O
and	O
glucocorticoid-mediated	O
inhibition	O
of	O
the	O
uptake	O
of	O
3-O-methyl-D-glucose	O
in	O
mononuclear	O
leukocytes	O
.	O

The	O
problem	O
of	O
the	O
neuro-immuno	O
interactions	O
on	O
the	O
level	O
of	O
the	O
protein	O
trans-factors	O
,	O
stimulating	O
interleukin-2	O
(	O
IL-2	O
)	O
gene	O
expression	O
was	O
discussed	O
.	O

Treatment	O
of	O
a	O
human	O
promyelocytic	O
leukemia	O
cell	O
line	O
,	O
HL-60	O
,	O
with	O
10	O
micrograms/mL	O
etoposide	O
or	O
2	O
microM	O
1-beta-D-arabinofuranosylcytosine	O
induced	O
NF-kappa	O
B	O
activation	O
within	O
1	O
hr	O
and	O
subsequently	O
caused	O
apoptosis	O
within	O
3-4	O
hr	O
.	O

Hormonal	O
Regulation	O
in	O
the	O
adgf-a	O
Mutant	O

Contrary	O
to	O
previous	O
assumptions	O
,	O
we	O
observed	O
that	O
p65	O
homodimers	O
can	O
interact	O
with	O
a	O
subset	O
of	O
DNA	O
sequences	O
not	O
recognized	O
by	O
p50	O
homodimers	O
.	O

The	O
HTLV-I	O
transcriptional	O
activator	O
tax	O
was	O
used	O
to	O
gain	O
insight	O
into	O
the	O
mechanism	O
of	O
lymphotoxin	O
(	O
LT	O
;	O
TNF-beta	O
)	O
gene	O
induction	O
.	O

It	O
is	O
generally	O
accepted	O
that	O
Bcl-2	O
exerts	O
its	O
antiapoptotic	O
effects	O
mainly	O
by	O
dimerizing	O
with	O
proapoptotic	O
members	O
of	O
the	O
Bcl-2	O
family	O
such	O
as	O
Bax	O
and	O
Bad	O
.	O

Hepatic	O
microsomes	O
and	O
isolated	O
hepatocytes	O
in	O
short	O
term	O
culture	O
desulfate	O
T3	O
sulfate	O
(	O
T3SO4	O
)	O
.	O

The	O
expression	O
of	O
an	O
active	O
PKB	O
is	O
sufficient	O
to	O
induce	O
E2F	O
activity	O
.	O

Anaphylatoxins	O
C5a	O
and	O
C3a	O
induce	O
nuclear	O
factor	O
kappaB	O
activation	O
in	O
human	O
peripheral	O
blood	O
monocytes	O
.	O

These	O
results	O
identify	O
a	O
potential	S
role	S
for	S
IL-7	S
signaling	S
pathways	S
in	S
transformation	S
by	S
v-Abl	S
while	O
demonstrating	O
that	O
a	O
combination	O
of	O
IL-4	O
and	O
IL-7	O
signaling	O
can	O
not	O
substitute	O
for	O
an	O
active	O
v-Abl	O
kinase	O
in	O
transformed	O
pre-B	O
cells	O
.	O

Through	O
manual	O
inspection	O
of	O
the	O
BLAST	O
alignments	O
,	O
11	O
clusters	O
were	O
discarded	O
because	O
they	S
are	S
highly	S
unlikely	S
to	S
code	S
readthrough	S
proteins	S
.	O

Constitutive	O
activation	O
of	O
Toll	O
signaling	O
leads	O
to	O
developmental	O
arrest	O
and	O
hematopoietic	O
defects	O
associated	O
with	O
melanotic	O
tumor	O
formation	O
[	O
35	O
]	O
,	O
similar	O
to	O
the	O
phenotype	O
of	O
the	O
adgf-a	O
mutant	O
.	O

The	O
inducible	O
C1	O
protein	O
was	O
partially	O
purified	O
by	O
three	O
chromatographic	O
steps	O
and	O
characterized	O
by	O
u.v	O
.	O
cross-linking	O
as	O
a	O
47	O
kDa	O
protein	O
.	O

Hypertranscription	O
is	O
a	O
consequence	O
of	O
at	O
least	O
one	O
chromatin	O
modification	O
:	O
the	O
acetylation	O
of	O
histone	O
H4	O
at	O
Lys16	O
,	O
which	S
is	S
thought	S
to	S
'loosen	S
'	S
chromatin	S
structure	S
,	S
thereby	S
allowing	S
the	S
general	S
transcription	S
machinery	S
easier	S
access	S
to	S
the	S
regulatory	S
regions	S
of	S
most	S
X-linked	S
genes	S
[	O
13	O
]	O
.	O

HTLV-1	O
Tax	O
induces	O
expression	O
of	O
various	O
immediate	O
early	O
serum	O
responsive	O
genes	O
.	O

AM580	O
,	O
a	O
stable	O
benzoic	O
derivative	O
of	O
retinoic	O
acid	O
,	O
has	O
powerful	O
and	O
selective	O
cyto-differentiating	O
effects	O
on	O
acute	O
promyelocytic	O
leukemia	O
cells	O
.	O

Genomic	O
DNA	O
from	O
l	O
(	O
3	O
)	O
72Cda/D-mib2	O
mutant	O
pupae	O
was	O
used	O
as	O
control	O
for	O
polymorphism	O
.	O

cAMP-dependent	O
regulation	O
of	O
proenkephalin	O
by	O
JunD	O
and	O
JunB	O
:	O
positive	O
and	O
negative	O
effects	O
of	O
AP-1	O
proteins	O
.	O

However	O
,	O
the	O
experimentally	O
derived	O
B-lymphoblastoid	O
cell	O
line	O
,	O
clone	O
13	O
,	O
expresses	O
high	O
levels	O
of	O
HLADQ	O
in	O
the	O
absence	O
of	O
HLA-DR	O
and	O
HLA-DP	O
,	O
despite	O
its	O
mapping	O
by	O
complementation	O
analysis	O
to	O
this	O
group	O
.	O

Unexpectedly	O
,	O
the	O
presence	O
of	O
nuclear	O
I	O
(	O
kappa	O
)	O
B	O
(	O
alpha	O
)	O
did	O
not	O
inhibit	O
NF-kappaB	O
binding	O
to	O
DNA	O
and	O
this	O
phenomenon	O
was	O
not	O
due	O
to	O
the	O
presence	O
of	O
IkappaBbeta	O
at	O
the	O
nuclear	O
level	O
.	O

Evidence	O
suggests	S
that	S
IL-10	S
may	S
inhibit	S
activation	S
of	S
the	S
transcription	S
factor	S
nuclear	S
factor-kappaB	S
(	S
NF-kappaB	S
)	S
through	S
an	S
unknown	S
mechanism	S
.	O

(	O
D–F	O
)	O
Expression	O
of	O
GFP-marked	O
glue	O
protein	O
(	O
SgsΔ3-GFP	O
)	O
in	O
salivary	O
gland	O
of	O
the	O
adgf-a	O
mutant	O
larvae	O
and	O
pupae	O
.	O

They	O
are	O
part	O
of	O
the	O
high	O
affinity	O
IgE	O
receptor	O
in	O
mast	O
cells	O
,	O
basophils	O
,	O
Langerhans	O
cells	O
,	O
and	O
possibly	S
other	S
cells	S
;	O
a	O
component	O
of	O
the	O
low	O
affinity	O
receptor	O
for	O
IgG	O
(	O
Fc	O
gamma	O
RIIIA	O
or	O
CD16	O
)	O
in	O
natural	O
killer	O
cells	O
and	O
macrophages	O
;	O
and	O
part	O
of	O
the	O
T	O
cell	O
antigen	O
receptor	O
in	O
subsets	O
of	O
T	O
cells	O
.	O

Interaction	O
of	O
transcription	O
factors	O
RFX1	O
and	O
MIBP1	O
with	O
the	O
gamma	O
motif	O
of	O
the	O
negative	O
regulatory	O
element	O
of	O
the	O
hepatitis	O
B	O
virus	O
core	O
promoter	O
.	O

By	O
Northern	O
analysis	O
,	O
UT-7	O
cells	O
expressed	O
detectable	O
levels	O
of	O
beta-	O
and	O
gamma-globin	O
but	O
not	O
alpha-globin	O
.	O

Dexamethasone	O
suppression	O
test	O
:	O
corticosteroid	O
receptors	O
regulation	O
in	O
mononuclear	O
leukocytes	O
of	O
young	O
and	O
aged	O
subjects	O
.	O

Significantly	O
,	O
the	O
CBF	O
sites	O
are	O
in	O
each	O
case	O
contained	O
within	O
the	O
minimum	O
essential	O
core	O
regions	O
required	O
for	O
inducible	O
activation	O
of	O
transcription	O
.	O

In	O
contrast	O
,	O
CD19	O
cross-linking	O
in	O
BLIN-1	O
cells	O
resulted	O
in	O
the	O
induction	O
of	O
NF-kappaB	O
,	O
but	O
had	O
no	O
apparent	O
effect	O
on	O
AP-1-binding	O
activity	O
.	O

Protein	O
latency	O
expression	O
was	O
determined	O
by	O
immunocytochemistry	O
.	O

The	O
immunosuppressant	O
drug	O
cyclosporin	O
A	O
blocks	O
a	O
calcium-dependent	O
signal	O
from	O
the	O
T-cell	O
receptor	O
(	O
TCR	O
)	O
that	O
normally	O
leads	O
to	O
T-cell	O
activation	O
.	O

The	O
physiological	O
relevance	O
of	O
this	O
phenomenon	O
is	O
emphasized	O
by	O
similar	O
CD30-mediated	O
effects	O
in	O
naive	O
B	O
cells	O
.	O

Elevated	O
cyclic	O
AMP	O
inhibits	O
NF-kappaB-mediated	O
transcription	O
in	O
human	O
monocytic	O
cells	O
and	O
endothelial	O
cells	O
.	O

Every	O
motif	O
finder	O
they	O
tested	O
was	O
found	O
to	O
be	O
sensitive	O
to	O
values	O
used	O
for	O
these	O
parameters	O
.	O

Proliferation	O
,	O
as	O
measured	O
by	O
the	O
percentage	O
of	O
cells	O
in	O
cycle	O
appeared	O
normal	O
,	O
as	O
did	O
rearrangement	O
and	O
expression	O
of	O
the	O
TCR	O
beta-chain	O
.	O

The	O
effect	O
of	O
toremifene	O
therapy	O
on	O
serum	O
immunoglobulin	O
levels	O
in	O
breast	O
cancer	O
.	O

IL-10	O
effected	O
dose-dependent	O
inhibition	O
of	O
tumor	O
necrosis	O
factor	O
alpha	O
(	O
TNF-alpha	O
)	O
release	O
in	O
PBMC	O
stimulated	O
by	O
LPS	O
and	O
C.	O
neoformans	O
,	O
with	O
significant	O
inhibition	O
seen	O
with	O
0.1	O
U/ml	O
and	O
greater	O
than	O
90	O
%	O
inhibition	O
noted	O
with	O
10	O
U/ml	O
.	O

However	O
,	O
both	O
pathways	O
were	O
necessary	O
for	O
another	O
transformation-related	O
activity	O
(	O
colony	O
formation	O
in	O
soft	O
agar	O
)	O
of	O
CTLL-2/Tax	O
.	O

To	O
better	O
understand	O
the	O
AP-1-dependent	O
luciferase	O
expression	O
in	O
Jurkat	O
T	O
cells	O
,	O
we	O
tested	O
two	O
specific	O
inhibitors	O
of	O
serine/threonine	O
phosphatases-1	O
and	O
-2A	O
:	O
okadaic	O
acid	O
and	O
calyculin	O
A	O
.	O

One	O
feature	O
of	O
this	O
chromatin	O
reorganization	O
is	O
the	O
formation	O
of	O
DNase	O
1	O
hypersensitive	O
sites	O
in	O
the	O
regions	O
of	O
active	O
globin	O
gene	O
promoters	O
.	O

We	O
propose	O
that	O
KBF1	O
is	O
a	O
competitive	O
inhibitor	O
of	O
NF-kappa	O
B	O
and	O
discuss	O
how	O
these	S
factors	S
may	S
be	S
involved	S
in	S
the	S
transient	S
expression	S
of	S
IL-2	S
and	S
IL-2R	S
alpha	S
genes	S
during	S
the	S
immune	S
response	S
.	O

Consistent	O
with	O
these	O
findings	O
,	O
VD-responsive	O
genes	O
are	O
induced	O
by	O
ATRA	O
treatment	O
of	O
Kasumi-1	O
cells	O
,	O
suggesting	S
that	S
the	S
genetic	S
program	S
underlying	S
monocytic	S
differentiation	S
is	S
activated	S
.	O

The	O
average	O
values	O
from	O
healthy	O
volunteers	O
did	O
not	O
differ	O
significantly	O
from	O
those	O
found	O
in	O
these	O
children	O
,	O
though	O
much	O
broader	O
range	O
was	O
found	O
in	O
patients	O
.	O

Electrophoretic	O
mobility	O
supershift	O
assays	O
determine	O
that	O
members	O
of	O
the	O
NF-kappa	O
B/Rel	O
family	O
of	O
transcription	O
factors	O
can	O
bind	O
to	O
this	O
site	O
in	O
vitro	O
and	O
that	O
DNA-binding	O
complexes	O
that	O
contain	O
p50	O
,	O
p52	O
,	O
p65	O
,	O
and	O
cRel	O
correlate	O
with	O
positive	O
regulation	O
whereas	O
the	O
presence	O
of	O
p50	O
correlates	O
with	O
negative	O
regulation	O
.	O

Only	O
one	O
protein	O
is	O
present	O
in	O
two	O
copies	O
,	O
which	O
are	O
94	O
%	O
identical	O
to	O
each	O
other	O
at	O
the	O
DNA	O
level	O
(	O
contigs	O
81987	O
and	O
6797	O
)	O
.	O

Expression	O
of	O
ADGF-A	O
in	O
salivary	O
glands	O
and	O
fat	O
body	O
(	O
as	O
well	O
as	O
in	O
other	O
tissues	O
)	O
is	O
not	O
required	O
for	O
full	O
rescue	O
,	O
as	O
demonstrated	O
by	O
use	O
of	O
the	O
Cg-Gal4	O
,	O
Dot-Gal4	O
,	O
but	O
especially	O
by	O
e33C-Gal4	O
driver	O
,	O
and	O
is	O
also	O
not	O
sufficient	O
to	O
rescue	O
the	O
phenotype	O
at	O
all	O
,	O
as	O
demonstrated	O
by	O
T110-Gal4	O
and	O
Lsp2-Gal4	O
(	O
Table	O
1	O
)	O
.	O

E	O
:	O
Expression	O
module	O
,	O
O	O
:	O
Orthology	O
module	O
,	O
C	O
:	O
Combined	O
module	O
,	O
T	O
:	O
Transitive	O
module	O
.	O

Using	O
electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSA	O
)	O
,	O
we	O
now	O
show	O
that	O
,	O
in	O
monocytes	O
stimulated	O
with	O
LPS	O
or	O
TNF	O
alpha	O
,	O
IL-10	O
inhibits	O
nuclear	O
stimulation	O
of	O
nuclear	O
factor	O
kappa	O
B	O
(	O
NF	O
kappa	O
B	O
)	O
,	O
a	O
transcription	O
factor	O
involved	O
in	O
the	O
expression	O
of	O
inflammatory	O
cytokine	O
genes	O
.	O

This	O
nuclear	O
NF-kappa	O
B	O
was	O
still	O
present	O
when	O
contaminant	O
LPS	O
was	O
removed	O
by	O
ultrafiltration	O
and	O
when	O
serum	O
was	O
omitted	O
.	O

Besides	O
binding	O
to	O
Apaf-1	O
,	O
just	O
as	O
CED-9	O
binds	O
and	O
thereby	O
regulates	O
CED-4	O
activity	O
,	O
mammalian	S
Bcl-2	S
family	S
members	S
have	S
been	S
proposed	S
to	S
regulate	S
mitochondrial	S
homeostasis	S
and	S
the	S
release	S
of	S
pro-apoptotic	S
factors	S
such	S
as	S
cytochrome	S
c	S
(	O
reviewed	O
in	O
[	O
17	O
]	O
)	O
.	O

While	O
p70I	O
kappa	O
B	O
gamma	O
inhibits	O
p50-	O
,	O
p65-	O
,	O
and	O
c-Rel-mediated	O
transactivation	O
and/or	O
DNA	O
binding	O
,	O
both	O
I	O
kappa	O
B	O
gamma-1	O
and	O
I	O
kappa	O
B	O
gamma-2	O
are	O
specific	O
for	O
p50	O
and	O
have	O
different	O
affinities	O
for	O
this	O
subunit	O
.	O

Although	O
Fas	O
upregulation	O
is	O
central	O
to	O
the	O
preservation	O
of	O
immunologic	O
tolerance	O
,	O
little	O
is	O
known	O
about	O
the	O
molecular	O
machinery	O
underlying	O
this	O
process	O
.	O

Associated	O
with	O
its	O
inhibitor	O
,	O
I	O
kappaB	O
,	O
NF-kappaB	O
resides	O
as	O
an	O
inactive	O
form	O
in	O
the	O
cytoplasm	O
.	O

It	O
seems	S
that	S
the	S
rearrangement	S
of	S
the	S
TCR	S
gamma	S
loci	S
in	S
the	S
gamma	S
delta	S
lineage	S
may	S
not	S
always	S
take	S
place	S
at	S
a	S
developmental	S
stage	S
strictly	S
equivalent	S
to	S
the	S
rearrangement	S
of	S
TCR	S
beta	S
in	S
the	S
alpha	S
beta	S
lineage	S
,	O
and	O
it	O
is	O
not	S
clear	S
just	S
how	S
early	S
the	S
two	S
lineages	S
diverge	S
.	O

Inhibition	S
of	S
RANTES	S
expression	S
did	S
not	S
appear	S
to	S
be	S
secondary	S
to	S
IL-2	S
inhibition	S
and	S
required	S
binding	S
to	S
the	S
intracellular	S
glucocorticoid	S
receptor	S
.	O

We	O
studied	O
their	O
activity	O
after	O
transfection	O
into	O
K562	O
cells	O
,	O
an	O
erythroleukemia	O
cell	O
line	O
with	O
an	O
embryonic-fetal	O
phenotype	O
.	O

As	O
glucocorticoids	O
regulate	O
interferon-alpha	O
(	O
IFN	O
alpha	O
)	O
production	O
,	O
we	O
hypothesized	S
that	S
IFN	S
alpha	S
,	S
a	S
cytokine	S
produced	S
predominantly	S
by	S
monocytes	S
in	S
AIDS	S
,	S
should	S
be	S
increased	S
in	S
cortisol-resistant	S
AIDS	S
,	S
attributing	S
the	S
lack	S
of	S
cortisol	S
inhibition	S
to	S
IFN	S
alpha	S
production	S
.	O

Expression	O
of	O
PILOT	O
,	O
a	O
putative	S
transcription	S
factor	S
,	O
requires	O
two	O
signals	O
and	O
is	O
cyclosporin	O
A	O
sensitive	O
in	O
T	O
cells	O
.	O

Nuclear	O
factor-kappaB	O
induction	O
in	O
CD45RO+	O
and	O
CD45RA+	O
T	O
cell	O
subsets	O
during	O
aging	O
.	O

These	O
compounds	O
strongly	O
increased	O
the	O
phorbol-12-myristate-13-acetate	O
response	O
,	O
whereas	O
we	O
have	O
not	O
observed	O
a	O
contribution	O
of	O
phosphatase	O
inhibitors	O
on	O
a	O
CCK-8-induced	O
luciferase	O
activity	O
.	O

Similar	O
to	O
their	O
approach	O
,	O
we	O
make	O
a	O
linear	O
estimation	O
with	O
the	O
following	O
factors	O
:	O

Constitutive	O
expression	O
of	O
1,25	O
(	O
OH	O
)	O
2D3	O
receptor	O
RNA	O
was	O
detected	O
in	O
various	O
kinds	O
of	O
hematopoietic	O
cells	O
,	O
including	O
macrophages	O
and	O
activated	O
T	O
lymphocytes	O
,	O
as	O
well	O
as	O
in	O
cell	O
lines	O
KG-1	O
(	O
myeloblasts	O
)	O
,	O
HL-60	O
(	O
promyelocytes	O
)	O
,	O
ML-3	O
(	O
myelomonoblasts	O
)	O
,	O
U937	O
,	O
THP-1	O
(	O
monoblasts	O
)	O
,	O
K562	O
(	O
erythroblasts	O
)	O
,	O
and	O
S-LB1	O
(	O
HTLV-1-transfected	O
T	O
lymphocytes	O
)	O
.	O

These	O
results	O
suggest	S
that	S
oxidative	S
signals	S
can	S
positively	S
and	S
negatively	S
regulate	S
T	S
cell	S
transcriptional	S
events	S
and	S
that	S
changes	S
in	S
cellular	S
redox	S
can	S
uncouple	S
AP-1	S
regulation	S
of	S
c-jun	S
from	S
transcriptional	S
up-regulation	S
of	S
IL-2	S
via	S
NF-AT	S
.	O

This	O
low	O
frequency	O
of	O
response	O
was	O
no	O
different	O
from	O
that	O
previously	O
detected	O
using	O
cultures	O
of	O
T	O
cells	O
and	O
autologous	O
dendritic	O
cells	O
.	O

Second	O
,	O
expression	O
of	O
D-mib	O
in	O
the	O
dorsal	O
Ser-signaling	O
cells	O
was	O
sufficient	O
to	O
rescue	O
the	O
D-mib	O
mutant	O
wing	O
phenotype	O
.	O

We	O
have	O
established	O
an	O
ADA	O
deficiency	O
model	O
in	O
Drosophila	O
in	O
order	O
to	O
study	O
the	O
effects	O
of	O
altered	O
adenosine	O
levels	O
in	O
vivo	O
.	O

Columns	O
are	O
colored	O
according	O
to	O
sequence	O
conservation	O
.	O

The	O
following	O
transcription	O
factors	O
were	O
studied	O
:	O
the	O
Octamer	O
factors	O
Oct-1	O
and	O
Oct-2	O
,	O
members	O
of	O
the	O
AP-1	O
factor	O
family	O
,	O
NF-AT	O
factors	O
,	O
in	O
particular	O
NF-ATp	O
,	O
and	O
members	O
of	O
the	O
Rel/NF-kB	O
family	O
.	O

Again	O
,	O
Ei-values	O
of	O
matches	O
between	O
RAG1s	O
and	O
the	O
new	O
PSSM	O
derived	O
from	O
multiple	O
alignment	O
of	O
15	O
Transib	O
TPases	O
(	O
the	O
two	O
GenBank	O
proteins	O
plus	O
all	O
our	O
TPases	O
)	O
were	O
much	O
smaller	O
(	O
approximately	O
10-6–10-3	O
;	O
Table	O
1	O
)	O
than	O
those	O
obtained	O
based	O
on	O
the	O
PSSM	O
constructed	O
from	O
the	O
nine	O
TPases	O
at	O
the	O
preceding	O
step	O
(	O
approximately	O
10-3–10-2	O
)	O
.	O

Comparison	O
of	O
cDNA	O
and	O
genomic	O
sequences	O
reveals	O
a	O
4-exon	O
structure	O
characteristic	O
of	O
the	O
FOS	O
family	O
of	O
genes	O
.	O

Both	O
antioxidants	O
inhibited	O
TNF-	O
or	O
PMA-induced	O
NF-kappa	O
B	O
activity	O
in	O
U1	O
cells	O
,	O
as	O
well	O
as	O
the	O
sustained	O
NF-kappa	O
B	O
activity	O
permanently	O
induced	O
by	O
the	O
virus	O
itself	O
in	O
chronically	O
HIV-infected	O
U937	O
cells	O
.	O

A	O
truncated	O
form	O
of	O
the	O
product	O
of	O
this	O
gene	O
translated	O
in	O
vitro	O
is	O
a	O
DNA-binding	O
protein	O
which	O
interacts	O
specifically	O
with	O
the	O
kappa	O
B	O
binding	O
site	O
found	O
in	O
many	O
inducible	O
genes	O
,	O
including	O
the	O
enhancer	O
in	O
human	O
immunodeficiency	O
virus	O
.	O

Another	O
important	O
activity	O
of	O
DEN	O
is	O
its	O
control	O
of	O
transcription	O
in	O
activated	O
T	O
cells	O
,	O
and	O
we	O
have	O
determined	O
that	O
an	O
NF-kappaB	O
site	O
is	O
critical	O
for	O
this	O
activity	O
.	O

Few	O
of	O
these	O
factors	O
are	O
expressed	O
exclusively	O
in	O
myeloid	O
cells	O
;	O
instead	O
it	O
appears	S
that	S
they	S
cooperatively	S
regulate	S
transcription	S
of	S
myeloid-specific	S
genes	S
.	O

META	O
(	O
D+	O
)	O
directed	O
transcription	O
of	O
a	O
linked	O
luciferase	O
gene	O
,	O
and	O
gel	O
shift	O
analysis	O
revealed	O
binding	O
of	O
inducible	O
,	O
CsA-sensitive	O
T	O
cell	O
factors	O
,	O
in	O
parallel	O
with	O
transfection	O
results	O
.	O

This	O
suggests	S
that	S
in	S
B	S
cells	S
,	S
CD40-induced	S
NF-kappa	S
B	S
activation	S
can	S
occur	S
independently	S
of	S
TRAF2	S
and	S
TRAF5	S
association	S
.	O

Identification	O
of	O
an	O
ionomycin/cyclosporin	O
A-responsive	O
element	O
within	O
the	O
human	O
T	O
cell	O
receptor	O
gamma	O
enhancer	O
.	O

When	O
activated	O
,	O
glucocorticoid	O
receptors	O
form	O
a	O
dimer	O
and	O
bind	O
to	O
DNA	O
after	O
migration	O
into	O
the	O
nucleus	O
.	O

The	O
likelihood	O
ratios	O
for	O
different	O
values	O
of	O
the	O
neighborhood	O
topology	O
score	O
are	O
shown	O
in	O
Figure	O
1B	O
.	O

The	O
ability	O
of	O
BHRF1	O
to	O
protect	O
MCF-Fas	O
cells	O
from	O
apoptosis	O
induced	O
by	O
various	O
stimuli	O
was	O
identical	O
to	O
that	O
of	O
Bcl-2	O
and	O
Bcl-xL	O
.	O

We	O
may	S
find	S
that	S
one	S
region	S
of	S
the	S
protein	S
is	S
required	S
for	S
embryonic	S
expression	S
and	S
another	S
for	S
adult	S
globin	S
gene	S
expression	S
.	O

Although	O
absent	O
in	O
nonexpressing	O
erythroleukemia	O
cell	O
lines	O
,	O
the	O
DNase	O
I	O
site	O
is	O
present	O
in	O
uninduced	O
myelomonocytic	O
cell	O
lines	O
and	O
is	O
not	O
changed	O
after	O
PMA	O
induction	O
.	O

These	O
data	O
suggest	S
that	S
PPARgamma	S
activation	S
may	S
play	S
a	S
role	S
in	S
monocyte	S
differentiation	S
and	S
function	S
analogous	S
to	S
its	S
well-characterized	S
role	S
in	S
adipocytes	S
.	O

Key	O
components	O
of	O
the	O
programmed	O
cell	O
death	O
pathway	O
are	O
conserved	O
between	O
Caenorhabditis	O
elegans	O
,	O
Drosophila	O
melanogaster	O
and	O
humans	O
.	O

Expression	O
of	O
v-src	O
in	O
T	O
cells	O
correlates	O
with	O
nuclear	O
expression	O
of	O
NF-kappa	O
B	O
.	O

The	O
prediction	O
schema	O
is	O
shown	O
in	O
Figure	O
2	O
.	O

First	O
,	O
clonal	O
analysis	O
revealed	O
that	O
the	O
activity	O
of	O
the	O
D-mib	O
gene	O
is	O
specifically	O
required	O
in	O
dorsal	O
cells	O
for	O
the	O
expression	O
of	O
Cut	O
at	O
the	O
wing	O
margin	O
.	O

Analysis	O
of	O
the	O
redox	O
status	O
of	O
1.3E2	O
does	O
not	O
reveal	O
any	O
difference	O
from	O
wild-type	O
70Z/3	O
.	O

Actually	O
,	O
tRNASec	O
and	O
tRNAPyl	O
have	O
unusual	O
secondary	O
structures	O
515	O
and	O
often	O
escape	O
detection	O
by	O
programs	O
without	O
special	O
consideration	O
.	O

Low	O
levels	O
of	O
c-jun	O
transcripts	O
were	O
detectable	O
in	O
untreated	O
HL-60	O
leukemic	O
cells	O
,	O
increased	O
significantly	O
by	O
6	O
h	O
,	O
and	O
reached	O
near	O
maximal	O
levels	O
by	O
24	O
h	O
of	O
exposure	O
to	O
32	O
nM	O
TPA	O
.	O

Specific	O
mRNAs	O
for	O
c-fos	O
and	O
c-jun	O
were	O
detectable	O
within	O
30	O
min	O
after	O
cell	O
activation	O
and	O
reached	O
maximal	O
levels	O
within	O
2	O
h	O
.	O

We	O
have	O
defined	O
the	O
mechanisms	O
of	O
transactivation	O
by	O
NFAT1	O
.	O

We	O
investigated	O
the	O
trophic	O
effect	O
resulting	O
from	O
activation	O
of	O
such	O
a	O
receptor	O
by	O
using	O
the	O
reporter	O
gene	O
strategy	O
.	O

NF-X2	O
,	O
which	O
contains	O
members	O
of	O
the	O
AP-1/ATF/CREB	O
families	O
of	O
transcription	O
factors	O
,	O
interacts	O
with	O
the	O
X2	O
box	O
(	O
5'-TGCGTCA-3	O
'	O
)	O
from	O
positions	O
-97	O
to	O
-91	O
in	O
the	O
DRA	O
promoter	O
.	O

Okadaic	O
acid	O
is	O
a	O
potent	O
inducer	O
of	O
AP-1	O
,	O
NF-kappa	O
B	O
,	O
and	O
tumor	O
necrosis	O
factor-alpha	O
in	O
human	O
B	O
lymphocytes	O
.	O

The	O
J	O
delta	O
1	O
segment	O
was	O
correctly	O
spliced	O
to	O
C	O
delta	O
;	O
in	O
addition	O
the	O
four	O
C	O
delta	O
exons	O
were	O
found	O
to	O
be	O
already	O
assembled	O
.	O

The	O
double	O
mutants	O
showed	O
a	O
lower	O
number	O
of	O
circulating	O
hemocytes	O
than	O
the	O
single	O
mutant	O
,	O
but	O
there	O
was	O
still	O
a	O
significant	O
increase	O
in	O
this	O
number	O
compared	O
to	O
wild	O
type	O
(	O
see	O
Figure	O
3	O
)	O
,	O
and	O
the	O
cells	O
showed	O
increased	O
clumping	O
.	O

The	O
reduction	O
in	O
gene	O
expression	O
resulted	O
from	O
the	O
ability	O
of	O
IL-10	O
to	O
suppress	O
IFN-induced	O
assembly	O
of	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
(	O
STAT	O
)	O
factors	O
to	O
specific	O
promoter	O
motifs	O
on	O
IFNalpha-	O
and	O
IFNgamma-inducible	O
genes	O
.	O

Prior	O
to	O
in	O
vivo	O
IL-2	O
administration	O
,	O
the	O
typical	O
binding	O
pattern	O
of	O
transcription	O
factors	O
in	O
PBMC	O
from	O
patients	O
resembled	O
that	O
seen	O
in	O
fresh	O
PBMC	O
from	O
healthy	O
individuals	O
.	O

THP	O
and	O
DHA	O
markedly	O
decreased	O
the	O
levels	O
of	O
TNF-alpha	O
and	O
IL-1	O
beta	O
in	O
the	O
circulation	O
of	O
mice	O
following	O
LPS	O
injection	O
.	O

In	O
contrast	O
,	O
tyrosine-phosphorylated	O
peptides	O
containing	O
Tyr374	O
or	O
Tyr396	O
did	O
not	O
interact	O
with	O
Stat3	O
or	O
block	O
Stat3	O
activation	O
.	O

Here	O
,	O
we	O
demonstrate	O
through	O
the	O
use	O
of	O
intracellular	O
staining	O
that	O
interleukin-1beta	O
(	O
IL-1beta	O
)	O
is	O
expressed	O
in	O
LCLs	O
and	O
investigate	O
the	O
influence	O
of	O
the	O
individual	O
latent	O
proteins	O
on	O
the	O
expression	O
of	O
IL-1beta	O
.	O

Direct	O
evidence	O
that	O
N-acetylcysteine	O
(	O
NAC	O
)	O
enhances	O
the	O
immune	O
response	O
of	O
peripheral	O
blood	O
T	O
cells	O
at	O
the	O
level	O
of	O
NF	O
(	O
kappa	O
)	O
B	O
is	O
presented	O
.	O

Selenoprotein	O
families	O
we	O
failed	O
to	O
detect	O
because	O
of	O
nonconserved	O
location	O
of	O
stop	O
codons	O

To	O
define	O
the	O
activation	O
of	O
the	O
STAT5	O
homologues	O
and	O
lower	O
molecular	O
weight	O
variant	O
in	O
human	O
monocytes	O
and	O
monocytes	O
differentiated	O
into	O
macrophages	O
by	O
culture	O
in	O
macrophage-CSF	O
(	O
M-CSF	O
)	O
,	O
we	O
measured	O
the	O
GM-CSF	O
induced	O
tyrosine	O
phosphorylation	O
of	O
STAT5A	O
,	O
STAT5B	O
,	O
and	O
any	O
lower	O
molecular	O
weight	O
STAT5	O
isoforms	O
.	O

Similarly	O
,	O
the	O
complexes	O
binding	O
the	O
consensus	O
AP-1	O
TRE	O
and	O
jun	O
TRE-like	O
motifs	O
in	O
cells	O
exposed	O
to	O
oxidative	O
signals	O
or	O
PHA/PMA	O
were	O
indistinguishable	O
,	O
being	O
composed	O
of	O
c-Fos	O
,	O
c-Jun	O
,	O
and	O
JunD	O
.	O

It	O
is	O
also	O
possible	S
to	S
define	S
Y	S
as	S
the	S
uniform	S
distribution	S
;	O
however	O
,	O
we	O
found	O
that	O
many	O
motifs	O
had	O
non-uniform	O
distributions	O
throughout	O
all	O
upstream	O
regions	O
of	O
the	O
genome	O
,	O
possibly	S
as	S
an	S
artifact	S
of	S
the	S
non-uniform	S
AT/CG	S
distributions	S
in	S
upstream	S
regions	S
32	O
.	O

None	O
of	O
the	O
alterations	O
observed	O
are	O
of	O
medical	O
relevance	O
.	O

BCL-6	O
,	O
a	O
POZ/zinc-finger	O
protein	O
,	O
is	O
a	O
sequence-specific	O
transcriptional	O
repressor	O
.	O

DNA	O
sequences	O
coding	O
for	O
these	O
proteins	O
,	O
P1_BF	O
through	O
P5_BF	O
,	O
were	O
manually	O
assembled	O
from	O
overlapping	O
WGS	O
sequences	O
(	O
data	O
available	O
upon	O
request	O
)	O
.	O

Finally	O
,	O
TPA	O
addition	O
to	O
monocytes	O
infected	O
with	O
HIV-1	O
inhibited	O
HIV-1	O
replication	O
,	O
as	O
determined	O
by	O
reverse	O
transcriptase	O
assays	O
,	O
in	O
a	O
concentration-dependent	O
manner	O
.	O

Thus	O
,	O
the	O
extinguishing	O
mechanism	O
is	O
effective	O
very	O
early	O
after	O
fusion	O
.	O

More	O
extensive	O
deletion	O
of	O
sequences	O
upstream	O
of	O
Cp	O
,	O
including	O
the	O
EBNA2-dependent	O
enhancer	O
,	O
resulted	O
in	O
nearly	O
complete	O
loss	O
of	O
Cp	O
activity	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
and	O
Southwestern	O
blotting	O
experiments	O
were	O
used	O
to	O
detect	O
the	O
binding	O
of	O
cellular	O
transactivation	O
factor	O
NF-KB	O
to	O
the	O
double	O
repeat-KB	O
enhancer	O
sequence	O
located	O
in	O
the	O
long	O
terminal	O
repeat	O
.	O

In	O
this	O
study	O
we	O
identified	O
a	O
sequence	O
element	O
present	O
in	O
the	O
most	O
proximal	O
region	O
located	O
between	O
bases	O
-214	O
and	O
-201	O
,	O
TTCTTCTAATTAA	O
,	O
which	O
is	O
important	O
in	O
the	O
high	O
constitutive	O
expression	O
of	O
CD20	O
in	O
mature	O
B	O
cells	O
and	O
the	O
induction	O
of	O
CD20	O
in	O
pre-B	O
cells	O
.	O

We	O
conclude	O
from	O
these	O
studies	O
that	O
the	S
phosphorylation	S
of	S
TRAF2	S
is	S
likely	S
to	S
play	S
an	S
important	S
role	S
in	S
regulating	S
signaling	S
by	S
virtue	S
of	S
its	S
ability	S
to	S
influence	S
the	S
CD40-TRAF2	S
interaction	S
.	O

A	O
differentiation-associated	O
pattern	O
of	O
BZLF1	O
expression	O
was	O
observed	O
,	O
BZ1	O
reacting	O
with	O
nuclei	O
of	O
the	O
upper	O
spinous	O
layer	O
of	O
the	O
lesion	O
.	O

Northern	O
blot	O
analysis	O
showed	O
that	O
IL-10	O
reduced	O
the	O
accumulation	O
of	O
ICAM-1	O
mRNA	O
in	O
IFN-gamma-stimulated	O
monocytes	O
.	O

In	O
this	O
study	O
we	O
examined	O
the	O
influence	O
of	O
local	O
estrogen	O
metabolism	O
on	O
the	O
differentiation	O
of	O
HL60	O
cells	O
and	O
normal	O
primitive	O
myeloid	O
progenitor	O
cells	O
.	O

Following	O
glucocorticoid	O
treatment	O
of	O
6TG1.1	O
cells	O
,	O
chromatin	O
fragmentation	O
was	O
observed	O
after	O
a	O
delay	O
of	O
24	O
h	O
.	O

Taken	O
together	O
,	O
these	O
findings	O
suggest	S
that	S
vincristine	S
resistance	S
confers	S
insensitivity	S
to	S
TPA-induced	S
differentiation	S
and	S
can	S
include	S
defects	S
in	S
PKC-mediated	S
signaling	S
events	S
and	S
induction	S
of	S
jun/fos	S
early	S
response	S
gene	S
expression	S
.	O

The	O
new	O
conserved	O
motifs	O
are	O
H-x3-L-x3-C-R-x-C-G	O
and	O
D-x3-I-h-P-x2-F-C-x2-C	O
,	O
and	O
their	S
function	S
remains	S
to	S
be	S
determined	S
.	O

Cell	O
activation	O
resulted	O
in	O
a	O
delayed	O
induction	O
of	O
STAT	O
DNA-binding	O
activity	O
,	O
which	O
was	O
sustained	O
for	O
several	O
days	O
,	O
was	O
composed	O
predominantly	O
of	O
Stat1	O
and	O
Stat3	O
,	O
and	O
was	O
blocked	O
by	O
cycloheximide	O
and	O
actinomycin	O
D	O
.	O

Evidence	O
for	O
the	O
involvement	O
of	O
Janus	O
kinase	O
3	O
and	O
interleukin-4	O
Stat	O
.	O

These	O
ROI-induced	O
effects	O
can	O
,	O
to	O
a	O
large	O
extent	O
,	O
be	O
attributed	O
to	O
the	O
activation	O
of	O
the	O
transcription	O
factor	O
NF-kappaB	O
.	O

Analyses	O
of	O
the	O
primary	O
amino	O
acid	O
sequence	O
of	O
the	O
activation	O
domain	O
predict	O
the	O
presence	O
of	O
three	O
alpha-helices	O
,	O
each	O
with	O
a	O
high	O
proportion	O
of	O
acidic	O
residues	O
.	O

PRRI	O
is	O
an	O
inducible	O
proximal	O
enhancer	O
,	O
located	O
between	O
nucleotides	O
-276	O
and	O
-244	O
,	O
which	O
contains	O
NF-kappaB	O
and	O
SRE/CArG	O
motifs	O
.	O

A	O
second	O
constraint	O
associated	O
with	O
a	O
hierarchical	O
ensemble	O
learning	O
method	O
is	O
the	O
multiplicative	O
increase	O
in	O
the	O
number	O
of	O
parameters	O
associated	O
with	O
it	O
,	O
though	O
this	S
problem	S
may	S
be	S
ameliorated	S
by	S
the	S
use	S
of	S
parameter-free	S
algorithms	S
that	S
employ	S
restricted	S
search	S
spaces	S
.	O

Besides	O
PAO	O
,	O
other	O
inhibitors	O
of	O
PTPase	O
,	O
including	O
pervanadate	O
and	O
diamide	O
,	O
also	O
blocked	O
TNF-dependent	O
NF-kappa	O
B	O
activation	O
and	O
induction	O
of	O
all	O
the	O
three	O
adhesion	O
proteins	O
.	O

In	O
a	O
converse	O
experiment	O
,	O
we	O
found	O
that	O
the	O
neur-driven	O
expression	O
of	O
D-mib	O
,	O
using	O
neurPGAL4	O
,	O
did	O
not	O
rescue	O
the	O
cuticular	O
neurogenic	O
phenotype	O
of	O
neurPGAL4/neur1F65	O
embryos	O
.	O

Therefore	O
,	O
to	O
evaluate	O
the	O
mechanism	O
of	O
TPA	O
responsiveness	O
of	O
the	O
SNE	O
motifs	O
and	O
of	O
a	O
related	O
16-bp	O
SEE	O
(	O
SRF/ETS	O
element	O
)	O
motif	O
found	O
in	O
the	O
HCMV	O
and	O
chimpanzee	O
CMV	O
MIE	O
enhancers	O
,	O
we	O
have	O
examined	O
the	O
functional	O
responses	O
and	O
protein	O
binding	O
properties	O
of	O
multimerized	O
wild-type	O
and	O
mutant	O
elements	O
added	O
upstream	O
to	O
the	O
SCMV	O
MIE	O
or	O
simian	O
virus	O
40	O
minimal	O
promoter	O
regions	O
in	O
the	O
U-937	O
,	O
K-562	O
,	O
HL-60	O
,	O
THP-1	O
,	O
and	O
Jurkat	O
cell	O
lines	O
.	O

Although	O
2	O
early	O
lytic	O
transcripts	O
,	O
BZLF1	O
and	O
BHRF1	O
,	O
were	O
also	O
detected	O
in	O
13	O
and	O
10	O
cases	O
,	O
respectively	O
,	O
the	O
lack	O
of	O
ZEBRA	O
staining	O
in	O
any	O
case	O
indicates	S
that	S
these	S
lytic	S
transcripts	S
are	S
most	S
likely	S
expressed	S
by	S
rare	S
cells	S
in	S
the	S
biopsies	S
entering	S
lytic	S
cycle	S
.	O

This	O
detection	O
suggested	S
a	S
preferential	S
activation	S
of	S
p50/c-Rel	S
in	S
medullary	S
thymocytes	S
,	O
whereas	O
p50/p65	O
was	O
present	O
in	O
both	O
cortical	O
and	O
medullary	O
regions	O
of	O
human	O
thymus	O
lobules	O
.	O

Basing	O
on	O
these	O
experiments	O
,	O
trans-cellular	O
activation	O
of	O
EBV	O
was	O
tested	O
by	O
cocultivation	O
of	O
BZLF	O
1-expressing	O
R59Z	O
activator	O
cells	O
with	O
the	O
R7-57	O
reporter	O
line	O
.	O

Differential	O
autoregulation	O
of	O
glucocorticoid	O
receptor	O
expression	O
in	O
human	O
T-	O
and	O
B-cell	O
lines	O
.	O

In	O
this	O
study	O
we	O
have	O
identified	O
the	O
peroxisome	O
proliferator-activated	O
receptor	O
(	O
PPAR	O
)	O
as	O
a	O
new	O
thyroid	O
hormone	O
receptor	O
(	O
THR	O
)	O
auxiliary	O
nuclear	O
protein	O
,	O
heterodimerizing	O
with	O
THR	O
in	O
solution	O
.	O

CTLA-4	O
engagement	O
by	O
mAbs	O
inhibits	O
,	O
while	O
CD28	O
enhances	O
,	O
IL-2	O
production	O
and	O
proliferation	O
upon	O
T	O
cell	O
activation	O
.	O

This	O
cluster	O
is	O
probably	S
an	S
artifact	S
of	S
close	S
phylogenetic	S
relationship	S
.	O

NF-AT	O
DNA	O
binding	O
can	O
be	O
reconstituted	O
in	O
vitro	O
using	O
semi-purified	O
AP1	O
proteins	O
mixed	O
with	O
cytosol	O
from	O
T	O
lymphocytes	O
.	O

Protease	O
inhibitors	O
block	O
lipopolysaccharide	O
induction	O
of	O
tissue	O
factor	O
gene	O
expression	O
in	O
human	O
monocytic	O
cells	O
by	O
preventing	O
activation	O
of	O
c-Rel/p65	O
heterodimers	O
.	O

We	O
have	O
reconstituted	O
ligand-dependent	O
activation	O
of	O
the	O
receptor	O
to	O
a	O
DNA-binding	O
form	O
by	O
using	O
the	O
dioxin	O
receptor	O
and	O
its	O
bHLH-PAS	O
partner	O
factor	O
Arnt	O
expressed	O
by	O
in	O
vitro	O
translation	O
in	O
reticulocyte	O
lysate	O
.	O

Our	O
findings	O
suggest	S
that	S
distinct	S
regulatory	S
elements	S
,	S
acting	S
somewhat	S
independently	S
of	S
each	S
other	S
,	S
control	S
expression	S
of	S
collagenase-1	S
.	O

Stimulation	O
of	O
HUVEC	O
with	O
thrombin	O
resulted	O
in	O
dose-	O
and	O
time-dependent	O
increases	O
in	O
ICAM-1	O
mRNA	O
and	O
cell	O
surface	O
expression	O
and	O
in	O
ICAM-1-dependent	O
endothelial	O
adhesivity	O
toward	O
polymorphonuclear	O
leukocytes	O
.	O

Moreover	O
,	O
this	O
domain	O
conferred	O
enhancing	O
activity	O
when	O
fused	O
to	O
the	O
Oct1	O
protein	O
,	O
which	O
by	O
itself	O
was	O
unable	O
to	O
stimulate	O
from	O
a	O
remote	O
position	O
.	O

We	O
have	O
also	O
observed	O
a	O
differential	O
expression	O
of	O
the	O
NF-YA	O
subunit	O
in	O
heme-treated	O
and	O
control	O
FLCs	O
and	O
during	O
monocyte-to-macrophage	O
differentiation	O
.	O

Duplicate	O
interactions	O
and	O
self-interactions	O
were	O
not	O
considered	O
.	O

In	O
infected	O
monocytes	O
,	O
which	O
die	O
by	O
apoptosis	O
,	O
the	O
expression	O
of	O
CREB	O
,	O
CTF	O
,	O
and	O
OTF-2	O
was	O
rather	O
suppressed	O
8	O
hours	O
after	O
infection	O
.	O

The	O
endothelium	O
plays	O
a	O
critical	O
role	O
in	O
inflammation	O
by	O
directing	O
circulating	O
leukocytes	O
into	O
extravascular	O
tissues	O
by	O
expressing	O
adhesive	O
molecules	O
for	O
leukocytes	O
[	O
e.g.	O
,	O
endothelial-leukocyte	O
adhesion	O
molecule	O
1	O
(	O
ELAM-1	O
)	O
and	O
intercellular	O
adhesion	O
molecule	O
1	O
(	O
ICAM-1	O
)	O
]	O
.	O

In	O
such	O
cells	O
,	O
DNA	O
binding	O
activity	O
of	O
NF-kappa	O
B	O
can	O
be	O
detected	O
without	O
intentional	O
stimulation	O
.	O

The	O
current	O
understanding	O
of	O
the	O
molecular	O
mechanisms	O
underlying	O
immunosenescence	O
is	O
still	O
fragmentary	O
.	O

RESULTS	O
:	O
LPS	O
increased	O
NF-kappaB	O
DNA	O
binding	O
and	O
TNF-alpha	O
release	O
in	O
human	O
monocytes	O
.	O

These	O
results	O
demonstrated	O
that	O
LPS-mediated	O
SAA	O
gene	O
induction	O
in	O
monocyte/macrophage	O
cells	O
is	O
primarily	O
due	O
to	O
the	O
induction	O
of	O
SAF	O
activity	O
.	O

c-Rel	O
is	O
a	O
target	O
of	O
pentoxifylline-mediated	O
inhibition	O
of	O
T	O
lymphocyte	O
activation	O
.	O

Using	O
reverse-transcription	O
PCR	O
differential	O
display	O
,	O
we	O
isolated	O
an	O
mRNA	O
species	O
expressed	O
in	O
IL-2-	O
but	O
not	O
IL-12-stimulated	O
NK	O
cells	O
.	O

Octamer	O
transcription	O
factors	O
and	O
the	O
cell	O
type-specificity	O
of	O
immunoglobulin	O
gene	O
expression	O
.	O

By	O
immunohistochemistry	O
,	O
p50	O
protein	O
was	O
detected	O
in	O
the	O
cytoplasm	O
and	O
nucleus	O
of	O
FDC	O
,	O
confirming	O
the	O
involvement	O
of	O
FDC	O
.	O

The	O
transcriptionally	O
active	O
factors	O
mediating	O
the	O
effect	O
of	O
the	O
HTLV-I	O
Tax	O
transactivator	O
on	O
the	O
IL-2R	O
alpha	O
kappa	O
B	O
enhancer	O
include	O
the	O
product	O
of	O
the	O
c-rel	O
proto-oncogene	O
.	O

This	O
study	O
strongly	O
suggests	S
that	S
DZA	S
may	S
be	S
a	S
potent	S
drug	S
for	S
the	S
treatment	S
of	S
diseases	S
in	S
which	S
NF-kappaB	S
plays	S
a	S
central	S
pathogenic	S
role	S
,	S
as	S
well	S
as	S
a	S
useful	S
tool	S
for	S
studying	S
the	S
regulation	S
and	S
physiological	S
functions	S
of	S
NF-kappaB	S
.	O

The	O
pAT	O
133	O
gene	O
is	O
immediately	O
induced	O
,	O
with	O
FOS-like	O
kinetics	O
,	O
in	O
human	O
T	O
cells	O
and	O
in	O
fibroblasts	O
.	O

LMP1	O
expression	O
induces	O
phenotypic	O
changes	O
resembling	O
B	O
cell	O
activation	O
,	O
such	O
as	O
cell	O
size	O
increase	O
and	O
up-regulation	O
of	O
cell	O
surface	O
activation	O
markers	O
.	O

Finally	O
,	O
both	O
PU.1	O
and	O
Spi-B	O
function	O
as	O
transcriptional	O
activators	O
of	O
the	O
immunoglobulin	O
light-chain	O
enhancer	O
E	O
lambda	O
2.4	O
when	O
coexpressed	O
with	O
Pip	O
(	O
PU.1-interaction	O
partner	O
)	O
in	O
NIH-3T3	O
cells	O
.	O

Antibodies	O
against	O
the	O
NF-kappa	O
B	O
and	O
Rel	O
proteins	O
and	O
UV	O
cross-linking	O
studies	O
revealed	O
the	O
presence	O
of	O
c-Rel	O
and	O
p65	O
and	O
the	O
absence	O
of	O
p50	O
in	O
the	O
TF	O
complex	O
and	O
further	O
showed	O
that	O
c-Rel/p65	O
heterodimers	O
selectively	O
bound	O
to	O
the	O
TF	O
kappa	O
B-like	O
site	O
.	O

Control	O
of	O
IL-5	O
production	O
may	S
be	S
effective	S
for	S
the	S
management	S
of	S
allergic	S
diseases	S
.	O

However	O
,	O
both	O
of	O
them	O
did	O
not	O
apply	O
their	O
methods	O
to	O
search	O
for	O
novel	O
amino	O
acids	O
.	O

IL-4	O
also	O
stimulated	O
all	O
three	O
kinases	O
and	O
substrates	O
,	O
but	O
unlike	O
in	O
immune	O
cells	O
,	O
IL-4	O
did	O
not	O
involve	O
JAK3	O
activation	O
for	O
its	O
signaling	O
in	O
colon	O
cancer	O
cell	O
lines	O
.	O

To	O
examine	O
the	O
role	O
of	O
EKLF	O
in	O
the	O
developmental	O
regulation	O
of	O
the	O
human	O
gamma-globin	O
gene	O
we	O
interbred	O
EKLF	O
heterozygotes	O
(	O
+/-	O
)	O
with	O
mice	O
harboring	O
a	O
human	O
beta-globin	O
yeast	O
artificial	O
chromosome	O
transgene	O
.	O

We	O
show	O
that	O
the	O
constitutive	O
expression	O
of	O
the	O
T24	O
Ha-ras	O
oncogene	O
in	O
EBV-immortalized	O
B	O
lymphoblasts	O
was	O
associated	O
with	O
the	O
induction	O
of	O
the	O
interleukin	O
2	O
receptor	O
alpha	O
subunit	O
,	O
with	O
an	O
impaired	O
immunoglobulin	O
gene	O
expression	O
,	O
altered	O
adhesion	O
properties	O
and	O
increased	O
survival	O
in	O
serum-free	O
medium	O
.	O

We	O
have	O
biochemically	O
and	O
functionally	O
characterized	O
a	O
new	O
transcription	O
factor	O
,	O
NP-TCII	O
,	O
which	O
is	O
present	O
in	O
nuclei	O
from	O
unstimulated	O
T	O
and	O
B	O
lymphocytes	O
but	O
is	O
not	O
found	O
in	O
nonhematopoietic	O
cells	O
.	O

Using	O
immunological	O
cross-linking	O
to	O
mimic	O
receptor	O
engagement	O
by	O
natural	O
ligands	O
,	O
we	O
now	O
show	O
that	O
CD15	O
(	O
Lewis	O
X	O
)	O
,	O
a	O
monocyte	O
counter-receptor	O
for	O
endothelial	O
selectins	O
may	S
participate	S
in	S
this	S
response	S
.	O

HIV-1	O
and	O
HIV-2	O
display	O
significant	O
differences	O
in	O
nucleic	O
acid	O
sequence	O
and	O
in	O
the	O
natural	O
history	O
of	O
clinical	O
disease	O
.	O

Moreover	O
,	O
the	O
apoptotic	O
process	O
was	O
not	O
related	O
to	O
Fas-Fas	O
ligand	O
interaction	O
;	O
however	O
,	O
an	O
antagonistic	O
anti-Fas	O
MAb	O
(	O
ZB-4	O
)	O
enhanced	O
apoptosis	O
in	O
HIV-infected	O
cells	O
without	O
inducing	O
apoptosis	O
in	O
uninfected	O
cells	O
.	O

Findings	O
that	O
xenogeneic	O
serum	O
promotes	O
leukocyte-endothelium	O
interaction	O
possibly	S
through	S
NF-kappa	S
B	S
activation	S
might	S
be	S
relevant	S
for	S
designing	S
future	S
therapeutic	S
strategies	S
aimed	S
at	S
prolonging	S
xenograft	S
survival	S
.	O

Reaper	O
,	O
Hid	O
,	O
Grim	O
,	O
and	O
Diablo/Smac	O
can	O
physically	O
interact	O
with	O
IAPs	O
,	O
thereby	O
inhibiting	O
the	O
anti-apoptotic	O
activity	O
of	O
IAPs	O
and	O
allowing	O
caspase	O
activation	O
.	O

In	O
toto	O
,	O
these	O
results	O
suggest	S
that	S
TG	S
induces	S
IL-2R	S
alpha	S
in	S
human	S
T	S
cells	S
through	S
a	S
PKC-independent	S
pathway	S
.	O

Tissue	O
factor	O
expression	O
of	O
human	O
monocytes	O
is	O
suppressed	O
by	O
lysophosphatidylcholine	O
.	O

Cells	O
were	O
stimulated	O
with	O
endotoxin	O
(	O
LPS	O
,	O
100	O
ng/mL	O
)	O
with	O
and	O
without	O
human	O
IL-10	O
(	O
10	O
ng/mL	O
)	O
.	O

In	O
this	O
report	O
we	O
present	O
the	O
characterisation	O
of	O
NF-kappaB	O
subunits	O
engaged	O
in	O
complexes	O
binding	O
to	O
the	O
HIV-1	O
NF-kappaB	O
site	O
in	O
human	O
8e51	O
T-cells	O
,	O
that	O
harbour	O
a	O
defective	O
HIV-1	O
.	O

Cyclin	O
A	O
was	O
observed	O
after	O
4	O
days	O
of	O
costimulation	O
with	O
anti	O
CD2	O
+	O
CD28	O
whereas	O
stimulation	O
by	O
anti	O
CD2	O
or	O
anti	O
CD28	O
alone	O
was	O
not	O
effective	O
.	O

In	O
addition	O
,	O
binding	O
studies	O
with	O
(	O
3H	O
)	O
dexamethasone	O
have	O
been	O
performed	O
to	O
determine	O
the	O
dissociation	O
constant	O
(	O
Kd	O
)	O
and	O
receptor	O
numbers	O
(	O
Ro	O
)	O
in	O
the	O
monocytes	O
of	O
these	O
two	O
groups	O
of	O
subjects	O
.	O

This	O
site	O
is	O
conserved	O
among	O
isolates	O
of	O
HIV-2	O
and	O
the	O
closely	O
related	O
simian	O
immunodeficiency	O
virus	O
,	O
and	O
transfection	O
assays	O
show	O
this	O
site	O
to	O
mediate	O
HIV-2	O
enhancer	O
activation	O
following	O
stimulation	O
of	O
monocytic	O
but	O
not	O
T-cell	O
lines	O
.	O

We	O
observed	O
in	O
the	O
present	O
study	O
that	O
lysoPC	O
(	O
1	O
to	O
10	O
micromol/L	O
)	O
dose-dependently	O
reduced	O
TF	O
activity	O
in	O
human	O
monocytes	O
,	O
as	O
elicited	O
by	O
lipopolysaccharide	O
(	O
LPS	O
)	O
.	O

True	O
positive	O
rate	O
versus	O
false	O
positive	O
rate	O
for	O
different	O
estimated	O
posterior	O
odds	O
ratios	O
.	O

The	O
integration	O
of	O
diverse	O
genomic	O
features	O
has	O
also	O
been	O
useful	O
in	O
the	O
investigation	O
of	O
the	O
related	O
but	O
broader	O
problem	O
of	O
predicting	O
protein-protein	O
associations	O
as	O
well	O
as	O
complex	O
and	O
pathway	O
membership	O
(	O
see	O
for	O
example	O
45	O
)	O
.	O

Anti-rheumatic	O
compound	O
aurothioglucose	O
inhibits	O
tumor	O
necrosis	O
factor-alpha-induced	O
HIV-1	O
replication	O
in	O
latently	O
infected	O
OM10.1	O
and	O
Ach2	O
cells	O
.	O

It	O
was	O
previously	O
demonstrated	O
that	O
stimulation	O
of	O
monocytic	O
cells	O
with	O
either	O
LPS	O
or	O
LAMPf	O
led	O
to	O
a	O
series	O
of	O
common	O
downstream	O
signaling	O
events	O
,	O
including	O
the	O
activation	O
of	O
protein	O
tyrosine	O
kinase	O
and	O
of	O
mitogen-activated	O
protein	O
kinase	O
cascades	O
.	O

IL-2	O
gene	O
transcription	O
is	O
affected	O
by	O
several	O
nuclear	O
proteins	O
.	O

On	O
the	O
basis	O
of	O
these	O
observations	O
,	O
it	O
has	O
been	O
proposed	S
that	S
reactivation	S
of	S
latent	S
HIV-1	S
harbored	S
in	S
chronically	S
infected	S
T	S
lymphocytes	S
,	S
monocytes	S
,	S
or	S
macrophages	S
plays	S
an	S
important	S
role	S
in	S
the	S
pathogenesis	S
of	S
AIDS	S
.	O

However	O
,	O
the	O
transcription	O
and	O
synthesis	O
of	O
interleukin	O
2	O
and	O
other	O
delayed	O
early	O
cytokines	O
were	O
markedly	O
attenuated	O
by	O
BCL-2	O
.	O

Likewise	O
,	O
enhanced	O
expression	O
of	O
exogenous	O
c-erbA/TR-alpha	O
in	O
erythroblasts	O
rendered	O
them	O
susceptible	O
to	O
modulation	O
of	O
differentiation	O
by	O
T3	O
,	O
suggesting	S
a	S
similar	S
function	S
of	S
both	S
receptors	S
.	O

Promoter	O
analysis	O
revealed	O
that	O
a	O
GATA	O
site	O
in	O
a	O
cryptic	O
promoter	O
in	O
the	O
second	O
intron	O
was	O
essential	O
and	O
sufficient	O
for	O
the	O
TAL1-	O
and	O
LMO-dependent	O
transcriptional	O
activation	O
,	O
and	O
GATA3	O
binds	O
to	O
this	O
site	O
.	O

The	O
mitogenic	O
combination	O
of	O
anti	O
CD2	O
+	O
anti	O
CD28	O
released	O
the	O
footprint	O
as	O
cells	O
were	O
committed	O
to	O
proliferation	O
.	O

V3	O
loop	O
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
suppresses	O
interleukin	O
2-induced	O
T	O
cell	O
growth	O
[	O
published	O
erratum	O
appears	O
in	O
AIDS	O
Res	O
Hum	O
Retroviruses	O
1997	O
May	O
1	O
;	O
13	O
(	O
7	O
)	O
:633	O
]	O

Accordingly	O
,	O
we	O
selected	O
a	O
prior	O
odds	O
ratio	O
of	O
interaction	O
of	O
1/400	O
which	O
is	O
similar	O
to	O
current	O
estimates	O
for	O
yeast	O
and	O
is	O
probably	S
still	S
quite	S
conservative	S
.	O

This	O
is	O
most	O
likely	S
due	S
to	S
the	S
fact	S
that	S
the	S
localization-derived	S
negative	S
trained	S
predictor	S
can	S
not	S
take	S
full	S
advantage	S
of	S
the	S
Transitive	S
module	S
,	O
since	O
the	O
network	O
resulting	O
from	O
the	O
predictions	O
of	O
the	O
Group	O
A	O
modules	O
likely	S
does	S
not	S
sample	S
the	S
whole	S
protein	S
pair	S
space	S
well	S
.	O

STAT1	O
and	O
STAT2	O
or	O
STAT1	O
and	O
STAT3	O
translated	O
in	O
reticulocyte	O
lysate	O
spontaneously	O
form	O
heterocomplexes	O
when	O
the	O
translation	O
lysates	O
are	O
mixed	O
at	O
0	O
degrees	O
C	O
.	O

Pentoxifylline	O
,	O
a	O
trisubstituted	O
xanthine	O
derivative	O
,	O
has	O
been	O
used	O
to	O
decrease	O
blood	O
viscosity	O
and	O
is	O
reasonably	O
well	O
tolerated	O
by	O
most	O
recipients	O
of	O
the	O
drug	O
.	O

The	O
plasmids	O
carrying	O
multiple	O
copies	O
of	O
the	O
P	O
sequence	O
showed	O
higher	O
responsiveness	O
to	O
the	O
stimulation	O
.	O

Plasma	O
18-hydroxycorticosterone	O
was	O
also	O
significantly	O
(	O
P	O
less	O
than	O
0.025	O
)	O
lower	O
(	O
PIH	O
,	O
1071	O
+/-	O
149	O
pmol/L	O
;	O
controls	O
,	O
1907	O
+/-	O
318	O
pmol/L	O
)	O
.	O

Despite	O
these	O
similar	O
mRNA	O
levels	O
,	O
BCL-6	O
protein	O
expression	O
was	O
threefold	O
to	O
34-fold	O
higher	O
in	O
germinal	O
center	O
B	O
cells	O
than	O
in	O
resting	O
B	O
cells	O
,	O
suggesting	S
that	S
BCL-6	S
protein	S
levels	S
are	S
controlled	S
by	S
translational	S
or	S
posttranslational	S
mechanisms	S
.	O

Terminal	O
differentiation	O
of	O
the	O
leukemic	O
cell	O
lines	O
U-937	O
and	O
HL-60	O
by	O
12-O-tetradecanoylphorbol-13-acetate	O
is	O
accompanied	O
by	O
marked	O
changes	O
in	O
gene	O
expression	O
.	O

After	O
treatment	O
of	O
APL	O
cells	O
with	O
AM580	O
either	O
alone	O
or	O
in	O
combination	O
with	O
granulocyte	O
colony-stimulating	O
factor	O
(	O
G-CSF	O
)	O
,	O
the	O
compound	O
induces	O
granulocytic	O
maturation	O
,	O
as	O
assessed	O
by	O
determination	O
of	O
the	O
levels	O
of	O
leukocyte	O
alkaline	O
phosphatase	O
,	O
CD11b	O
,	O
CD33	O
,	O
and	O
G-CSF	O
receptor	O
mRNA	O
,	O
at	O
concentrations	O
that	O
are	O
10-	O
to	O
100-fold	O
lower	O
than	O
those	O
of	O
ATRA	O
necessary	O
to	O
produce	O
similar	O
effects	O
.	O

topoisomerases	O
I	O
and	O
II	O
)	O
in	O
nuclear	O
extracts	O
was	O
measured	O
using	O
a	O
PBR	O
322-relaxation-assay	O
.	O

Altogether	O
,	O
the	O
data	O
provide	O
the	O
evidence	O
that	O
both	O
pathways	O
complement	O
each	O
other	O
in	O
regulating	O
gene	O
expression	O
and	O
,	O
conversely	O
,	O
downregulate	O
the	O
TcR	O
transduction	O
mechanisms	O
.	O

Taken	O
together	O
,	O
these	O
findings	O
suggest	S
that	S
PWM	S
is	S
able	S
to	S
initiate	S
an	S
intracytoplasmic	S
signalling	S
cascade	S
and	S
EGR-1	S
induction	S
in	S
normal	S
human	S
B	S
cells	S
.	O

Two	O
kappa	O
B-like	O
motifs	O
at	O
positions	O
-98	O
to	O
-108	O
of	O
the	O
GM-CSF	O
promoter	O
were	O
also	O
recognized	O
but	O
with	O
much	O
lower	O
affinities	O
.	O

This	O
suggests	S
that	S
diverse	S
agents	S
thought	S
to	S
activate	S
NF-kappa	S
B	S
by	S
distinct	S
intracellular	S
pathways	S
might	S
all	S
act	S
through	S
a	S
common	S
mechanism	S
involving	S
the	S
synthesis	S
of	S
ROI	S
.	O

The	O
composition	O
of	O
NF-AT	O
protein	O
is	O
still	O
not	O
fully	O
elucidated	O
.	O

Loss-of-function	O
mutants	O
in	O
diap1	O
have	O
a	O
very	O
striking	O
early	O
embryonic	O
phenotype	O
:	O
virtually	O
all	O
cells	O
display	O
an	O
apoptotic	O
morphology	O
,	O
as	O
well	O
as	O
displaying	O
DNA	O
fragmentation	O
seen	O
by	O
TUNEL	O
labeling	O
,	O
four	O
to	O
five	O
hours	O
into	O
development	O
[	O
47,49,50	O
]	O
.	O

This	O
may	S
have	S
implications	S
for	S
pathophysiological	S
conditions	S
that	S
involve	S
the	S
upregulation	S
of	S
these	S
molecules	S
(	S
e.g	S
.	S
inflammation	S
and	S
atherosclerosis	S
)	S
.	O

We	O
postulate	O
that	O
MBP-induced	O
release	O
of	O
IL-8	O
by	O
neutrophils	O
may	S
contribute	S
to	S
the	S
pathophysiology	S
of	S
acute	S
asthma	S
and	S
other	S
inflammatory	S
lung	S
diseases	S
.	O

Others	O
,	O
such	O
as	O
the	O
general	O
transcription	O
factor	O
TBP	O
(	O
TATA-Binding	O
Protein	O
)	O
,	O
require	O
a	O
specific	O
orientation	O
and	O
will	O
only	O
function	O
if	O
bound	O
to	O
motifs	O
on	O
a	O
specific	O
DNA	O
strand	O
30	O
.	O

When	O
all	O
18	O
TPases	O
were	O
combined	O
with	O
the	O
original	O
GenBank	O
set	O
,	O
the	O
Ei	O
values	O
of	O
matches	O
between	O
RAG1s	O
and	O
the	O
Transib	O
PSSM	O
dropped	O
significantly	O
further	O
(	O
10-9–10-4	O
;	O
Table	O
1	O
)	O
.	O

Down-regulation	O
of	O
NF-kappaB	O
activation	O
is	O
known	O
to	O
inhibit	O
HIV	O
replication	O
from	O
the	O
latently	O
infected	O
cells	O
.	O

Retinoic	O
acid	O
inhibits	O
CD40	O
+	O
interleukin-4-mediated	O
IgE	O
production	O
in	O
vitro	O
.	O

We	O
previously	O
reported	O
that	O
human	O
umbilical	O
vein	O
EC	O
provide	O
costimulatory	O
signals	O
to	O
PHA-stimulated	O
PBL	O
via	O
CD2	O
:	O
lymphocyte	O
function-associated	O
Ag-3	O
and	O
an	O
unidentified	O
ligand	O
pair	O
,	O
resulting	O
in	O
a	O
three-	O
to	O
eight-fold	O
enhancement	O
of	O
IL-2	O
production	O
.	O

Nuclear	O
run-on	O
assays	O
,	O
transfection	O
studies	O
using	O
various	O
VCAM-1	O
promoter	O
reporter	O
gene	O
constructs	O
,	O
and	O
electrophoretic	O
mobility	O
shift	O
assays	O
indicated	S
that	S
NO	S
represses	S
VCAM-1	S
gene	S
transcription	S
,	S
in	S
part	S
,	S
by	S
inhibiting	S
NF-kappa	S
B	S
.	O

The	O
present	O
study	O
demonstrates	O
the	O
existence	O
of	O
kappa	O
B-specific	O
binding	O
factors	O
present	O
in	O
human	O
glial	O
astrocytes	O
that	O
differ	O
from	O
prototypical	O
NF-kappa	O
B	O
.	O

Deoxycholate	O
treatment	O
of	O
the	O
cytoplasmic	O
extract	O
prepared	O
from	O
cells	O
stimulated	O
by	O
TNF-alpha	O
in	O
the	O
presence	O
of	O
Cu2+	O
resulted	O
in	O
the	O
release	O
of	O
NF	O
kappa	O
B	O
from	O
I	O
kappa	O
B	O
alpha	O
,	O
indicating	S
that	S
Cu2+	S
interferes	S
with	S
the	S
dissociation	S
of	S
the	S
NF	S
kappa	S
B-I	S
kappa	S
B	S
complex	S
.	O

Performance	O
comparisons	O

IL-2-induced	O
beta-casein	O
expression	O
was	O
enhanced	O
by	O
dexamethasone	O
,	O
and	O
this	O
synergistic	O
effect	O
of	O
Dexamethasone	O
requires	O
the	O
sequence	O
between	O
-155	O
and	O
-193	O
in	O
the	O
beta-casein	O
promoter	O
.	O

These	O
findings	O
suggest	S
that	S
the	S
synergy	S
between	S
SLP-76	S
and	S
Vav	S
in	S
regulating	S
IL-2	S
gene	S
expression	S
reflects	S
the	S
cooperation	S
between	S
different	S
signaling	S
pathways	S
.	O

Many	O
domain–domain	O
interfaces	O
remain	O
to	O
be	O
resolved	O

In	O
the	O
CD45-negative	O
variant	O
,	O
the	O
effect	O
of	O
pervanadate	O
on	O
tyrosine	O
phosphorylation	O
was	O
globally	O
decreased	O
and	O
some	O
phosphorylated	O
substrates	O
were	O
specifically	O
missing	O
.	O

As	O
a	O
result	O
,	O
the	O
RAG1	O
core	O
is	O
split	O
into	O
separate	O
exons	O
at	O
the	O
aa	O
position	O
that	O
corresponds	O
to	O
position	O
460	O
in	O
the	O
human	O
RAG1gene	O
[	O
29,34,38	O
]	O
.	O

A	O
theoretical	O
pathway	O
of	O
transcriptional	O
regulation	O
of	O
the	O
androgen	O
receptor	O
(	O
AR	O
)	O
gene	O
is	O
via	O
a	O
cAMP	O
response	O
element	O
(	O
CRE	O
)	O
present	O
in	O
its	O
promoter	O
region	O
(	O
-508	O
to	O
-501	O
)	O
.	O

We	O
compared	O
U-937	O
cell	O
adhesion	O
and	O
adhesion	O
molecule	O
expression	O
in	O
human	O
umbilical	O
venous	O
(	O
HUVECs	O
)	O
and	O
arterial	O
(	O
HUAECs	O
)	O
endothelial	O
cells	O
exposed	O
to	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)	O
,	O
interleukin-1	O
,	O
and	O
lipopolysaccharide	O
(	O
LPS	O
)	O
.	O

A	O
single	O
point	O
assay	O
of	O
glucocorticoid	O
receptors	O
(	O
GR	O
)	O
in	O
human	O
lymphocytes	O
based	O
on	O
the	O
measurement	O
of	O
specific	O
dexamethasone	O
binding	O
has	O
been	O
developed	O
and	O
compared	O
with	O
a	O
common	O
multi-point	O
Scatchard	O
analysis	O
.	O

All	O
analyzed	O
adgf-a	O
mutant	O
larvae	O
carrying	O
the	O
SgsΔ3-GFP	O
construct	O
showed	O
normal	O
expression	O
of	O
Sgs-GFP	O
in	O
salivary	O
glands	O
(	O
Figure	O
7D	O
)	O
.	O

These	O
results	O
define	O
distinct	O
roles	O
for	O
the	O
two	O
forms	O
of	O
I	O
kappa	O
B	O
and	O
demonstrate	O
the	O
necessity	O
for	O
stringent	O
control	O
of	O
NF-kappa	O
B	O
.	O

The	S
mechanism	S
(	S
s	S
)	S
regulating	S
this	S
activation	S
remains	S
unknown	S
.	O

To	O
determine	O
whether	S
the	S
IL-10R	S
has	S
signaling	S
functions	S
similar	S
to	S
IL-6R	S
in	S
cells	S
normally	S
expressing	S
these	S
receptors	S
,	O
leukocytes	O
of	O
the	O
B-	O
,	O
T-	O
,	O
and	O
NK-cell	O
lineages	O
were	O
treated	O
with	O
either	O
cytokine	O
.	O

These	O
results	O
indicate	S
that	S
the	S
adhesion	S
of	S
RA	S
synovial	S
cells	S
to	S
matrices	S
such	S
as	S
hyaluronic	S
acid	S
through	S
CD44	S
could	S
up-regulate	S
VCAM-1	S
expression	S
and	S
VCAM-1-mediated	S
adhesion	S
to	S
T	S
cells	S
,	S
which	S
might	S
in	S
turn	S
cause	S
activation	S
of	S
T	S
cells	S
and	S
synovial	S
cells	S
in	S
RA	S
synovitis	S
.	O

We	O
used	O
the	O
mutation	O
crqKG01679	O
,	O
caused	O
by	O
a	O
P-element	O
insertion	O
in	O
the	O
first	O
untranslated	O
exon	O
of	O
crq	O
,	O
which	O
leads	O
to	O
pupal	O
lethality	O
.	O

Transcripts	O
of	O
mouse	O
AML1/PEBP2	O
alpha	O
B	O
were	O
also	O
detected	O
in	O
day	O
12	O
fetal	O
hematopoietic	O
liver	O
and	O
in	O
the	O
bone	O
marrow	O
cells	O
of	O
newborn	O
mice	O
.	O

Reactivation	O
of	O
Kaposi	O
's	O
sarcoma-associated	O
herpesvirus	O
infection	O
from	O
latency	O
by	O
expression	O
of	O
the	O
ORF	O
50	O
transactivator	O
,	O
a	O
homolog	O
of	O
the	O
EBV	O
R	O
protein	O
.	O

Mutants	O
in	O
Toll	O
signaling	O
pathway	O
were	O
obtained	O
from	O
Dr.	O
S.	O
Govind	O
:	O
cactE8	O
,	O
cactIIIG	O
,	O
and	O
cactD13	O
mutations	O
in	O
the	O
cact	O
gene	O
on	O
Chromosome	O
II	O
.	O

Correlations	O
were	O
found	O
between	O
plasma	O
IFN	O
alpha	O
and	O
receptor	O
Kd	O
on	O
monocytes	O
of	O
AIDS-GR	O
(	O
r	O
=	O
0.77	O
)	O
and	O
between	O
IFN	O
alpha	O
and	O
plasma	O
cortisol	O
in	O
the	O
same	O
group	O
(	O
r	O
=	O
0.74	O
)	O
.	O

Thus	O
,	O
depending	O
on	O
the	O
cellular	O
environment	O
,	O
the	O
short-	O
and	O
long-term	O
effects	O
of	O
Tax	O
expression	O
can	S
be	S
quite	S
different	S
.	O

Radiolabeled	O
hormone/receptor	O
complexes	O
of	O
nuclei	O
isolated	O
from	O
cells	O
exposed	O
for	O
3	O
h	O
to	O
radiolabeled	O
hormone	O
--	O
in	O
contrast	O
to	O
identical	O
experiments	O
with	O
intact	O
cells	O
--	O
did	O
not	O
disappear	O
from	O
the	O
nuclear	O
compartment	O
upon	O
incubation	O
of	O
nuclei	O
with	O
identical	O
concentrations	O
of	O
the	O
unlabeled	O
compound	O
.	O

In	O
some	O
circumstances	O
,	O
it	O
is	O
more	O
informative	O
to	O
use	O
partial	O
ROC	O
curves	O
(	O
ROCn	O
curves	O
)	O
which	O
illustrate	O
the	O
number	O
of	O
true	O
positives	O
identified	O
by	O
the	O
predictor	O
that	O
score	O
higher	O
than	O
the	O
n	O
highest	O
scoring	O
negatives	O
,	O
plotted	O
for	O
all	O
values	O
from	O
0	O
to	O
n	O
.	O

Dimerization	O
of	O
NF-KB2	O
with	O
RelA	O
(	O
p65	O
)	O
regulates	O
DNA	O
binding	O
,	O
transcriptional	O
activation	O
,	O
and	O
inhibition	O
by	O
an	O
I	O
kappa	O
B-alpha	O
(	O
MAD-3	O
)	O
.	O

The	O
v-erb	O
A	O
oncogene	O
of	O
avian	O
erythroblastosis	O
virus	O
is	O
a	O
mutated	O
and	O
virally	O
transduced	O
copy	O
of	O
a	O
host	O
cell	O
gene	O
encoding	O
a	O
thyroid	O
hormone	O
receptor	O
.	O

In	O
this	O
study	O
,	O
we	O
focus	O
on	O
theoretical	O
ORFs	O
with	O
one	O
inframe	O
stop	O
codon	O
,	O
termed	O
``	O
interrupted	O
ORFs	O
''	O
(	O
iORFs	O
)	O
(	O
Figure	O
1a	O
)	O
.	O

In	O
both	O
transformed	O
and	O
normal	O
lymphocytes	O
,	O
OKA	O
stimulation	O
induced	O
intense	O
phosphorylation	O
of	O
the	O
constitutively	O
expressed	O
Sp1	O
protein	O
in	O
the	O
nucleus	O
,	O
a	O
property	O
of	O
OKA	O
not	O
shared	O
by	O
TNF	O
,	O
phorbol	O
ester	O
,	O
or	O
PHA	O
and	O
interleukin	O
2	O
.	O

By	O
searching	O
protein	O
Ag	O
for	O
clusters	O
of	O
amino	O
acids	O
containing	O
cysteine	O
and	O
two	O
of	O
the	O
other	O
amino	O
acids	O
we	O
were	O
able	O
to	O
predict	O
17	O
out	O
of	O
23	O
empirically	O
known	O
T-cell	O
determinants	O
in	O
the	O
Ag	O
with	O
a	O
relatively	O
low	O
number	O
of	O
false	O
(	O
positive	O
)	O
predictions	O
.	O

The	O
molecular	O
mechanism	O
underlying	O
IL-2	O
transcriptional	O
blockade	O
in	O
anergic	O
T	O
cell	O
clones	O
is	O
not	O
fully	O
understood	O
.	O

In	O
order	O
to	O
study	O
CD14	O
gene	O
regulation	O
,	O
the	O
human	O
CD14	O
gene	O
was	O
cloned	O
from	O
a	O
partial	O
EcoRI	O
digested	O
chromosome	O
5	O
library	O
.	O

The	O
experimental	O
interactions	O
were	O
filtered	O
to	O
only	O
include	O
interactions	O
with	O
exactly	O
two	O
partners	O
(	O
see	O
Methods	O
)	O
.	O

Transcription	O
factor	O
requirements	O
for	O
U2	O
snRNA-encoding	O
gene	O
activation	O
in	O
B	O
lymphoid	O
cells	O
.	O

Copyright	O
1999	O
Academic	O
Press	O
.	O

After	O
4	O
hours	O
,	O
IL-1	O
beta	O
and	O
IL-8	O
concentration	O
of	O
the	O
cell-free	O
supernatant	O
had	O
increased	O
by	O
268	O
+/-	O
36	O
%	O
and	O
210	O
+/-	O
7	O
%	O
,	O
respectively	O
,	O
and	O
cellular	O
MCP-1	O
content	O
had	O
increased	O
by	O
170	O
+/-	O
8	O
%	O
.	O

Therefore	O
,	O
we	O
additionally	O
investigated	O
other	O
transcription	O
factors	O
of	O
possible	S
importance	S
such	O
as	O
CREB	O
,	O
CTF	O
,	O
OTF-1	O
,	O
and	O
OTF-2	O
.	O

Hence	O
,	O
induction	O
of	O
cell	O
surface	O
expression	O
of	O
this	O
leukocyte	O
adhesion	O
molecule	O
by	O
tumor	O
necrosis	O
factor	O
(	O
TNF	O
)	O
-alpha	O
was	O
reduced	O
by	O
40	O
%	O
in	O
the	O
presence	O
of	O
CsA	O
,	O
and	O
this	O
was	O
reflected	O
by	O
a	O
29	O
%	O
decrease	O
in	O
neutrophil	O
adhesion	O
.	O

(	O
D–H	O
)	O
Wings	O
from	O
wild-type	O
(	O
D	O
)	O
,	O
D-mib1	O
(	O
E	O
)	O
,	O
SerRX82/Serrev6.1	O
(	O
F	O
)	O
,	O
D-mib2/D-mib4	O
(	O
G	O
)	O
,	O
and	O
UAS-D-mib2/+	O
;	O
D-mib1/D-mib2	O
flies	O
(	O
H	O
)	O
.	O

Complete	O
loss	O
of	O
zygotic	O
D-mib	O
activity	O
in	O
homozygous	O
D-mib1	O
and	O
trans-heterozygous	O
D-mib2/D-mib3	O
,	O
D-mib1/D-mib3	O
and	O
D-mib1/D-mib2	O
individuals	O
led	O
to	O
late	O
pupal	O
lethality	O
.	O

As	O
with	O
egr-3	O
,	O
expression	O
of	O
egr-2	O
was	O
blocked	O
by	O
cyclosporin	O
A	O
.	O

Collectively	O
,	O
our	O
results	O
demonstrate	O
that	O
nuclear	O
translocation	O
and	O
activation	O
of	O
NF-kappa	O
B	O
rank	O
among	O
the	O
short-term	O
cellular	O
responses	O
elicited	O
following	O
CD30	O
ligation	O
.	O

rBPI21	O
,	O
a	O
recombinant	O
N-terminal	O
fragment	O
of	O
human	O
bactericidal/permeability-increasing	O
protein	O
(	O
BPI	O
)	O
,	O
inhibited	O
LPS-induced	O
E-selectin	O
expression	O
when	O
added	O
at	O
the	O
same	O
time	O
as	O
,	O
and	O
up	O
to	O
6	O
h	O
after	O
,	O
LPS	O
.	O

In	O
clones	O
stably	O
overexpressing	O
hIRAK	O
a	O
weak	O
constitutive	O
activation	O
of	O
NFkappaB	O
correlated	O
with	O
a	O
low	O
basal	O
IL-2	O
production	O
which	O
was	O
enhanced	O
in	O
an	O
IL-1-dependent	O
manner	O
.	O

Of	O
the	O
four	O
pyrrolysine	O
proteins	O
detected	O
,	O
three	O
methylamine	O
methyltransferases	O
have	O
been	O
experimentally	O
confirmed	O
to	O
contain	O
pyrrolysine	O
617	O
.	O

Protein	O
phosphorylation	O
has	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
these	O
two	O
factors	O
:	O
(	O
1	O
)	O
it	O
induces	O
the	O
transactivating	O
capacity	O
of	O
the	O
AP-1	O
protein	O
c-Jun	O
;	O
and	O
(	O
2	O
)	O
it	O
is	O
involved	O
in	O
the	O
release	O
of	O
the	O
cytoplasmic	O
inhibitor	O
,	O
I	O
kappa	O
B	O
,	O
from	O
NF-kappa	O
B	O
,	O
allowing	O
translocation	O
of	O
the	O
latter	O
into	O
the	O
nucleus	O
.	O

Lung	O
instillation	O
of	O
TNF-alpha	O
in	O
alveolar	O
macrophage-depleted	O
rats	O
restored	O
the	O
NF-kappaB	O
activation	O
response	O
in	O
whole	O
lung	O
.	O

Erythropoietin	O
(	O
Epo	O
)	O
,	O
the	O
primary	O
regulator	O
of	O
the	O
production	O
of	O
erythroid	O
cells	O
,	O
acts	O
by	O
binding	O
to	O
a	O
cell	O
surface	O
receptor	O
(	O
EpoR	O
)	O
on	O
erythroid	O
progenitors	O
.	O

Changes	O
in	O
these	O
signaling	O
molecules	O
during	O
cytokine	O
treatment	O
were	O
also	O
investigated	O
.	O

To	O
test	O
whether	S
the	S
correlation	S
is	S
an	S
artefact	S
of	S
the	S
distribution	S
of	S
the	S
values	S
,	O
we	O
recalculated	O
the	O
correlation	O
1000	O
times	O
,	O
each	O
time	O
shuffling	O
one	O
distribution	O
randomly	O
.	O

The	O
functional	O
significance	O
of	O
c-Rel	O
involvement	O
in	O
the	O
CD28-responsive	O
complex	O
is	O
demonstrated	O
by	O
transient	O
transfection	O
analysis	O
,	O
where	O
cotransfection	O
of	O
c-Rel	O
augments	O
the	O
level	O
of	O
expression	O
of	O
a	O
chloramphenicol	O
acetyltransferase	O
reporter	O
gene	O
linked	O
to	O
the	O
CD28-responsive	O
element	O
.	O

Using	O
RT-PCR	O
,	O
IL-1beta	O
was	O
shown	O
to	O
be	O
up-regulated	O
in	O
EBV-transformed	O
LCLs	O
as	O
well	O
as	O
in	O
group	O
III	O
Burkitt	O
's	O
lymphoma	O
(	O
BL	O
)	O
cell	O
lines	O
,	O
compared	O
with	O
group	O
I	O
BL	O
cell	O
lines	O
.	O

Taken	O
together	O
,	O
these	O
observations	O
suggest	S
that	S
HIV	S
gene	S
expression	S
may	S
be	S
activated	S
in	S
infected	S
monocytes	S
through	S
interaction	S
of	S
the	S
cells	S
with	S
complement-opsonized	S
particles	S
and	S
that	S
enhanced	S
viral	S
replication	S
is	S
associated	S
with	S
C3	S
receptor-mediated	S
nuclear	S
translocation	S
of	S
the	S
NF-kappa	S
B	S
complex	S
.	O

Thus	O
,	O
our	O
data	O
establish	O
that	O
ATF/CREB	O
factors	O
functionally	O
modulate	O
histone	O
H4	O
gene	O
transcription	O
at	O
distal	O
and	O
proximal	O
promoter	O
elements	O
.	O

Inhibition	O
of	O
HIV-1	O
latency	O
reactivation	O
by	O
dehydroepiandrosterone	O
(	O
DHEA	O
)	O
and	O
an	O
analog	O
of	O
DHEA	O
.	O

The	O
response	O
element	O
for	O
NF-AT	O
is	O
a	O
sequence	O
localized	O
between	O
-285/-254	O
in	O
the	O
IL-2	O
regulatory	O
region	O
.	O

Isolation	O
and	O
characterization	O
of	O
murine	O
fra-1	O
:	O
induction	O
mediated	O
by	O
CD40	O
and	O
surface	O
Ig	O
is	O
protein	O
kinase	O
C	O
dependent	O
.	O

Some	O
gene-gene	O
entries	O
were	O
not	O
recovered	O
in	O
the	O
conversion	O
between	O
different	O
identifiers	O
,	O
or	O
due	O
to	O
the	O
deletion	O
or	O
replacement	O
of	O
some	O
Entrez	O
Locus	O
IDs	O
.	O

While	O
most	O
of	O
the	O
cells	O
from	O
wild-type	O
larvae	O
are	O
GFP-positive	O
(	O
F	O
)	O
,	O
just	O
few	O
of	O
the	O
cells	O
from	O
late	O
third	O
instar	O
adgf-a	O
larvae	O
are	O
stained	O
by	O
GFP	O
at	O
this	O
stage	O
(	O
G	O
)	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
the	O
molecular	O
mechanism	O
by	O
which	O
agents	O
that	O
elevate	O
intracellular	O
cAMP	O
inhibit	O
the	O
expression	O
of	O
the	O
tumor	O
necrosis	O
factor	O
alpha	O
(	O
TNFalpha	O
)	O
,	O
tissue	O
factor	O
,	O
endothelial	O
leukocyte	O
adhesion	O
molecule-1	O
,	O
and	O
vascular	O
cell	O
adhesion	O
molecule-1	O
genes	O
.	O

This	O
resulted	O
in	O
concomitant	O
decrease	O
in	O
nuclear	O
NF-kappaB	O
DNA-binding	O
activity	O
and	O
endogenous	O
long	O
terminal	O
repeat	O
transcriptional	O
activity	O
.	O

In	O
S107	O
cells	O
stably	O
transfected	O
with	O
relB	O
genes	O
,	O
stimulation	O
of	O
nuclear	O
RelB	O
translocation	O
by	O
CD40	O
was	O
observed	O
.	O

Transfected	O
U937	O
cells	O
stably	O
overexpressing	O
PKC-zeta	O
displayed	O
a	O
longer	O
doubling	O
time	O
,	O
lower	O
saturation	O
density	O
at	O
confluency	O
,	O
and	O
an	O
increase	O
in	O
adherence	O
to	O
plastic	O
as	O
compared	O
to	O
control	O
cells	O
.	O

The	O
adgf-a	O
Mutant	O
Phenotype	O
Is	O
Rescued	O
by	O
Expression	O
of	O
ADGF-A	O
in	O
the	O
Lymph	O
Glands	O

Transcription	O
factor	O
NF-E2	O
is	O
crucial	O
for	O
regulation	O
of	O
erythroid-specific	O
gene	O
expression	O
.	O

This	O
inhibition	O
,	O
which	O
occurred	O
with	O
a	O
parallel	O
activation	O
of	O
c-Jun	O
transactivating	O
functions	O
and	O
expression	O
,	O
was	O
reflected	O
by	O
transfection	O
experiments	O
at	O
the	O
IL-2	O
promoter	O
level	O
,	O
and	O
involved	O
not	O
only	O
the	O
inhibition	O
of	O
NF-kappaB-driven	O
reporter	O
activation	O
but	O
also	O
that	O
of	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
(	O
NFAT	O
)	O
.	O

The	O
expression	O
and	O
activity	O
of	O
NF-kappa	O
B	O
and	O
Sp1	O
were	O
,	O
therefore	O
,	O
analyzed	O
in	O
isolated	O
T	O
cells	O
and	O
DCs	O
from	O
humans	O
and	O
mice	O
.	O

Here	O
,	O
we	O
show	O
that	O
zinc	O
addition	O
in	O
a	O
serum-	O
and	O
lipopolysaccharide-free	O
cell	O
culture	O
system	O
leads	O
to	O
significantly	O
enhanced	O
levels	O
of	O
interleukin	O
1	O
beta	O
(	O
IL-1	O
beta	O
)	O
and	O
tumour	O
necrosis	O
factor	O
alpha	O
(	O
TNF-alpha	O
)	O
and	O
to	O
expression	O
of	O
the	O
corresponding	O
mRNA	O
in	O
human	O
peripheral	O
blood	O
mononuclear	O
cells	O
(	O
PBMC	O
)	O
.	O

Binding	O
of	O
the	O
drug	O
inhibits	O
isomerase	O
activity	O
,	O
but	O
studies	O
with	O
other	O
prolyl	O
isomerase	O
inhibitors	O
and	O
analysis	O
of	O
cyclosporin-resistant	O
mutants	O
in	O
yeast	O
suggest	S
that	S
the	S
effects	S
of	S
the	S
drug	S
result	S
from	S
the	S
formation	S
of	S
an	S
inhibitory	S
complex	S
between	S
the	S
drug	S
and	S
isomerase	S
,	S
and	S
not	S
from	S
inhibition	S
of	S
isomerase	S
activity	S
.	O

In	O
this	O
group	O
,	O
however	O
,	O
receptor	O
levels	O
and	O
morning	O
plasma	O
cortisol	O
values	O
showed	O
a	O
negative	O
correlation	O
,	O
indicating	S
a	S
subtle	S
down-regulatory	S
effect	S
.	O

The	O
Transitive	O
module	O
,	O
which	O
can	O
only	O
be	O
used	O
in	O
combination	O
with	O
other	O
modules	O
,	O
increases	O
substantially	O
the	O
scores	O
and	O
number	O
of	O
interactions	O
predicted	O
.	O

In	O
transfection	O
assays	O
,	O
TRADD	O
and	O
TES2	O
synergistically	O
mediated	O
high-level	O
NF-kappaB	O
activation	O
.	O

Activation	O
of	O
primary	O
human	O
T-lymphocytes	O
through	O
CD2	O
plus	O
CD28	O
adhesion	O
molecules	O
induces	O
long-term	O
nuclear	O
expression	O
of	O
NF-kappa	O
B	O
.	O

The	O
binding	O
of	O
natural	O
or	O
synthetic	O
ligands	O
to	O
nuclear	O
receptors	O
is	O
the	O
triggering	O
event	O
leading	O
to	O
gene	O
transcription	O
activation	O
or	O
repression	O
.	O

We	O
show	O
here	O
that	O
proerythroblasts	O
and	O
mature	O
erythroid	O
cells	O
contain	O
a	O
diffusible	O
activity	O
(	O
TAG	O
)	O
capable	O
of	O
transcriptional	O
activation	O
of	O
GATA-1	O
and	O
that	O
this	O
activity	O
decreases	O
during	O
the	O
terminal	O
differentiation	O
of	O
erythroid	O
cells	O
.	O

Moreover	O
,	O
both	O
in	O
cell	O
lines	O
and	O
in	O
primary	O
leukemia	O
cells	O
that	O
are	O
resistant	O
towards	O
induction	O
of	O
apoptosis	O
by	O
DILs	O
and	O
doxorubicin	O
,	O
antagonization	O
of	O
NFkappaB	O
activity	O
partially	O
restored	O
apoptosis	O
sensitivity	O
.	O

Stimulation	O
of	O
U1	O
cells	O
by	O
LPS	O
alone	O
induced	O
minimal	O
levels	O
of	O
HIV	O
expression	O
,	O
which	O
was	O
significantly	O
enhanced	O
by	O
granulocyte-macrophage	O
colony-stimulating	O
factor	O
(	O
GM-CSF	O
)	O
.	O

Abstract	O

DNA	O
from	O
peripheral	O
blood	O
leukocytes	O
of	O
six	O
patients	O
from	O
five	O
families	O
with	O
various	O
degrees	O
of	O
androgen	O
insensitivity	O
was	O
studied	O
.	O

This	O
leads	O
to	O
significantly	O
lower	O
transcription	O
enhancement	O
by	O
sites	O
derived	O
from	O
the	O
interleukin	O
2	O
receptor	O
or	O
T-cell	O
receptor	O
genes	O
in	O
S194	O
cells	O
.	O

Different	O
cocktails	O
of	O
the	O
identified	O
ligands	O
were	O
added	O
to	O
sorted	O
CD34+Thy-1+	O
single	O
cells	O
.	O

It	O
had	O
previously	O
been	O
thought	S
that	S
ZEBRA	S
's	S
capacity	S
to	S
disrupt	S
EBV	S
latency	S
resided	S
primarily	S
in	S
its	S
ability	S
to	S
activate	S
transcription	S
of	S
genes	S
that	S
encode	S
products	S
required	S
for	S
lytic	S
replication	S
.	O

For	O
example	O
,	O
the	O
major	O
complexes	O
in	O
yeast	O
have	O
been	O
predicted	O
by	O
this	O
strategy	O
25	O
.	O

There	O
was	O
,	O
however	O
,	O
a	O
significant	O
difference	O
in	O
the	O
amounts	O
of	O
the	O
nuclear	O
protein	O
,	O
REF-1	O
(	O
which	O
regulates	O
AP-1	O
DNA	O
binding	O
by	O
altering	O
the	O
redox	O
status	O
of	O
FOS	O
and	O
JUN	O
proteins	O
)	O
,	O
in	O
alveolar	O
macrophages	O
compared	O
with	O
monocytes	O
.	O

The	O
half-life	O
of	O
both	O
inhibitors	O
is	O
increased	O
in	O
HeLa	O
cells	O
.	O

The	O
data	O
strongly	O
suggest	S
an	S
endocrine	S
,	S
autocrine	S
and/or	S
paracrine	S
role	S
for	S
calcitriol	S
in	S
immune	S
regulation	S
.	O

p60	O
was	O
purified	O
from	O
CESS	O
cells	O
and	O
peptide	O
microsequencing	O
of	O
this	O
protein	O
revealed	O
that	O
it	O
was	O
lymphocyte-specific	O
protein	O
1	O
(	O
LSP1	O
)	O
,	O
that	O
is	O
here	O
characterized	O
as	O
the	O
most	O
prominent	O
protein	O
kinase	O
C	O
substrate	O
in	O
B	O
cells	O
.	O

Consistent	O
with	O
theses	O
results	O
,	O
nuclear	O
extracts	O
prepared	O
from	O
quiescent	O
cells	O
formed	O
a	O
specific	O
complex	O
with	O
this	O
element	O
,	O
whereas	O
extracts	O
prepared	O
from	O
cells	O
treated	O
with	O
anti	O
CD2	O
+	O
anti	O
CD28	O
failed	O
to	O
do	O
so	O
after	O
cells	O
entered	O
a	O
proliferative	O
state	O
.	O

Because	O
such	O
an	O
ORF-based	O
study	O
is	O
independent	O
from	O
the	O
tRNA	O
analysis	O
,	O
it	O
can	O
either	S
identify	S
candidate	S
organisms	S
missed	S
by	S
the	S
previous	S
study	S
or	S
strengthen	S
its	S
negative	S
conclusion	S
.	O

We	O
propose	S
that	S
the	S
hydrophobic	S
C-terminal	S
tail	S
of	S
CAML	S
forms	S
its	S
effector	S
domain	S
,	S
thus	S
implicating	S
the	S
N-terminal	S
hydrophilic	S
domain	S
in	S
a	S
regulatory	S
role	S
.	O

Moreover	O
,	O
each	O
catalytic	O
residue	O
is	O
a	O
part	O
of	O
a	O
motif	O
that	O
is	O
conserved	O
in	O
the	O
Transib	O
TPases	O
and	O
RAG1	O
(	O
motifs	O
4	O
,	O
6	O
,	O
and	O
10	O
in	O
Figures	O
3	O
and	O
Figure	O
S3	O
)	O
.	O

Transfection	O
of	O
Jurkat	O
cells	O
with	O
the	O
NF-kappaB	O
subunits	O
p50	O
and	O
p65	O
confers	O
resistance	O
against	O
Fas-mediated	O
apoptosis	O
.	O

We	O
also	O
identified	O
a	O
potent	O
inhibitory	O
sequence	O
within	O
its	O
N-terminal	O
domain	O
.	O

The	O
sea	O
urchin	O
and	O
lancelet	O
proteins	O
are	O
marked	O
by	O
“_SP”	O
and	O
“_BF”	O
following	O
the	O
identification	O
numbers	O
of	O
the	O
corresponding	O
contigs	O
.	O

The	O
results	O
showed	O
that	O
the	O
activation	O
of	O
U2	O
snRNA	O
transcription	O
in	O
B-cells	O
also	O
requires	O
an	O
enhancer	O
comprising	O
both	O
the	O
Oct	O
and	O
at	O
least	O
one	O
Sp	O
1-binding	O
site	O
.	O

Enzymatic	O
assay	O
of	O
alpha-galactosidase	O
in	O
blood	O
leucocytes	O
,	O
skin	O
fibroblasts	O
,	O
Epstein-Barr	O
virus	O
transformed	O
lymphoid	O
cell	O
lines	O
,	O
and	O
hair	O
follicles	O
of	O
the	O
twins	O
and	O
their	O
parents	O
confirmed	O
the	O
heterozygous	O
status	O
of	O
the	O
twins	O
and	O
indicated	S
that	S
Fabry	S
disease	S
had	S
occurred	S
as	S
a	S
result	S
of	S
a	S
de	S
novo	S
mutation	S
.	O

Northern	O
blot	O
experiments	O
demonstrate	O
further	O
that	O
TCF-1	O
alpha	O
mRNA	O
is	O
highly	O
tissue	O
specific	O
,	O
found	O
primarily	O
in	O
the	O
thymus	O
or	O
T	O
cell	O
lines	O
.	O

Third	O
,	O
unlike	O
in	O
the	O
case	O
of	O
Transib	O
transposons	O
,	O
TIRs	O
of	O
hAT	O
transposons	O
are	O
different	O
from	O
RSS	O
both	O
in	O
terms	O
of	O
DNA	O
sequence	O
similarities	O
and	O
their	O
conservation	O
patterns	O
(	O
Figure	O
S7	O
)	O
.	O

In	O
order	O
to	O
elucidate	O
possible	S
mechanisms	S
underlying	S
endothelial	S
cell	S
activation	S
by	S
xenogeneic	S
serum	S
,	O
we	O
focussed	O
on	O
transcription	O
factor	O
NF-kappa	O
B	O
,	O
a	O
central	O
regulator	O
for	O
the	O
induction	O
of	O
different	O
genes	O
,	O
including	O
adhesive	O
molecules	O
and	O
chemoattractants	O
.	O

From	O
these	O
results	O
,	O
we	O
can	S
conclude	S
that	S
electrostatic	S
interactions	S
of	S
retinoids	S
with	S
the	S
RAR	S
alpha-LBD	S
play	S
a	S
significant	S
role	S
in	S
ligand	S
binding	S
.	O

To	O
gain	O
a	O
rough	O
estimate	O
of	O
the	O
false	O
positive	O
rate	O
due	O
to	O
this	O
assumption	O
,	O
we	O
counted	O
how	O
many	O
protein	O
pairs	O
in	O
the	O
PDB	O
contain	O
an	O
iPfam	O
domain	O
pair	O
that	O
does	O
not	O
mediate	O
an	O
interaction	O
in	O
one	O
complex	O
structure	O
but	O
does	O
so	O
in	O
another	O
.	O

Restriction	O
analysis	O
revealed	O
that	O
neutrophils	O
express	O
the	O
GH-N	O
gene	O
but	O
not	O
the	O
GH-V	O
gene	O
.	O

Similarly	O
,	O
CTL	O
raised	O
against	O
the	O
parent	O
peptide	O
did	O
not	O
recognize	O
the	O
succinimide	O
derivative	O
of	O
this	O
peptide	O
.	O

BEAM	O
and	O
SPACER	O
are	O
run	O
independently	O
;	O
PRISM	O
runs	O
on	O
the	O
top	O
100	O
motifs	O
output	O
by	O
BEAM	O
.	O

TCR	O
signaling	O
was	O
triggered	O
by	O
treating	O
Jurkat	O
T	O
cells	O
with	O
PHA	O
or	O
anti-CD3	O
Abs	O
,	O
and	O
NF-kappaB	O
activation	O
was	O
monitored	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
and/or	O
by	O
kappaB-dependent	O
reporter	O
assays	O
.	O

ML-9	O
also	O
induced	O
alpha-naphthyl	O
acetate	O
esterase	O
(	O
ANAE	O
)	O
activity	O
,	O
another	O
monocytic	O
differentiation	O
marker	O
,	O
more	O
rapidly	O
than	O
VD3	O
.	O

Each	O
of	O
these	O
three	O
genes	O
can	O
induce	O
programmed	O
cell	O
death	O
when	O
overexpressed	O
in	O
the	O
developing	O
Drosophila	O
eye	O
or	O
in	O
various	O
tissue-culture	O
assays	O
.	O

At	O
the	O
most	O
proximal	O
P0	O
site	O
,	O
NFAT-containing	O
complexes	O
devoid	O
of	O
NFAT2	O
were	O
readily	O
inducible	O
in	O
the	O
Th1	O
clones	O
,	O
but	O
hardly	O
or	O
not	O
in	O
the	O
Th2	O
clones	O
.	O

Northern	O
blot	O
analysis	O
of	O
polyadenylated	O
RNA	O
purified	O
from	O
activated	O
human	O
B	O
cells	O
revealed	O
a	O
single	O
mRNA	O
transcript	O
of	O
approximately	O
2.3	O
kb	O
.	O

However	O
,	O
the	O
value	O
of	O
the	O
likelihood	O
ratio	O
it	O
contributes	O
is	O
below	O
20	O
for	O
over	O
50	O
%	O
of	O
protein	O
pairs	O
in	O
the	O
LR400	O
dataset	O
(	O
which	O
means	O
that	O
for	O
these	O
protein	O
pairs	O
,	O
the	O
Combined	O
module	O
must	O
be	O
used	O
in	O
combination	O
with	O
other	O
modules	O
to	O
achieve	O
a	O
total	O
likelihood	O
ratio	O
above	O
400	O
)	O
.	O

In	O
addition	O
,	O
monocytes	O
and	O
IFN-U937	O
cells	O
both	O
responded	O
to	O
red	O
cells	O
sensitized	O
with	O
antibodies	O
against	O
a	O
variety	O
of	O
specificities	O
of	O
assumed	S
(	S
although	S
not	S
documented	S
)	S
clinical	S
significance	S
for	S
blood	S
transfusion	S
recipients	S
.	O

The	O
c-jun	O
mRNA	O
,	O
which	O
is	O
constitutively	O
expressed	O
in	O
human	O
peripheral-blood	O
monocytes	O
at	O
relatively	O
high	O
levels	O
,	O
was	O
also	O
slightly	O
augmented	O
by	O
LTB4	O
,	O
although	O
to	O
a	O
much	O
lower	O
extent	O
than	O
c-fos	O
.	O

Mobilization	O
of	O
nuclear	O
factor-kappaB	O
(	O
NF-kappaB	O
)	O
activates	O
transcription	O
of	O
genes	O
encoding	O
endothelial	O
adhesion	O
molecules	O
and	O
chemokines	O
that	O
contribute	O
to	O
monocyte	O
infiltration	O
critical	O
in	O
atherogenesis	O
.	O

Stop	O
codon	O
usage	O

Whether	S
endogenous	S
Neur	S
binds	S
and	S
activates	S
Ser	S
remains	O
to	O
be	O
tested	O
.	O

The	S
delayed	S
development	S
and	S
low	S
pupariation	S
rate	S
in	S
the	S
adgf-a	S
mutant	S
larvae	S
(	S
see	S
Figures	S
2A	S
and	S
7A	S
)	S
could	S
be	S
caused	S
by	S
an	S
effect	S
on	S
hormonal	S
regulation	S
of	S
development	S
.	O

These	O
results	O
imply	S
that	S
at	S
least	S
three	S
signals	S
are	S
required	S
to	S
activate	S
the	S
GM-CSF	S
proximal	S
promoter	S
,	S
and	S
that	S
the	S
signals	S
impinge	S
on	S
distinct	S
transcription	S
factors	S
that	S
bind	S
to	S
the	S
hCLEO	S
and	S
NF-kappa	S
B	S
regions	S
of	S
the	S
promoter	S
.	O

The	O
minimal	O
promoter	O
of	O
the	O
human	O
B29	O
gene	O
is	O
contained	O
within	O
a	O
193-bp	O
region	O
5	O
'	O
of	O
these	O
multiple	O
start	O
sites	O
.	O

Adherence	O
to	O
either	O
fibronectin	O
or	O
collagen-coated	O
plastic	O
had	O
little	O
consistent	O
effect	O
on	O
PDGF	O
(	O
B	O
)	O
mRNA	O
accumulation	O
.	O

We	O
have	O
used	O
a	O
DNA-binding/immunoprecipitation	O
assay	O
to	O
analyze	O
the	O
capacity	O
of	O
human	O
glucocorticoid	O
receptor	O
(	O
hGR	O
)	O
,	O
generated	O
in	O
rabbit	O
reticulocyte	O
lysates	O
,	O
to	O
bind	O
DNA	O
.	O

Mutations	O
affecting	O
the	O
5	O
'	O
guanine	O
residues	O
of	O
the	O
kappa	O
B	O
site	O
were	O
unable	O
to	O
compete	O
for	O
these	O
NF-kappa	O
B-related	O
proteins	O
.	O

NB4	O
cells	O
pulse-exposed	O
(	O
30	O
minutes	O
)	O
to	O
all-trans	O
retinoic	O
acid	O
(	O
ATRA	O
)	O
,	O
washed	O
,	O
and	O
cultured	O
(	O
3	O
days	O
)	O
with	O
either	O
dimethylsulfoxide	O
(	O
DMSO	O
)	O
or	O
hexamethylene	O
bisacetamide	O
(	O
HMBA	O
)	O
had	O
a	O
prominent	O
increase	O
in	O
levels	O
of	O
C/EBP	O
epsilon	O
mRNA	O
and	O
an	O
increase	O
in	O
granulocytic	O
differentiation	O
,	O
but	O
exposure	O
to	O
either	O
DMSO	O
or	O
HMBA	O
alone	O
had	O
no	O
effect	O
on	O
base	O
levels	O
of	O
C/EBP	O
epsilon	O
and	O
did	O
not	O
induce	O
differentiation	O
.	O

Measurement	O
of	O
the	O
transcriptional	O
activity	O
of	O
the	O
HIV-1	O
promoter	O
after	O
transient	O
transfection	O
of	O
the	O
HIV-1	O
provirus	O
DNA	O
or	O
of	O
long	O
terminal	O
repeat-luciferase	O
constructs	O
showed	O
a	O
positive	O
correlation	O
between	O
the	O
transcriptional	O
and	O
the	O
replication	O
defects	O
for	O
most	O
mutants	O
.	O

Up	O
to	O
date	O
,	O
the	S
biological	S
function	S
of	S
Spi-B	S
remains	S
unknown	S
.	O

Is	O
GATA-1	O
necessary	O
for	O
globin	O
gene	O
switching	O
?	O

We	O
propose	S
a	S
model	S
in	S
which	S
binding	S
of	S
a	S
myeloid-specific	S
factor	S
(	S
PU.1	S
)	S
allows	S
a	S
general	S
factor	S
(	S
Sp1	S
)	S
to	S
bind	S
in	S
a	S
tissue-specific	S
fashion	S
thereby	S
contributing	S
to	S
the	S
myeloid-specific	S
expression	S
of	S
CD11b	S
.	O

Furthermore	O
,	O
in	O
vitro	O
mutagenesis	O
experiments	O
demonstrated	O
that	O
inducible	O
interleukin-2	O
enhancer	O
function	O
requires	O
the	O
presence	O
of	O
either	S
EBS1	S
or	S
EBS2	S
.	O

Full-length	O
ERP	O
expresses	O
only	O
negligible	O
DNA-binding	O
activity	O
by	O
itself	O
.	O

We	O
show	O
here	O
that	O
at	O
levels	O
relevant	O
to	O
human	O
disease	O
,	O
production	O
of	O
the	O
human	O
p75TNF-R	O
in	O
transgenic	O
mice	O
results	O
in	O
a	O
severe	O
inflammatory	O
syndrome	O
involving	O
mainly	O
the	O
pancreas	O
,	O
liver	O
,	O
kidney	O
,	O
and	O
lung	O
,	O
and	O
characterized	O
by	O
constitutively	O
increased	O
NF-kappaB	O
activity	O
in	O
the	O
peripheral	O
blood	O
mononuclear	O
cell	O
compartment	O
.	O

By	O
dividing	O
the	O
search	O
space	O
into	O
tractable	O
domains	O
,	O
SCOPE	O
mitigates	O
the	O
potential	O
liabilities	O
associated	O
with	O
ensemble	O
methods	O
,	O
resulting	O
in	O
a	O
program	O
that	O
is	O
capable	O
of	O
finding	O
cis-regulatory	O
elements	O
of	O
arbitrary	O
length	O
,	O
degree	O
of	O
degeneracy	O
,	O
motif	O
orientation	O
and	O
frequency	O
of	O
occurrence	O
.	O

Results	O

In	O
studies	O
initiated	O
to	O
evaluate	O
relationships	O
between	O
EBV	O
latent	O
genes	O
and	O
p53	O
,	O
p53	O
levels	O
were	O
found	O
to	O
increase	O
approximately	O
10-fold	O
4	O
to	O
5	O
days	O
after	O
EBV	O
infection	O
of	O
purified	O
resting	O
human	O
B	O
cells	O
;	O

Here	O
,	O
we	O
describe	O
the	O
effect	O
of	O
383-bp	O
(	O
delta383	O
)	O
and	O
99-bp	O
(	O
delta99	O
)	O
sequences	O
containing	O
the	O
PYBF-binding	O
site	O
on	O
transcription	O
from	O
various	O
globin	O
and	O
non-globin	O
promoters	O
,	O
using	O
a	O
transient	O
assay	O
with	O
the	O
cat	O
reporter	O
gene	O
in	O
murine	O
erythroleukemia	O
(	O
MEL	O
)	O
cells	O
,	O
a	O
cell	O
line	O
with	O
abundant	O
PYBF	O
activity	O
.	O

Remarkably	O
,	O
these	O
two	O
drugs	O
inhibit	O
each	O
other	O
's	O
actions	O
,	O
raising	S
the	S
possibility	S
that	S
both	S
act	S
by	S
means	S
of	S
a	S
common	S
immunophilin	S
(	S
immunosuppressant	S
binding	S
protein	S
)	S
.	O

Glucocorticoid	O
receptors	O
were	O
investigated	O
in	O
a	O
whole	O
cell	O
dexamethasone	O
binding	O
assay	O
in	O
mononuclear	O
leukocytes	O
.	O

After	O
short-term	O
,	O
in	O
vitro	O
exposure	O
to	O
therapeutical	O
levels	O
,	O
distinct	O
changes	O
in	O
P-glycoprotein	O
,	O
steroid	O
receptors	O
,	O
p53	O
and	O
Bcl-2	O
expression	O
take	O
place	O
.	O

